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How it all began 
Preface: how it all began 
When I practised as a veterinary surgeon it occurred to me that I often spent more 
time listening to the personal problems of the owner than treating their pets. 
Although I was not trained to be a human physician or psychiatrist. I felt that 
I failed in my duty. Consequently, in the evenings I took psychology classes and 
I became fascinated by one specific book, the Modern Synopsis of the 
Comprehensive Textbook of Psychiatry by Kaplan and Sadock. I was puzzled by 
the fact that in the human psychiatric diagnostic procedure it seemed to be 
common practice to start a therapy - of course after making an inventory of 
symptoms and their impact on everyday life - without a search for a cause. How 
totally different that was from what I had learned as a vet. 
According to my veterinary medical education it was considered malpractice 
to start a therapy without at least trying to find a cause of the problems. This 
golden standard - first making an inventory of symptoms, then a search for the 
cause of the symptoms (i.e. differential diagnostic research), and finally starting a 
therapy specifically aimed at eliminating the cause - is common practice in both 
veterinary and human somatic medicine. Still, I now was dealing with psychiatric 
conditions. Could it be, so I pondered on this issue, that psychiatric diagnostic 
rules did not correspond to somatic diagnostic rules? 
On the other hand, although we had not yet unravelled the mysteries of the 
brain, it is an organ like other organs, so there should be a cause to find in case 
of malfunction, even in psychiatric disorders. What did psychiatric researchers 
focus on to resolve this problem, I wondered. I remembered treating a little dog 
suffering from fly catcher's syndrome, compulsively trying to catch imaginary flies. 
Definitely mad. This dog happened to suffer from eczema as well and I prescribed 
a restricted elimination diet, an effective treatment of eczema in veterinary practice 
in many patients. What happened following a 6-week period of diet was striking: 
the dog trotted into the surgery without a twitch or snatch, the owner following 
with a big smile on his face. I was astounded to find that not only the eczema had 
vanished but also the fly catching. What a strange and puzzling coincidence it 
seemed to be at the time, but now I wondered whether there might have been a 
connection between the somatic and the psychiatric problems of the little dog. 
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Preface and Fidgety Philip 
Several weeks later I happened to hit upon a study investigating the effects of 
a restricted elimination diet on ADHD in children. Reading it I got truly interested, 
I searched for more literature on this subject, thought about the little mad dog and 
I kept on reading. That was how I spent my evenings, reading, writing, thinking 
and rethinking, with my children fast asleep. I discovered that the answers to my 
questions inevitably led to even more questions and I enjoyed it to the full. I 
realised I had found my future: science. You may find the results of my thoughts 
and research in this thesis, and I would highly recommend chapters 1, 8 and 9, 
which in particular comprise the results of my considerations on the cause of 
ADHD. 
10 
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The Story of Fidgety Philip 
A poem by Dr Heinrich Hoffman, a German physician, published in 1845 
"Let me see if Philip can 
Be a little gentleman: 
Let me see if he is able 
To sit still for once at table": 
Thus Papa bade Phil behave: 
And Mamma looked very grave 
But fidgety Phil, 
He won't sit still; 
He wriggles, 
And giggles, 
And then, I declare, 
Swings backwards and forwards. 
And tilts up his chair, 
Just like any rocking horse— 
"Philip! I am getting cross!" 
11 
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See the naughty, restless child 
Growing still more rude and wild. 
Till his chair falls over quite, 
Philip screams with all his might. 
Catches at the cloth, but then 
That makes matters worse again. 
Down upon the ground they fall. 
Glasses, plates, knives, forks, and all. 
How Mamma did fret and frown, 
When she saw them tumbling down! 
And Papa made such a face! 
Philip is in sad disgrace. 
12 
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Where is Philip, where is he? 
Fairly covered up you see! 
Cloth and all are lying on him; 
He has pulled down all upon him. 
What a terrible to-do! 
Dishes, glasses, snapt in two! 
Here a knife, and there a fork! 
Philip, this is cruel work. 
Table all so bare, and ah! 
Poor Papa, and poor Mamma 
Look quite cross, and wonder how 
They shall have their dinner now 
13 
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Introduction 
In this general introduction a description is given of Attention-Deficit/Hyperactivity 
Disorder (ADHD) and ADHD Not Otherwise Specified (ADHD-NOS), of comorbid 
disorders often identified in children with ADHD, of the impact of ADHD on child 
and society, and of the aetiology, i.e. the genetic and environmental factors 
involved in ADHD, Subsequently, this introduction elaborates on one specific 
environmental risk factor of ADHD, i.e. food, on studies eliminating or 
supplementing food constituents like additives and fatty acids, on restricted 
elimination diet studies, on the current assessment and therapy of ADHD, and on 
the role of food in the current therapeutic approach of ADHD. Finally, the aim of 
this thesis, i.e. the relationship between ADHD and food in coherence with the 
objectives of each of the six studies involved, will be explained. 
1.1 ADHD 
1.1.1. From MBDto ADHD 
The first description of hyperactive and ungovernable child behaviour was 
published in 1845, in a book written by Dr Heinrich Hoffman, a German physician.' 
This illustrated booklet comprised a series of 10 different poems, mostly about 
children showing inappropriate behaviour. Especially the poem about "Fidgety 
Philip" became well known, not only in Germany but throughout Europe,2 although 
of course we do not know whether little Philip suffered from ADHD or whether he 
just choose an awkward way of telling his parents that he really disliked Brussels 
sprouts. Be that as it may, fact is that the symptoms described in the poem 
correspond with some of the ADHD symptoms described in the Diagnostic and 
Statistical Manual of Mental Disorders, fourth edition (DSM-IV).3 
The first detailed account of ADHD symptoms was given in 1902, by Dr George 
Still in a Lancet publication,4 and up to the second half of the twentieth century 
these behavioural problems were thought to be caused by organic encephalic 
lesions, indicated as minimal brain damage (MBD).5 As research showed that no 
organic neurological alterations could be detected in these children6 the phrase 
"minimal brain damage" was changed into "minimal brain dysfunction". Still, as it 
was not easy to differentiate between minimal brain dysfunction and temperament,7 
and as in fact all psychiatric disorders may be the consequence of some 
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dysfunction of the brain, the aetiological formulation of the problem, i.e. MBD, 
evolved into a more descriptive formulation, making an inventory of symptoms 
without referring to a cause. 
To date, inattention, overactivity and impulsivity symptoms are described in 
two generally accepted and overlapping concepts: Hyperkinetic Disorder, as 
described in the International Classification of Diseases (ICD),8 and Attention-
Deficit/Hyperactivity Disorder (ADHD), as described in the DSM.3 Considering 
that the studies included in this thesis were based on the DSM, the terminology 
applied in this thesis is restricted to the DSM-terminology. In the DSM-III, the first 
manual including this behavioural disorder, the symptoms were represented as 
Attention Deficit Disorder with Hyperactivity (ADDH).9 This description was not 
accepted without scrutiny10 and the question was raised whether a clinical 
diagnosis could be made using behavioural instruments." Some researchers 
preferred to refer to ADDH as ADDH-syndrome.12 Nevertheless, despite some 
resistance, to date, in 2011, the DSM-III ADDH criteria have evolved into the 
DSM-IV ADHD criteria, and are based on behavioural symptoms and the 
concurrent impairment. 
1.1.2. Diagnostic criteria 
According to the DSM-IV criteria ADHD is a psychiatric disorder characterised by 
developmentally inappropriate symptoms of inattention, impulsive behaviour and 
hyperactivity.3 In most children the behavioural problems start before the age of 5 
(frequently before the age of 2 years), and the disorder often persists into 
adolescence and adulthood.13 The ADHD symptoms comprise 18 characteristic 
features, i.e. 9 concerning inattentive behaviour and 9 concerning hyperactive/ 
impulsive behaviour. The inattentive symptoms refer to children who: 1) are often 
careless, 2) often have difficulty in sustaining attention, 3) often do not seem to 
listen, 4) often fail to finish schoolwerk, 5) often have difficulty organizing tasks, 
6) often avoid tasks that require sustained mental efforts, 7) often lose things, 8) are 
often easily distracted, 9) are often forgetful in daily activities. The hyperactive/ 
impulsive symptoms refer to children who: 1) often fidget with hands or feet, 2) often 
leave their seat when remaining seated is expected, 3) often run about or climb 
excessively, 4) often find it difficult to play quietly, 5) often act as if driven by a motor, 
6) often talk excessively, 7) often blurt out answers before questions have been 
completed, 8) often have difficulty to await their turn, 9) often interrupt on others. 
18 
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Figure Number of a child's inattentive (I) ADHD symptoms (0-9) and hyper­
active/impulsive (H/l) ADHD symptoms (0-9), and the corresponding 
ADHD diagnosis 
D 
ι 
Q 
< 
I H I H 
max min 
ADHD 
combined 
type 
I H I H 
max min 
ADHD 
inattentive 
type 
I H I H 
max min 
ADHD 
hyperactive/ 
impulsive type 
I H I H 
max min 
Not meeting 
ADHD 
criteria 
To meet the DSM-IV-diagnostic criteria of ADHD the child has to comply with five 
conditions: 
A) the number of symptoms (see figure) 
Based on the number and kind of symptoms which must have been manifest 
for at least the last 6 months, ADHD is divided into three different types. 
1) Combined type: children who show at least 6 inattentive symptoms and at 
least 6 hyperactive/impulsive symptoms, may meet the criteria of the 
combined type. 
2) Predominantly inattentive type: children who show at least 6 inattentive 
symptoms and less than 6 hyperactive/impulsive symptoms, may meet the 
criteria for the predominantly inattentive type. 
3) Predominantly hyperactive/impulsive type: children who show at least 6 
hyperactive/impulsive symptoms and less than 6 inattentive symptoms, may 
meet the criteria for the predominantly hyperactive/impulsive type. 
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Β) the onset of symptoms 
Some symptoms that cause impairment were present before the age of 7. 
C) the manifestation of the symptoms 
Some impairment has to be present in more than one setting, i.e. at home and 
at school or at day care. 
D) the impairment caused by the symptoms 
The symptoms have to be more frequent and severe than in typically developing 
children at a comparable level of development, i.e. there must be clear 
evidence of clinically significant impairment in social and academic functioning. 
E) the absence of Pervasive Developmental Disorder (PDD) and psychotic 
disorders 
Also, the symptoms must not be better accounted for by another mental disorder 
In order to make reasonable decisions concerning ADHD, diagnostic 
thresholds, age and the impairment (e.g. at home, at school, with friends) as a 
result of the symptoms should be taken into account.14 Consequently, it is 
important to emphasize that ADHD is more than the sum of symptoms. For 
instance. Fidgety Philip definitely showed a number of ADHD symptoms. He was 
careless and did not listen, he did not follow the instructions given, he fidgeted, 
he did not remain seated, he acted like he was driven by a motor and showed 
behaviour unsuitable for the occasion. Furthermore, father and mother expected 
him to behave badly, considering the father who bade his son to behave, and the 
mother who looked grave. Still, more information about the impact of his behaviour 
would be necessary, in order to establish the impact of Philip's behaviour and in 
order to decide whether ADHD would be the appropriate diagnosis. 
1.1.3. Category or continuum 
According to the ADHD guidelines of the National Institute for Health and Clinical 
Excellence (NICE) 'ADHD is a valid clinical disorder that can be distinguished 
from comorbid conditions and the normal spectrum. ADHD differs from the 
normal spectrum because there are high levels of hyperactivity/impulsivity and/or 
inattention that result in significant psychological, social and/or occupational 
impairment that occurs across multiple domains and settings and persists over 
time".15 Although ADHD is defined as a distinct category16 epidemiological and 
twin studies have provided evidence for ADHD as a continuum rather than a 
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discrete category.1720 In a recent magnetic resonance imaging (MRI) study Shaw 
at al provided further neurobiological evidence for dimensionality of the disorder.2' 
Lubke found that ADHD fitted best in three different classes, i.e. mild, moderate 
and severe, and most children with ADHD combined type belonged to the 
extreme end of the continuum.20 Whether or not ADHD is considered a categoric 
or a dimensional disorder, the ADHD diagnosis has proved to be stable, in the 
sense of predicting the ADHD diagnosis;22 children meeting the ADHD criteria 
were likely to continue to meet the criteria during a period of 8 years, thus 
supporting the predictive validity of the DSM-IV ADHD criteria.23 
Conversely, this stability does not hold for the three types of ADHD 
(predominantly inattentive, hyperactive/impulsive, combined),222425 which were 
particularly defined to divide the heterogeneous group of children with ADHD in 
more homogeneous groups, in order to facilitate the diagnostic and therapeutic 
procedures.22 Children with ADHD appeared to shift unsystematically from one 
type into another, consequently the typing of ADHD seems unpredictable and 
unstable over time.222425 Therefore it is advised to alter the current nominal typing 
into continuous typing, i.e. counting the numbers of both dimensions (inattentive 
and hyperactive/impulsive), because a robust association of symptom count with 
future impairment has been found.22 
1.1.4. Prevalence 
According to the DSM-IV ADHD affects 3 to 5% of all children,3 but the prevalence 
of ADHD tends to increase. The worldwide prevalence is now estimated at 5.3%, 
and is associated with significant variability.26 A recent report concerning the 
administrative ADHD prevalence, i.e. the number of parent reported children 
diagnosed with ADHD and taking ADHD medication, showed that in the USA this 
percentage had increased from 7.8% in 2003 to 9.5% in 2007, an increase of 
21.8%.27 In Germany the administrative prevalence of ADHD showed an increase 
of 45% during 2000-2007.28 
The ADHD prevalence is 2.1 times greater in boys than in girls.29This difference 
might be explained by the higher prevalence of the predominantly inattentive type 
in girls,3032 which symptoms are less intruding or inconvenient than the more 
prominent hyperactive/impulsive symptoms. Consequently, girls are less likely to 
be referred for further diagnostic research and treatment.32 According to the 
multiple threshold model, which implies that multiple factors (genetic as well as 
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environmental) are involved in the causation of ADHD and contribute additively to 
the liability for ADHD, girls may have a higher threshold for ADHD than boys,33 
which may be another explanation of the difference in occurrence between boys 
and girls. Still, although the differences in prevalence between boys and girls are 
well-established, more research is needed to explain these differences.34 
Unfortunately, the risks of non-treatment in both boys and girls are equal, and in 
70-80% of children diagnosed with ADHD the symptoms and concomitant 
impairment will persist into adolescence and adulthood.3' 
1.2.ADHD-NOS 
Some children do not meet the criteria for ADHD but nevertheless show prominent 
symptoms of inattention and/or hyperactivity/impulsivity, to such an extent that 
the child's development is negatively affected. In these children the diagnosis 
ADHD Not Otherwise Specified (ADHD-NOS) might be made.3 This diagnosis 
may be applicable to children who meet the ADHD criteria but who show ADHD 
symptoms in one setting only (at home or at school), or to children who are too 
young to go to school. Of course the younger the child the more difficult it will be 
to establish the diagnosis, especially since the behaviour of young children may 
correspond with some ADHD symptoms. Still, according to the DSM-IV in toddlers 
the diagnosis may be established, because even children of 2 or 3 years old 
should be able to sit with an adult, or to listen to a story. The behavioural problems 
in young children may be assessed using the Preschool Age Psychiatric 
Assessment.35 Furthermore, considering the medication studies that have been 
conducted in preschoolers, ADHD may be a real problem in young children. 
These medication studies have shown favourable effects of medication, although 
the effects seem to be smaller and some side effects seem to be greater than in 
school-age children.36 3e 
1.3. Comorbid disorders 
ADHD is generally diagnosed in combination with other psychiatric disorders and 
co-occurrence of two or more child psychiatric disorders is common.39 In the 
22 
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majority of children with ADHD at least one comorbid condition is reported: 
according to a 2007 analysis in US children 33% suffered from one comorbid 
condition, 16% suffered from 2, and 18% reported 3 or more comorbid disorders.40 
Oppositional Defiant Disorder (ODD), affecting at least 40-60% of children with 
ADHD, and Conduct Disorder (CD) are the most frequent reported comorbid 
disorders in children with ADHD.41 Although DSM-IV diagnostic criteria for ADHD 
exclude PDD,42 children with ADHD often show symptoms of PDD Not Otherwise 
Specified (PDD-NOS)4245 and a high co-occurrence rate for ADHD and PDD-NOS 
exists. Furthermore, tic and anxiety disorder are comorbidities often reported46 
and the comorbitidy between ADHD and major depression disorder in children 
and adolescents is substantial.47 
Other non-psychiatric common comorbid disorders include motor disorders 
like developmental coordination disorder (DCD)48 and learning disorders like 
dyslexia and dyscalculia;46 according to parent reports 46% of children with 
ADHD had a learning disorder, versus 5% of children without ADHD.40 ADHD is 
overrepresented in children with coeliac disease4950 and, finally, sleep disorders51 
and physical complaints like eczema, asthma, headache, bellyache, enuresis 
and encopresis are conditions often reported by parents of children with 
ADHD.5254 
1.4. The impact of ADHD 
ADHD is a disorder that affects the child and his or her environment substantially. 
The impairment is not limited to family life, but is also existing at school, play 
ground and in everyday life. Apart from the social consequences, preschool 
children with ADHD are more often referred to special education and need more 
physical and speech therapy than a control group without ADHD.55 Furthermore, 
children with ADHD are more often visiting a general practitioner or a specialist, 
they are more often hospitalised and have more major injuries than a control 
group without ADHD.5657 Consequently, the demands for social and healthcare 
services are considerable,5859concomitantly affecting the parents' professional 
productivity.57 Children with comorbid psychiatric disorders like ODD and CD are 
even more difficult to handle by parents and teachers. They give rise to significant 
parenting stress, they have more problems, and need more health and educational 
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care than children with ADHD only.40 These children have a worse prognosis 
compared to children without comorbidity.60 
In most children the problems persist into adolescence and adulthood273' and 
these children are even more at risk for long term negative outcomes.6061 
Adolescents with ADHD show increased academic failure and an increased risk 
of driving accidents. They may develop aggressive and antisocial behaviour, 
resulting in a poorer social environment.60 Research has shown that in particular 
ADHD with comorbid ODD or CD may predict an early onset of criminal behaviour62 
and children with or without comorbidity show worse delinquency outcomes.63 
Furthermore, in detained male adolescents, 90% of the subjects reported at least 
one psychiatric disorder -75% of which were ODD and/or CD-, and parent-
reported ADHD, CD and childhood-onset CD predicted serious recidivism.6465 
Finally, adults with ADHD are at risk of unemployment, problems at work, divorce 
and drug abuse.6667 
Not only the child and his or her environment suffer from ADHD, the societal 
costs of ADHD are considerable also. According to a Dutch study assessing the 
medical costs of ADHD patients and their mothers, the annual direct medical 
costsof children with ADHD were € 2040, which proved to be 11 times higher than 
the costs of children with no behavioural problems.58 The mean annual medical 
costs of the mothers were € 728, almost 5 times higher than the costs of mothers 
of children without behavioural problems.56 Additional other societal costs, like 
special education, behavioural interventions, placing in care, associated costs in 
adulthood, substance use and costs of crime68 were not included in the 
calculations of the Dutch study. Summarizing, the impact of ADHD on everyday 
life is considerable for both the child and the child's environment, with significant 
social as well as economical consequences, resulting in impairment of life and 
substantial direct and indirect societal costs. 
1.5. Aetiology: genetic and environmental factors 
involved 
Since 1902, following the first description of the clinical symptoms of ADHD in The 
Lancet, the behavioural problems of children have been the subject of many 
investigations. Twin and adoption studies have provided evidence that genetic 
24 
General introduction 
factors play a dominant role in ADHD69 with a heritability estimate of 75%.707' 
Many genes of small effect are involved, interacting with each other and with 
environmental risk factors, but no genes of large effect have been found yet.70 
Furthermore, in children with ADHD a significantly increased rate of large, rare 
copy number variants (CNVs, i.e. chromosomal duplications and deletions) has 
been found,72 especially in children with intellectual disability (IQ score <70), 
suggesting that routine genetic research and screening for these mutations could 
be helpful for children with ADHD.71 Still, it is important to emphasize that high 
heritability and the presence of rare CNVs must not be confused with genetic 
determinism;13 genomic risk prediction is obvious in Mendelian diseases, but in 
complex disorders genetic variants may explain the disease risk only partially.'3 
Thus, the genetic architecture of ADHD is complex and not conclusive.74 
Furthermore, considering that the increased rates of large CNVs were only 
found in the small minority (16%) of children with ADHD and were also found in 
7% of the control group children without ADHD,7'75 these additional results may 
serve as an example for the intricateness of this subject. Also, epigenetic changes 
may play a role in ADHD. Epigenetics is the process that governs the function of 
genes and is most commonly defined as the study of heritable changes in 
genome function that occur without a change in DNA sequence. Epigenetic 
effects in gene activation and inactivation are increasingly understood to be 
important in phenotype transmission and development. Considering the diversity 
of genotypes as well as phenotypes, ADHD sharing specific genes with autism, 
epilepsy, schizophrenia and mental retardation,7'76 further studies investigating 
the associations between genotypes and phenotypes are important, perhaps 
resulting in previously overlooked similar phenotypic elements that might link the 
genotypic outcomes.76 
Despite all scientific reseach and efforts to unravel the mysteries of ADHD the 
exact aetiological pathways of ADHD are still unknown.137'To date, ADHD is 
considered a complex and multifactorial disorder in which genetic as well as 
environmental risk factors may be involved.'8 Although according to the Dutch 
ADHD guidelines environmental factors do not have a strong influence on the 
development of ADHD,77 biological environmental factors (e.g. complications 
during pregnancy and delivery, smoking or alcohol use by the mother during 
pregnancy, and low birth weight, prematurity or dysmaturity) as well as 
psychosocial environmental factors (e.g. low social class, foster placement, 
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parental mental disorders, and family dysfunction) are associated with ADHD.79 
According to the polygenic multiple threshold model,33 every risk factor (genetic, 
biological and psychosocial) may have a small effect on the increasing 
vulnerability to the disorder, additive as well as interactive, and the cumulative 
effect of these risk factors, if exceeding a threshold, may lead to ADHD.70 
Individuals may differ in their response to environmental factors, and some 
individuals who have ADHD related genes may only develop the disorder when 
they are exposed to risk factors.80 I.e., it is conceivable that the child's genetic 
constituency may be interpreted as a genetic vulnerability to environmental risk 
factors.6974 
Not until recently specific gene-environment interactions have been studied in 
ADHD by means of "gene-environment" (GxE) studies. It is conceivable that the 
predominating negligence of environmental factors may have been caused by the 
very high heritability of ADHD.79 Contrary to the posited notion that ADHD results 
from a cumulation or a confluence of genes and environment, which of course is 
true, the GxE theory goes a step further, i.e. genotype and environment may 
increase or decrease each others effect, resulting in an actual interplay between 
genes and environment.79 Consequently, some genotypes may be disadvanta-
geous, but only in combination with specific environmental factors, and some 
environments may be detrimental, but only to certain individuals with specific 
genotypes.79 An appealing example is the Siamese cat, whose black tips are 
defined by the environment, to be more specific, by the temperature. A Siamese 
kept in the fridge will grow black hair only, but kept in the desert will be white as 
snow.75 
On top of that, gene expression and epigenetic processes may be altered or 
induced by environmental factors,7581 indicating that GxE studies are very exciting 
and may be promising for the future. Concluding, genes and environmental 
factors may interact with each other in complex ways,69 emphasizing the 
importance of studies into environmental factors.79 More research is needed to 
define to what extent environmental factors may influence the genotype and play 
a role in ADHD, and to investigate whether risk reduction and treatment could be 
achieved by modifying the environment.80 
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1.6. Food as a specific environmental risk factor of ADHD 
One of the environmental research areas meriting greater attention is the impact 
food may have on behaviour and behavioural disorders. There is growing 
awareness among healthcare providers that the composition and quality of our 
food may play a role in determining not only our physical well-being, but also our 
behaviour. The pharmacological effects of certain foods, like caffeine (improving 
concentration), chocolate (affecting mood), and alcohol (changing behaviour) are 
well known.82 Foods are also involved in allergic and highly genetic diseases like 
asthma and eczema. Various environmental factors (e.g. dust mites, pet animals, 
pollen or foods) may play an important role and may contribute to the development 
of these disease.8384 Avoiding incriminated risk factors may reduce or even 
prevent the symptoms, thus offering the opportunity to reduce the intake of drugs 
to a minimum. 
Based on the comorbidity of ADHD and allergic disorders which occurs in 
40% of children with ADHD85 a causal relationship between allergies and ADHD 
was suggested.85 87 Conversely, other studies showed no conclusive evidence for 
this association8889 finding no discrepancy in the number of children showing 
ADHD behaviour with and without an allergic disorder.548889 The occurrence of 
adverse physical reactions to foods (e.g. eczema, asthma, allergic rhinitis, 
gastrointestinal disturbances)90 in combination with the high comorbidity of 
behavioural and physical complaints,46 stimulated speculation that foods might 
not only affect organs like the skin, the gastrointestinal tract and the respiratory 
system, but might also have an impact on the brain, resulting in adverse 
behavioural effects.53 If so, in children (genetically) vulnerable to ADHD specific 
foods may trigger the disorder, commensurable with strawberry triggering 
eczema, orange triggering asthma, or wheat triggering coeliac disease. 
Consequently, avoiding the incriminated foods will lead to a decrease of 
symptoms. In order to investigate the relationship between food and behaviour in 
the previous century two types of studies have been performed; studies 
eliminating or supplementing one or several food components, i.e. additive and 
supplement studies, and studies eliminating many foods, i.e. restricted elimination 
diet (RED) studies. 
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1.7. Additive and supplement studies 
Additive studies are defined as studies eliminating or provocating one or a few 
food components. Between 1970 and 2000 many additive studies investigated 
the effect of food dyes, preservatives or other specific food components (e.g. 
sugar or chocolate) on ADHD. These studies have convincingly shown that 
additives or specific food components are not to blame for ADHD,9'97 Recent 
studies into the effects of additives showed that exposure to food colours and 
benzoate preservatives may result in some degree of hyperactivity in all children 
of the general population, but not specifically in children with ADHD.9899 
Furthermore, the effect sizes were small, and it is undetermined whether either 
food colours, or preservatives, or both engendered the effect.9899 Other studies 
eliminating only one or a few diet components, like a gluten free diet or the 
Feingold diet, did not result in statistically significant and clinically relevant results 
on ADHD as well.9'100 Concluding, despite the common association and the 
expectation of parents that sugar and additives may cause ADHD, a diet excluding 
just a few food components, like gluten, sugar or chocolate/6 78 or an additive free 
diet is of no benefit to ADHD.53 According to the European and the NICE guidelines 
there is no evidence for the effectiveness of these diets and they should not be 
prescribed.13'5 The Dutch multidisciplinary ADHD guidelines, provided by the 
Trimbos Institute (Netherlands Institute of Mental Health and Addiction) are 
consistent with the European and the NICE guidelines.77 
In addition to additive studies, eliminating some food components, supplement 
studies have been performed, characterised by supplementing a specific food 
component or nutrient. In short, no evidence exists for the effectiveness of 
supplementation of vitamins or herbs.97100 Furthermore, clinical effects of zinc, 
iron, or magnesium supplementation are equivocal,101102 not significant,103 or too 
little studies are available to draw any conclusions.101 Supplementation with poly-
unsaturated fatty acids (PUFA), more specifically omega-3 and omega-6 fatty 
acids [essential fatty acids (EFA)], has also been studied as a treatment for 
ADHD. In fact, supplementation of omega-3 fatty acid or alpha-linolenic acid, 
mostly referred to as fish oil, is widely applied for all kinds of diseases, including 
ADHD. To date, fish oil appears to have grown into a panecea, of which the food 
industry is taking full advantage, adding fish oil to all kinds of foods, even to pet 
food. Contrary to the canvassing texts on foods, up to now research has shown 
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no convincing evidence for a clear effect of omega-3 fats on our health, neither 
on total mortality, cardiovascular events or cancer,105 nor on ADHD.106109 
A recent randomised placebo-controlled trial in children and adolescents with 
ADHD showed that omega 3/6 supplementation (eye q) was not statistically 
superior to placebo. In children with comorbid ODD, i.e. the majority of children 
with ADHD, a clinical response was lacking altogether. In a subgroup of children 
without ODD but with comorbid reading and learning disorders, the supplement 
only just reached statisticial significance.110 A review recently conducted by the 
National Institute for Public Health and the Environment in the Netherlands, found 
that omega 3/6 fatty acid supplementation does not show clinically relevant 
effects on ADHD.104 Similarly, in a systematic review Raz et al concluded that 
omega 3/6 trials "have generally been unsuccesful in demonstrating any 
behavioural effects".109 Overall, despite many trials supplementing either omega-3 
fatty acids (fish oil) or omega-6 fatty acids or both, evidence for the effect on 
ADHD is limited and results are inconsistent.107 Consequently, fatty acids are not 
recommended as a primary or supplementary treatment for children with 
ADHD.1577104109 
1.8. RED studies 
Between 1985 and 2000 the effects of a restricted elimination diet (RED) on ADHD 
have been investigated in six randomised controlled dietary studies,525385111 M3 of 
which five studies used a double-blind placebo controlled design.525385'"113 The 
rationale for using a highly restrictive diet was the assumption that a child might 
show adverse behavioural reactions after eating any foods. If so, this would 
explain why excluding just one or two different foods, as happened in the additive 
studies,9'97 would not be an effective method to investigate the existence of a 
diet-behaviour connection in a child.53 Consequently, contrary to the additive 
studies in which the children adhered to their normal diet, the RED studies 
involved a total change of diet, allowing only a few different foods and excluding 
not only additives but many different foods. In short, in the additive studies 
parents were told what the child should not eat, in the RED studies parents were 
told what the child was allowed to eat. 
In the RED studies the children followed an individually composed restricted 
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elimination diet (RED) for 4 weeks at the most. Basic foods were rice, meat, 
vegetables, fruit and water, i.e. the few foods diet as described by Carter,53 but 
most studies used a more elaborate diet and adapted the diet for each child 
individually. The RED trials have shown that in 24% (in the study using the most 
extensive diet which lasted 8 days only)113 to 82% (in the study using the most 
restricted diet in a highly selected population)85 of subjects significant behavioural 
improvements were established following the RED. A meta-analysis of the five 
double-blind placebo-controlled RED studies52538511,113 resulted in an aggregated 
standardized mean difference of 0.80, which is a large effect size.106 Considering 
that the majority of these studies (3/5) were conducted in children selected via 
diet clinics5385or allergy clinics,111 the results of the RED studies are applicable to 
a subgroup of children with ADHD, showing convincing controlled evidence of 
efficacy97114 Consequently, in 2001 application of an RED in predetermined cases 
was included in a basic algorithm for treatment of ADHD in the United Kingdom.100 
The mechanism in which foods may exert their effects on ADHD has not been 
investigated yet. It is hypothesised that ADHD is allergy related115 and that a 
shared genetic aetiology may be underlying both allergic conditions (e.g. asthma) 
and ADHD.116 In allergic diseases like asthma, rhinitis and eczema environmental 
factors play an important triggering role.117119 According to the revised 
nomenclature of allergy, hypersensitivity is the coordinating term for all allergic 
and non-allergic reactions triggered by environmental factors, the definition being 
as follows: "Hypersensitivity describes objectively reproducible symptoms or 
signs, initiated by exposure to a defined stimulus at a dose tolerated by normal 
subjects."120 The manifestation of asthma symptoms following exposure to dust 
mites, will meet the definition of hypersensitivity, the dust mite being the defined 
environmental stimulus. Similarly, if a child shows ADHD symptoms after eating 
normal amounts of specific foods, these foods may, like the dust mite in asthma, 
be considered as clearly identified stimuli tolerated by typical subjects. 
Consequently, in some children ADHD may be the result of a hypersensitive 
reaction as described in the definition above. The results of the RED studies, 
investigating the effects of food on ADHD symptoms, support the existence of a 
hypersensitivity mechanism. If a child shows ADHD after eating certain foods and 
if blood tests show increased levels of immunoglobulin (Ig) against the incriminated 
foods,120 then in this specific child ADHD may be the consequence of an allergic 
reaction to foods. Allergy is a hypersensitivity reaction initiated by specific 
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immunologie mechanisms,120 and may be antibody-mediated and/or 
cell-mediated. In antibody-mediated allergies immunoglobulins like IgE or IgG 
are involved.121 According to Gaitens a behavioural response to food is probably 
not IgE-mediated, but there might well be a connection between ADHD and 
allergies based on a ποη-lgE-mediated mechanism.122 Consequently, in children 
showing an ADHD-response to foods, cell-mediated allergy (i.e. mediated by a 
chronic immune stimulus to Τ cells) may be involved. 
In children with food-induced ADHD but without an established allergic 
mechanism, a non-allergic hypersensitivity may be involved, in which 
pharmacologic, toxic,53 or epigenetic7b 81 mechanisms may play a role. Considering 
the high comorbidity of functional gastrointestinal disorders and psychiatric 
disorders even the gut brain axis (i.e. the link between the gastrointestinal tract 
and the central nervous system), an unexplored area where ADHD is concerned, 
may play a role in ADHD.123 Furthermore, modulation of behaviour via gut 
microbiotica is another new and interesting concept.124 Concluding, more research 
is necessary to establish whether in children with food-induced ADHD an allergic 
or a non-allergic hypersensitivity mechanism is involved. 
1.9. Current assessment and therapy of ADHD 
According to the guidelines the ADHD diagnosis should only be made by a 
trained health care professional, with expertise in diagnosing ADHD. The ADHD 
assessments should comprise: 1) parent interview, including a developmental 
history of the child and family members, family functioning, social network, a 
psychiatric interview concerning DSM-IV-diagnoses and parent rating scales; 
2) child interview, although the interviewer must realise that behavioural problems 
may not manifest themselves in a new and exciting setting; 3) school information 
about the functioning and the behaviour of the child at school and about the 
teacher-child relationship; 4) psychological tests if there are any problems related 
to learning or progress at school, 5) general examination of physical health, 
including weight and height, further investigations only to be executed on medical 
grounds (e.g. EEG in case of a history of seizures, gene assessments in case of 
developmental delay, audiograms in case of hearing problems, and neuro­
psychological tests in case of suspicion of brain lesions).1377 
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To date, the management of ADHD is generally based on multimodal 
treatments."5 According to the NICE ADHD guidelines the order of treatment 
should depend on the severity of symptoms and the level of impairment of 
functioning. In children with moderate ADHD and moderate impairment parent 
training and parent education, if desired combined with child group treatment 
(cognitive behavioural therapy), should be the first-line treatment. In children with 
severe ADHD and severe impairment drug treatment should be first-line, 
preferably combined with group based parent training.15 According to the 
European guidelines for hyperkinetic disorder psycho-education should be the 
base of treatment, followed by psychological and behavioural interventions (i.e. 
parent training and behavioural interventions in the family; behavioural 
interventions at school; cognitive behaviour therapy of the child).13 Psychophar-
macological treatment should be considered if the effects of psychological 
interventions are insufficient or if the case meets the criteria for severity of 
symptoms and of impairment of functioning that warrant direct medication 
treatment.1377 
1.10. The role of food in the current therapy of ADHD 
As yet not any diet is part of the current therapy of ADHD. So far only seldom an 
elimination diet is referred to as a possible treatment for ADHD.125 Indeed, in an 
analysis of the current literature by the American Academy of Pediatrics' 
Committee on Quality Improvement, conducted for the purpose of developing an 
evidence-based clinical practice guideline for the treatment of the school-aged 
child with ADHD, the results of the RED studies were not mentioned at all.126 In a 
recent "balanced review of the literature, both in support and against the 
possibility of foods or additives causing behavior disorders" all RED studies were 
ignored.127 Furthermore, in a review "emphasising new developments and 
focusing on pathways of discovery that could lead to improved treatments for 
patients with ADHD" the authors referred to additive studies only in order to 
deduce that there are "mostly negative studies of dietary factors".70 Of course, it 
is correct that the additive studies, investigating the effect of elimination of 
additives or other food components on the behaviour of children with ADHD, have 
convincingly shown not to be effective and are not considered part of the treatment 
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of ADHD.13'5 Conversely, convincing evidence exists for the effectiveness of an 
individually constructed elimination diet in selected groups of children.971'4 
Moreover, in 2001 an RED was incorporated in an algorithm for ADHD treatment 
if: 1) there was a clue in history that dietary factors might be involved; 2) a 
paediatric dietician was available to monitor the diet; 3) the child and family were 
motivated to follow a diet.100 Considering the existing evidence available at the 
time of the above-mentioned reviews, it is amazing that all RED studies have 
been disregarded by the reviewers. 
Despite the recommendation in the UK ADHD algorithm100 the European 
guidelines state that: "there is not yet enough scientific evidence to establish 
guidelines for dietary approach, more research is needed".13 More amazing still is 
the guidelines' advice that a diary approach is considered applicable if parents 
suspect that foods affect their child's behaviour, to investigate whether a link 
exists between behaviour and food intake.131'' This recommendation appears to 
be consensus based rather than evidence based, because no scientific evidence 
exists for a relationship between keeping a diary and finding foods that may 
cause ADHD. Concluding, despite convincing evidence for the effects of an RED 
in subgroups of children with ADHD, the current ADHD therapy does not comprise 
an RED. 
1.11. Aim and structure of this thesis 
This thesis comprises two main aims. First, the relationship between ADHD and 
food and the relationship between psychiatric and/or physical comorbid disorders 
and food is examined, in heterogeneous groups of young children with ADHD, 
using an individually constructed RED. The hypothesis is tested that a restricted 
elimination diet may have a beneficial effect on both the behavioural problems 
and the somatic complaints in an unselected group of children with ADHD. 
Second, two possible mechanisms of action in which food may exert its effects 
are investigated, i.e. a direct immunological mechanism and an indirect 
mechanism, affecting family structure. The hypotheses are tested that 1) an 
immunological mechanism is involved in food-induced ADHD, and 2) the effects 
of an RED may be mediated by changes in family environment. Consequently, the 
thesis is divided in two parts corresponding with the main aims. 
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1.11.1. Part 1: 
the effect of an RED on ADHD, ODD and comorbid complaints 
Most previously performed studies applying an RED focussed on selected 
subgroups, eg, the participants were recruited via diet or allergy clinics. In 
Chapter 2. a pilot study is described investigating the effects of an RED on ADHD, 
ODD and physical complaints in a group of children not selected for atopic 
constitution or diet affinity. Only children familiar with risk factors for ADHD, e.g. 
prematurity, dysmaturity, alcohol use during pregnancy or foster placing, were 
excluded. This study focuses on the question whether nutrition can be regarded 
as a potential ADHD risk factor in a heterogeneous group of children and whether 
it is recommendable to execute a follow up study with a randomised controlled 
design. Chapter 3 describes the follow up study, a randomised controlled trial 
(RCT) executed in a comparable heterogeneous group of children with ADHD 
and comorbid complaints. The aim was to investigate whether the results of the 
previous open study could be replicated in a randomised controlled design. In 
Chapter 4 the RED results on sleep problems and physical complaints are 
investigated, in the group of children described in Chapter 3. 
1.11.2. Part 2: 
the potential working mechanisms of an RED on ADHD and ODD 
In Chapter 5. based on the results of all previous RED studies in children with 
ADHD, showing evidence of efficacy on both psychiatric and physical conditions, 
the hypothesis is postulated that ADHD, like asthma and eczema, might be 
considered a (non-)allerglc hypersensitivity disorder. Based on definitions of 
allergic conditions this hypothesis is explained and motivated. Chapter 6 
describes the Impact of Nutrition on Children with ADHD (INCA) study. In this 
pragmatic study, using a randomised controlled design with blinded measurements 
by a paediatrician, the effects of the RED are investigated in an unselected group 
of children with ADHD. Contrary to the studies described in Chapters 2 and 3, 
children familiar with risk factors for ADHD are not excluded, in order to determine 
how generally applicable this RED treatment will be within a general group of 
young children with ADHD. Furthermore, it is investigated whether an 
immunological mechanism may be involved, using IgE and IgG blood tests. The 
results of the blood tests may provide additional information about the mechanisms 
of foods in children with ADHD, may enable us to segregate between non-allergic 
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or allergic mechanisms in food-induced ADHD and may eventually facilitate the 
RED procedure. Finally, in Chapter 7 another possible mechanism In which food 
may exert its effects is explored, i.e. a change in family structure and family 
environment. It Is conceivable that behavioural improvements after following an 
RED may also be mediated by changes in family environment due to the strict 
scheme the family has to follow during the RED. This study aimed to investigate 
whether changes in family environment may contribute to the positive behavioural 
effects of an RED in children with ADHD, in a subsample of the INCA study. 
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Abstract 
Objective. To determine whether a standard elimination diet can decrease ADHD 
symptoms in a heterogeneous group of young children with ADHD. 
Design. Open, descriptive. 
Method. 40 children, 36 boys and 4 girl, aged 3-7 (average 4.8 years), who met 
the DSM-IV criteria for ADHD, followed their usual diet for 2 weeks (the baseline 
period) and thereafter a 2-week elimination diet, based on the few foods diet (rice, 
turkey, pear and vegetables). The behaviour of the child was evaluated at study 
entry, at the end of the baseline period and at the end of the diet by means of 
three measurements: the abbreviated Conners' scale, the ADHD Rating Scale 
and a physical complaints questionnaire. Teachers completed the abbreviated 
Conners' scale and the ADHD Rating Scale twice, at start and at the end of the 
diet. 
Results. According to the parent ratings. 25 children (62%) showed at the end of 
the elimination diet an improvement in behaviour of at least 50% on both the 
Conners' scale and the ADHD Rating Scale. Nine children (23%) withdrew from 
the study because the parents were unable to stick to the diet or because the 
child fell ill. Ten of 15 children with both parent and teacher ratings responded at 
home as well as at school. 
Conclusion. In young children with ADHD an elimination diet can lead to a 
statistically significant decrease in symptoms. 
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Introduction 
Attention deficit/hyperactivity disorder (ADHD) is a common child psychiatric 
disorder, characterized by hyperactive behaviour, impulsivity and inattention [1], 
Genetic factors play an important part in the development of ADHD, Besides 
genetic factors, pre- and postnatal environmental risk factors may be involved in 
the development of the disorder [2]. 
In the seventies of the previous century, the relationship between food 
colourings and behaviour has been thoroughly investigated, and no significant 
effect of food additives on ADHD was found [3-5], The hypothesis that any food 
component may cause behavioural problems led to research into the effect of a 
diet consisting of hypo-allergenic foods, such as rice, turkey, vegetables and 
pear, i.e. the few foods diet. In double-blind, placebo controlled research, 
approximately 70% of the participants responded to this diet with statistically 
significant behavioural improvements [6-9], However, the participating children 
were children with an atopic constitution or were selected via diet clinics. 
The objective of this pilot study was to establish the effects of a standard 
elimination diet on ADHD symptoms in a heterogeneous and non-selected group 
of young children with ADHD, The hypothesis was tested that in young children 
with ADHD, an elimination diet leads to a decrease of symptoms of at least 50% 
on the abbreviated Conners' scale (ACS) [10] and on the ADHD rating scale 
(ARS) [11]. 
Subjects and methods 
Subjects 
Children were recruited through media announcements or were referred by child 
psychiatrists. Children were included if (1) they met the DSM-IV ADHD criteria 
[12], (2) they were between 3 and 7 years old, and (3) they did not use psychotropic 
medication. Children were excluded if any biological environmental factors that 
can contribute to the development of ADHD, such as prematurity of the child or 
alcohol abuse by the mother during pregnancy, were reported [13]. 
Forty children were enrolled in the trial: 36 boys and 4 girls, aged 3-7 (average: 
4.8). Eleven out of 40 children were clinically diagnosed with ADHD prior to study 
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entry. In all children the diagnosis was confirmed by means of a structured child 
psychiatric interview (SPI) [14]. Thirty-six children met the criteria for ADHD 
combined subtype, 4 children met the criteria for ADHD hyperactive impulsive 
subtype, and 31 children also met the criteria for Oppositional Defiant Disorder 
(ODD). In 24 children an atopic constitution was reported, whereby the existence 
of a clinically manifested allergy in at least one first grade relative (a parent or 
sibling) was used as a criterion. All parents gave informed consent. 
End points 
The most important end point was the score on the ACS [10]. This questionnaire 
has been frequently used in ADHD treatment research and consists of 10 
questions, concerning the core symptoms restlessness, impulsivity and 
inattention, using a four-point rating scale. The total score may range between 0 
and 30. The ACS was completed by the parents at study entry, at the end of the 
baseline period and at the end of the elimination diet (table 1), 
The second end point was the score on the ARS [11], This questionnaire 
consists of the 9 DSM-IV-items regarding inattention and the 9 DSM-IV-items 
regarding impulsivity and hyperactivity, each marked out on a four-point rating 
scale. The parents completed the ARS in accordance with the ACS, the teachers 
completed both questionnaires at start and the end of the diet period. 
The third questionnaire concerned comorbid physical complaints of the child. 
An inventory was made of physical complaints in the past year, such as gastro-
intestinal problems, headache, stomach-ache, eczema, asthma, excessive 
perspiration and sleeping problems [15]. Each question was to be answered with 
'no', 'sometimes', or 'often'. There were two measurement moments: at start and 
end of the trial. The questionnaire was completed by the parents only. 
Finally, the SPI was repeated at the end of the elimination diet in order to 
establish whether or not the children still met the criteria for ADHD and ODD. 
Procedure and intervention 
At start the SPI was used to verify the child's behavioural problems, i.e. ADHD 
with or without ODD. Three questionnaires were completed by the parents, after 
which the child started a 2-week baseline period in which no foods were to be 
eliminated. The parents kept an extended food and behaviour diary and had to 
observe the child closely. At the end of the baseline period the ACS and ARS were 
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SPI 
χ 
Baseline period Elimination diet 
ARS = ADHD rating scale 
ACS = abbreviated Conners' scale; 
SPI = Structured Psychiatric Interview 
I 
completed for the second time. Subsequently, the children started the 2-week 
elimination diet. The elimination diet was based on the 'few foods' diet, consisting 
of rice, turkey, pear, vegetables and water [8, 16]. In order to create a more
 0 
comprehensive and more feasible diet, the few foods diet was complemented wit 
specific foods, such as corn, apple, wheat and honey, which were allowed 
according to a strict schedule. All children followed the same diet, and parents 
kept an extensive diary during the elimination diet. 
Statistical analysis 
The parent questionnaires which were completed at the end of the baseline 
period and at the end of the elimination diet were compared using a paired t-test. 
The teacher questionnaires were compared using the Wilcoxon test because of 
the smaller numbers. The binary end points (number of responders and 
nonresponders and children with or without an atopic constitution) were compared 
using Fisher's exact test. A participant was defined a responder if the behavioural 
improvement was at least 50%, at both the ACS and the ARS. The statistical 
analyses were done with SPSS (version 9.0 for Windows). 
Table 1 Time table and questionnaire moments 
Questionnaires Week 0 Week 1 Week 2 Week 3 Week 4 Week 5 Week 6 
Physical complaints χ χ 
ARS parents χ χ χ 
ARS teacher χ χ 
ACS parents χ χ χ 
ACS teacher χ χ 
χ 
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Results 
Nine of 40 children (23%) who started the trial withdrew prematurely from the 
study: 3 children withdrew before the start of the trial because their parents lacked 
the motivation to start a diet; 3 children withdrew in course of the study due to 
illness of the child or lack of motivation of the child; and 3 children left the trial 
during the elimination diet period. Thirty-one children completed the study. 
Teacher data were available of 15/31 children, teacher data were missing due to 
holidays or because the child was younger than 4 years old. 
ADHD symptoms 
The parents' (n = 31; table 2) and teacher's (n = 15; table 3) ACS and ARS 
scores were significantly lower at measurement point 3 (end of elimination diet 
period) when compared to measurement point 2 (end of baseline period). The 
improvements concerned both inattentive and hyperactive-impulsive symptoms. 
At the end of the study 4/31 children still met the criteria for ADHD (p<0.0001). 
According to the parent measurements 25 children belonged to the responders, 
i.e. 62% of all 40 children and 81% of 31 children who completed the study. Fifteen 
of 40 children (38%) belonged to the nonresponders: 9/40 were dropouts and 
6/40 completed the diet but did not respond favourably. According to the teacher 
data 10/15 children were responders at home as well as at school; 1/15 child 
responded at home but not at school, 4/15 children were nonresponders both at 
home and at school. 
ODD symptoms 
A significant decrease of ODD symptoms was observed at the end of the 
elimination diet (see table 2), At the start of the trial 26/31 children met the ODD 
criteria and 2/26 children still met the ODD criteria at the end of the diet (p<0.0001): 
21/26 were responders (81%), showing behavioural improvements of at least 50%. 
Physical complaints 
At the start of the trial 20/31 children suffered from 3 or more physical complaints, 
such as stomach-ache, headache, unusual thirst and/or excessive perspiration, 
diarrhoea, eczema or asthma. At the end of the elimination diet all 20 children 
showed a significant decrease in physical complaints (table 4). In 13 children. 
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9 responders and 4 nonresponders, the physical complaints had disappeared 
completely. The number of children with an atopic constitution did not differ 
between the responders (13/25) and nonresponders [4/6, (p = 0.43)]. 
Table 2 Parent measurements (n=31); average symptom scores on the 
abbreviated Conners' scale (ACS), the ADHD rating scale (ARS), and 
the number of ADHD and oppositional defiant disorder (ODD) criteria 
ACS 
ARS inattention 
ARS hyperactivity/ 
impulsivity 
ARS total score 
ADHD 
ODD 
start trial end end 
baseline diet elimination diet 
mean (SD) mean (SD) mean (SD) 
24.13 (3.29) 25.35 (2.42) 8.84 (5 98) 
19.10 (425) 20.58 (4.21) 7.81 (5.53) 
22.42 (365) 23.35 (2.39) 8.42 (5.95) 
41 52 (6.60) 43.61 (5.12) 16.23 (11.04) 
15.03 (2.27) - 3.49 (4 75) 
6 (1.4) 1.3 (1.8) 
95%-CI 
14.28-18.75* 
10.36-15.19* 
12.86-1701* 
23.18-31.59* 
9.74-13.42t 
3.86-5.60' 
*p = 0.0001 (difference end baseline diet vs end elimination diet paired t-test); 
' p = 0 0001 (difference number of criteria start trial vs end elimination diet. Wilcoxon test) 
Table 3 Teacher measurements (n=15); average symptom scores on the 
abbreviated Conners' scale (ACS) and the ADHD rating scale (ARS) 
end baseline end elimination 
diet diet 
95%-CI P* 
ACS 
ARS inattention 
ARS hyperactivity/impulsivity 
ARS total score 
mean (SD) 
18.13 (3.60) 
13.27 (5.26) 
16.73 (4 79) 
30.00 (7.16) 
mean (SD) 
10.27 (4.57) 
840 (5.53) 
9.80 (5.45) 
18.20 (9.56) 
5.94-9.79 
239-734 
418-9.68 
7.40-16.20 
0.001 
0007 
0.001 
0.001 
*p-value Wilcoxon Test 
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Table 4 Physical complaints* at start trial and end elimination diet, in diet 
responders and diet nonresponders 
number of responders (n = 25) nonresponders (n = 6) 
physical complaints 
start trial 
η (%) 
20 (80) 
5(20) 
0(0) 
end diet 
η (%) 
0(0) 
16(64) 
9(36) 
start trial 
η (%) 
0(0) 
5(83) 
1(17) 
end diet 
π (%) 
0(0) 
2(34) 
4(66) 
•Gastro-intestinal problems, headache, stomach ache, eczema, asthma and excessive perspiration 
Discussion 
This open pilot study showed that an elimination diet may affect behavioural 
problems of young children with ADHD in a favourable way. The number of 
responders was considerably, and in accordance with results of previous diet 
studies [6-9], Still, the high number of responder might be due to the selection 
procedure, excluding children with known pre- and postnatal risk factors for 
ADHD. Furthermore, the high responder rate might be consequential of the 
strictness of the elimination diet; in another elimination diet study, allowing foods 
which may trigger ADHD behaviour [17], a response percentage of 24 was found 
[10]. 
At the start of the study 84% (26/31) of children also met the criteria for ODD. 
Children with comorbid ODD have a worse prognosis compared to children 
without ODD [18, 19], In this study the elimination diet showed a favourable effect 
on both ADHD and ODD symptoms. 
Children were not selected for affinity with dietary intervention, atopic 
background or allergies. According to previous studies, atopic children with 
ADHD might [9] or might not [20] respond to an elimination diet. In this study no 
association was found between an atopic constitution and response to the diet. 
Furthermore, although the participants were not selected for physical complaints, 
these complaints occurred frequently. As children suffering from physical 
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symptoms tend to respond less to medication [21], an elimination diet might be 
especially worth trying in these children. 
An important limitation of this study is the open design, without a control 
group and with open measurements. Still, the teacher's observations confirmed 
the observations by the parents, and previous studies have shown that parental 
observations could be confirmed in a double-blind placebo controlled design, 
with objective tests [22]. In fact, hypo-allergenic diets have already provided 
convincing, double-blind placebo controlled evidence as a treatment of ADHD in 
selected subgroups of children with ADHD [23]. 
The mechanism of food in children with ADHD is not clear yet. It is hypothesised 
that the increase of atopic disorders may be due to a more general hypersensitiv-
ity of man to foods [24]. Allergic, pharmacological or toxic mechanisms may be 
involved in ADHD, i.e. an immunologic mechanism of food [16], or a direct 
mechanism of food components targeting the neurotransmitter system in the 
brain [25]. Laboratory studies have shown that certain additives, such as 
erythrosine, may affect the neurotransmitters release in the brain [26]. 
The results of this exploratory study elucidate the need for further controlled 
studies into the effect of an elimination diet on ADHD and into the long-term effect 
of foods. Furthermore, it is advised to investigate whether an elimination diet may 
cause nutrient deficiencies. Additionally, although children may show statistically 
significant improvements in behaviour following an elimination diet, it is important 
to emphasize that the diet does not eliminate the underlying vulnerability to food, 
i.e. commensurable to medication treatment adlet is not a cure of ADHD [13]. The 
diet has some advantages: the duration of action of an elimination diet is 24 hours 
a day and the diet reduces comorbid ODD and physical complaints. However, 
when children do not stick to the dietary restrictions, the symptoms will return, 
and high levels of motivation and perseverance of parents and children are 
required in order to see a diet intervention through. 
Considering that a diet may play a role in prevention of ADHD, follow-up 
studies might focus on young children again [19]. In young children, with less 
freedom of movement, the compliance to the elimination diet is easier to control 
and the impact of the diet on their social activities will be less intrusive. The extent 
of the effects of an elimination diet on ADHD are not quit clear yet, and the diet 
demands a lot from parents and children. Therefore, as yet caution is advised in 
the application of the elimination diet in practice. 
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Abstract 
The aim of this study is to assess the efficacy of a restricted elimination diet in 
reducing symptoms in an unselected group of children with Attention deficit/ 
hyperactivity disorder (ADHD). Dietary studies have already shown evidence of 
efficacy in selected subgroups. 
Twenty-seven children (mean age 6.2) who all met the DSM-IV criteria for 
ADHD, were assigned randomly to either an intervention group (15/27) or a 
waiting-list control group (12/27). Primary endpoint was the clinical response, i.e. 
a decrease in the symptom scores by 50% or more, at week 9 based on parent 
and teacher ratings on the abbreviated ten-item Conners Scale and the ADHD 
DSM- IV Rating Scale. 
The intention-to-treat analysis showed that the number of clinical responders 
in the intervention group was significantly larger than that in the control group 
[parent ratings 11/15 (73%) versus 0/12 (0%); teacher ratings, 7/10 (70%) versus 
0/7 (0%)]. The Number of ADHD criteria on the ADHD Rating Scale showed an 
effect size of 2.1 (Cohen's d) and a scale reduction of 69.4%. Comorbid symptoms 
of oppositional defiant disorder also showed a significantly greater decrease in 
the intervention group than it did in the control group (Cohen's d 1.1. scale 
reduction 45.3%). 
A strictly supervised elimination diet may be a valuable instrument in testing 
young children with ADHD on whether dietary factors may contribute to the 
manifestation of the disorder and may have a beneficial effect on the children's 
behaviour. 
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Introduction 
Attention deficit/hyperactivity disorder (ADHD) is one of the most common 
behavioural disorders in childhood, with symptoms often persisting across 
adolescence into adulthood [16]. Long-term risk outcomes of children with ADHD 
include underachievement at school and antisocial personality disorder, 
delinquency and substance abuse, marital breakdown and unemployment at 
adult life [19]. 
ADHD is a multifactorial disorder in which genetic risk factors predominate 
and various other environmental factors may be involved [5, 32]. The exact 
aetiological pathways of ADHD, however, are still unknown [22, 31]. According to 
current professional guidelines, medication and psychosocial interventions are 
the methods of treatment mostly recommended and most frequently used [12. 18, 
31]. According an expert opinion, it is important to avoid overreliance on currently 
available pharmacological approaches, suggesting that, among others, more 
research on dietary effects is essential [29]. 
There is evidence for the effectiveness of an individually constructed 
elimination diet, the "few foods" approach [15]. Dietary studies using a few foods 
diet, i.e. a restricted elimination diet consisting of a limited number of foods [7, 8, 
14, 17. 25, 26], have shown evidence of efficacy in subgroups selected for history 
of food sensitivity or atopic constitution [2]. A Dutch open pilot study in which 40 
children with ADHD followed a few foods diet [23], resulted in a reduction of at 
least 50% in the symptom scores on rating scales completed by parents and 
teachers in 62% of the subjects. The present randomised controlled trial study 
was designed to assess the efficacy of a few foods diet in a group of ADHD 
children unselected for affinity with dietary interventions or the presence of physical 
problems. This study has been registered as an International Standard Randomised 
Controlled Trial, number ISRCTN47247160. 
Methods 
Study population 
Participants were selected from a consecutive series of 79 Dutch children who 
were referred to the ADHD Research Centre between January and June 2006. Of 
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these children, 27 were enrolled in the trial (figure 1). They were between 3,8 and 
8.5 years old and they all met the criteria as defined in the Diagnostic and 
Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV) for ADHD 
Combined Type or Predominantly Hyperactive-Impulsive Type [1], The following 
exclusion criteria were used: adopted or foster children, co-existing neurological 
diseases, an IQ below 70, prematurity or dysmaturity, use of alcohol, or smoking 
by mother during pregnancy [31], and co-existence of other psychiatric disorders, 
except for oppositional defiant disorder (ODD) and conduct disorder (CD). The 
screening involved a systematic and complete review of the symptoms and 
diagnostic criteria of all DSM-IV axis I disorders occurring in childhood. None of 
the children used psychotropic medication. 
Parents were given verbal and written information about the study, and duly 
signed informed parental consent forms were obtained before randomisation. 
Children who were already on a diet had to cease this diet at least 2 weeks before 
the start of the trial. 
Figure 1 Trial profile 
79 children screened 
for eligibilny 
52 excluded 
43 did not meet inclusion criteria 
9 refused to participate 
15 assigned to intervention group 
2 dropped out 
1 child sick 
1 withdrawn 
13 completed the trial 
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Design and procedures 
The efficacy of an elimination diet in children with ADHD was tested by comparing 
outcomes in the children randomly assigned to the intervention group to the outcomes 
in those assigned to the waiting-list (control) group. Subjects were randomly allocated 
to one of the two groups by means of a sequence of numbered cards in sealed 
unmarked envelopes that were prepared by an independent paediatrician. Each card
 0 
contained a reference to the group to which the child would be allocated, and for -o 
each allocation an equal number of cards [21] was used. The envelopes were picked 
and opened by the parents in the presence of the researcher, and treatment was then 
dispensed in accordance to the allocation on the card. 
There were three measurement points: at study entrance (week 0), after the 
baseline diet (week 3) and after the elimination diet or waiting period (week 9). 
An overview of the time schedule regarding measure points and rating scales is 
presented in table 1. 
Table 1 Time table 
Measure Rating Rating Intervention group Control group 
points scales scales 
parents teacher 
Week! 1 ACS-1, Start of baseline diet 
Entrance trial ARS-1 
Week 2 Baseline diet 
Baseline diet ends 
Waiting list starts 
Waiting list 
Waiting list ends 
Elimination diet 
starts (if desired) 
ACS: Abbreviated Conners Scale, ARS ADHD Rating Scale; SPI Structured Psychiatric Interview 
After the first assessments all children started with a 2-week baseline diet in 
which they adhered to their normal diet, no foods were eliminated. During the 
Weeks 2 ACS-2, ACS-2, Baseline diet ends 
After baseline ARS-2, ARS-2 Elimination diet starts 
SPI 
Week 4-9 Elimination diet 
Week 9 3 ACS-3, ACS-3, Elimination diet ends 
Atendpoint ARS-3, ARS-3 
SPI 
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baseline diet the parents kept an extended diary in order to enable an assessment 
of the child's normal diet, its behaviour and activities. After the baseline diet and 
the second assessment, the intervention group started with an individually 
composed elimination diet [15], which had to be followed for a period of 5 weeks. 
The elimination diet consisted of rice, turkey, lamb, vegetables, fruits, margarine, 
vegetable oil, tea, pear juice and water [8, 23]. The control group was placed on 
a waiting list and continued their own, freely chosen diet. At the start of the trial 
the parents of the control group were informed that they could start with the 
elimination diet immediately after the last assessment if they so wished. 
Primary endpoints were the parent and teacher ratings on the Abbreviated 
ten-item Conners Scale (ACS) and the ADHD Rating Scale (ARS) before and after 
the elimination diet or the waiting period. The ACS [9], has often been used in 
ADHD treatment studies [7, 8, 14, 23, 25]. It consists of ten items of behaviour, 
focusing on overactivity, impulsivity and inattention, and uses a four-point rating 
scale (0 never, 1 sometimes, 2 often, 3 always). The ARS is a frequently used 
rating scale based on the DSM-IV criteria for ADHD [21, 29]. The scores are 
divided in three parts: the Number of ADHD criteria (18 in all), the nine items 
regarding inattention and the nine items regarding impulsivity and hyperactivity, 
the latter both marked out on a four-point rating scale [13]. 
Secondary endpoints were parent ratings on ODD symptoms measured by a 
structured psychiatric interview (SPI) based on the DSM-IV criteria for ODD. The 
parents and teachers who filled in the questionnaires could not be blinded as they 
had to supervise the food intake of the child and knew whether the child was 
following an elimination diet. 
Statistical analysis 
SPSS version 9.0 was used for all statistical analyses. Data was analysed on an 
intention-to-treat basis, with last observations carried forward in cases of missing 
data. Descriptive parameters for indicating effect size were % scale reduction and 
Cohen's d. Effects were tested at Ρ < 0.05; all testing was two-tailed. Subjects 
were defined as showing clinically significant improvement (responders) if the 
difference between measure point 3 (after the elimination diet) and measure point 
2 (after the baseline diet) was 50% or more on both the ACS and the ARS. Data 
was analysed by Student's t test and Fisher's exact test. 
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Results 
In sum 79 children were screened for eligibility, 43 of these failed to meet the 
inclusion criteria, and 9 refused to participate. As a result 27 children entered the 
study and were randomised to the intervention group [15] or the control group 
[12], The descriptive characteristics of the subjects enrolled are presented in 
table 2, Of the 27 children, 3 (11%) were lost to follow up: one child assigned to 
the control group withdrew after randomisation, whilst two children assigned to 
the intervention group dropped out, one because of illness, the other because the 
parents lacked motivation to stick to the diet (see figure 1), For 17 of the 27 
children, teacher data was available, in the other cases school contact at both 
Baseline and Endpoint rating was not possible due to holidays or teacher's illness. 
Table 2 Descriptive characteristics of study participants at time of inclusion 
Intervention group Ν (%) Control group Ν (%) 
Number of participants 
Boys 
Age (mean, (SD)) 
ADHD combined type 
ADHD predominantly 
hyperactive-impulsive type 
Co-morbid ODD 
On dietary restriction 
15 
12/15 
6,3 
10/15 
5/15 
12/15 
0/15 
(800%) 
(16) 
(66,7%) 
(33,3%) 
(80,0%) 
(0%) 
12 
10/12 
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8/12 
4/12 
10/12 
1/12 
(83.3%) 
(1,7) 
(66.7%) 
(33,3%) 
(83.3%) 
(8.3%) 
Primary outcomes 
Table 3 shows the parent ratings on the ACS, ARS and the SPI for both the 
intervention group and the control group (1) at the start of the trial, (2) after the 
baseline diet, and (3) at the end of the trial. The mean scores at the start of the 
trial and after the baseline diet was greater than 22.7 points (ACS) and 13.7 points 
(ARS Number of ADHD criteria, 18 at the most) in both the intervention and the 
control groups. There was no significant difference in the scores of both 
measurement points. At the end of the trial the mean scores in the intervention 
group showed a 62.6% improvement on the ACS and a 70.3% improvement on 
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Table 3 Parent ratings, last observation carried forward, at entrance of the trial (Start), after baseline (Base), and at endpoint (End) 
05 
05 
ACS 
ARS Number of 
ADHD 
criteria 
ARS 9 items 
inattention 
ARS 9 items 
hyperactivity/ 
impulsivity 
SRI 
ODD-critena a 
SR = Scale Reductie 
Start 
2 3 7 
(3.7) 
143 
(1.9) 
19.9 
(4.5) 
23 2 
(1.4) 
Base 
mean 
(SD) 
22.7 
(4.1) 
13.8 
(2.3) 
18.7 
(4.8) 
2 0 8 
(2.7) 
6.5 
(1.2) 
:N=12in 
Interventie 
N = 
End 
8.5 
(7.5) 
4.1 
(4.8) 
6.5 
(5.7) 
8.7 
(6.8) 
2.9 
(2.7) 
intervention 
m group 
5 
difference 
(95% CI 
Base-End) 
14.2 
(97-18.7) 
9 7 
(6.8-12.6) 
12.1 
(8.0-16.3) 
12.1 
(8.2-15.9) 
3.6 
(1.7-5.4) 
group, N=10in 
Ρ 
* 
(% SR) 
< 0 0 1 
* 2 3 
(62.6) 
<.001 
*2.6 
(70.3) 
<.001 
*3.2 
(652) 
<.001 
*2.3 
(58.2) 
< 0 0 1 
Start 
2 4 9 
(4.5) 
13.7 
(2.0) 
186 
(4.5) 
23.2 
(30) 
•1.7 
(554) 
control group; * Effe 
Base 
Mean 
(SD) 
24.9 
(4.2) 
13.7 
(3.5) 
17.6 
(6.1) 
2 2 4 
(4.5) 
5.4 
Control 
N = 
End 
26 0 
(4.6) 
13.4 
(3.9) 
18 3 
(53) 
2 2 8 
(5.6) 
5.3 
(1.3) (1.3) 
et size Base-End, Coh 
group 
12 
difference 
( 9 5 % CI 
Base-End) 
-11 
(-2.4-0.2) 
0.3 
(-0.4-0.9) 
-0.8 
(-1.7-0.2) 
-0.4 
(-1.6-0.8) 
0.1 
(-0.9-1.1) 
3n'sd 
Ρ 
* 
(% SR) 
<0.09 
*-0.2 
(-4.4) 
<0.43 
*0.1 
(2.2) 
<0.10 
*-0.1 
(-4.0) 
< 0 4 6 
*-0.1 
(-1.8) 
<0.83 
*0.1 
(1.9) 
Control group versus 
Intervention group, 
End rating 
Ν = 2 7 
mean ρ 
difference * 
(95% CI) (%SR) 
17.6 
(12.5-22.6) 
9.4 
(5.9-12.8) 
11.8 
(7 4-16.2) 
14.1 
(9.1-19.1) 
2.4 
(0.4-4.3) 
•c.OOl 
*2 8 
(67.3) 
<.001 
«2.1 
(69.4) 
<.001 
*2.3 
(64.5) 
<.001 
*2.3 
(618) 
<.02 
*1.1 
(45.3) 
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the ARS Number of ADHD criteria (P < 0.001). In the waiting-list group the scores 
increased by 4.4% (ACS) and decreased by 2.2% (ARS Number of ADHD criteria). 
Children in the intervention group showed a significantly greater decrease in 
behaviour problems than children in the control group, with a treatment effect—i.e. 
the difference in improvement between the intervention and control group—of 
17.6 (95% Confidence Interval (CI) 12.5-22.6, Ρ < 0.001, Student's ί test) on the 
ACS and 9.4 (95% CI 5.9-12.8, Ρ < 0.001) on the ARS Number of ADHD criteria. 
The treatment effect on the ARS included both inattention symptoms (mean 
difference 11.8, Ρ < 0.001) and hyperactivity/impulsivity symptoms (mean 
difference 14.1, Ρ < 0.001). The effect size (Cohen's d) was 2.8 (67.3% scale 
reduction) on the ACS and 2.1 (69.4% scale reduction) on the ARS Number of 
ADHD criteria. According to the parent ratings 11/13 children (85%) in the 
intervention group who completed the study showed an improvement of 50% or 
more, (mean difference on the Number of ADHD criteria 11.2 (95% CI 9.0-13.5, Ρ 
< 0.001). None of the children in the control group (0/11) showed an improvement 
of 50% or more (mean difference on the Number of ADHD criteria 0.3 (95% CI -0 4 
to 0.9, Ρ < 0.43). 
Table 4 shows the teacher ratings on the ACS and the ARS for both the 
intervention group and the control group (1) after the baseline diet, and (2) at the 
end of the trial. The parents' conclusions in table 3 were confirmed by the 
teachers. The treatment effect was 13.3 on the ACS (95% CI 7.5-19.1, Ρ < 0.001) 
and 8.4 on the ARS Number of ADHD criteria (95% CI 4,8-11.9, Ρ < 0.001), 
including both inattention symptoms (mean difference 8.3, Ρ < 0.011) and 
hyperactivity/impulsivity symptoms (mean difference 12.8, Ρ < 0.002). The effect 
size (Cohen's d) was 2.4 (64.3% scale reduction) on the ACS and 2.5 (70.6% 
scale reduction) on the ARS Number of ADHD criteria. 
According to the parent ratings, 11 out of the 15 children in the intervention 
group (73%) could be classified as responders. defined as showing behavioural 
improvement of at least 50% on both the ACS and the ARS, All responders did not 
meet the DSM-IV criteria for ADHD anymore. In the control group, none of the 12 
children (0%) were classified as responders (two-tailed Fisher's exact test, Ρ < 
0.001). According to the teacher ratings (N = 17) 7/10 children in the intervention 
group were responders (70%), versus 0/7 children (0%) in the control group 
(two-tailed Fisher's exact test, Ρ < 0.01). 
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Table 4 Teacher ratings after baseline (Base) and at endpoint (End) 
0 0 
m^Wm 
ACS 
ARS Number of 
ADHD 
criteria 
ARS 9 items 
inattention 
ARS 9 items 
hyperactivity/ 
impulsivity 
* Effect size Base-End 
Intervention group 
N=10 
Base End Base-End 
19.1 
(5.6) 
12.0 
(2.9) 
16.4 
(7.4) 
20.1 
(5.3) 
Coher 
mean difference ρ 
(SD) ( 95% CI) * 
(%SR) 
7.4 11.7 <.001 
(5.3) (8.0-15.4) *2.1 
(61.3) 
3.5 8.5 <.001 
(3.4) (6.4-10.7) *2.7 
(70.8) 
7.0 9.4 <.001 
(6.1) (5.9-12.9) *1.4 
(57.3) 
7.3 12.8 <.001 
(4.8) (8.6-17.0) *2.5 
(63.7) 
's d: SR = Scale Reduction 
Control group 
Base End 
21.1 
(6.7) 
10.9 
(4.3) 
13.6 
(6.8) 
20.6 
(7.4) 
mean 
(SD) 
•Hi 
20.7 
(5.9) 
11.9 
(3.3) 
153 
(4.3) 
20.1 
(7.7) 
N=7 
Base-End 
difference 
( 95% CI) 
0.4 
(-1.9-2.8) 
-1.0 
(-3.2-1.2) 
-1.7 
(-6.2-2.8) 
0.4 
(-1.3-2.2) 
Ρ 
* 
(%SR) 
<0.667 
*0.1 
(1.9) 
<0.309 
*-0.3 
(-9.2) 
<0.389 
*-0.3 
(-12.5) 
<0.573 
*0.1 
(2.4) 
Contro group 
versus intervention group 
End rating 
mean 
difference 
(95% CI) 
13.3 
(7.5-19.1) 
8.4 
(4.8-11.9) 
8.3 
(2.6-14.0) 
12.8 
(6.4-19.3) 
Ρ 
* 
(% SR) 
< .001 
*2.4 
(64.3) 
<.001 
*2.5 
(70.6) 
<.011 
*1.6 
(54.2) 
<.002 
*2.0 
(63.7) 
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Secondary outcomes 
At the entrance of the trial, 12/15 children in the intervention group (80%) and 
10/12 children in the control group (83%) met the DSM-IV criteria for ODD 
according to the SPI (see table 3). The mean number of ODD symptoms was 6.5 
in the intervention group (the DSM-IV-diagnostic criteria for ODD are met if the 
child complies with four or more out of eight symptoms) and 5.4 in the control 
group. At the end of the trial, 4/15 children in the intervention group (27%) and 
10/12 children in the control group (83%) still met the ODD-criteria, the mean 
number of ODD symptoms now being 2.9 in the intervention group and 5.3 in the 
control group. The difference between the measure points at the beginning and 
attheendof thetrial was3.6(95%CI 1.7-5.4, Ρ < 0.001) in the intervention group 
and 0.1 (95% CI -0.9 to 1.1, Ρ < 0.83) in the control group, with a mean difference 
of 2.4 (95% CI 0.4-4.3, Ρ < 0.02). The effect size (Cohen's d) was 1.1 (45.3% scale 
reduction). 
Discussion 
Our results show that a carefully supervised few foods diet in young children with 
ADHD, followed for 5 weeks at the most, can exhibit substantial changes in 
behaviour. Seventy percent of the children showed behavioural improvements of 
50% or more according to the ratings of parents and teachers and did not meet 
the DSM-IV criteria for ADHD anymore. The results of this randomised controlled 
study do not differ from the results of equivalent studies [7, 8, 14. 17, 25, 26]. All 
controlled trials on ADHD and foods using a few foods diet show a more or less 
beneficial effect on the behaviour of the subjects. The extent of restriction of the 
elimination diet seems important and may affect the degree of the behavioural 
improvements: a diet including too many foods may reduce the number of 
responders [25]. Consequently, a diet excluding just one or a limited number of 
foods, like sugar or additives, would be of little benefit to children with ADHD [8, 
10. 15]. Recent additive trials have shown that some degree of hyperactivity, 
when exposed to artificial food colours and benzoate preservatives, may be 
applied to all 3-year old children, not exclusively to hyperactive children [4, 20]. 
This might imply that there is a general adverse effect of additives or preservatives 
on the behaviour of all young children, with a small effect size (0.18). 
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As we wanted to investigate the influence of foods on ADHD, we excluded 
children with potentially predisposing environmental risk factors for ADHD, like 
prematurity, dysmaturity and foetal exposure to maternal alcohol or cigarettes 
[31]. Efforts were made to obtain an unbiased sample, the children were not 
preselected for affinity with dietary intervention. 
At the entrance of the study, 22/27 children also met the criteria for ODD, 80% 
of the children in the intervention group and 83% of the children in the control 
group. Co-existence of ODD is very common in ADHD [31]. At the end of the trial, 
all children in the control group still met the criteria, but in the intervention group 
the number of children meeting the ODD-criteria had diminished by 66%, We 
expected the children in the intervention group to show deterioration of their ODD 
behaviour, opposing the dietary restrictions which they surely would not like. 
It appears as if the elimination diet triggers a significant change in both 
ADHD symptoms and ODD symptoms. This is important, as ADHD-children with 
co-morbid ODD/CD are at risk for long-term maladjustment [3]. It is tempting to 
speculate that the appliance of an elimination diet in young children might reduce 
this risk 
Study limitations 
This study is an open-label controlled trial, without placebo. The elimination diet 
used in this study was very restricted, only a few foods were allowed, thus making 
it impossible to compose a reliable placebo diet. The fact that even a small 
change in the diet of a child, like removing additives, may have a beneficial effect 
on the behaviour of children [4, 20], illustrates the difficulties of constructing a 
placebo diet. Parents and teachers were aware of the intervention, which is a 
limitation that needs to be acknowledged. Although open randomised controlled 
trials are commonly used when blinding is difficult [6, 11, 24, 27, 28, 30, 33. 34], 
we recommend replication of this trial with blinded measurements by an 
independent observer [6]. Also the incorporation in future studies of objective 
tests of attentional performance and executive functioning should be considered. 
It is conceivable that the increased attention for the child during the elimination 
diet contributes to the behavioural improvements. In order to measure the effects 
of increased attention during this trial, all parents had to keep an extended diary 
during the baseline diet, having to watch their child carefully. The second 
assessment took place at the end of the baseline diet. There were no significant 
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differences between the scores at the entrance of the trial and after baseline. Still 
the placebo effects of expectation and intense caregiver involvement have to be 
considered. 
The adherence to a restricted elimination diet can be considered as 
burdensome, dietary management is difficult and puts a considerable strain on 
the family [8], so this method will not be applicable to all children with ADHD. Still 
dietary investigation can be an option for some children, and parents who are 
interested should be offered the possibility to follow a few foods diet with their 
child, provided that a trained dietician is available to supervise the intervention 
[15]. If the diet has a beneficial effect on the behaviour, challenge tests with 
specific foods should be exhibited to identify the incriminated foods and to make 
the diet more manageable. Further research could focus on the follow up of 
dietary interventions in children with ADHD and on the feasibility of long-term 
dietary restrictions. 
The mechanisms in which foods exerts its effects remain unclear. Toxic, phar-
macological, or immunologic mechanisms could be involved and the physiological 
effects of different foods may vary [8]. More research on this topic is needed. 
In conclusion, this study confirms the results of earlier studies [7, 8, 14, 17, 25, 
26], that a strictly supervised and restricted elimination diet can affect the 
behaviour of some children with ADHD and may be a valuable instrument in 
testing young children with ADHD on whether dietary factors may contribute to 
the manifestation of the disorder. 
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Abstract 
Attention deficit/hyperactivity disorder (ADHD), a common behavioural disorder 
in children, may be associated with comorbid physical and sleep complaints. 
Dietary intervention studies have shown convincing evidence of efficacy in 
reducing ADHD symptoms in children. In this pilot study, we investigated the 
effects of an elimination diet on physical and sleep complaints in children with 
ADHD. 
A group of 27 children (3.8-8.5 years old), who all met the Diagnostic and 
Statistical Manual of Mental Disorders, Fourth Edition criteria for ADHD, were 
assigned randomly to either a diet group (15/27) or a control group (12/27). The 
diet group followed a 5-week elimination diet; the control group adhered to their 
normal diet. Parents of both groups had to keep an extended diary and had to 
monitor the behaviour and the physical and sleep complaints of their child 
conscientiously. The primary endpoint was the clinical response, i.e. a decrease 
of physical and sleep complaints, at the end of the trial, based on parent ratings 
on a Physical Complaints Questionnaire. 
The number of physical and sleep complaints was significantly decreased in 
the diet group compared to the control group (p<0.001), with a reduction in the 
diet group of 77% (p<0.001, effect size=2.0) and in the control group of 17% 
(p=0.08, effect size=0.2). Specific complaints that were significantly reduced 
were in three domains: headaches or bellyaches, unusual thirst or unusual 
perspiration, and sleep complaints. The reduction of complaints seemed to occur 
independently of the behavioural changes (p = 0.1). However, the power of this 
comparison was low. A positive correlation existed between the reduction of 
physical and behavioural symptoms (p<0.01). The reduction did not differ 
between children with or without an atopic constitution (p = 0.7). 
An elimination diet may be an effective instrument to reduce physical 
complaints in children with ADHD, but more research is needed to determine 
the effects of food on (functional) somatic symptoms in children with and without 
ADHD. This trial was registered as an International Standard Randomised 
Controlled Trial, ISRCTN47247160. 
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Introduction 
Attention deficit/hyperactivity disorder (ADHD) [1], one of the most common 
behavioural disorders in childhood, with symptoms of inattention, hyperactivity 
and impulsivity [18], often coexists with other problems, like oppositional defiant 
disorder, depression, anxiety, physical complaints (e.g. headache, eczema and 
diarrhoea) and sleep complaints [9-11, 13, 14, 16, 21, 22, 27, 29, 35, 39]. The 
exact aetiological pathways of ADHD are still unknown: genetic risk factors 
including multiple genes (some of which are involved in the regulation of the
 0 
9 
immune system [30]) and environmental factors are involved. Ί 
To date, pharmacotherapy, combined with behavioural management, is the *· 
most effective treatment of ADHD [20]. Despite initial symptom improvement 
during this treatment, the follow-up study of the Multimodal Treatment Study of 
children with combined-type ADHD [24] showed that these children exhibit 
significant impairment in adolescence, implicating that innovative treatment 
approaches are needed [24]. Moreover, as treatment with psychostimulants like 
methylphenidate, with a duration of action of between 3 and 12 h [39], neither 
leads to resolve the behavioural problems in the early morning and in the evening 
nor resolves the comorbid physical complaints, it is worthwhile to investigate 
other treatments of ADHD and their effects on comorbid complaints. 
One of these alternative treatment methods for ADHD may be an elimination 
diet. The effects of an elimination diet on ADHD have been investigated in several 
controlled studies [5, 9, 13, 22, 31, 34, 36], showing a significant effect of a 
restricted elimination diet on symptoms of ADHD and establishing that there 
clearly is a diet behaviour connection [2, 6]. Considering the comorbidity between 
ADHD and physical complaints (in one study, 20 out of 31 children with ADHD 
were reported to have at least two physical complaints [29]), one may speculate 
about a connection between food, ADHD and physical complaints. Given that (1) 
an elimination diet can significantly reduce ADHD symptoms [5, 9, 13, 22, 31, 34, 
36], (2) the vast majority of children with ADHD suffers from co-occurring physical 
complaints [9,13, 22, 29], (3) children with ADHD and extensive physical problems 
tend to respond less favourably to medication [3], (4) medication treatment does 
not solve the physical complaints or even causes some of these complaints [39] 
and (5) that a diet can have a positive effect on physical complaints in children 
and adults without ADHD [4, 41], it is timely to study the potentially beneficial 
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effects an elimination diet may have on physical and sleep complaints in children 
with ADHD. 
In four previous studies, the effect of an elimination diet on comorbid physical 
symptoms in children with ADHD has already been investigated, resulting both in 
a reduction of the behavioural as well as of the physical complaints [9, 13, 22, 29]. 
Most of the children participating in these studies were diagnosed with allergy or 
had an atopic constitution (being defined as having at least one parent or sibling 
with an allergic disease like asthma, eczema, hay fever or allergic rhinitis), thus 
limiting the extrapolation of findings to children with ADHD without allergies or an 
atopic constitution. Another limitation of these previous studies is that they did 
not report on whether or not the improvement of physical complaints coincided 
with improvements in ADHD symptoms. It is important for clinical health care, i.e. 
to predict the effects of an elimination diet, and for scientific reasons, i.e. to 
increase our knowledge about the aetiology of ADHD and physical complaints, to 
investigate whether reduction in ADHD symptoms and physical complaints go 
hand in hand when applying an elimination diet. 
The current study aimed to examine these issues. We previously reported that 
an elimination diet had a statistically significant and clinically relevant effect on 
ADHD symptoms as reported by both parents and teachers, with effect sizes of 
2.1 and 2.5, respectively [31], The results on the endpoints concerning physical 
and sleep complaints will be presented in this paper. More specifically, we aimed 
to (1) examine whether physical and sleep complaints in children with ADHD 
could be diminished using an elimination diet, (2) investigate whether the effect of 
an elimination diet on physical and sleep complaints was limited to those children 
who clearly showed behavioural improvements to the elimination diet, and (3) 
investigate whether the effect of an elimination diet on physical and sleep 
complaints was restricted to children with an atopic constitution. 
Subjects and methods 
Subjects 
Participants were selected from a sample of 79 Dutch children who were referred 
to the Dutch ADHD Research Centre in Eindhoven, specialised in scientific 
research on food and ADHD. Children were included if (1) they were between 3 
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and 8 years old; (2) they met the criteria for ADHD, as defined in the Diagnostic 
and Statistical Manual of Mental Disorders, Fourth Edition for ADHD Combined 
Type or Predominantly Hyperactive-Impulsive Type [1]: (3) their behavioural 
problems were present before the age of 4 or (4) they were medication naïve. 
Children were excluded if (1) they were diagnosed with Autism Spectrum Disorder 
or with ADHD Predominantly Inattentive Type [28], (2) they were pre-or dysmature 
at birth [30, 40] or (3) the mother had been smoking during pregnancy. A total of 
43 children of the 79 failed to meet the criteria, and nine refused to participate. As 
a result, 27 children entered the study between January and July 2006 and were 
randomly allocated to the diet group (15) or the control group (12), see figure 1, 
Twenty-four children, 13 in the diet group and 11 in the control group, completed 
the study. At the start of the trial, there was no difference between the number of 
physical complaints or the severity of ADHD symptoms in diet group and control 
group (table 1). 
Table 1 Baseline characteristics of the 24 children who completed the 
interventions 
Characteristic Diet group, 
N=13 
Control group, 
N=11 
Fisher exact 
ρ value (two-sided) 
mean (% or SD) mean (% or SD) 
Boys 
Mean age (SD) 
Mean number of ADHD 
Criteria (SD) 
Co-morbid ODD 
Atopic constitution family 
Allergy diagnosed in child 
On dietary restriction 
Mean number of physical 
Problems (SD) 
Sleep complaints 
10/13 (76.9%) 
6,3 
14.4 
(1.6) 
(2.0) 
12/13 (80.0%) 
9/13 
1/13 
0/13 
3.0 
5/13 
(69.2%) 
(7.7%) 
(0%) 
(1.4) 
(38.5%) 
9/11 
6.2 
13.7 
10/11 
8/11 
2/11 
1/11 
2.8 
5/11 
(81.8%) 
(1.7) 
(2.1) 
(83.3%) 
(72.7%) 
(18.2%) 
(9.1%) 
(2.2) 
(45.5%) 
>0.99 
0.91' 
0.44' 
0.60 
099 
058 
0.46 
0.81 = 
>0.99 
Ν number of participants, a Students ( test 
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Figure 1 Flow diagram of subject participation throughout the study 
79 children screened 
for eligibility 
— 
i 
52 excluded 
43 did not me« inclusion criteria 
9 refused to participate 
2 7 randomised 
15 assigned to intervention group 
i 
2 dropped out 
! child sick 
Î withdrawn 
i 
13 completed the trial 
12 assigned to control group 
i 
1 dropped out «itbdrawn 
11 completed the trial 
Protocol 
The efficacy of an elimination diet on the reduction of physical and sleep 
complaints in children with ADHD was tested in this randomised controlled trial 
(RCT) by comparing outcomes within diet and control group, before and after 
intervention and between groups. Subjects were randomly allocated to one of the 
two groups by means of a sequence of numbered cards in sealed unmarked 
envelopes that were prepared by an independent paediatrician. Each card 
contained a reference to the group to which the child would be allocated, and for 
each allocation, an equal number of cards (20) were available. The envelopes 
were picked and opened by the parents in the presence of the researcher, and 
treatment was then dispensed in accordance to the allocation on the card. 
All children started with a 2-week baseline diet in which they adhered to their 
normal diet; no foods were eliminated. Children who were already on a diet had to 
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cease this diet at least 2 weeks before the start of the trial. During the baseline 
diet, the parents kept an extended diary and had to observe their child carefully, 
in order to assess the child's normal diet, his/her behaviour, physical complaints, 
sleep complaints and activities. There were two measurement points: at the end 
of the baseline diet and at the end of the elimination diet (diet group) or the control 
period (control group). 
The diet group started, after the baseline diet and the first assessment, with 
the elimination diet, which had to be followed for a period of 5 weeks. The 
elimination diet was based on a few foods diet, as described by Hill and Taylor in 
their basic algorithm for treatment of ADHD [19]. The rationale behind the few 
foods diet was the assumption that children might present with ADHD symptoms 
after eating any kind of foods. Therefore, the diet consisted only of a limited 
number of hypo-allergenic foods, like rice, turkey, lamb, a range of vegetables 
(lettuce, carrots, cauliflower, cabbage and beet), pears and water. All other foods 
were prohibited, but vegetables, fruits, rice and meat were allowed every day, in 
normal doses. Calcium was supplied daily via non-dairy rice drink with added 
calcium; children were not at risk for nutrient deficiencies. This few foods diet was 
complemented with specific foods like potatoes, fruits, corn and wheat, to be 
eaten on days and in doses stated in advance according to a compulsory intake 
schedule [9, 29, 31]. As a result of this strategy, an elimination diet as 
comprehensive as possible could be composed for each individual child, thus 
making the intervention less incriminating for child and parents. If there was no 
improvement by the end of the second week, the diet was restricted and gradually 
limited to the few foods diet [9, 29, 31]. The second measurement point occurred 
at the end of the elimination diet. 
The control group continued, after the first assessment, their baseline diet, i.e. 
their normal diet in which no foods were excluded, for a period of 5 weeks. 
Unfortunately, in dietary studies using a very restricted diet, it is not possible to 
create a reliable placebo diet, thus impeding a placebo-controlled trial. Therefore, 
this study is an RCT, which is often used in studies when no placebo is available, 
such as studies into the effects of cognitive behaviour therapy, eczema or other 
medical intervention trials [32, 37, 38, 41, 43, 45]. As it is conceivable that the 
child's behaviour and somatic complaints might improve because of the special 
attention which parents have to give to their child in order to fill in the diary 
correctly, parents of children in the control group also had to keep an extended 
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diary and had to monitor the behaviour and the physical and sleep complaints of 
their child conscientiously. The second measurement point was at the end of the 
control period. 
At the start of the trial, the parents of the control group were informed that they 
could start with the elimination diet immediately after the last assessment, if they 
wished so. Parents were given verbal and written information about the study, and 
written informed parental consent was obtained before randomisation 
Measures 
Physical and sleep complaints were measured using the Physical Complaints 
Questionnaire (PCQ) [28, 29]. This questionnaire consisted of 36 questions, of 
which 18 items were relevant with respect to specific physical and sleep 
complaints. Items were rated on a four-point scale, concerning the problems 
during the past week: problems which occurred every day (3), several times a 
week (2), once a week (1) or less than once a week (0). The questionnaire had to 
be filled in by the parents twice, e.g. before and after the elimination diet or control 
period. The physical complaints concerned 16 items and were subtyped into 
seven domains: (1) pain (headaches, abdominal pains and growing pains), 
(2) unusual thirst or unusual perspiration, (3) eczema, (4) asthma or persisting 
cold (rhinitis), (5) skin problems (blotches in the face, red ears, red-edged mouth 
or bags under the eyes), (6) tiredness and (7) gastrointestinal problems (diarrhoea, 
constipation and flatulence). Two of the 18 questions concerned sleep complaints, 
i.e. problems with sleeping in (sleep initiation or sleep onset) and sleeping on 
(sleep maintenance). A domain was considered to be present when rated 2 
(several times a week) or 3 (every day) for at least one of the items within that 
domain. A problem was considered to be absent when the score was 0 or 1 for all 
items within that domain. 
Statistical analysis 
Main endpoints were the parent ratings on the PCQ at the end of the RCT to 
establish the effect of the intervention on physical and sleep complaints 
Differences in averages within groups (effect size), before and after the trial, were 
tested by Student's t test and expressed by Cohen's d, a standardised measure 
of the effect size with an effect size of 0.2 indicative of a small effect and 0.8 of a 
large effect. Differences in average number of complaints between groups, at the 
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end of the trial, were analysed using linear regression, including the number of 
complaints at the start of the trial as covariate. 
Differences in presence/absence of complaints between groups, at the end of 
the trial, were analysed using exact logistic regression, because the endpoints 
were binary. PCQ ratings at the start of the study were included as covariate. 
Here, the effect of intervention was expressed in terms of odds ratios (OR) and 
theirp values. 
After finishing the RCT, all children in the control group (N=11) also completed 
the elimination diet, resulting in 24 children in total who underwent the elimination 
diet, i.e. 13 children from the diet group, during the RCT, and 11 children from the 
control group, following the RCT. The secondary endpoints, analysed using linear 
and exact logistic regression, and calculated in all 24 children who completed the 
diet, were (1) the effects of the elimination diet on physical and sleep complaints 
in children who showed ADHD symptom reduction of 50% or more after following 
the elimination diet, i.e. responders, and in children who showed less than 50% 
ADHD symptom reduction, the nonresponders [31] and (2) the effects of the 
elimination diet on physical and sleep complaints in children with and without an 
atopic constitution. 
Spearman rank correlation coefficients were calculated to study the 
improvement of physical complaints and ADHD core symptoms after having 
followed the diet. STATA 10 was used for all statistical analyses. Effects were 
tested atp=0.05. 
Results 
Effect of the intervention on physical and sleep complaints in diet group 
and control group 
The results of the intervention on physical and sleep complaints in both groups 
are shown in table 2 and figure 2. The total number of complaints in the diet 
group was 44 (average, 3.4 per child) at the start of the trial and ten complaints 
(average, 0.8) at the end of the trial, a reduction of 77% (p<0.001), with a 
standardised effect size (Cohen's d) of 2.0 (table 3). In the control group. 36 
complaints (average, 3.3) were reported at the start of the trial and 30 (average, 
2.7) at the end of the trial, a reduction of 17% (p=0.08), with an effect size of 0.2. 
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Using linear regression and taking the initial number of complaints into 
account, the difference in average number of complaints at the end of the trial 
between the diet and control group equalled 2.04 (95% confidence interval (CI) 
114-2.94, p<0.001, residuals being normally distributed, ρ value of Shapiro-Wilk 
test equals 0.55). 
In three domains [(1) headaches or bellyaches (OR= 13.25), (2) unusual thirst 
or unusual perspiration (OR= 10.04) and (3) sleep complaints (OR=11.77)], the 
complaints were significantly less reduced in the control group than in the diet 
group (p<0.05). 
Figure 2 Physical and sleep complaints in the diet group and the control 
group at start and at endpoint 
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CO 
Headaches, abdominal pains, growing pains 
Unusual thirst, unusual perspiration 
Eczema 
Asthma, rhinitis 
Blotches in face, red ears, red-edged mouth, 
bags under eyes 
Tiredness 
Diarrhoea, constipation, flatulence 
Problems with sleeping in or sleeping on 
Total number of complaints, including 
sleep complaints 
Diet group, N= 
Start trial 
Ν children 
% children 
9 (69%) 
10(77%) 
1 (8%) 
2 (15%) 
2 (15%) 
9 (69%) 
6 (46%) 
5 (38%) 
44 
=13 
End trial 
Ν children 
% children 
1 (8%) 
0 (0%) 
0 (0%) 
1 (8%) 
1 (8%) 
4 (31%) 
2 (15%) 
1 (8%) 
10 
Control group 
Start trial 
Ν children 
% children 
9 (82%) 
6 (54%) 
5 (45%) 
2 (18%) 
3 (27%) 
3 (27%) 
3 (27%) 
5 (45%) 
36 
N=11 
End trial 
Ν children 
% children 
6 (54%) 
4 (27%) 
5 (45%) 
1 (9%) 
3 (27%) 
3 (27%) 
3 (27%) 
5 (45%) 
30 
Exact OR 
13.25a 
10 04 
5.00 
1.00 
1,50 
358 
4,66 
11,77 
16.20" 
ρ value OR 
0.05 
0.05 
033 
0.99 
080 
0.32 
0,24 
0,05 
0,001 
!
 The odds of having complaints at the end of the trial is 13,25-fold higher in the control group compared to the diet group; b Based on 80 initial complaints 
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Table 3 Average number of physical complaints, including sleep complaints, 
per child per intervention group at start and at endpoint 
Average no. of complaints 
Start End Start minus end 
Difference (95% CI) Effect size' (% SR) 
ρ value 
Diet group (N=13) 3.4b 0,8 2.6 (1 8 to 3,4) 2.0 (77.3) p=0.001 
Control group (N=11) 3,3b 2,7 0.6 ( 0,1 to 1.2) 0.2 (16.7) p=0.08 
SR scale reduction; a Effect size start-end, Cohen's d. " Difference at startp=0.89 (Student s ί test) 
Effect of the elimination diet on physical and sleep complaints in children 
with and without ADHD symptom reduction 
This effect was calculated in all 24 children who followed the elimination diet, 13 
children of the diet group and 11 children of the control group following the RCT 
Of these children, 20/24 belonged to the responders, 11/13 children of the diet 
group and 9/11 children of the control group. The responders, having to show a 
minimal ADHD symptom reduction of 50%, showed an average reduction on the 
ADHD rating scale of 69.4% (effect size, 2.1), according to the parent ratings, and 
an ADHD symptom reduction of 70.6% (effect size, 2.5), according to the teacher 
ratings. 
Before following the diet, there was an average of 3.2 physical and sleep 
complaints per child in the responder group and 2.5 in the nonresponder group. 
After the diet, these averages were 0.9 and 1.5, respectively. In the responder 
group, there was a significant reduction of physical complaints (p<0.001); in the 
nonresponder group, the reduction was not significant (p = 0.35), with standardised 
effect sizes of 1.4 and 0.8, respectively. 
Linear regression, including the initial number of complaints as covariate, 
revealed a difference in average number of complaints between the responder 
and nonresponder group of 0.82 (p value 0.10, residuals normally distributed, ρ 
value of Shapiro-Wilk test equals 0.62). The correlation between the total number 
of physical and sleep complaints and the total number of ADHD criteria on the 
ADHD rating scale, before and after the diet, was calculated using Spearman 
rank correlation coefficients. Spearman's rho was 0.54 (p<0.01), indicating there 
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was a positive correlation between the reduction of the physical and the 
behavioural symptoms. Statistical analyses to investigate the difference in effect 
of the elimination diet on the specific physical domains in responders and 
nonresponders could not be performed as there were only four nonresponders. 
Effect of the elimination diet on physical and sleep complaints in children 
with and without an atopic constitution 
This effect was calculated in all 24 children who followed the elimination diet. An 
atopic constitution, i.e. having at least one parent or sibling with allergic complaints
 0 
like asthma, eczema, hay fever or allergic rhinitis, was present in 17/24 (70.8%) 
children, equally divided over the diet group (9/13, 69.2%) and the control group *• 
(8/11, 72.7%; Fisher's exact test, p=0.99). At the start of the trial, an average of 3 5 
complaints per child was observed in the atopic children and an average of 2.0 
per child in the non-atopic group. After the diet, these averages were 1.2 and 0.6, 
respectively. In the atopic as well as in the non-atopic children, there was a 
significant reduction of physical complaints, (p values <0.001 and 0 04, 
respectively) with standardised effect sizes of 1.5 and 1.1, respectively. 
Although the reduction within both groups was significant, linear regression 
did not show a significant difference between the atopic and non-atopic group at 
the end of the diet while adjusting for the initial number of complaints (difference 
equals 0.18 complaints, p=0.70, residuals normally distributed, ρ value of 
Shapiro-Wilk test equals 0.73). 
Complaint specific analyses could not be performed due to the low number of 
non-atopic children (n=7). 
Discussion 
Physical complaints, such as headache, bellyache, tiredness, eczema and sleep 
complaints, are common comorbid problems in children with ADHD [10, 11, 16, 
21, 27, 35, 39], with a prevalence of sleep complaints up to 50% [39]. In contrast 
to comorbid psychiatric conditions, relatively little is known on the comorbidity of 
ADHD and physical complaints. In this study, we examined whether physical and 
sleep complaints in 24 children with ADHD were improved by an elimination diet 
using a randomised controlled design. We previously described that the diet 
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significantly reduced the ADHD symptoms in this group of patients [31]. In the 
current study, in which the subjects were not preselected for somatic symptoms, 
23/24 (96%) children had one or more physical complaints, indicating that 
comorbidity between ADHD and physical complaints is high, thus underlining the 
importance of studying physical complaints in ADHD. 
The results of this pilot study should be interpreted in the light of several 
limitations. First, in this study, a very restricted elimination diet was used, thus 
making it impossible to compose a reliable placebo diet. Furthermore, parents 
had to be aware of the intervention and had to pay attention to what the child 
should eat. Therefore, we had to choose for an open RCT. Although a blinded 
RCT should be given preference to, open RCTs are commonly used and accepted 
when blinding is difficult and when no placebo is available, e.g. in studies into the 
effects of cognitive behaviour therapy, eczema, obesity, autism or other medical 
intervention trials [7, 12, 15, 32, 37, 38, 41, 43, 45]. Also, the well known and highly 
cited Multimodal Treatment Study of Children with ADHD, the MTA-study, was not 
blinded [26]. To compensate for the absence of a placebo diet, the parents in the 
control group, like the parents in the diet group, had to monitor and to observe 
their child intensively, writing down the behaviour and the physical and sleep 
complaints of their child conscientiously in a diary. It is conceivable that the 
child's behaviour and somatic complaints might improve because of the special 
attention which parents had to pay to their child. In our study, the reduction of the 
total numbers of complaints in the diet group (77%) was 4.6-fold compared to the 
reduction in the control group (17%; p = 0.001), indicating that the effect of an 
increase of attention may be small, when compared to the effect of an elimination 
diet. Second, the trial lasted only 5 weeks, which is a short period of time. 
Follow-up studies should include a follow-up period of at least 1 year. Finally, the 
sample size of the study was relatively small; consequently, the data reported 
here should be considered exploratory. Nevertheless, due to the considerable 
effect sizes in this study, statistically significant differences between diet and 
control were obtained. 
The effect of the intervention on physical and sleep complaints did not differ 
significantly between children who did or did not show ADHD symptom reduction 
after following the diet. The adjusted difference between both groups amounted 
to 0.82 (p = 0.10), suggesting the diet is equally effective in reducing physical 
complaints in responders and nonresponders. However, the power of this analysis 
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is low (0.26), as the nonresponder group consisted of four children only. 
Correlation analyses revealed that ADHD symptom reduction and the reduction 
of physical complaints were correlated significantly. We hypothesise, considering 
the effect size of an elimination diet on both ADHD and physical complaints, that 
there may be a common underlying mechanism for both conditions. This 
mechanism may be a hypersensitivity reaction to food, which could be an 
etiological factor of both conditions [30]. This hypersensitivity mechanism might 
either be allergic, i.e. related to the induction of IgE or IgG antibodies or of a 
cell-mediated response [30], or not allergic, i.e. related to a toxic or pharmacologic 
mechanism. When there is no effect of an elimination diet on one or more of the 
complaints, other etiological mechanisms are likely and should be considered. 
In this study, 71% of the ADHD children had an atopic constitution. This high 
prevalence may be related to the possibility that parents acquainted with allergic 
disorders are more willing to let their child follow an elimination diet than parents 
unfamiliar with allergies. On the other hand, atopy is a widespread condition, 
found in many children. A UK study reported that 39% of children in the UK had 
been diagnosed with one or more atopic conditions [17], and positive skin prick 
tests to at least one allergen was found in 63.7% of urban children [23]. Our study 
shows that in atopic and in non-atopic children, the number of physical and sleep 
complaints did not differ significantly before (p= 0.081) as well as after (p=0.32) 
the elimination diet. We did find, although not statistically significant, that at the 
start of the trial more physical complaints were reported in atopic children 
(average, 3.5 per child) than in non-atopic children (average, 2.0 per child). The 
results of this study indicate that the presence of an atopic constitution is not a 
moderator of the effect of an elimination diet on physical complaints and sleep 
complaints in children with ADHD, but do suggest atopy is an important condition 
co-occurring with ADHD, 
The subjects in our study were young, but children of 4 years and older are 
generally expected to be able to tell that it hurts and where it hurts. Therefore, 
headache, abdominal pains and pain in the legs or arms (growing pains) are 
probably reliably reported. However, restless legs or breathing difficulties may be 
more difficult for a child to describe, so it may be conceivable that the number of 
physical complaints is underestimated. We would like to emphasise that the sleep 
complaints were reported by the parents, not by the child. These complaints are 
generally well visible to the parents and have a large impact on family life. As 
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ADHD has an increased association with sleep-related movement disorders such 
as restless legs syndrome [44], the relationship between food, ADHD and sleep 
complaints should be investigated more thoroughly in follow-up studies. 
Although we do not know the mechanisms in which an elimination diet exerts 
its effects on physical and sleep complaints in ADHD, our findings indicate that 
the results of this study may be important for children with physical complaints or 
sleep complaints and ADHD. They even may be important for children with 
physical conditions without ADHD [4, 8, 25, 42] and for children with functional 
somatic symptoms, as these are common health complaints in 5-7-year-old 
children [33]. 
More research on the effects of foods and on the underlying mechanism is 
advised to investigate whether children with ADHD and co-occurring physical 
complaints may represent a specific ADHD subgroup. We hypothesise that there 
may be a common underlying genetic mechanism contributing to both medical 
conditions, comparable to the mechanism found by Campbell et al., in children 
with co-occurring autism and gastrointestinal conditions [8]. Consequently, the 
further unravelling of the genetic architecture of ADHD is very important to identify 
a common genetic pattern or genetic vulnerability in children with ADHD and 
physical complaints. Also, it is important to segregate between non-allergic or 
allergic mechanisms involved. This includes analysis of the role of IgE and IgG 
antibodies being specific for the food and the possible involvement of Τ 
cell-mediated hypersensitivity. 
In studies specifically asking for physical complaints in children with ADHD, it 
turns out that comorbidity is high [9, 13, 22, 29]. This high comorbidity between 
physical symptoms and ADHD does not reflect clinical practice, which may be 
due to the fact that in children with ADHD, it is not current practice to ask for 
physical complaints specifically. A general question like 'are there any physical 
complaints' may not be sufficient, generating too little information. Many of the 
physical symptoms investigated in this trial would not have been mentioned by 
the parents if we had not asked for them. 
Because diets are not without its limitations (socially handicapping, putting a 
strain on the whole family), they should only be applied after responsiveness has 
been individually and carefully tested by means of an elimination diet, supervised 
and administered by trained staff [34]. If a child following the diet shows beneficial 
behavioural or physical effects, sequential introduction of foods is necessary to 
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identify the incriminated foods [9, 13], so that the eventual diet of the child will be 
as comprehensive as possible. If a child who responds favourably to the diet will 
not proceed with this provocation period and returns to its usual diet, consequently, 
the problems are likely to return. 
Further controlled studies are needed to verify the efficacy of an elimination 
diet in children with physical complaints and to provide a feasible algorithm for 
treatment, especially for children with behavioural or physical complaints 
triggered by foods. We will pursue this issue in a large (N=100) sample of ADHD 
children using an RCT (the Impact of Nutrition on Children with ADHD study) 
currently underway, the protocol of which can be found on the website of The 
Lancet (http://www.thelancet.com/ protocol-reviews/06PRT-7719). 
Clinical implications and conclusion 
Our study shows that hypersensitivity to food may play an etiologic role in physical 
and sleep complaints in children with ADHD and suggests that an elimination diet 
may be a valuable tool to manage these problems in ADHD children. As functional 
somatic symptoms are common health complaints in 5-7-year-old children [33], 
the results of this study may be important for all children. Still, the sample size 
was small, and we cannot rule out expectation effects. Therefore, more research 
is needed to determine the effects of food on physical and sleep complaints in 
children with and without ADHD. 
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Abstract 
Research data concerning the causal association between attention deficit 
hyperactivity disorder (ADHD) and allergies are conflicting. Allergic disorders, like 
asthma and eczema are clinical syndromes in which both genetic predisposition 
and environmental factors (pets, pollen and foods) contribute to its development. 
The hypothesis of ADHD, in some children also being an allergic disorder, is 
postulated based on comparison of the mechanisms underlying the development 
of ADHD and allergic disorders. According to the accepted terminology, ADHD 
may comply with the criteria of hypersensitivity, allergy and atopy. 
This hypothesis has to be thoroughly tested by randomized controlled trials 
using environmental triggers and immunologic research. As genes related to the 
immune system may be associated with ADHD, further genetic research is 
compulsory. Immunotherapeutic approaches, using immunotherapy and 
probiotics. can subsequently be implicated in the treatment of ADHD. If hyper-
sensitivity to environmental stimuli like foods contributes to the development of 
ADHD, the assessment and treatment of ADHD will have to be reconsidered, 
thereby improving the quality of care for these patients. 
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Introduction 
Attention deficit hyperactivity disorder (ADHD) is a highly heritable psychiatric 
disorder that affects 2-12% of children worldwide (1, 2). It is as yet unknown 
whether the prevalence of children with ADHD is increasing. Several environmental 
influences are known that raise the risk for ADHD development (1), but the exact 
aetiological pathways are still largely unknown (3). Medication and psychosocial 
intervention are the most frequently used methods of treatment (4). As our 
knowledge about the cause(s) of ADHD remains speculative (5), it is important 
not only to unravel the genetic architecture of ADHD, but also to determine to 
what extent environmental factors can be regarded as risk factors for developing 
the disorder. Psychosocial and biological environmental influences like foetal
 0 
ST 
distress, hypoxia and family dysfunction are considered to have aetiological Î 
importance (1), and a complete assessment needs to take account of all these ^ 
influences (6). 
To date, clinicians do not consider environmental factors such as exposure to 
foods or inhalants of much importance and do not pay much attention to them in 
the current diagnostic process of ADHD. These environmental factors, however, 
do play a major role in other complex genetic diseases, like asthma and eczema 
(7. 8). Here we argue that exposure to foods and inhalants and subsequent 
hypersensitive mechanisms can be important in the multifactorial causation of 
ADHD and this should have consequences for diagnosis and treatment of this 
disorder. 
The old hypothesis: ADHD being engendered by allergic 
disorders 
Eventually ADHD was hypothesized being a side effect of allergic disorders: 
allergic reactions engendering cholinergic/adrenergic activity imbalances in the 
central nervous system, leading to ADHD symptoms in some children (9). Other 
studies suggested the possibility of a causal relationship between allergies and 
ADHD (10, 11), based on a surprisingly high proportion of children with ADHD 
having associated symptoms of allergic disorders. Recently, children with ADHD 
were found to display skin prick test results to common aeroallergens consistent 
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with allergic rhinitis (12). However, there is increasing evidence that neither 
asthma nor its treatment are causing behavioural or school problems in 
school-age children, yet lingering concerns regarding this issue persist (2, 13). 
When comparing atopic and non-atopic children for the prevalence of ADHD no 
association between immunoglobulin E (IgE)-mediated atopic responsiveness 
and ADHD was found (14-16). Biederman et al. (13) found no substantial 
aetiological or pathophysiological relationship between asthma and ADHD. The 
risk for asthma did not meaningfully differ between ADHD and control children 
(13). Despite the range of diverse studies that attempt to understand the 
co-morbidity of asthma and psychiatric diagnoses (17), the controversy whether 
or not ADHD and asthma are causally linked still exists in the literature. 
Asthma is a leading cause of childhood chronic medical illness, affecting 
7-15% of children and the prevalence rates have dramatically increased by 74% 
between 1980 and 1994 (2). In addition, a rising prevalence of food hypersensitiv-
ity and of severe allergic reactions to food has been reported the last decade (18). 
Thirty-nine per cent of all children in the United Kingdom have been diagnosed 
with one or more atopic conditions and 11% with more than one atopic disorder 
(19). These data imply that there is a significant chance that asthma and ADHD 
can occur in the same individual, so co-morbidity of ADHD and allergic disorders 
should not be very surprising (20). Furthermore, from various studies it is 
concluded that asthma and ADHD show an independent transmission within 
families (2, 13, 16). This is consistent with the notion that although ADHD and 
asthma or eczema might occur simultaneously, these disorders need not be 
causally related with each other (2, 13,16). Therefore we reject the old hypothesis, 
ADHD being caused by allergic disorders, replacing it by a new hypothesis, 
ADHD being a (non-)allergic hypersensitivity disorder itself. 
The new hypothesis: ADHD being an (non-)allergic 
hypersensitivity disorder 
The lack of a causal correlation between asthma and ADHD does not exclude the 
presence of a common pathophysiological mechanism underlying the development 
of asthma and/or ADHD when exposed to similar environmental triggers. Such a 
mechanism can exist without a direct causal relationship between both diseases. 
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According to the nomenclature of allergy, allergic disorders are clinical 
syndromes each defined by a group of symptoms and signs in target organs, in 
which genetic predisposition and exposure to environmental factors (dust mites, 
pets, tobacco smoke, foods) both contribute to its development (21). 
ADHD and asthma are both highly hereditary diseases. Polymorphic variants 
in several genes involved in regulation of the dopamine and related neurotrans-
mitter pathways are reported to be associated with ADHD (22). Not only the 
dopaminergic system, but also the noradrenergic and histaminergic systems can 
be involved with ADHD (23). 
The term 'hypersensitivity' should be used for allergic and non-allergic 
reactions for which environmental triggers are held responsible (21). Hypersensi-
tivity is an "umbrella" term to cover for allergic hypersensitivity, i.e. with a defined 
or strongly suspected immunological mechanism, and for non-allergic hypersen-
sitivity, i.e. with an immunological mechanism excluded. Eighty per cent of 
childhood asthma has been reported to be allergic, resulting from immunological 
reactions, being IgE- (extrinsic) or non-lgE-mediated (intrinsic) (21). It has been 
suggested that eczema can be differentiated into an atopic and nonatopic 
eczema form. Only atopic eczema might follow the distribution and risk pattern 
that have been ascribed to asthma and hay fever. As the immunological 
mechanism underlying the development of eczema and the role of IgE antibodies 
in the aetiology of the disease are less well known, the term IgE-associated is 
used, the word 'associated' being provisional (24). 
From this, it is clear that the different types of allergic diseases are 
heterogeneous with respect to the role of the immunopathology underlying the 
cause of these diseases. Although ADHD has never been postulated as an 
allergic disorder itself, we are of the opinion that ADHD symptoms may be caused 
or "triggered" by several heterogeneous factors, reflecting different mechanisms 
underlying the disorder, as has been stated before (25). Some of these 
mechanisms may represent allergic immunopathology. 
Strengthening the new hypothesis 
According to the revised and widely accepted terminology of allergies, ADHD 
meets the criteria of hypersensitivity. Displaying asthma symptoms after exposure 
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to dust mites reflects a hypersensitive reaction in which the dust mite is the 
defined stimulus. Equally, showing ADHD symptoms after eating normal amounts 
of certain foods (10, 15, 26-30), or after pollen exposure (31), can be a matter of 
hypersensitivity, in which the foods and pollen reflect the defined stimulus which 
is tolerated by normal subjects (see figure). More research is needed to determine 
whether such a hypersensitivity reaction is allergic or non-allergic with respect to 
its underlying cause. Recent research has shown that the effect of food additives 
on behaviour may occur independently of the presence of an atopic status or the 
presence of hyperactive behaviour, probably via a non-lgE-dependent histamine 
release from mast cells and basophilic granulocytes (32). Some children can 
react to food components, including additives, with the development of atopic 
symptoms (33), or ADHD-like symptoms (34), while only seldom children will react 
to an isolated additive component alone (26). Some degree of hyperactivity when 
exposed to food additives and benzoate preservatives may be applied to all 
children, not exclusively to hyperactive or atopic subgroups (32, 35). Recently, it 
has been described using outgrowth of murine neuroblastoma cells in vitro that 
specific combinations of common food additives show synergistic effects to 
inhibit neuronal cell differentiation (36). These food additives show their effect at 
concentrations theoretically achievable in plasma by ingestion of foods or drinks 
that are typically consumed by children. 
When ADHD symptoms develop in response to food components, and when 
an immunological mechanism can be defined which underlies this development, 
then ADHD is a consequence of an allergic response. The immune mechanism 
can be related to the induction of IgE antibodies or be a consequence of other 
mechanisms. This is in accordance with the revised allergy nomenclature. 
Subsequently, if the child has the atopic constitution, it may be called 'atopic' 
ADHD. As yet, we do not know to what extent these mechanisms take place, 
whether they are limited to a subgroup or affect the majority of children with 
ADHD. 
When stepping beyond the borders of the brain we find preliminary studies on 
the effects of pollen and foods (defined stimuli) on ADHD symptoms which are in 
line with our hypothesis, and support the existence of a hypersensitive mechanism 
(10. 15, 25-31). All dietary studies, following the food dye-challenge research in 
the 1970s and unlike the challenge studies using an individually constructed 
elimination (few foods) diet (10, 15, 26-30), show evidence of efficacy for a 
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properly selected subgroup (37, 38). In a nasal pollen challenge study (31), 
significant neurobehavioural regression was induced in children with ADHD. This 
regression occurred in both allergic and non-allergic children, and was not 
associated with the presence of respiratory symptoms. The results of these 
studies are consistent with our hypothesis, but far more research is needed to 
accept or reject our hypothesis. 
Figure Triggers and mechanisms of asthma, eczema and attention deficit 
hyperactivity disorder (ADHD) according to the old hypothesis 
(dashed arrow) and the new hypothesis (solid arrow) 
Triggers Hypersensitivity Mechanisms Symptoms/Diagnosis 
Allergic (IgE or non-lgE-associated) 
Non-allergic 
Allergic (IgE or non-lgE-mediated) 
Non-allergic 
Allergic? 
Non-allergic? 
— • 
— • 
Eczema 
Asthma 
1 
k 
H^^B^BI^^ 
^^ ^ 
• • 
ADHD 
The underlying mechanisms of asthma, eczema and ADHD can be based on allergic sensitization, 
resulting in immunoglobulin E (IgE) or non-lgE-mediated mechanisms, or upon non-allergic 
mechanisms. Determining the underlying mechanism may have consequences for diagnosis and 
treatment of the disorder. 
Testing the hypothesis 
This hypothesis has to be thoroughly tested by randomized controlled trials in 
unselected subjects by the following. 
1. Genetic research: ADHD is a genetically complex disorder, including among 
others the involvement of multiple genes, gene-environment correlation, gene-
environment interaction and importance of developmental factors (39). Several 
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genes are able to regulate the immune system and may be associated with 
development of the symptoms of ADHD (40, 41). Consequently the further 
unravelling of the genetic architecture of ADHD is very important. 
2. Immunological research: dopamine transporters are causally implicated in 
ADHD, and are targets for drugs like methylphenidate. These receptors are 
abundantly expressed on human T-cells, and trigger the selective secretion of 
immune-regulatory cytokines, like interleukin (IL)-10 (42). Furthermore, these 
receptors react by activating STAT6, a pivotal transcription factor in Th2 cells of 
the immune system (43). 
3. Blood tests: these tests are used to segregate between non-allergic or allergic 
mechanisms involved. This includes analysis of the role of IgE and IgG 
antibodies being specific for the food and inhalant components and the 
possible involvement of cell-mediated hypersensitivity (24). This enables us to 
understand the processes that initiate and regulate these responses. As a 
result of the poor prognostic value and reliability of food-specific IgE (44), a 
true allergy to a foodstuff is revealed by oral provocation tests or by improvement 
during an avoidance diet, being an essential tool in the diagnostic procedure 
(45). 
4. The development of immunotherapeutic treatments: when allergic triggers are 
involved in ADHD, these will necessitate the development of new treatment 
strategies. Recently, children suffering from eczema symptoms, whether or not 
linked to a food allergy, are efficiently treated by the use of probiotics (46, 47), 
Moreover, when inhalant components are implicated in the development of 
ADHD symptoms, also allergen-specific immunotherapy might be useful. The 
potential use of these new anti-allergic strategies needs to be evaluated with 
children suffering from ADHD symptoms. 
5. By determining the effects of environmental influences, using few foods diets 
(10, 15, 26-30) and inhalant challenges, e.g. pollen (31), the number and 
features of children with ADHD in which a hypersensitive mechanism may be 
involved can be identified. 
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Implications for clinical practice 
According to our hypothesis, hypersensitivity to environmental stimuli like foods 
and inhalants contributes to the development of ADHD, and thus the assessment 
and treatment of ADHD will have to be reconsidered. As allergic and non-allergic 
conditions may present with similar symptoms, an accurate allergy diagnosis is 
important in order to treat the patient most appropriately (48). Confirmation of this 
hypothesis will result in considering ADHD as two different entities: hypersensitive 
and non-hypersensitive ADHD, in accordance with the two variants of eczema 
depending on the determination of the effects of attributable risks (49). Determining 
and avoiding such triggers will reduce the predisposition to ADHD, and 
consequently reduce the use of medication. This new insight will improve the 
quality of care for ADHD patients in the future. 
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Abstract 
Background The effects of a restricted elimination diet in children with attention-
deficit hyperactivity disorder (ADHD) have mainly been investigated in selected 
subgroups of patients. We aimed to investigate whether there is a connection 
between diet and behaviour in an unselected group of children. 
Methods The Impact of Nutrition on Children with ADHD (INCA) study was a 
randomised controlled trial that consisted of an open-label phase with masked 
measurements followed by a double-blind crossover phase. Patients in the 
Netherlands and Belgium were enrolled via announcements in medical health 
centres and through media announcements. Randomisation in both phases was 
individually done by random sampling. 
In the open-label phase (first phase), children aged 4-8 years who were 
diagnosed with ADHD were randomly assigned to 5 weeks of a restricted 
elimination diet (diet group) or to instructions for a healthy diet (control group). 
Thereafter, the clinical responders (those with an improvement of at least 40% on 
the ADHD rating scale [ARS]) from the diet group proceeded with a 4-week 
double-blind crossover food challenge phase (second phase), in which high-IgG 
or low-IgG foods (classified on the basis of every child's individual IgG blood test 
results) were added to the diet. 
During the first phase, only the assessing paediatrician was masked to group 
allocation. During the second phase (challenge phase), all persons involved were 
masked to challenge allocation. Primary endpoints were the change in ARS score 
between baseline and the end of the first phase (masked paediatrician) and 
between the end of the first phase and the second phase (double-blind), and the 
abbreviated Conners' scale (ACS) score (unmasked) between the same 
timepoints. Secondary endpoints included food-specific IgG levels at baseline 
related to the behaviour of the diet group responders after IgG-based food 
challenges. 
The primary analyses were intention to treat for the first phase and per protocol 
for the second phase. INCA is registered as an International Standard Randomised 
Controlled Trial, number ISRCTN 76063113. • 
Findings Between Nov 4, 2008, and Sept 29, 2009, 100 children were enrolled 
and randomly assigned to the control group (n=50) or the diet group (n=50). 
Between baseline and the end of the first phase, the difference between the diet 
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group and the control group in the mean ARS total score was 237 (95% CI 
18 6-28-8; p<0 0001) according to the masked ratings. The difference between 
groups in the mean ACS score between the same timepolnts was 118 (95% CI 
9 2-14 5; p<00001). The ARS total score Increased In clinical responders after 
the challenge by 20-8 (95% CI 14 3-27 3; ρ<0Ό001) and the ACS score increased 
by 116 (7-7-15 4; p<0 0001). In the challenge phase, after challenges with either 
high-IgG or low-lgG foods, relapse of ADHD symptoms occurred in 19 of 30 
(63%) children, independent of the IgG blood levels. There were no harms or 
adverse events reported In both phases. 
Interpretation A strictly supervised restricted elimination diet is a valuable 
instrument to assess whether ADHD is Induced by food. The prescription of diets 
on the basis of IgG blood tests should be discouraged. 
Funding Foundation of Child and Behaviour, Foundation Nuts Ohra, Foundation 
for Children's Welfare Stamps Netherlands, and the KF Hein Foundation. 
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Introduction 
Attention-deficit hyperactivity disorder (ADHD) affects 5% of children worldwide 
and is characterised by excessive and impairing inattentive, hyperactive, and 
impulsive behaviour [1]. Genetic and environmental factors are involved [2], and 
ADHD is often accompanied by oppositional defiant disorder [3]. Children with 
ADHD and comorbid oppositional defiant disorder are difficult for parents, 
guardians, and teachers to handle, give rise to substantial parenting stress, and 
have a worse prognosis for adverse outcomes (ie, an increased risk of developing 
conduct disorder and antisocial personality disorder) than have children without 
comorbidity [4], At present, ADHD is treated with psychoeducation, parent 
training, child behavioural interventions, and drugs [5] but follow-up studies have 
reported limited long-term effects of multimodal treatment [6,7]. 
One of the risk factors for ADHD that could be targeted for intervention is food 
[8], Reports of adverse physical reactions to foods (eg, eczema, asthma, and 
gastrointestinal problems) that affect various organ systems [9] have led to the 
suggestion that foods might also affect the brain, resulting in adverse behavioural 
effects [10]. Colourings and preservatives might have some effect on the 
behaviour of children with or without ADHD, but additives do not cause ADHD 
[2,5,11.12]. An individually constructed restricted elimination diet, which consists 
of some hypo-allergenic foods, might be effective for treatment of ADHD [8,11]. 
The rationale of this diet for children with ADHD is to investigate whether ADHD is 
triggered by foods—ie, to identify a hypersensitivity reaction to foods. In a small 
randomised controlled trial that investigated the effects of a restricted elimination 
diet [13], we reported statistically significant and clinically relevant effects on 
ADHD and oppositional defiant disorder. 
In children with ADHD that is triggered by foods, ADHD meets the criteria of 
hypersensitivity according to allergy nomenclature [14]. Accordingly, we 
postulated that ADHD might be an allergic or non-allergic hypersensitivity 
disorder in some children [15]. IgE is implicated in typical food allergies. In 
reactions to food that are not mediated by IgE, assessment of IgG levels might be 
useful [16], and IgG blood tests are offered—especially in complementary care 
[17]—with the aim of establishing a relation between foods and ADHD. According 
to this theory, eating foods that induce high IgG levels would lead to a substantial 
behavioural relapse whereas eating those that induce low IgG levels would not. 
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However, there is no evidence for the effectiveness of these tests [18]. 
The primary aim of the Impact of Nutrition on Children with ADHD (INCA) 
study was to investigate the effects of a restricted elimination diet on behaviour in 
children with ADHD. The secondary aim was to differentiate between non-allergic 
and allergic mechanisms in food-induced ADHD. 
Methods 
Participants 
Children were recruited at medical health centres and through media 
announcements in the Netherlands and Belgium. Interested parents or guardians 
(hereafter called parents) were provided with verbal and written information about 
the study. Eligible children were assessed for ADHD and comorbid disorders by 
a senior paediatrician (JT) using a structured psychiatric interview (SPI). Children 
were included if they had been diagnosed with ADHD of any subtype [1]. Further 
inclusion criteria were children's age 4-8 years (sufficiently young to maximise 
dietary compliance), and parents with adequate knowledge of Dutch and who 
were motivated to follow a 5-week restricted elimination diet. Exclusion criteria 
were children receiving drugs or behavioural therapy for ADHD, children already 
following a diet, or family circumstances that were likely to prevent completion of 
the study. The presence of comorbid psychiatric disorders was not a reason for 
exclusion. 
The INCA study was approved by the medical ethics committee of Wageningen 
University and by the executive board and ethics committee of Catharina Hospital 
Eindhoven. The parents of children who participated in the trial provided written 
informed consent before week 1 of the study. 
Randomisation and masking 
INCA consisted of two phases. The first phase was an open-label phase with 
masked paediatrician measurements. After the baseline assessment, eligible 
children were randomly assigned to either a diet group or a control group. 
Randomisation was individually done by random sampling. Ten blocks of ten 
identical, sealed envelopes containing concealed treatment codes were made by 
a masked epidemiologist (KF) to prevent unbalanced assignment of treatment 
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over time. Parents randomly picked and opened an envelope. Staff who recruited 
and assessed patients were not involved in the procedure used to generate group 
allocations. 
Because the diet was individually tailored and restricted, a reliable placebo 
diet was not possible, thus parents and teachers could not be masked to group 
allocation. Also, the researcher (LP) who provided expert advice to parents and 
teachers during the diet period could not be masked. Parents were instructed not 
to reveal dietary information to the paediatrician (JT) who did masked assessments 
[19], 
The second phase was a double-blind crossover food challenge phase in the 
diet group. Eligible children from the diet group were randomly assigned, by 
simple sampling, to one of two challenge groups. Each group was offered either 
three foods that induce low IgG levels or three that induce high IgG levels in a 
crossover design. The three foods within each group were selected by an 
independent dietician who was masked to group assignment. The researcher, 
paediatrician, parents, and teachers were masked to IgG allocation. KF did the 
data entry for both phases and was masked to the assigned treatment. 
Procedures 
During the trial we used four questionnaires to assess outcome: the 18-item 
ADHD rating scale (ARS) [20], ten-item abbreviated Gönners' scale (ACS) [21], 
strengths and difficulties questionnaire (SDQ) [22], and SPI [23]. The ARS, which 
is based on the diagnostic and statistical manual of mental disorders part IV 
(DSM-IV) criteria for ADHD, consists of nine inattention and nine hyperactivity 
and impulsivity criteria, with a four-point scale (0 = never [less than once a week], 
1=sometimes [several times a week], 2=often [once a day], and 3=very often 
[several times a day]). Three measures were taken from the ARS: total score 
(0-54), inattention score (0-27), and hyperactivity and impulsivity score (0-27). 
The ACS, also a four-point rating scale, covers hyperactivity, impulsivity, attention, 
mood, and temper tantrums. The DSM-IV-based SPI was used to assess 
oppositional defiant disorder (with the eight DSM-IV oppositional defiant disorder 
criteria) and conduct disorder (with seven of the 15 DSM-IV conduct disorder 
criteria relevant to this young group of patients, ie, criteria 1-5, 9, and 11). The 
SDQ provides a total difficulties score on the basis of the results of four problem 
subscales: emotional symptoms, and conduct, hyperactivity-inattention, and 
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peer problems. Unmasked parent and teacher assessments (ACS, ARS, and SPI) 
and masked paediatrician assessments (ARS and SPI) were done at baseline 
and at the end of the first phase (week 9 in the diet group and week 13 in the 
control group; table 1). The masked paediatrician based his ratings on information 
obtained from the parents as well as on his own observation and assessment of 
the child's behaviour and presentation. The masked measurements were used for 
all analyses in the first phase, apart from the ACS score and the week 9 
measurements in the control group. Blood samples were taken at the start and 
end of the first phase. 
After the baseline assessments, randomisation was done, and parents started 
a 2-week baseline period during which they did not exclude any foods from their 
child's diet. Parents kept extended diaries (containing information on the child's 
diet, behaviour, activities, physical complaints, and medications; webappendix 
page 1) and closely monitored their child's behaviour. After the baseline period 
(in week 3), the second unmasked parent assessment took place (ACS and ARS) 
and parents and teachers filled in the SDQ. 
During week 4 (start of the first phase), the diet group started a 5-week 
individually designed restricted elimination diet, which has been described 
elsewhere [24] (webappendix page 2). Briefly, the diet consisted of the few-foods 
diet (ie, rice, meat, vegetables, pears, and water) [8,24] complemented with 
specific foods such as potatoes, fruits, and wheat. The aim was to create an 
elimination diet as comprehensive as possible for each individual child, to make 
the intervention easy for children and their parents to follow [10,13]. If the parents 
reported no behavioural changes by the end of the second diet week, the diet 
was gradually restricted to the few-foods diet only [10]. At the end of the first 
phase, all children were assessed by the masked paediatrician (ARS and SPI), 
unmasked parent and teacher ratings (ACS, ARS, and SPI) were done, the SDQ 
was completed by all parents and teachers, and blood samples were taken. 
Children in the diet group who had behavioural improvement of at least 40% on 
the ARS—ie, clinical responders—entered the challenge phase; the non-
responders left the trial. 
IgE and IgG levels were analysed from the blood samples taken at week 1. 
Total IgE, food-specific IgE (to chicken egg, peanut, soy, milk, fish, and wheat), 
and food-specific total IgG levels to 270 different foods were assessed with 
ELISA. Based on the levels of IgG (/jg/mL) in serum, measured with a certified 
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IgG-speciflc food screening test (ImuPro test), each analysed food was 
categorised as a low-IgG food or a high-IgG food. 
In the diet group responders, in the second phase (double-blind crossover 
challenge phase; weeks 10-13), two groups of foods consisting of either three 
high-IgG or three low-IgG foods were consecutively added to the restricted 
elimination diet, each for 2 weeks. For every child, the composition of the food 
challenge groups was tailored by the dietician on the basis of total IgG levels to 
270 different foods, which were assessed in the first blood samples. Any of the 
270 foods could be chosen by the dietician, except for foods that caused 
increased IgE levels (to preclude an anaphylactic reaction), were disliked by the 
child, or were already part of the diet. Thus, the foods added in the challenge 
phase were individually chosen and differed per child. All children were to 
complete both challenges, and each challenge food group had to be eaten every 
day in equal amounts during the 2-week period or until behavioural changes 
occurred. 
All behavioural measurements in the challenge phase were double-blind. 
Parent ACS and ARS assessments were done after each challenge; the other 
measurements were done at week 13 or at week 11 if there was a relapse in 
behaviour during the first challenge (table 1). If the child's behaviour showed no 
relapse (according to the double-blind parent ARS score) during the first challenge 
period (weeks 10-11), the child proceeded with the second challenge (weeks 
12-13), and a third blood sample was taken at week 13. Conversely, if the ADHD 
problems returned during the first challenge, the third blood sampling was 
brought forward, after which the challenge foods were eliminated again. After a 
washout period, the length of which depended on the remission of the behavioural 
problems, the second challenge would start, after which the randomised 
controlled trial ended. 
After the baseline period, the control group followed the first phase until week 
13 and received healthy food advice according to the guidelines of the Dutch 
Nutrition Centre. Parents continued to keep an extended diary until the end of the 
trial (week 13). Measurements took place at comparable times to the measurements 
in the diet group (table 1). At week 13, the second blood sample was taken, after 
which all parents of children who did not show behavioural improvements were 
offered the possibility of starting the diet. 
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Table 1 Measurement points during baseline, and the first and second 
phases 
Diet group Control group 
Base*ine period 
Weeks 1-3 
Weekl 
End of week I 
During week 3 
First phase 
Weeks 4-9 
During week 9 
Second phase* 
Weeks 10-11 
Week 11 
Weeks 12-13 
End of week 13 
No foods excluded 
ACS. ARS, SPI (LP: P. T) 
A I ^ S P I U T ) 
Blood samples taken 
Randomisation 
ACS. ARS (LP: P) 
SDQ(P,T) 
Restricted elimination diet 
ACS. ARS. SR (LP: P. T) 
ARSlSPI(JT) 
SDQ (P. T) 
Blood samples taken 
Rrst double-blind challenge 
ACS. ARS, SPIt (LP: R T) 
ARSt. SPIt (JT) 
SDQt(P.T) 
Blood samples taken! 
Second doubie-bhnd challenge 
ACS. ARS. SPI* (LP: P. T) 
ARS*.Sm(JT) 
SDQ* (P.T) 
Blood samples taken* 
No foods excluded 
ACS. ARS, SPI (LP: Ρ, Τ) 
ARS. SPI (JT) 
Blood samples taken 
Randomisation 
ACS. ARS (LP: P) 
SDQ (P.T) 
Healthy food advice 
ACS. ARS, SPI (LP: Ρ) 
SDQ (Ρ) 
Healthy food advice 
ACS, ARS (LP: P) 
Healthy food advice 
ACS. ARS. SPI (LP: P,T) 
ARS. SPI (JT) 
SDQ (P.T) 
Blood samples taken 
Masking (paediatrician only) during the first phase (diet group and contiol group) is for group assignment, masking 
(paediatrician researcher, parent, and teacher) during the second phase (diet group only) is for challenge assignment. 
ACS-abbreviated Conners' scale. ARS-attention-deficit hyperactivity disorder rating scale. SPI-structured psychiatric 
interview. LP-researcherassessor P-parent.T-teacher.JT-paediatridan assessor. SOQ-stiengths and dHüculties 
questionnaire. 'D ie t group responders only. tResponderswho relapsed only tThosc who had not relapsed at 11 weeks. 
The first phase primary endpoints were the difference in ARS (masked paediatrician 
assessment) and ACS scores (parent; unmasked assessment) between baseline 
and the end of the first phase. The challenge phase primary endpoints. in the 
clinical responders, were the change in ARS and ACS score from the end of the 
first phase to week 11 (after the first challenge) and week 13 (after the second 
challenge). A relapse in ADHD behaviour was defined as an ARS increase of at 
least 40% of the ARS score at the end of the first phase, and up to at least 60% of 
the ARS baseline score. 
The first phase secondary endpoints were the IgE blood levels at the start of 
the trial associated with the behavioural changes at the end of the first phase, and 
the child's comorbid behavioural problems, assessed by the change in SPI-scores 
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(masked paediatrician) from week 1 and SDQ-scores (parent) from week 3 to the 
end of the first phase. The challenge phase secondary endpoints were the 
food-specific IgG levels at baseline related to the behaviour of the diet group 
responders after IgG-based food challenges. The other secondary endpoints of 
physical and sleep problems assessed with the other complaints questionnaire 
[24], and other blood tests, as specified in the INCA protocol, will be assessed in 
a separate paper. 
Statistical analysis 
In our previous randomised controlled trial [13], 11 of 15 children in the diet group 
and none of 12 children in the control group showed behavioural improvements 
of 40% or more. We therefore assumed that a behavioural improvement of at least 
40% would occur in 60% of children in the diet group and in 20% of those in the 
control group in this study. To achieve 80% power (a=0.05, two sided test), taking 
into account a potential block effect and 10% dropouts, we calculated that 40 
children per group were needed. To allow for a potentially higher percentage of 
dropouts, we included ten extra children per group. 
We did statistical analyses with Stata (version 10) and SPSS (version 15). In 
the first phase, masked measurements were done at Catharina Hospital Eindhoven 
by JT and unmasked measurements were done at the ADHD Research Centre 
Eindhoven by LP. In the second phase, double-blind measurements were done 
by JT and LP. The first phase ARS and SPI analyses were done with the masked 
measurements and were by intention to treat, last observation carried forward. 
The challenge phase analyses were per protocol. To assess the agreement 
between the unmasked (parent) and masked paediatrician measurements for 
ARS and SPI, we calculated kappa values [25], and intra-cluster correlation 
coefficients (ICCs) [26] for categorical and continuous parameters, respectively. 
Kappa values greater than 0.75 (ICC >0.80) were taken to represent excellent 
agreement beyond chance; values below 0.40 (ICC <0.40) suggested poor 
agreement. 
Behavioural endpoint scores were analysed by a general linear model with 
treatment (diet group vs control group), block, and their interaction as independent 
variables and baseline scores as covariates. The most reduced model was 
selected but treatment and block were forced in each model. We assessed the fit 
of the models with the link test command of Stata. The association between 
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Figure 1 Trial profile 
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clinical response (yes or no) and treatment, and its association with IgE blood 
levels was calculated with Fisher's exact test. We analysed the effect of the 
crossover challenges (low-IgG or high-IgG) on the child's behaviour with the 
Mainland-Gart procedure [27]. We did a second analysis that also included those 
children who responded equally to both challenges with the Prescott test [27]. 
The effect of the challenges (low-IgG, high-IgG) was expressed as odds ratios 
(ORs) and estimated by generalised estimated equations (binomial distribution, 
logit link), with adjustment for challenge period and intra-patient correlation. 
INCA is registered as an International Standard Randomised Controlled Trial, 
number ISRCTN 76063113. The protocol for this study was peer reviewed and 
accepted by The Lancet; a summary of the protocol was published on the 
journal's website, and the journal then made a commitment to peer review the 
primary clinical manuscript. 
Role of the funding source 
The sponsors of the study had no role in the study design, data collection, data 
analysis, data interpretation, writing of the manuscript, or in the decision to submit 
for publication. All authors had full access to the data in the study and LMP, NNR, 
and JKB had final responsibility for the decision to submit for publication. 
Results 
Between Nov 4, 2008, and Sept 29, 2009. 100 children were enrolled and 
randomly assigned to the control group (n=50) or the diet group (n=50; figure 1) 
Most children were boys and the mean age was 6.9 years (SD 1.3; table 2). Of the 
41 children in the diet group who completed the first phase, the diet of 17 was 
restricted to the few-foods diet only. 
Table 3 and figure 2 show the ARS results from the first phase. Of the 41 
(82%) of 50 children in the diet group who completed the first phase, nine (22%) 
of 41 did not and 32 (78%) of 41 did respond to the diet (figure 1). The mean 
difference in ARS score between baseline and the end of the first phase was 
significantly higher in the diet group than in the control group for both the masked 
paediatrician (p<0.0001) and unmasked teacher ratings (p<0.0001; table 3) 
When comparing the unmasked (parent; LP) with the masked (JT) ARS and SPI 
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measurements from the first phase, both kappa and ICC of inter-rater agreement 
were greater than 0.40 (mean 0.90 [SD 0.07] for ICC and 0.83 [0.20] for kappa). 
The ACS score difference between baseline and the first phase was also 
significantly higher in the diet group than in the control group for both parent 
(p<0.0001) and teacher (p<0.0001) ratings (table 3). 
The difference between groups on the oppositional defiant disorder criteria 
measured by the SPI at the end of the first phase was also significant for both the 
masked paediatrician (p<0.0001) and teacher ratings (p=0.0320; table 3, figure 
2). Because only three children in the diet group met the criteria for conduct 
disorder, we did not analyse these results. The decrease in hyperactivity-
inattention problems, measured on the SDQ, was similar to the decrease on the 
ARS (webappendix page 3) 
Pre-specified IgE immunological analyses in responders (32 of 41) and 
nonresponders (nine of 41) in the diet group showed no association between 
clinical response and increased IgE blood levels. Total IgE was increased in six of 
30 responders (data missing for two children) and two of nine nonresponders 
a (p=1.0, Fisher's exact test). Food-specific IgE levels were increased in one of 31 5> 
responders (data missing for one child) and one of nine nonresponders (p=0.41, 
Fisher's exact test). 
Of the 32 children who were clinical responders, 30 proceeded to the 
challenge phase (figure 1). 19 of 30 showed a behavioural relapse after one or 
both challenges. The ACS (unmasked parent) and ARS (masked paediatrician) 
results in the children in the diet group who were included in the challenge phase 
(n=30) were compared with the results of the children in the control group who 
completed the trial (n = 42: figure 3). The decrease in ARS total score in the clinical 
responders from baseline to the end of the first phase was 35.9 (95% CI 33.2-38.6; 
p<0.0001), which subsequently increased after the challenge by 20.8 (14.3-27.3; 
p<0.0001). The decrease in ACS score in the clinical responders from baseline to 
the end of the first phase was 18.3 (95% C116.7-19.9; p<0.0001), which increased 
after the challenge by 11.6 (7.7-15.4; p<0.0001). In the control group, the ARS 
score did not differ between the measurements at week 1 and week 9 (0.8, 95% 
CI -0.4 to 2.0; p = 0.21) and week 9 and week 13 (0.8. -0.4 to 2.0; p=0.17). In the 
control group, the ACS score did not differ between week 1 and week 9 (0.2, 95% 
CI-0.8 to 0.4; p=0.5) and between week 9 and week 13 (0.2.-0.5 to 1.0; p=0.57). 
SDQ measurements showed similar results (webappendix page 4). Because 
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Table 2 Demographics and characteristics during week 1 
Boys 
Age (yean) 
Pregnancy and birth' 
Mother smoked during pregnancy 
Pregnancy »36 weeks 
Problems at birth (hypoxia, incubated) 
Parental data 
Non-native parent(s) 
1 parent or co-parenting 
Adopted or foster child 
Age of onset of behavioural problems 
Oyears 
a-4 years 
>4ycars 
Psychiatric history 
Referred because of ADHD symptoms 
On ADHD drugs before start of trial 
Allergy data at start of trial 
Increased total IgE level 
Increased food-specific IgE level 
ADHD diagnoses at start of trial 
Combined type 
Inattentive type 
Hyperactive type 
Other psychiatric diagnoses at start of trial 
Oppositional defiant disorder 
Conduct disorder 
Diet group (n-SO) 
4 4 ( 8 8 * ) 
6 8 (13) 
5(10%) 
4(8%) 
5 (10») 
5(10%) 
3 (6S) 
3(6%) 
33(66%) 
16(32«) 
1(2%) 
40(80%) 
6(12%) 
8(16%) 
5(10%) 
41(82%) 
3 (6S) 
6(12%) 
20(40%) 
3(6%) 
Control group (n-50) 
42 (84%) 
7-0 (1-3) 
2(4%) 
4(8%) 
4(8%) 
7(14%) 
3(6%) 
1(2%) 
38 (76%) 
11(22%) 
1(2%) 
44(88%) 
8(16%) 
6(12%) 
9(18%) 
44(88%) 
3(6%) 
3(6%) 
27(54%) 
5(10%) 
Dat*ar«numb«f (%) or itwan (SD). ADHO-attent »on-deficit hyperactivity disorder-*Data missing for two adopted 
children in the diet group and one in the control group-
only six of 30 teacher data were available at the end of the second phase, we did 
not analyse these results. 
29 of 30 children were included in the IgG assessments (no suitable high-IgG 
foods were available for one responder; figure 1). 11 of 29 children were randomly 
assigned to start with the low-IgG challenge and 18 to the high-IgG challenge. 
Each challenge was followed by the other challenge. 13 of 29 low-IgG challenges 
and 13 of 29 high-IgG challenges resulted in a relapse of ADHD behaviour. 
No relapse was reported in 11 of 29 children, eight had relapses after both 
challenges, 15 had relapses after the first challenge, and 11 after the second 
challenge. The sequence of the challenges (low-IgG then high-IgG or high-IgG 
then low-IgG) was not significantly associated with the relapse of ADHD symptoms 
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Table 3 ADHD rating scale, abbreviated Conner's scale, and structured psychiatric interview scores at start and end of the 
first phase 
Diet group (parent η-50; teacher CK 37) Control group (parent η ·50; teacher η·40) End rating* 
Start End Difference ρ value t Scale Cohen's Start End Difference ρ value t Scale Cohen's Difference pvaluet 
(week9) (95%CI) reduction d (week 13) (95%CI) reduction d (95%CI) 
(«) (H) 
ADHD rating scale 
Parent total score (JT, 0-54) 
Teachertotal score (IP; 0-54) 
Parent inattention score 
(JT:««?) 
Teacher inattention score 
(LP: 0-27) 
Parent hyperactivity and 
impulsivrty score (JT; 0-27) 
Teacher hyperactivity and 
impulsivity score (IP: 0-27) 
AbbrwiatedConners'scale 
Parent (IP; 0-30) 
Teacher (LP. 0-30) 
453 
(4-7) 
344 
(67) 
212 
(4-1) 
151 
(5 7) 
24-1 
(35) 
193 
(5-0) 
237 
(34) 
18 5 
0-8) 
Structured psychiatric Interview 
Parent ODD score (JT; 0-8)* 
Teacher ODD score (LP; 0-8)5 
55 
(11) 
4 9 
(11) 
211 
(16-8) 
201 
(10-1) 
9 9 
8 6 
(6-1) 
112 
(8-6) 
115 
(frO) 
117 
(87) 
119 
(6-7) 
19 
(23) 
21 
(29) 
242 
(195-290) 
143 
(11Ϊ-171) 
113 
(8 9-138) 
6 5 
(49-82) 
12^ 
(105-153) 
7« 
(fr2-»5) 
12-0 
(94-14-6) 
6 « 
( 4 * 8 4 ) 
3 * 
(2 5-4-6) 
2 ^ 
(15-40) 
<00001 
-OOOOl 
< o-oooi 
«OOOOl 
«<KK)01 
<<M)001 
<αοοοι 
«αοοοι 
«OOOOl 
-00001 
534 
416 
53 3 
43 0 
53 5 
404 
50-7 
359 
654 
571 
20 
167 
162 
110 
196 
141 
182 
122 
200 
128 
47« 
(41) 
39 2 
(7-8) 
232 
(3 5) 
195 
(52) 
244 
Gl ) 
197 
(6-6) 
235 
G9) 
191 
(45) 
55 
(12) 
52 
(11) 
462 
(58) 
39 6 
(8-6) 
22^ 
(3-6) 
19 3 
(52) 
23 3 
(45) 
20 3 
(6-3) 
234 
(47) 
199 
(46) 
53 
(14) 
50 
(17) 
13 
(0-2 to 25) 
-04 
(-17tol-0) 
0 2 
(-0-4 to 08) 
0 3 
(-0-6 to 11) 
11 
{02to2O) 
-0< 
(-14 to 0 2) 
01 
(-0-7 to 0-8) 
-0« 
(-14to-03) 
0 2 
(-a3to07) 
0 2 
(-0 4 to 0 9) 
0O23 
0580 
0433 
0587 
0O12 
0-128 
0828 
0O03 
0488 
0501 
27 
-10 
0 9 
15 
45 
-3 0 
0 3 
-4 3 
36 
38 
028 
-0O5 
0 09 
004 
028 
-0-09 
002 
-a i8 
0-15 
014 
237 
(186-288) 
« 3 
(12 0-186) 
(91-144) 
7 4 
(54-9-4) 
11-9 
(9-Î-14-5) 
8 6 
(6-8-10-3) 
11« 
(92-145) 
75 
(59-9-2) 
3-6 
(25-48) 
20 
(02-39) 
<0-0001 
«0-0001 
<0-0001 
«0O001 
«OOOOl 
«0-0001 
«0O001 
«0O001 
«0-0001 
00320 
Data »re mew {SO)>ll data »re masked «c«^t few the t M < i ^ 
fesearcher 00 l> oppositional défunt disorder, * Adjusted for scofe at sUrt and bbek. The in^ 
fit in aflaiufysts. tGeneralised linear model. tOiet group ηΊΟ. contrd group n«27 $Dtct group n«8, control group n« 13. 
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(Mainland-Gart p=1.0: Prescott p-0.38). The generalised estimated equations 
model showed no significant effects of IgG type (high-IgG vs low-IgG OR 0.86. 
95% CI 0.36-2.09; p=0.75) or challenge period (first challenge vs second 
challenge 0.55, 0.23-1.33; p = 0.26). Parents, teachers, and children reported no 
harms or adverse events in the first or second phase. 
Figure 2 Distribution (Box-Whisker plots) of behaviour scores (%) at start 
and end of the first phase 
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Scores accord ing to masked paediatr ician (A) and unmasked teacher (B) ratings of control group 
(in grey) and diet g r o u p (in white) To facilitate c o m p a r i s o n between the various measures, scores 
have been standardised as percentages of the m a x i m u m score per measures. ARS = ADHD Rating 
Scale; ARStot = total score, m a x i m u m score 54 (100%); ARSatt = inattention score, maximum 
score 27 (100%); ARShyp - hyperactivity /impulsivity score, m a x i m u m score 27 (100%); ODD = 
Opposit ional Defiant Disorder, m a x i m u m score 8 (100%). Bars = m a x i m u m and minimum score. 
Shaded boxes = interquarti le range Horizontal bars within boxes = median. 
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Figure 3 Behaviour scores at week 1, week 9, and week 13* 
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Discussion 
In the INCA study, the restricted elimination diet had a significant beneficial effect 
on ADHD symptoms In 32 (64%) of 50 children, and reintroducing foods led to a 
significant behavioural relapse in clinical responders. Blood tests assessing IgG 
levels against foods did not predict which foods might have a deleterious 
behavioural effect. The effect of the diet was consistent and had a similar effect In 
reducing both ADHD and oppositional defiant disorder symptoms. Because of 
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the worse prognosis of children with comorbid oppositional defiant disorder 
compared with those without comorbid disease, interventions that reduce 
oppositional defiant disorder symptoms have great clinical potential. The number 
of children with conduct disorder was, in accordance with the young age of the 
patients, too small to draw conclusions. 
Total IgE levels were increased only in a few children, equally in responders 
and nonresponders, suggesting that the underlying mechanism of food sensitivity 
in ADHD (which could be related to genetic factors [28]) is non-allergic, although 
we cannot rule out the involvement of a cell-mediated allergic response. In the 
second phase, some eliminated foods were added to the diet of the responders. 
Although the challenges consisted of only two groups of three different individually 
selected foods, there was a substantial relapse in behaviour in 63% of children. 
We recorded no difference in behavioural effects after challenge with high-IgG or 
low-IgG foods. These results suggest that use of IgG blood tests to identify which 
foods are triggering ADHD is not advisable. However, IgG blood tests might be 
useful in other diseases [29,30]. 
Our results must be viewed in light of some limitations. First, in the first phase, 
we did an open-label randomised controlled trial with masked measurements by 
an independent paediatrician because parents, teachers, and researchers could 
not be masked. This method is generally accepted and applied when a 
double-blind randomised controlled trial cannot be done [31-37]. Nevertheless, 
expectations of the parents cannot be fully ruled out as a possible cause of the 
behavioural improvements. Theoretically, the fact that the second assessment 
was done by the paediatrician after 9 weeks in the diet group compared with after 
13 weeks in the control group might have led to unmasking of the paediatrician. 
To prevent this from happening, the paediatrician was not informed about any 
previous assessments. Because of the number of children included, with new 
children starting every week, and some children from the diet and control groups 
returning every week for their second assessments, the paediatrician was unlikely 
to remember whether he had seen a particular child 9 or 13 weeks earlier. Parents 
were also instructed not to reveal any information about group assignment. 
Second, we cannot rule out that the behavioural improvements during the first 
phase might have been caused by increased attention for the child in the diet 
group. However, to avoid differences between groups the control group received 
healthy food advice and parents kept an extended diary of their child's behaviour 
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during the trial. Furthermore, the relapse in behaviour during the second phase, 
which required comparable parental attention as in the first phase, might be 
regarded as an internal replication of the effects of the diet. Third, we applied a 
tailor-made diet for each child to minimise the burden of the diet. In 24 (59%) of 41 
children this individually composed diet proved to be sufficient. 
Research in context 
Systematic review 
We first searched PubMed and the Cochrane Library with no date limits set (search 
terms ADHD AND diet', 'ADHD AND elimination diet' and ADHD AND food ) and 
then screened the references of relevant articles. Our search identified seven published 
randomised controlled trials [10,13,38-42]. that applied some form of restricted 
elimination diet (ie, a diet that did not just focus on single foods such as additives or 
sugar) in children with ADHD. 
Interpretation 
The total number of children involved in these trials was 188 (age 2 15 years), and all 
trials showed evidence for the efficacy of a restricted elimination diet on ADHD The 
overall weighted effect size of this group of heterogeneous studies was 1.6. but treatment 
groups were either small or only patients who had an allergic constitution were included, 
which thus impeded extrapolation of the results to the general population. Our study 
shows comparable effect sizes in patients who are representative of the general ADHD 
population, supporting the implementation of a dietary intervention in the standard of 
care for all children with ADHD 
A strength of the INCA study was its design, which included multiple ratings, 
its large sample size, and blood tests to investigate the existence of an 
immunological mechanism of action. Furthermore, the heterogeneous sample is 
representative of the general population of children with ADHD, and thus the 
results of our study are applicable to young children with ADHD whose parents 
are motivated to follow a 5-week dietary investigation period (panel). Another 
strength is the investigation of the effects of the diet on comorbid disorders such 
as oppositional defiant disorder. The results of the multiple ratings are consistent, 
which provides evidence for the clinically relevant beneficial effects of a restricted 
elimination diet on ADHD and oppositional defiant disorder. 
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The mechanisms and effects of food need to be investigated—eg, at a 
functional and structural brain level and in relation to genetic factors that increase 
the susceptibility to ADHD. Also, the challenge procedure, which is done to 
identify the incriminated foods in clinical responders, should be made as easy as 
possible to follow, to increase the feasibility of the diet. Furthermore, the long-term 
effects of foods should be investigated; children might outgrow the sensitivity to 
the incriminating foods when they are avoided for a long period of time. 
Our study shows considerable effects of a restricted elimination diet in an 
unselected group of children with ADHD, with equal effects on ADHD and 
oppositional defiant disorder. Therefore, we think that dietary intervention should 
be considered in all children with ADHD, provided parents are willing to follow a 
diagnostic restricted elimination diet for a 5-week period, and provided expert 
supervision is available. Children who react favourably to this diet should be 
diagnosed with food-induced ADHD and should enter a challenge procedure, to 
define which foods each child reacts to, and to increase the feasibility and to 
minimise the burden of the diet. In children who do not show behavioural 
improvements after following the diet, standard treatments such as drugs, 
behavioural treatments, or both should be considered. 
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Webappendix page 1 
INCA diary (compressed format) 
RED-dairy of: day - -2011 
Medication Food and drinks Activities* Physical complaints 
and behaviour 
Night 
Breakfast 
Snack 
Lunch 
Snack 
Dinner 
Evening 
Night 
* Register all activities: at home, at school, breaks at school, at sports, at day care, when playing 
going to hair dresser, at day trips, swimming, visits, etc. 
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Webappendix page 2 
The INCA Restricted Elimination Diet 
This individually composed Restricted Elimination Diet (RED), which had to be 
followed for 5 weeks at the most, was based on the few foods diet as described 
by Hill and Taylor [1]. Assuming that children might show ADHD symptoms after 
eating any kind of foods, the few foods diet consisted only of a limited number of 
hypo-allergenic foods, like rice, turkey, lamb, a range of vegetables (lettuce, 
carrots, cauliflower, cabbage, beet), pears and water [2]. In our study the RED 
was complemented with specific foods like potatoes, fruits, and wheat, to be 
eaten according to a compulsory intake schedule, in order to compose an 
elimination diet as comprehensive as possible for each individual child, thus 
making the intervention less incriminating for child and parents [3,4]. If the parents 
reported no behavioural changes by the end of the second week, the RED was 
further restricted and gradually limited to the few foods diet: all other foods were 
prohibited, but vegetables, rice and meat were allowed every day, in unlimited 
amounts. Calcium was supplied daily via non-dairy rice drink with added calcium, 
ensuring that children were not at risk for nutrient deficiencies. 
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Webappendix page 3 
Web-table 1 SDQ measurements according to parent and teacher ratings 
at start and at end phase 1 
Diet group 
(Parent: n=50 resp 41* for start and end measurement) 
(Teacher: n=50 resp 33* for start and end measurement) 
Start End Mean difference 
ρ value' %SRb Cohen's d 
<0 0001 49 2 0 8 
0 044 26 0 0 3 
<0 0001 572 1 1 
010 198 03 
<0 0001 52 8 2 4 
<0 0001 22 8 12 
<0 0001 30 6 0 3 
010 150 02 
<0 0001 49 6 17 
<00001 216 07 
<0 0001 76 6 16 
0 004 281 0 4 
SDQ Strengths and Difficulties Questionnaire: emotion^emolional symptoms scale. conduct= 
conduct problems scale, hyper=hyperactivity-inattention scale, peer=peer problems scale, total 
diff=total difficulties score [the sum of all scales], impact=impact score [the sum of items on overall 
distress and social impairment, interfering with home life, peer relationships, leisure activities and 
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start-end 
Parent 
emotion 
Teacher 
emotion 
Parent 
conduct 
Teacher 
conduct 
Parent 
Hyper 
Teacher 
Hyper 
Parent 
Peer 
Teacher 
Peer 
Parent 
total diff 
Teacher 
total diff 
Parent 
impact 
Teacher 
impact 
37 
(27) 
25 
(2 7) 
36 
(2 0) 
27 
(2 0) 
89 
(12) 
86 
(17) 
29 
(2 4) 
26 
(2 2) 
191 
(51) 
164 
(49) 
38 
(18) 
22 
(15) 
19 
(20) 
19 
(2 0) 
17 
(16) 
22 
(21) 
41 
(26) 
66 
(2 5) 
21 
(24) 
22 
(20) 
98 
(61) 
128 
(5 7) 
10 
(17) 
16 
(16) 
18 
(1 2-2 5) 
06 
(0 0-1 3) 
21 
(13-2 8) 
05 
(-01-12) 
47 
(38-56) 
23 
(1 5-31) 
09 
(0 5-13) 
05 
(-01-12) 
95 
(7 5-115) 
43 
(2 3-6 3) 
29 
(12-3 6) 
09 
(0 3-14) 
INCA study, an open RCT with blinded measurements and blood tests 
(Parent 
(Teacher 
Start End 
Mean 
(SD) 
Control group 
n=48* resp 42* for start and end measurement) 
: n=47* resp 42* for start and end measurement) 
End rating control versus diet 
group, adjusted for scores at 
start and block* 
31 30 
(2 4) (2 5) 
27 20 
(2 4) (2 2) 
3 7 3 5 
(25) (23) 
32 30 
(2 2) (2 4) 
95 91 
(0 8) (1 3) 
87 8 6 
(17) (17) 
24 24 
(19) (2 3) 
29 29 
(21) 
187 
(51) 
(19) 
180 
(6-1) 
175 16-5 
(5 6) (6 0) 
39 29 
(2 2) (2 0) 
27 24 
(1 5) (2 0) 
Mean difference 
(95% CI) 
start-end 
02 
(-0-4-08) 
07 
(0 0-1 4) 
03 
(-0 3-0 9) 
00 
(-0 4-0 4) 
03 
(-01-0 8) 
02 
(-0 4-0 5) 
00 
(-05-05) 
00 
(-05-05) 
08 
(-0 5-21) 
1 1 
(-0 5-2 6) 
1 0 
(0 5-1 5) 
04 
(-01-0 8) 
ρ value3 %SRb Cohen's d 
0 1 
03 
01 
01 
0-3 
01 
0 0 
00 
0 I 
02 
05 
02 
048 
0052 
031 
100 
015 
075 
67 
26 9 
7-9 
38 
35 
15 
100 0 0 
100 
020 
017 
14 
4 4 
5-8 
<0 0001 25 0 
0 09 111 
Mean difference 
(95% CI) 
-14 
(-2-2- -0 6) 
01 
(-0 7-0 8) 
-18 
(-2 5--1Ό) 
-0 5 
(-0 4-15) 
-4 9 
(-5 9- -4 0) 
-21 
(-3 0- -1 3) 
-0 8 
(-1-4--016) 
05 
(01-12) 
-83 
(-101--61) 
-30 
(-5-2--0 7) 
-19 
(-2 7--12) 
-0 5 
(-11-02) 
ρ value' 
0001 
0 88 
<00001 
0 28 
<00001 
<00001 
0014 
013 
<00001 
0009 
<00001 
017 
classroom learning]. *The number of forms included in the computations depended on the number 
of forms received eventually [the forms had to be filled in at home (parent) or at school (teacher) and 
had to be returned per post]. dBased on GLM. t>%SR=% scale reduction 'The interaction between 
block and group was insignificant (GLM) and the link test showed sufficient fit in all analyses. 
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Web-table 2 SDQ measurements according to parent* ratings in diet responders 
(n=30), at start and at end phase 2 
Diet group Responders 
Return behavioural problems after challenge 
n=19 
Start End 
phase2 phase 2 Mean difference 
-0 9 
-2 4 
-0 4 
-2 2 
-2-1 
SDQ=Strengths and Difficulties Questionnaire: emotion=emotional symptoms scale, conduct^ 
conduct problems scale, hyper-hyperactivity-inattention scale, peer=peer problems scale, total 
diff=total difficulties score [the sum of all scales], impact^impact score [the sum of items on overall 
distress and social impairment, interfering with home life, peer relationships, leisure activities and 
classroom learning] 'Teacher data were not analysed, as only 6/30 teachers returned the forms 
8
 Based on GLM ,'%SR=% scale reduction 
Emotion 
Conduct 
Hyper 
Peer 
Total diff 
Impact 
15 
(15) 
13 
(10) 
32 
(18) 
1 4 
(16) 
73 
(3 7) 
05 
(10) 
Mean 
(SD) 
33 
(2 4) 
38 
(17) 
77 
(19) 
2-1 
(21) 
168 
(50) 
37 
(19) 
(95% CI ) 
start-end 
-18 
(-2 9- -0 7) 
-2 5 
(-3 4- -1 6) 
-4 5 
(-5 6--3 5) 
-0 7 
(-12--0 2) 
-9 5 
(-121--6 9) 
-32 
(-4 2--21) 
ρ value3 
0 002 
<0 0001 
<0 0001 
0 005 
<00001 
<00001 
%SRb 
-1200 
-1923 
-1406 
-50 0 
-1301 
-640 0 
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Diet group Responders 
No return behavioural problems after challenge 
n=11 
Start 
phase \ 
End 
I phase 2 
Mean 
(SD) 
17 
(21) 
11 
(10) 
3-1 
(11) 
17 
(20) 
76 
(4-4) 
03 
(0 6) 
15 
(18) 
09 
(09) 
35 
(16) 
19 
(22) 
79 
(49) 
06 
(13) 
Mean difference 
(95% CI) 
start-end 
02 
(-11-15) 
02 
(-0 7-1 1) 
-05 
(-17-0 8) 
-0 2 
(-08-05) 
-0-3 
(-37-31) 
-04 
(-11-0 4) 
ρ value" %SRb Cohen's d 
0 79 
0 68 
0 49 
0 58 
088 
035 
182 
-129 
-3 9 
-1333 
02 
-03 
-0 1 
-0 1 
-03 
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Abstract 
Objectives Research has shown conclusive evidence for the effects of a 
Restricted Elimination Diet (RED) on Attention Deficit Hyperactivity Disorder 
(ADHD) and Oppositional Defiant Disorder (ODD) in young children. However, 
behavioural Improvements may also be mediated by changes in family 
environment following an RED. We aimed to Investigate whether changes of 
family environment contributed to the positive behavioural effects of an RED In 
children with ADHD. 
Method Twenty-four children with ADHD, a subsample of the Impact of Nutrition 
on Children with ADHD (INCA) study Investigating the effects of an RED on ADHD 
and ODD1, were randomised to either a 5-week RED intervention (n = 11). or a 
control intervention^ = 13). An additional No-ADHD control group did not receive 
any intervention (n = 23). Blinded (ADHD groups) and open assessments 
(No-ADHD control group) at start and end of the trial concerned the children's 
behaviour (assessed by the ADHD Rating Scale and a Structured Psychiatric 
Interview) and family structure and relationships (assessed by the Family 
Environment Scale [FES]). 
Results When compared to the norm, significantly higher FES scores were found 
in both ADHD groups and In the No-ADHD control group at baseline. Both ADHD 
groups showed significantly higher scores for conflicts than the No-ADHD control 
group. When comparing start and end measurements, no differences in family 
environment were found in both ADHD groups. 
Conclusions The effects of an RED on ADHD and ODD symptoms are not 
mediated by improvement of family environment. 
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Introduction 
Attention-Deficit Hyperactivity Disorder (ADHD), characterized by problems in 
attention, impulse control and activity regulation2, is one of the most common 
psychiatric disorders, with a strong genetic disposition.3 Both biological as well as 
psychosocial environmental factors are related to ADHD, including prenatal maternal 
smoking, prematurity, low birth weight, foetal distress, foster placing and disturbed 
parent-child relationships.46 An important, albeit controversial, environmental factor 
that may trigger ADHD is food7. Research investigating the effects of additives like 
colourings and preservatives on ADHD, has shown that, although additives may have 
some effects on the behaviour of all children (effect size 0.3), additives do not cause 
ADHD.8 Conversely, recent research investigating the effects of a Restricted 
Elimination Diet (RED), i.e. eliminating many kinds of foods from the child's diet, has 
shown statistically significant and clinically relevant results, with effect sizes on the 
ADHD DSM-IV Rating Scale varying from 1.7 according to the open teacher 
measurements to 2.0 according to the blinded paediatrician measurements.1 These 
results confirm the outcomes of seven previous randomised controlled trials, 
investigating the effects of an RED on ADHD, with an overall effect size of 1.6.' 
One could argue that the children's behavioural changes might be due to 
concomitant improvement of parental behavioural strategies, caused by the strict -J 
parental supervision necessary to comply with the RED. Research has shown that 
ADHD is associated with disruptive parent-child relationships and poor parenting 
structure9,2, even more when children are suffering from comorbid oppositional 
defiant disorder (ODD).6 Conversely, consistent parenting and positive parent-child 
interactions are associated with improvements of child behaviour.13 This suggests 
the possibility that behavioural improvements assessed in the RED trials might be 
mediated by the strict parenting structure necessary to follow the RED, rather than 
be a direct result of the diet. 
The present study uses a subsample of the Impact of Nutrition on Children 
with ADHD (INCA) study and investigated whether the effects of an RED on ADHD 
and ODD symptoms as previously reported1, can be explained by changes in 
family structure during the intervention. A group of No-ADHD control children was 
included as a comparison group, to investigate changes in family structure over 
time. Our study is the first study investigating the effects of following an RED on 
parenting abilities. 
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Methods 
Participants 
Children with ADHD were recruited as part of the INCA study (n = 100), 
investigating the effects of an RED on ADHD and ODD in children, the results of 
which have been reported elsewhere.' All parents of children entering the INCA 
study in September 2009 (ADHD RED group η = 11, ADHD control group η = 13), 
took part in this study. INCA inclusion criteria were 1) the children were diagnosed 
with ADHD any subtype2, 2) children were age 4-8, 3) their parents had sufficient 
command of the Dutch language and 4) parents were motivated to follow an RED 
during a 5-week period. Exclusion criteria were children taking medication for 
ADHD or receiving behavioural therapy, children already following a diet, or family 
circumstances which were likely to impede completion of the study. The INCA 
study was approved by the Medical Ethics Committee of Wageningen University 
and by the executive board and ethics committee of Catharina-Hospital Eindhoven. 
A control group (n = 23) consisting of children without ADHD, aged 4-8 years, 
was recruited through the teachers of the participating INCA-children. All teachers 
were contacted by phone and were asked to distribute an information leaflet, 
concerning a request to participate in this study, to parents of children without 
any behavioural problems at school. Interested parents filled in the ADHD DSM-IV 
Rating Scale (ARS) and subsequently were contacted by phone. Parents of all 
children participating in this trial gave written informed consent before the start of 
the study. 
Measures 
Three questionnaires were used to assess outcome; 1) the Dutch version of the 
Family Environment Scale (FES)14, to assess family relationships and parenting 
structure; 2) the 18-item ADHD DSM-IV Rating Scale (ARS)'5 to assess ADHD, 
and 3) a semi-structured, DSM-IV-based, psychiatric interview ([SRI]16, to assess 
ODD. The FES consists of 77 yes/no questions related to 7 subscales: 1) cohesion 
(family commitment and support), 2) expressiveness (expression of feelings), 
3) conflict (expression of anger and aggression), 4) organization (structure and 
planning of family life), 5) control (rules used in family life), 6) family values (opinion 
about norms and behaviour) and 7) social orientation (involvement in the 
social environment). Each subscale consists of 11 questions and scores range 
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from 0 to 11, higher scores indicating a more positive environment, with the 
exception of the conflict scale. In this study two index scores were used: the 
Family Relationships Index (FRI), based on three subscales (i.e. cohesion, 
expressiveness and conflict) and the Family Structure Index (FSI), based on two 
subscales (i.e. organization and control). Higher scores indicate better family 
relationship and parental structure.1' Both FES subscales and FES indices have 
shown good reliability and adequate validity.14 The two subscales which are not 
linked to the two indices i.e. family values and social orientation are not included 
in this article. 
The ARS, based on the DSM-IV criteria for ADHD, was used to assess ADHD, 
and consists of 18 criteria, nine inattention and nine hyperactivity/impulsivity 
criteria, using a 4-paint scale (0 = never [less than once a week], 1 = sometimes 
[several times a week], 2 = often [once a day], and 3 = very often [several times 
a day]), with a maximum of 54 points. 
Comorbid ODD was assessed by the SPI, based on the eight DSM-IV-ODD-
criteria, with a maximum of 8 points. A detailed description of the behavioural 
questionnaires has been published elsewhere.' 
Procedures 
The study design is shown in figure 1. The assessment points of all questionnaires, 
in both ADHD groups and in the No-ADHD control group, were at baseline and at 
the end of the trial, and data were collected in all children participating in the 
study (n = 47). After the baseline assessments the ADHD group (n = 24) was 
randomised to the ADHD RED group (n = 11) or the ADHD control group (n = 13). 
The ADHD control group received healthy food advices according to the 
guidelines of the Dutch Nutrition Centre, the ADHD RED group followed a 5-week 
individually composed RED. The RED, of which the details are described 
elsewhere18, was based on the few foods diet, consisting of rice, meat, vegetables, 
pears, and water. This diet was complemented with specific foods such as 
potatoes, fruits, and wheat, in order to create an elimination diet as comprehensive 
as possible for each individual child, thus making the diet easier for children and 
their parents to follow. If the parents reported no behavioural changes by the end 
of the second diet week, the diet was gradually restricted to the few foods diet 
only. After the baseline assessments the control group without ADHD (n = 23) did 
not receive any intervention. 
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The FES was filled in by the parents in both ADHD groups and the No-ADHD 
control group. The ADHD and ODD behavioural ratings in both ADHD groups 
were executed by a paediatrician blinded for treatment assignment', whereas the 
behavioural ratings in the No-ADHD control group were unmasked parent 
assessments. 
Statistics 
Statistical analyses were done with STATA version 10 and SPSS version 15. 
Statistical significance was based on α = 0.05, two sided, and clinical relevance 
was expressed by means of effect sizes (ES), with ES > 0.5 indicating a clinically 
significant effect.19 FES-outcomes at baseline before randomisation were 
compared between ADHD group, No-ADHD control group and norm score 
provided by the FES manual, based on 941 mother reports.1,1 P-values for 
differences between groups were obtained using General Linear Model (GLM) 
and additionally Cohen's d was calculated as effect size estimate. P-values for 
comparisons with the norm were obtained by the Welch-Satterthwaite equation. 
To assess any mediating effects of FES on the behaviour of the children, the 
FES-outcomes at the end of the study were analysed by GLM, using group (ADHD 
RED, ADHD control, No-ADHD control) as independent variable and the scores 
at start of the trial as covariate to adjust for differences that were potentially 
present at start already. 
ADHD and ODD analyses were by intention-to-treat, last observation carried 
forward, and based on the blinded measurements in both ADHD groups. A 
detailed description has been published elsewhere.1 Repeated measurement 
models were used to separately analyse the moderating role of the two FES 
indices (Relationship and Structure) on the effect of the RED on ADHD and ODD 
scores. Independent variables were 1) group (ADHD RED or ADHD control), 2) 
measurement point (start or end), and FES indices (FRI of FSI). Child was added 
as repeated effect to adjust for potential infra-child correlation (Generalized 
Estimated Equations, Gaussian distribution, exchangeable covariance structure). 
Dependent variables were ADHD and ODD scores. All 2-way interactions (FRI 
and FSI χ group, FRI and FSI χ measurement point, group χ measurement point), 
and 3-way interactions (FRI and FSI χ group χ measurement point) were evaluated. 
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Figure 1 Study design 
ADHD Group 
24 children with ADHD 
Behavioural Assessments (BA): 
completion Family Environment 
Scale (FES) 
4Γ 
11 randomly assigned 
to ADHD Restricted 
Elimination Diet (RED) 
group 
End 
11 BA 
11 completed FES 
IE 
13 randomly assigned 
to ADHD control group 
(healthy food advices) 
Control Group 
23 children without ADHD 
i 
BA 
Completion FES 
2 children left RCT 
before the 2"° BA; 
1 parent did not 
complete the FES 
End 
11 BA 
12 completed FES 
2 parents did 
not complete 
the 2n a BA; 
1 parent did 
not complete 
the FES 
End 
21 BA 
22 completed FES 
Results 
In both the ADHD control group and the No-ADHD control group two families left 
the study prematurely and one family did not complete the second FES-question-
naire. None of the families in the ADHD RED group left the trial. Most FES 
questionnaires were completed by the mother (43 / 47), and most children were 
boys (38 / 47). No significant differences regarding age, family size, number of 
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siblings and single parent families were found between the ADHD groups and 
No-ADHD control group (see table 1). In the ADHD group 11/24 children (46%) 
were also diagnosed with comorbid ODD (6/11 children in de ADHD RED group, 
5 / 13 in the ADHD control group). In the No-ADHD control group one child met 
the criteria for ODD, none of them meeting the criteria for ADHD, 
Table 1 Baseline characteristics of study participants 
Boys 
Age in years (mean (SD)) 
Parental 1 sibling data 
Step/single parent family 
FES completed by mother 
Family size, number of siblings 
Only child 
1 sibling 
2 siblings 
3 siblings 
Meeting criteria ADHD 1 ODD 
ADHD 
ODD 
ADHD RED 
η = 11 
10 (91%) 
7.7 (0 9) 
01 (0%) 
11 (100%) 
0 (0%) 
5 (45%) 
4 (36%) 
2(18%) 
114(100%) 
6 (55%) 
ADHD control 
n = 13 
10(77%) 
7.2(1.2) 
1 (8%) 
11 (85%) 
3 (23%) 
8 (63%) 
2 (15%) 
0 (0%) 
134 (100%) 
5 (38%) 
No-ADHD 
control 
η = 23 
18(78%) 
6.8(1.4) 
2 (9%) 
21 (91%) 
0 (0%) 
16(70%) 
6 (26%) 
1 (4%) 
Ο
4
 (0%) 
1 (4%) 
P-value 
Fisher 
exact 
0.708 
01151? 
1.000 
0.668 
0.0732 
0.0283 
0431' 
0.5623 
0.2033 
0.001 
ANOVA: 2 overall p-value. ' tested against other categories; 4 frequency equals 100% or 0% by 
definition 
Baseline comparison of family relationships index (FRI) and family 
structure index (FSI) in ADHD and No-ADHD control families 
At baseline the FRI and the FSI scores of the ADHD group preceding randomisation 
(n = 24) were similar to the scores of the No-ADHD control group (n = 23) (see 
table 2). Also no differences were found between the ADHD RED group (n = 11) 
and the ADHD control group (n = 13). Both ADHD groups showed significantly 
more conflicts on the conflict subscale than the No-ADHD control group, whereas 
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on the other subscales no significant differences were found. When compared to 
the norm scores provided by the FES-manual, significantly higher scores of PR! 
and FSI were found in both ADHD groups and in the No-ADHD control group at 
baseline. 
Effects of RED on family relationships index (FRI) and family structure 
index (FSI) 
The FRI and FSI baseline and endpoint scores of the ADHD RED group and 
ADHD control group are presented in table 3. No intervention effect was found on 
the FRI and FSI, neither in the ADHD RED group nor in the ADHD control group. 
Effects of RED on ADHD and ODD symptoms taking into account any 
effects of family relationships and family structure 
The effects of the diet intervention on ADHD and ODD are shown in table 3. The 
analysis of the ADHD score using a repeated measurement design showed that 
FRI was significantly associated with the ADHD score (i.e. a higher FRI was 
related to less ADHD symptoms), independent of ADHD group and measurement 
moment (estimate -0.8, 95% CI = -1.5 - -0.1, ρ = 0.024, see figure 2.1 A and B) 
The 2-way and 3-way interactions with group and measurement point were non- -g 
significant. No effect of FSI on ADHD score was found, (estimate 0.8, 95% CI = -J 
-0.2 - 1.8, ρ = 0.134), and the 2-way and 3-way interactions were non-significant. 
suggesting that changes in both FRI and FSI did neither mediate nor moderate 
the results of the RED on ADHD symptoms. 
A similar analysis for ODD score equally showed a significant association for 
FRI, independent of ADHD group and measurement moment (estimate -0.2, 95% 
CI = -0.4 - -0.03, ρ = 0.022), indicating that a higher FRI was related to less ODD 
symptoms (see figure 2.2A and B). No effect of FSI on ODD score was found 
(estimate 0.2, 95% CI = -0.1 - 0.5, ρ = 0.238). Again 2-way and 3-way interactions 
were non-significant, suggesting that changes in both FRI and FSI did neither 
mediate nor moderate the results of the RED on ODD symptoms. 
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Table 2 FES ratings in ADHD group, No-ADHD control group and the FES-manual norm, at start trial 
Cohesion 
Expressiveness 
Conflict 
Organization 
Control 
FRI 
FSI 
1 
Π=24 
Difference 1-21 Difference 1-32 Difference 2-32 
n=23 n=941 
ADHD No-ADHD Norm Mean ρ value Cohen's d Mean ρ value Cohen's d Mean ρ value Cohen's d 
group Control 
group 
difference 
8.9 
(1.7) 
10.1 
(1.3) 
4.7 
(2.2) 
8.3 
(1.5) 
9.5 
(13) 
25.3 
(3.8) 
17.8 
(2.1) 
Mean 
(SD) 
9.1 
(0.9) 
9.7 
(1.2) 
3.0 
(2.1) 
8.7 
(1.0) 
9.5 
(1.2) 
2 6 8 
(2.9) 
18.3 
(17) 
8.5 
(2.0) 
8.3 
(2.2) 
5.0 
(2.5) 
8 0 
(23) 
8.5 
(2.1) 
2 2 9 
(3.4) 
16.5 
(3.8) 
-0.2 
(-1.0-0 4) 
0.3 
(-0.4-1.1) 
1.7 
(0.5-2.9) 
-0.4 
(-1.2-0.3) 
0.0 
(-07-07) 
-1.5 
(-3.5-0.4) 
-0.5 
(-1.6-0 7) 
difference 
0.59 
0.352 
0.007 
0.230 
0951 
0.123 
0.429 
-0.2 
0.3 
0.8 
-0.3 
0.0 
-04 
-0.3 
0.4 
1 8 
-0.3 
0.3 
10 
2.4 
1.3 
0.134 
<0.0001 
0.256 
0.175 
0.001 
0.003 
0.003 
0 2 
1 0 
-0.1 
0 2 
0 6 
0 7 
0 4 
difference 
0 6 
1.4 
-2.0 
0.7 
1.0 
3.9 
0.003 
<00001 
<0,0001 
0.002 
<0.0001 
<0 0001 
04 
0 8 
-0 9 
0 4 
06 
1.2 
<0.0001 06 
FES: Family Environment Scale: SD Standard Deviation: FRI: Family Relationships Index (consisting of cohesion, expressiveness and conflict); FSI: Family Structure 
Index (consisting of organization and control): 'Based on GLM, 2Based on Welch-Satterthwaite equation 
Table 3 Comparison of ADHD score, ODD score and FES ratings within and between ADHD RED group and ADHD Control group 
at start and at end of trial 
ADHD RED 
N=11 
ADHD Control 
N=12 
Start End 
Mean 
(SD) 
44,6 
(4,1) 
3.3 
(2.0) 
8.7 
(1.4) 
10.1 
(1.2) 
5.6 
(2.2) 
8.4 
(1.4) 
94 
(1.0) 
24.3 
(3.2) 
17.7 
(1.7) 
Mean 
difference 
(95% CI ) 
start-end 
26.5 
(18.2-34,9) 
1.3 
(-0.2-2.8) 
-0.2 
(-0.9-0.5) 
0.1 
(-0.2-0.4) 
0.8 
(0.0-1.6) 
-0.2 
(-0.8-0.5) 
-0.5 
(1,0) (-0,8-0.1) 
25,2 -0,9 
(3,2) (-21-0,3) 
18,4 -0,6 
(1,0) (-1,4-0,2) 
18.1 
(12.9) 
2,0 
(2.0) 
8.9 
(1.1) 
10.0 
(1.6) 
4.7 
(2.2) 
8.6 
(0.7) 
9.8 
ρ value Cohen's d 
<00001 
0.101 
0 606 
0.576 
0041 
0.606 
0.004 
0.136 
0121 
28 
07 
-02 
01 
04 
-0.2 
-0.4 
-03 
-0.5 
Start End 
Mean 
(SD) 
46,0 
(4.2) 
3,2 
(2.3) 
8.9 
(2.0) 
10.2 
(1.5) 
4.3 
(16) 
8.1 
(1.6) 
9.5 
(1.4) 
25.8 
(4.0) 
17.6 
(2.7) 
43.7 
(7.1) 
2.9 
(2.6) 
9.0 
(1.6) 
10.0 
(1.1) 
3.8 
(1.5) 
8.0 
(1.6) 
9.6 
(1.5) 
26.3 
(2.8) 
17.6 
(2.8) 
Mean 
difference 
(95% CI) 
start-end 
2,3 
(-0,-5,6) 
0.2 
(-0,3-0,8) 
-0,2 
(-0,7,-0,4) 
0,2 
(-0,4-0,7) 
0.5 
(-0.1-1.1) 
0.1 
(-0.6-07) 
-0.1 
(-0.6-0.5) 
-0.5 
(-1.8-0.8) 
0.0 
(-1.1-1.1) 
End rating ADHD 
Control versus ADHD 
RED group, adjusted 
for score at start 
ρ value Cohen's d Mean ρ value 
difference 
(95% CI) 
<0.0001 
0.201 
0.883 
0.840 
0.904 
0.332 
0.295 
0.882 
0 282 
0156 
0.411 
0.575 
0.538 
0.083 
0804 
0.772 
0455 
1 000 
0.4 
01 
-0,1 
0.2 
0,3 
0,1 
-0.1 
-0,1 
0,0 
25.1 
(16,4-33.8 
1.0 
(-0.5-2.5) 
-01 
(-0,8-0,7) 
0.1 
(-0,6-0.7) 
-0.1 
(-1.0-0.9) 
0,4 
(-0,4-12) 
0.3 
(-0,3-1,0) 
-0,1 
(-1,6-1,4) 
0,7 
(-0,6-1.9) 
ADHD: Attention-Deficit Hyperactivity Disorder; ODD: Oppositional Defiant Disorder, FES: Family Environment Scale; SD Standard Deviation, FRI: Family Relationships 
Index (consisting of cohesion, expressiveness and conflict); FSI: Family Structure Index (consisting of organization and control); * last observation carried forward 
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Figure 2.1 Family Relationship Index (A), Family Structure Index (B) and 
Predicted ADHD total score for ADHD control and ADHD RED 
group at start and end. Prediction based on the final GEE model 
ADHD control ADHD RED 
25 30 15 20 
Family Relationship Index 
* . 
20 10 
Family Structure Index 
• Predicted ADHD score at start 
A Predicted ADHD scores at end 
Fitted predicted ADHD scores at start 
Fitted predicted ADHD scores at end 
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Figure 2.2 Family Relationship Index (A), Family Structure Index (B) and 
Predicted ODD total score for ADHD control and ADHD RED 
group at start and end. Prediction based on the final GEE model 
s 4 
A 
20 10 
Family Structure Index 
• Predicted ODD score at start 
* Predicted ODD scores at end 
Fitted predicted ODD scores at start 
Fitted predicted ODD scores at end 
155 
Chapter 7 
Discussion 
The main aim of this study was to investigate whether the beneficial behavioural 
effects in children with ADHD following an RED', may be explained by an 
improvement of family environment, i.e. family relationships and family structure. 
Our findings indicate that 1) family environment in families of children with ADHD, 
motivated to follow a 5-week RED, is similar to the family environment of a 
No-ADHD control group and better than the FES-manual norm; 2) family 
relationships and structure are not affected by following a 5-week RED; 3) the 
effects of an RED on ADHD and ODD symptoms are not mediated by changes in 
family relationships and structure (in fact, there were no changes); 4) family 
relationships but not family structure are inversely associated with ADHD and ODD. 
At baseline we did not find any significant differences in family environment 
between the ADHD group (n = 24) and the No-ADHD control group (n = 23). nor 
between the ADHD RED group (n = 11) and the ADHD control group (n = 13). All 
groups, however, showed a better family environment compared to the norms. 
Consequently, relationships and structure of ADHD families taking part in this 
study were (more than) adequate. These findings are consistent with the findings 
of Pimentel at al20, who found that parental practices of mothers of children with 
ADHD were similar to those of a validation sample. Conversely, our results are 
contrary to the findings of Kepley & Ostrander21 who found that families with 
ADHD were less cohesive and expressive than families without ADHD. It is 
conceivable that this discrepancy may be caused by the fact that, in advance, 
parents were adequately informed about the stringency of the diet. It is conceivable 
that parents who dreaded this challenge would decide not to participate, and that 
only parents who were confident of their parenting capacities, would decide to 
participate. Consequently, our sample may have consisted of families with an 
above average family environment only. 
We found no differences in family relationships and structure when comparing 
the start and end measurements of both ADHD groups. Consequently, in our 
sample the RED did not affect family environment. Considering that all families in 
the ADHD RED group completed the study, we could not investigate the parenting 
capacities of parents not complying with the diet. 
The results of the RED on the behavioural outcomes of the ADHD group, i.e. 
statistically significant and clinically relevant improvements of ADHD and ODD in 
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64% of the children, have been discussed elsewhere.1 The analyses of two-way 
and three-way interactions of the family relationships and structure indices and 
behaviour, with group and measurement point as independent variables, showed 
that family relationships and structure did not mediate the effect of the RED on 
ADHD and ODD symptoms. However, we found an inverse correlation between 
family relationship and both ADHD and ODD symptoms, i.e. a higher family 
relationships index score co-occurred with less ADHD and ODD symptoms. 
These findings are consistent with the findings of Deault6, showing that ADHD is 
associated with conflicted parent-child relationships. We found no significant 
association between family structure and both ADHD and ODD symptoms. 
Limitations of this study should be noted. First, the ADHD-group only 
consisted of families with good family environment. It is conceivable that families 
with less adequate family environments were deterred from following an RED, 
which may have led to a sample bias. Consequently, our study shows that in 
families with an average family environment an RED is a feasible intervention in 
children with ADHD. Second, it is conceivable that parenting problems might 
impede the compliance to and the completion of the RED, but this aspect could 
not be investigated because all families assigned to the ADHD RED group 
completed the diet. Concluding, behavioural improvements of children with 
ADHD and ODD following an RED are not mediated by improvements of family 
relationships and structure. The results of our study are applicable to those 
families of young children with ADHD motivated to follow a 5-week RED. 
Key points 
• At baseline family environment scores of the ADHD group were similar to those of a 
control group without ADHD and better than those of the norm group 
• The ADHD group reported significantly more conflicts than the control group 
without ADHD at baseline 
• In families of children with ADHD, with or without ODD, family relationships and 
family structure did not change during a 5 week Restricted Elimination Diet (RED) 
• Behavioural improvements of children with ADHD, with or without ODD, were not 
mediated by changes in family environment during the RED 
• ADHD and ODD were negatively associated with family relationships but not with 
family structure 
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8.1. General introduction 
Chapter 1 of this thesis is a general introduction that provides an overview of the 
history, diagnosis and aetiology of ADHD. Furthermore, the current assessment 
and therapy of ADHD is described and food as a specific environmental factor is 
discussed, considering the results of additive studies, supplement studies and 
restricted elimination diet (RED) studies in children with ADHD. No relevant effects 
have been found of additive free diets on ADHD, and the results of studies 
supplementing omega-3 (fish oil) and/or omega-6 fatty acids are commensurable 
to the results of additive studies, i.e. no relevant beneficial effects of fatty acids on 
ADHD have been found. Conversely, there is convincing evidence for the 
statistically significant and clinically relevant effects of an RED on ADHD. In a 
meta-analysis including all double-blind placebo controlled RED studies 
conducted preceding the studies discussed in this thesis, an average effect size 
of 0.8 was calculated, which is impressive. For comparison, the effect size of 
methylphenidate, the most used drug in children with ADHD, may vary from 
0.6-0.9. Subsequently, in 2001 an RED was included in a UK algorithm for 
treatment of ADHD. Still, despite the results of the RED studies and the 
recommendation for application, an RED is not part of the current ADHD 
assessment or therapy yet. 
8.2. Part 1 
The overall aim of Part 1 of this thesis was to investigate the effects of an RED on 
ADHD in heterogeneous groups of children with ADHD, in order to determine 
whether the RED results are applicable to the general population of children with 
ADHD, and to investigate the RED effects on comorbid ODD, physical complaints 
and sleep problems. 
In Chapter 2 an exploratory pilot study is described in which a group of 
young children with ADHD, of whom 84% also suffered from comorbid ODD, 
followed a 2-week RED. Children were not selected for atopic constitution or diet 
affinity and all children with ADHD whose parents were motivated to follow an 
RED were included. Conversely, children whose parents reported unfavourable 
environmental factors associated with ADHD were excluded from participation. 
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According to parents' and teachers ADHD measurements 62% of children 
showed behavioural improvements of at least 50% following the RED. According 
to the ODD measurements an ODD symptom decrease of 50% or more was 
shown in 81% of children with comorbid ODD. The diet response did not differ 
between children with or without an atopic constitution. Physical and sleep 
complaints were reported in the majority of children, which diminished significantly 
following the RED. 
Chapter 3 reports the results of a randomised controlled trial (RCT) in which 
children with ADHD were randomised either to an RED group or to a control 
group. In accordance with the previous study, the children included in this study 
were not preselected, but children with potentially predisposing environmental 
factors were excluded. The results shown in Chapter 2 were confirmed in this 
randomised controlled design: following the RED impressive effect sizes of 2.1 
(ADHD) and 1.1 (ODD) were established, according to both parents' and teacher's 
measurements. The ADHD behaviour improved with an average of 70% in 85% of 
children. ODD improvements, with an average of 55%, were shown in 73% of 
children with comorbid ODD. No significant ADHD or ODD improvements were 
established in the control group. 
In Chapter 6 the INCA study is described, which comprises two parts. Based 
on the immunological assessments chapter 6 has been incorporated in part 2 of 
this thesis. Conversely, the first and behavioural part of Chapter 6 is a follow-up 
study of the RCT discussed in Chapter 3, consequently, this part of the INCA 
study will be discussed here. The INCA study was an RCT including an unselected 
and heterogeneous group of children with ADHD; no children were excluded. 
According to parent, teacher and blinded paediatrician ADHD measurements the 
majority of children showed striking behavioural improvements following an RED. 
Sixty-four per cent of children in the diet group showed behavioural improvements 
of an average of 60%; the average improvements in responders were 89% (see 
chapter 9.1, figure 1). The average ODD improvements in diet group children with 
comorbid ODD were 65%, and were found in 70% of children; the average 
improvements in the ODD responders also amounted to 89% (see chapter 9.2, 
figure 2). In the control group no significant improvements of ADHD as well as 
ODD were found. 
The responders did not meet the criteria of ADHD and ODD anymore, neither 
at home nor at school, thus confirming the results of previous studies (see chapter 
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2 and chapter 3). Considering that the children participating in the INCA study 
were representative of the general population of children with ADHD, the INCA 
results are applicable to all young children with ADHD whose parents are 
motivated to follow a 5-week RED. 
In Chapter 4 the effects of an RED on comorbid physical and sleep complaints 
in children with ADHD were investigated following an RED. Significant symptom 
reduction was shown in three domains: headaches or bellyaches, unusual thirst 
or unusual perspiration, and sleep complaints. The total number of complaints 
was significantly reduced in the RED group (a reduction of 77%, effect size 2.0) 
but not in the control group (a reduction of 17%, effect size 0.2). The symptom 
reduction did not differ between children with or without an atopic constitution 
and did not differ between children who did or did not show behavioural 
improvements following the RED. The results of this RCT confirm the findings of 
the pilot study described in Chapter 2. 
Conclusions part 1: An RED may have considerable effects on ADHD and 
comorbid ODD, physical complaints and sleep problems, thus confirming and 
strengthening the results of the previous RED studies. The double-blind placebo 
controlled RED studies have shown that the beneficial effects of an RED on ADHD 
are not moderated by parental expectations, and all studies investigating the 
relationship between an RED and ADHD resulted in statistically significant and 
clinically relevant improvements of behaviour. Therefore, in accordance with the 
recommendations mentioned in Chapter 6. the conclusion is warranted that an 
RED is beneficial to the majority of young children with ADHD, with an overall 
effect size of 1.2, and that it is timely for an RED to be implemented. In responders 
the behavioural problems may diminish to such an extent that they do not meet 
the ADHD and ODD criteria anymore and show normal behaviour. Considering 
that children with comorbid ODD have a worse prognosis, interventions that may 
reduce ODD have great clinical potential. The INCA study, as discussed in 
Chapter 6, used the most pragmatic design including a heterogeneous group of 
children Consequently, the results of this study are applicable to all young 
children with ADHD provided that parents are motivated and able in terms of 
parenting skills and time resources to follow a 5-week diet. 
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8.3. Part 2 
The overall aim of Part 2 of this thesis was to investigate the occurrence of an 
underlying immunological mechanism of food in children with ADHD by means of 
IgE and IgG blood tests. Furthermore, the effect of an RED on family structure and 
environment was considered in order to define whether behavioural improvements 
during an RED were instigated by improvements of parental capabilities. 
In Chapter 5 it is hypothesised that ADHD may be a (non-)allergic hyper-
sensitivity disorder. According to the terminology of allergy the manifestation of 
ADHD when eating normal amounts of foods which are usually tolerated by the 
general population, implies that the criteria of a hypersensitivity reaction are met. 
The hypersensitivity hypothesis in ADHD is in accordance with other hyper-
sensitivity disorders, e.g. the manifestation of asthma when exposed to dust mite 
or the manifestation of eczema when eating strawberries. The hypersensitivity 
triggering ADHD may be allergic or non-allergic, depending on whether or not an 
immunological mechanism will be established. 
The occurrence of an immunological mechanism was investigated in the 
second part of Chapter 6. In all children participating in the INCA study 
immunological parameters (IgE and IgG blood levels) were determined at the 
start of the trial and following an RED or control period. At the start of the trial only 
a minority of children showed increased IgE-levels (14%), and no association was 
found between a behavioural response to the RED and increased IgE blood 
levels, thus confirming previous findings that IgE or an atopic constitution is not 
related to a hypersensitivity reaction to foods in children with ADHD. Chapter 6 
also focussed on IgG, investigating whether a relationship might exist between 
IgG blood levels against specific foods and ADHD behaviour. It was shown that 
IgG blood levels did not predict behavioural changes in RED responders; no 
differences in behavioural relapses were established after challenges with either 
high-IgG foods or low-IgG foods. These results suggest that the underlying 
mechanism of food hypersensitivity in ADHD is non-allergic, although the 
involvement of a cell- mediated allergic response cannot be ruled out. 
The main aim of Chapter 7 was to investigate whether the children's behavioural 
improvements following an RED were due to improvement of family structure and 
environment as a consequence of the strict structure of the diet. The results 
indicated that family abilities in families motivated to enter an RED trial were 
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equivalent or even better than those of families without ADHD, and that an RED 
did not affect family structure or family environment. It is conceivable that only 
parents confident of their parenting capacities decided to participate in the RED 
trial, consequently the results of this study are applicable to those families 
motivated to follow a 5-week RED. 
Conclusions part 2: ADHD may, in the majority of children, be considered a hy-
persensitivity disorder triggered by food. The underlying mechanism of food hy-
persensitivity in children with ADHD appears not to be IgE or IgG mediated, 
consequently a non-allergic mechanism or a cell-mediated allergic response may 
be involved. Furthermore, families motivated to follow an RED have shown 
excellent parenting capabilities and an RED does not affect family structure or 
family environment. 
8.4. General discussion 
Chapter 9 of this thesis is a general discussion in which the results of this thesis are 
elucidated in coherence with all previous RED results and in light of the current 
opinions of ADHD. The general discussion concludes with recommendations for 
further research into this intriguing subject (see chapter 9.6), with a proposal for an 
Algorithm for Multimodal Diagnosis and Treatment of ADHD in which the results of 
this thesis are incorporated (see chapter 9.7, figure 4), and with suggestions for the 
DSM-V which may lead to improvement of our child mental health (see chapter 9.8). 
8.5. Conclusions and recommendations 
Taking the results of all previous and recent RED studies into account, there is 
conclusive evidence for the statistically significant and clinically relevant effects 
of an RED on ADHD and ODD. The RED studies discussed in this thesis have 
shown that an RED has a beneficial effect on ADHD and comorbid ODD in 60% 
of children with ADHD, to such an extent that in children responding to an RED the 
behavioural problems, ADHD as well as comorbid ODD, disappear completely 
(see chapter 9.1, figure 1 and chapter 9.2, figure 2). 
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The impact of an RED appears not to be limited to ADHD and ODD, but is also 
manifest in the frequently occurring comorbid physical and sleep complaints in 
children. Consequently, an important environmental cause of ADHD, ODD, 
comorbid physical complaints and sleep problems has now been established; 
this recognition may lead to a paradigm shift with regard to our knowledge and 
opinions on the aetiology of ADHD and may have considerable consequences for 
the current diagnostic procedure and therapy of ADHD. 
8.5.1. Implementation of RED research 
The most important recommendation is implementation of RED research In young 
children with ADHD. Right now, the main therapy of children with ADHD is 
medication, eliminating symptoms during 3-12 hours (the duration depending on 
the drug), with an effect size of 0.6-0.9 and with disappointing long-term effects. 
This dissertation has shown that in the majority of young children ADHD may be 
caused by food and that an RED is an effective treatment of ADHD in children 
diagnosed FI-ADHD, preventing symptoms 24/7, with an effect size of 1.2 and 
with promising long-term prospects. The pros of an RED are to such an extent 
that RED research should be implemented especially in young children with 
ADHD, consequently, all young children with ADHD should be offered the 
opportunity to participate in RED research, provided that expert supervision is 
available. Children with ADHD responding favourably to an RED should be 
diagnosed with food-induced ADHD (FI-ADHD), considering that in these children 
food appears to be the predominant cause of ADHD and that elimination of 
specific foods results in normal, typical behaviour. Children not responding to an 
RED should be diagnosed with Classic ADHD (C-ADHD); in these children the 
cause of the disorders remains, for the time being, unknown. These children, just 
like children of parents not motivated to start or to comply with an RED, should start 
treatment as usual. 
Children diagnosed with FI-ADHD are advised to start a challenge period, as 
described in the Algorithm for Treatment in chapter 9.7, in order to establish the 
incriminated foods, at the end of which the therapy consists of dietary advice to 
avoid a limited number of foods. Offering children with ADHD the opportunity to 
start RED research may consequently result in prevention of ADHD and in 
improvement of the children's prospects. 
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Finally, the concurrent economical effects of every child completing the RED 
research may be impressive. According to a Dutch report, making a rough 
inventory of some of the costs of ADHD by comparing the costs including RED 
research with the current costs of ADHD, implementation of RED research may 
yield savings of 7.000 euros per year per child starting RED research. 
8.5.2. alleviation of the challenge period 
Facilitation of the challenge period is another important recommendation. This 
part of the RED research is the most poignant part for parents, child and school, 
due to the recurrent behavioural relapses during this period. All efforts should 
be made to facilitate this period by means of expert coaching and by means 
of follow-up research in order to define the mechanisms of food in children 
with FI-ADHD. It must be noted that, until an easier method is available to define 
the incriminated foods, the current challenge period is crucial to determine the 
incriminated foods and thereby to compose a feasible diet. At the end of 
the challenge period the child's diet will be practically normal and the child 
will have to avoid the incriminated foods only, which may differ per child. Thus, 
compared to the RED and the challenge period the final dietary restrictions will be 
easy to adhere to, and relapses will only occur if the child does not stick 
to the diet. Concluding, additional expert coaching during the challenge period 
will increase the compliance and further research should focus on facilitating 
the challenge period and on defining the mechanisms of food In children with 
FI-ADHD. 
8.5.3. Follow-up research 
Some RED studies have already shown that the beneficial effects continue 
unabated during a follow-up period of one year. Also, the preliminary results of 
the INCA 10-month follow-up study show that the behavioural effects, in children 
who adhere to their diet, persist. Still, it is important to investigate the effects of an 
RED during a longer period of time, and to investigate whether children may 
overgrow the sensitivity to specific foods when avoiding the incriminated foods. 
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8.6. Acknowledgement and consensus 
In 2001 RED research was already advised to be applied in subgroups of children 
with ADHD. Unfortunately, this advice has been confronted with a striking deficit 
of attention and has, just like all previous RED research and despite convincing 
evidence, generally been ignored. Now, in 2011, RED research has repeatedly 
been conducted in heterogeneous groups of children, thus confirming the results 
of the previous RED trials in groups of children representative of the general 
population of children with ADHD. Consequently, this thesis results in the advice 
to implement RED research in all young children with ADHD. Acknowledgement 
of the impact of food on ADHD is needed in order to achieve consensus. It would 
be deplorable, especially for all children suffering from ADHD, if the advices 
resulting from this thesis would sink into oblivion, commensurable to the 2001 
advices. 
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Introduction 
ADHD is an aetiologically complex disorder in which genes and environment play 
a substantial role. So far, the exact aetiology of ADHD and the extent of the 
interaction between genes and environment are still unknown. This thesis shows 
that food has a considerable impact on ADHD, comorbid ODD and physical 
complaints in the majority of young children with ADHD whose parents are 
motivated to follow an RED. Consequently, the results of this thesis may be 
considered an important step forward towards the understanding of the 
pathogenesis of ADHD, which may lead to improvement of the diagnostic and 
therapeutic procedures. 
Considering that the findings of each separate study included in this thesis 
have been discussed at the end of each chapter, this general discussion will 
focus on the overall findings of all RED studies and on the consequences these 
findings may have on our knowledge of ADHD. Based on the current point of view 
as described in the introduction of this thesis, the impact of an RED on ADHD, on 
ODD, on physical complaints and sleep problems, and on our knowledge of the 
aetiology of ADHD will be discussed. Furthermore the discussion elaborates on 
the mechanisms in which an RED exerts its effects, on follow-up research, on the 
practical implications and implementation of the RED findings in general practice, 
including a proposal for a multimodal algorithm for diagnosis and treatment, and 
on suggestions for the DSM-V that will be implemented in 2013. 
9.1. The Impact of an RED on ADHD 
The results of the INCA study (see Chapter 6). investigating the effects of an RED 
on ADHD in an unselected group of young children with ADHD, are impressive.' 
Both the number of children responding favourably to the RED and the extent of 
the behavioural improvements are remarkable. The average improvement in the 
responders (32/50 children), based on the measurements by the blinded 
paediatrician, was 89%, the number of ADHD symptoms decreasing from 15.2 to 
1.7, which is an impressive change in behaviour (see figure 1).Thenonresponders 
showed an average improvement of 17%, the ADHD symptoms decreasing from 
15.6 to 12.9. 
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Figure 1 Average number of DSM-IV ADHD symptoms (0-18) at start 1NCA 
and at end RED 
18 
6 15.4 15.3 15 2 15.6 
start end start end start end start end 
All children All children who Responders Nonresponders 
locf completed RED π = 32 η = 9 
η = 50 η = 41 
LOCF = last observation carried forward 
The INCA results confirm and strengthen the results of preceding randomised 
controlled RED studies, all showing considerable effects of an RED on ADHD in 
selected as well as in unselected groups of children,18 with an overall effect size 
of 1.2 (see table 1). This effect size is impressive, taking into account that the 
effect size of methylphenidate (the most used drug in children with ADHD) may 
vary from 0.6-0.9.910 The effect sizes of the RED RCTs vary from 0.6-1.8, depending 
on the study design (see table 2). Five out of 8 studies used a double-blind 
placebo controlled (DBPC) design, of which in three studies a food challenge 
(FC) design2 4 5 and in two studies a placebo diet was applied.37 The remaining 
three studies used an open design,16eone of which with blinded measurements.1 
Below the pros and cons of each design will be discussed. 
176 
General discussion 
First of all, 5 out of 8 studies used a double-blind placebo controlled (DBPC) 
design. In a recent meta-analysis concerning these 5 studies an average effect 
size of 0.8 was calculated," which of course is impressive. Still, two out of 5 DBPC 
studies, the placebo diet studies, resulted in the lowest effect sizes when 
compared to the other RED RCTs (see table 2).3 7 This difference may be explained 
by the fact that, in order to conceal the treatment conditions, these studies had to 
allow a wide variety of foods, i.e. they applied a more elaborate verum diet. 
According to the researchers a more stringent diet would have jeopardised the 
double-blind conditions, although it might have resulted in greater behavioural 
changes.3 Furthermore, one placebo diet study used a very short diet period of 8 
days only,7 while the average diet period of the other RCTs was 3.7 weeks (varying 
from 2-5 weeks); thus an 8 day diet period may be considered too short to 
effectuate behavioural changes. It is conceivable that if the diet was followed for 
a longer period of time the results might have been different. 
Three out of 5 DBPC studies used a DBPCFC design following the open diet 
period (in order to identify the responders) and the open challenge period (in 
orderte identify the incriminated foods).245 Two of these studies lasted more than 
12 months,24 as the challenge period following the RED comprised at least 40 
different foods, which were reintroduced at a rate of one a week. If the ADHD 
symptoms recurred, the challenged food was withdrawn again, conversely, if the 
behaviour did not change, the challenged food was incorporated in the RED, thus 
gradually resulting in elaboration of the RED and normalization of the diet. 
Following the challenge period the DBPCFC was conducted, with foods that 
could be disguised and which had caused deterioration of the behaviour during 
the challenge period. These studies have shown that open findings could be 
confirmed in a double-blind design. A disadvantage of DBPCFC design is that the 
challenged foods had to be concealed during the DBPC part of the trial. 
Consequently the amounts of the challenged foods were limited, possibly 
resulting in smaller behavioural effects4 than in the open RCTs (see table 2). 
Concluding, two out of 3 DBPCFC studies established the long term effect of 
an RED, that is, at least for a period of one year. All DBPCFC studies showed that 
most children reacted to more than one food and that the incriminated foods, i.e. 
the combination of foods the child reacted to, were different for each child. In 
addition, despite lower effect sizes which are in accordance with the limitations 
due to the blinded design, the DBPC studies are of paramount importance to 
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illustrate that behavioural changes following a diet are not attributable to 
expectations, believes, hopes of parents or changes in family structure. 
Three out of 8 RCTs used an open design.168 Although an open design is 
considered second best, it is often used in trials faced with blinding difficulties 
(see Chapter 6). Considering the disadvantages of the DBPC method, i.e. a too 
elaborate RED in the placebo diet trials and a too small amount of challenged 
foods in the food challenge trials, in studies applying an RED the open design is 
a legitimate choice. Furthermore, the results of the DBPCFC trials have shown 
that parents' findings can be relied upon, as the open parents' results were 
confirmed in the DBPCFC design. In addition, an open design has two important 
advantages: 1) the diet may be as stringent as necessary, thus achieving the 
most optimal behavioural effects; and 2) the diet may be constructed for each 
child individually, in order to achieve the most optimal diet for each child (see 
Chapter 6). These optimal dietary circumstances may have lead to the open RCTs' 
higher effect sizes, i.e. an average ES of 1.8. In all open RCTs the parents' results 
were confirmed by the teacher's findings.'68 On top of that, the results of one of 
the open RCTs, the INCA study (see Chapter 6). were based on the measurements 
of a paediatrician blinded for treatment conditions,1 which were also confirmed by 
the teacher's measurements. Finally, the INCA study proceeded following the 
RED with a DBFC, and the relapse in behaviour during the DBFC may be regarded 
as an internal replication of the effects of the RED. 
Concluding, the 3 open RCTs show higher effect sizes than the DBPC studies, 
which are confirmed by teacher's measurements and blinded measurements, 
and these studies are of paramount importance to emphasize the magnitude of 
the effect an RED may have on the behaviour of children with ADHD. 
Considering that RCTs are executed to confirm or refute the results of 
previously conducted pilot studies without a randomised controlled design, and 
considering that all RED RCTs confirm the results of these pilot studies, additional 
evidence is provided by two previously performed Dutch open pilot studies.I^,3 
One of these open studies is discussed in Chapter 2.i3 the other study was 
published in a peer reviewed Dutch Child and Adolescent Psychology Journal. 
This study included an unselected group of 64 children, meeting the DSM-IV 
criteria for ADHD and aged 3-15 (average age 6.7), of which six children left the 
study prematurely.'2 In this pilot study, 34/58 children (59%) showed behavioural 
improvements of more than 50% following the RED, according to parents' and 
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teachers measurements. To examine whether younger children tend to respond 
more favourably to the RED, the group was divided into two age categories, 
children aged 3-7 (n=40) and children aged 8-15 {n=18). 24/40 children aged 3-7 
were diet responders (60%), and 10/18 children aged 8-15 were diet responders 
(56%). Consequently, the age of children participating in RED trials does not 
predict the response to the diet. Another interesting aspect of this pilot study is 
the subtype versus responder differentiation: 18/25 children who met the ADHD 
criteria for the combined type were diet responders (72%), as were 14/24 children 
who met the predominantly hyperactive/impulsive type criteria (42%) and 2/9 
children who met the predominantly inattentive type criteria (22%). In most RED 
studies the children were not divided in subgroups," or the inattentive subgroup 
was too small to be analysed.1813 Still, according to these results children who 
meet the combined type criteria tend to respond most to an RED, while children 
who meet the inattentive type criteria are likely to respond least. Conversely, all 
studies analysing the effects of an RED on both groups of ADHD symptoms1813 
showed that both the hyperactive/impulsive symptoms and the inattentive 
symptoms decreased equally after following the RED. 
In sum, the findings of the RED RCTs may be taken seriously. The results of 
the double-blind placebo controlled RED studies have shown that the results are 
not caused by parental expectations or by changes in family structure. The RED 
RCTs confirm the results of previously executed pilot studies, thus providing even 
more evidence for the effect of an RED on ADHD, and it is important to note that 
all studies investigating the relationship between an RED and ADHD resulted in 
statistically significant and clinically relevant improvements of behaviour. 
Therefore, in accordance with the recommendations mentioned in Chapter 6, 
the conclusion is warranted that an RED is beneficial to the majority of young 
children with ADHD, with an overall effect size of 1.2, and that it is timely for an 
RED to be incorporated in our overall knowledge on ADHD. In responders the 
behavioural problems may diminish to such an extent that they do not meet the 
ADHD criteria anymore and show normal behaviour. The INCA study, as discussed 
in Chapter 6. used the most pragmatic design including a heterogeneous group 
of children. Consequently, the results of this study may be considered 
representative of the general population of children with ADHD, i.e. the results are 
applicable to all young children with ADHD provided that parents are motivated 
and able in terms of parenting skills and time resources to follow a 5-week diet. 
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Table 1 Summary of all 8 RED RCTs, including effect sizes 
CD 
O 
Age Diagnosis 
at start 
Methods 
Egger DBPCFC 
1985 
2 
Kaplan 
1989 
3 
Carter 
1993 
2-15 Hyperkin 
syndrome 
DBPC diet 3.5-6 DSM-
DBPCFC 3-12 DSM-II 
7,5 Boris DBPCFC DSM-III-R 
1994 
Schulte OpenRCT „ „ ICD-9 
+-2.0 1996 
Open RED 
n=761 
open challenge 
n=56, 
dbpcfc" η=25 
RED vs placebo 
diet 
dbpc^ n=24 
Open RED 
n=78, 
open challenge 
n = 59 
dbpcfc" n=19 
Open RED 
n=26 
open challenge 
n=19 
dbpcfc n=16 
Open RED vs 
challenge diet^ 
n=21 
Selection RED ES Weight Contribution 
period ACS to Weighted 
ES 
Selected 
Group* 4 weeks 103 0.11 0.12 
Aselected 
group 4 weeks 0.55 0.11 0.06 
Selected 
Groep* 3-4 weeks 0.61 0.09 0.05 
Selected 
Group** 2 weeks 1.60 0.07 0.12 
Aselected 
group# 3 weeks 1.26 0.10 0.12 
Schmidt DBPCdiet 6-12 DSM-II 
1997 
Pelsser Open RCT 3-8 DSM-IV 
2009 
Open RCT, 
blinded 
measure­
ments 
Pelsser 
2011 
4-8 DSM-IV 
RED vs placebo 
diet 
dbpc" n=49 
REDn=15vs 
waiting list n=12 
REDn=50vs 
waiting list n=50 
blinded 
measurements 
Total η RCT 
219 
Aselected 
Group 
Aselected 
group* 
Aselected 
group 
8 days 
5 weeks 
5 weeks 
0.59 0.22 
2.35 0.07 
1.82 0.23 
Average Total 
ES=1.2 1.00 
0.13 
016 
0.42 
Weighted 
ES=1.2 
ACS = abbreviated ACS = ACS = abbreviated conners scale; RCT = Randomised Controlled trial, DBPCFC = double-blind placebo controlled food challenge 
ES = effect size; Λ = crossover; 'subjects selected via diet clinics; "subject selected via allergy clinic, #exclusion of children with risk factors for ADHD (e.g. 
premature, dysmature, foster child, IQ<70) 
uojssnosia 
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Table 2 Effect size per RED RCT design 
RCT Average ES Weighted average ES 
' DB placebo diet design η =2 0.57 0.58 
DBPCFC design 
y
 1.08 1.05 
n = 3 
Open design
 1 8 1 1 7 8 
n=3 
RCT » Randomised Controlled trial; DB = double-blind; DBPCFC - double-blind placebo 
controlled food challenge; ES = effect size 
The weighted average ES has been calculated by weighting the average ES by the number 
of children in each study relative to the total number of children in the particular design. I.e., 
the weighted average ES of the open design studies (see table 1. study 5, 7 and 8). including 
86 children (21+15+50) - 1 26*21/86+2.35*15/86+1.82*50/86 - 1 78 
9.2. The Impact of an RED on ODD 
The INCA study also investigated the effects of an RED on comorbid ODD in an 
unselected group of young children with ADHD (see Chapter 6).' Equally to the 
effects of the RED on ADHD, both the number of children with ODD responding 
favourably to the RED and the extent of the behavioural improvements were 
impressive. In the RED group 14/20 children belonged to the responders, i.e. after 
following the RED 14/19 children did not meet the ODD criteria anymore and 
showed behavioural improvements of at least 40%. The average ODD improvement 
in the responders, based on the measurements by the blinded paediatrician, was 
89% and the number of symptoms decreased from 5.4 to 0.6. The nonresponders 
(5/19) showed behavioural improvements of 14%, the number of symptoms 
decreasing from 5.8 to 5.0 (see figure 2). 
The INCA ODD results confirm and strengthen the results of preceding RED 
studies, i.e. one RCT8 and one pilot study.13 In the pilot study, which is discussed 
in Chapter Σ.'3 the ODD criteria decreased from 6.0 at the start of the study to 1.3 
at the end of the RED. In the RCT, which is discussed in Chapter 3,B the average 
number of criteria decreased from 6.5 to 2.9 and the number of children meeting 
the criteria of ODD decreased by 66%. Furthermore, the teacher's findings 
confirmed the blinded paediatrician's findings (see Chapter 6). 
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The conclusion is warranted that an RED is beneficial to the majority of 
children with ADHD and comorbid ODD, with an effect size of 2.0.' In responders 
the behavioural problems diminished to such an extent that at the end of the RED 
they did not meet the criteria of ODD anymore and showed typical behaviour. As 
discussed at the end of section 9.1. the INCA study used the most pragmatic 
design, consequently the heterogeneous group of children participating in this 
study may be considered representative of the general population of children with 
ADHD and comorbid ODD, i.e. the results are applicable to all young children with 
ADHD and ODD, provided that parents are willing and able to follow a 5-week 
RED. 
Figure 2 Average number of ODD symptoms (0-8) at start INCA and at 
end RED 
I 9 
start I M l l l 
All children with 
comorbid ODD 
locf 
η = 20 
5.5 
start end 
All children who 
completed RED 
η = 19 
Γ, 4 
0 6 
start end 
Responders 
η = 14 
5 8 
5 0 
start end 
Nonresponders 
n = 5 
LOCF = last observat ion carr ied forward 
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9.3. The impact of an RED on physical complaints and 
sleep problems in children with ADHD 
Sleep disorders'4 and physical complaints like eczema, asthma, headache, 
bellyache, enuresis and encopresis are conditions often reported by parents of 
children with ADHD.2415 RED studies including the assessment and analysis of 
these comorbid problems found evident treatment effects on sleep problems (i.e. 
sleep latency, getting out of bed and night awakenings)3 and on headache, 
unusual thirst and abdominal pains.2 In Chapter 2n and Chapter 416 the effects of 
an RED on physical and sleep complaints have been discussed, showing 
significant symptom reduction specifically in the domains of headache and 
bellyache, unusual thirst and perspiration, and sleep complaints, thus establishing 
not only a decrease of behavioural problems, but also of physical complaints as 
a result of an RED. Furthermore, the responders showed significantly more 
physical complaints than the nonresponders, i.e. 80% of the responders and 
none of the nonresponders reported 3 or more physical complaints.13 As 
discussed in Chapter 4. the RED effect on physical and sleep complaints was 
established both in RED responders and in nonresponders.16 Also, no differences 
were found between the number of physical complaints in atopic and non-atopic 
children.1316 
This specific subject, i.e. physical complaints in children with ADHD, belongs 
to the frontiers of our ADHD knowledge. The high comorbidity found in the RED 
studies does not reflect clinical practice and may be explained by the fact that the 
RED researchers specifically inquired after all kinds of physical complaints,24and 
applied a physical complaints questionnaire.1316 Furthermore, in general practice 
physicians are not aware of the importance to scrutinize this aspect of ADHD. It is 
not part of the routine to use a specific physical complaints questionnaire when 
ADHD is concerned, and they are not accustomed to ask for seemingly vapid 
complaints like unusual thirst or perspiration or pain in limbs. It may also be 
conceivable that many of the physical complaints, unless urgent and impairing, 
will not be reported by parents in a psychiatric or psychological setting, as 
parents may not be aware of the relevance of these complaints. To illustrate this: 
many parents participating in the Dutch RED studies reacted amazed and 
concurrently with recognition when hearing the specific questions, exclaiming 
"indeed, you're describing my child, how striking that you ask". 
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In conclusion, the relationship between food, psychiatric and somatic disorders 
is a challenging subject in need of more research. Considering that the current 
approach of ADHD, i.e. drug treatment, does not affect comorbid physical 
complaints and may even cause some of these complaints" and considering that 
children with ADHD and physical problems tend to respond less favourably to 
medication,18 it is important to underline the impact of an RED. This impact 
appears not to be limited to ADHD and ODD, but is also manifest in the frequently 
occurring comorbid physical and sleep complaints in children. 
9.4. The implications of the RED findings for our 
knowledge of ADHD aetiology 
9.4.1. ADHD and genes 
Despite many efforts made to unravel the ADHD mysteries the exact aetiology of 
ADHD is still unknown.1920 However, it is quite clear that ADHD 'runs in families", 
i.e. it is a highly heritable disorder with a heritability estimate of 75%, established 
in twin and adoption studies.21 Consequently, ADHD research has been 
predominantly focussed on genetics, as a logical consequence of the high 
heritability results of twin studies, and on the brain, as a result of the dopamine 
hypothesis of ADHD, strengthened by the effects of medicines like methylphem-
date, which enhance the dopamine function.22 By now bioinformatic analyses 
have described extensive gene-protein networks that include many genes that 
may be involved in ADHD.23 Yet, no genetic markers of major effect have been 
established24and most genes involved in ADHD seem to be of small effect size.9 
• s 
Genome wide association studies (GWAS) thus far have shown inconclusive and 
divergent findings,25 and the effects of the genes involved in ADHD account for 
only a small part of the considerable heritability observed in twin studies.26 
Concluding, how exactly genetic factors contribute to the development of ADHD 
is not quite clear and more research is imperative. 
9.4.2. The threshold model: genes and environment 
More research might focus on the specific contribution of environmental factors 
to ADHD, which have been rather under-researched.27 Some environmental 
factors are specifically denominated in the threshold model, which implies that 
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ADHD is a complex disorder, "caused by the confluence of many different types 
of risk factors (i.e. genetic and environmental factors), with every risk factor having 
a small effect on the increasing vulnerability to the disorder through their additive 
and interactive effects".9 If a threshold is exceeded, then ADHD will become 
manifest, and according to this model no one causal factor is necessary or 
sufficient to initiate the disorder.9 The environmental factors considered relevant 
in ADHD are perinatal risk factors (e.g. prematurity, prenatal maternal smoking or 
alcohol consumption, low birth weight and dysmaturity) and psychosocial risk 
factors (e.g. family or marital conflicts, foster placement, low social class and 
parental mental disorders).92628 
9.4.3. Environment: association or causal 
Unfortunately, it is not yet quite clear whether the established association between 
these environmental risk factors and ADHD is causal. In fact, many environmental 
factors are influenced by genetic factors.22 For instance, the association between 
maternal smoking during pregnancy, a well-known risk factor for ADHD, may 
represent an inherited effect, as the association was significantly higher in biologically 
related mother-child pairs than in unrelated pairs.29 Consequently, smoking during 
pregnancy may be associated with ADHD, but may not be a true causal factor for 
ADHD.29 Considering that in practice an established association sows the seed of a 
causal relationship, it it is important to emphasize that an association found between 
two factors does not imply that a causal relationship exists: an established association 
is necessary in order to establish a causal relationship, but an established association 
alone is not evidential for the existence of a causal relationship.30 A striking example 
of an association in ADHD that is not causal, is the often established lower essential 
fatty acid (EFA) blood levels in children with ADHD. It has been repeatedly proven 
that supplementation of EFA does not affect ADHD behaviour,^ although the EFA 
blood levels do increase following the supplementation.32 I.e., although low EFA 
blood levels are often found in children with ADHD, there is no causal relationship 
between these low blood levels and ADHD. Still, suggestive advertisements and 
media smelling breaking news report otherwise, and to date, despite inconvincing 
evidence, there is a surprisingly positive opinion among parents, the media 
and some professionals about the potential benefits of EFA treatment of ADHD. To 
prevent this from happening, it is important that physicians and researchers should 
be careful with causal claims, also when ADHD is concerned.33 
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9.4.4. Food, the missing environmental factor in the threshold model 
It is evident that prominent associations between genes and environment have 
been established in ADHD. Consequently, although it is not quite clear to what 
extent genes and environment are causal, it is obvious that the current aetiologic 
perception of ADHD is based on the multifactorial threshold model. However, a 
query may be raised as to the actual applicability of the threshold model. It is true 
that there is overwhelming evidence for an association between genetic and 
environmental risk factors and ADHD, but ambiguities remain concerning the 
pathophysiologic significance of both risk factors. In addition, the threshold 
model does not take the results of the RED studies into account. This implies that 
the threshold model, although it comprises environmental risk factors, does not 
encompass one important environmental factor, i.e. food. 
Food is an environmental factor which has been thoroughly and conclusively 
investigated in children with ADHD, and which has proven to play an important 
triggering role in ADHD. Although the impact of food on ADHD may appear a 
novelty, the first RED RCT was conducted in 1985 and published in The Lancet, 
after which 5 independent RCTs followed, all of them resulting in the same 
conclusion. In 2001 these 6 RCTs eventually led to the incorporation of an RED in 
an UK algorithm for ADHD treatment.34 It is intriguing and disconcerting that, 
despite the results of these studies and the treatment recommendation, no 
attention has been paid to this studies and to the effect of the RED in for the most 
part excellent review studies.9263536 Considering the RED evidence available at 
the time of these reviews, it is amazing that, as explained in the introduction, all 
RED studies have been overlooked by the reviewers. This incomplete information 
may result in readers (mainly expecting information to be comprehensive and 
relying on the data given) who remain ignorant of the facts. Given this ignorance 
it is once again important to emphasize the following: 1) there is conclusive 
evidence for the effects of food on ADHD; 2) all RED studies have shown that an 
RED may normalise the behaviour in the majority of children with ADHD to such 
an extent that in children responding to an RED the behavioural problems, ADHD 
as well as comorbid ODD, disappear completely (see figure 1 and figure 2). 
In conclusion, an important environmental cause of ADHD and comorbid 
ODD has now been established (see Chapter 6) and this recognition may have 
considerable consequences and may eventually lead to a paradigm shift with 
regard to our knowledge and opinions on the aetiology of ADHD. 
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9.4.5. Food-Induced ADHD (FI-ADHD) 
In children with ADHD responding favourably to an RED, the RED responders or 
children with food-induced ADHD (FI-ADHD), food may be considered a 
necessary cause of the disorder, and elimination of specific foods will result in 
normal, typical behaviour. A necessary cause may be defined as a risk factor 
without which the effect cannot occur, just like a specific infectious agent is a 
necessary cause for a particular infectious disease.3037 To elucidate the point of 
view that food can be considered a necessary cause of ADHD in children with 
FI-ADHD, ADHD may be compared to coeliac disease. Coeliac disease is an 
intestinal condition triggered by gluten in individuals susceptible for gluten and is, 
like ADHD, a multifactorial disease in which both genetic and environmental 
factors are involved. Twin studies in coeliac disease have shown heritability 
estimates of 60-90%,38 suggesting a genetic role in determining phenotypic 
differences between individuals. However, despite substantial heritability 
"elimination of gluten from the diet is a typical example of environmental 
intervention that, in the case of coeliac disease, can result in total recovery".38 
The aetiologic analogy of ADHD and coeliac disease is striking. In both coeliac 
disease and ADHD genetic factors play a dominant role, but the environmental 
factors, in coeliac disease as well as in children with FI-ADHD, are decisive and 
will determine whether or not the symptoms manifest themselves or disappear. In 
sum, notwithstanding the substantial contribution of genetic factors, environmental 
factors and in particular foods are important and decisive in both coeliac disease 
and FI-ADHD. 
9.4.6. Gene-Environment studies 
Considering 1) the established genetic component of ADHD, 2) the association 
between genetic and environmental risk factors, and 3) the finding that food is a 
necessary cause of ADHD in children with FI-ADHD, further research into both 
genetic and environmental risk factors for ADHD is of the essence to develop 
effective strategies that eventually may lead to adequate ADHD treatment and 
risk reduction and may contribute to the long-term management of ADHD.39 To 
date gene-environment (GxE) studies, investigating the interaction between 
genetic and environmental risk factors in order to find aetiologic clues,26 are 
considered increasingly important in ADHD research. GxE research investigates 
the assumption that genotypic and environmental factors may increase or 
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decrease each other's effect, resulting in an actual interplay between genes and 
environment.26 Unfortunately, until now GxE research did not focus on food, which 
may be due to the former disregarding of the RED studies, but focuses on the 
currently recognised perinatal and psychosocial environmental factors only. 
Considering the information of the RED studies, it would be intriguing to investigate 
into what extent genetic factors may contribute to FI-ADHD. 
9.4.7. Food, a necessary cause of ADHD in children with FI-ADHD 
It is a challenging hypothesis that an underlying genetic vulnerability to show 
ADHD after eating specific foods may be found in all children with FI-ADHD, If so, 
then both genetic factors as well as food factors are necessary causes, similar to 
the temperature sensitivity in the Siamese cat (see also Chapter 1.5): both the 
genetic vulnerability and the temperature are causal of the cat's black tips.40 The 
combination of both necessary causes designates a sufficient cause: if both 
causes exist, the effect must occur. In fact, if a genetic vulnerability is underlying 
the effect of food in children with FI-ADHD, then the combination of both food and 
genetic constitution may be considered as a sufficient-component cause (i.e. "a 
sufficient-component cause is made up of a number of components, no one of 
which is sufficient on its own but which taken together make up a sufficient 
cause").37 Metaphorically speaking: the genetic constitution of a child with ADHD 
may be compared to a loaded gun, and the food the child reacts to may be 
considered the pulling of the trigger. If the trigger is pulled the results may be a 
disaster for the person the loaded gun was aimed at, likewise it is a disaster when 
the child eats foods it should not eat and consequently shows ADHD and/or ODD 
behaviour again. Conversely, if the necessary genetic constitution, i.e. the genetic 
vulnerability to show ADHD after eating certain foods, is missing in a child, the 
metaphoric gun would be unloaded, consequently pulling the trigger (i.e. eating 
specific foods) would not cause any harm. 
On the other hand, although it is seems obvious to assume that genes are 
involved in FI-ADHD, it is possible that future research will result in the conclusion 
that genes are not related to FI-ADHD and that FI-ADHD may manifest itself 
independent of the genetic constitution the child has inherited from his or her 
parents. In that case, food may be the only necessary cause involved, comparable 
to infectious diseases, in which the environmental trigger only, i.e. the infectious 
agent, is considered a necessary cause. Drawing an analogy between food as a 
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cause of ADHD and infectious agents as a cause of infectious diseases it is 
self-evident that without the infectious agent in the infectious disease, or without 
the incriminated foods in FI-ADHD, there is no disease or disorder. In both cases 
the environmental trigger is a necessary cause. Remarkably, it is intriguing and 
worth mentioning that in the era before Robert Koch, the founder of bacteriology, 
infectious diseases were believed to be inherited disorders.41 This idea was 
abolished immediately after Koch's discovery of infectious agents, and up to now 
the infectious agents are considered the necessary cause of infectious diseases. 
Imagine the amazement that, in the twentieth century, adoption and twin studies 
confirmed the heritability of susceptibility to several infectious diseases, showing 
remarkable differences in individuals and at the level of populations.4' Consequently, 
despite general consensus that infectious diseases are caused by specific 
agents, even in these diseases an underlying genetic vulnerability may be part of 
the cause. 
Still, despite the fact that even infectious diseases seem to manifest themselves 
in genetic vulnerable subject, hypothetically food might be the only necessary 
cause of FI-ADHD. Considering food as a necessary cause of FI-ADHD is in 
contrast with the psychopathologie assumption that environmental triggers are 
considered probabilistic.26 A probabilistic cause increases the probability or 
chance of its effect occurring, but may be neither necessary nor sufficient for the 
disease to occur.37 This probabilistic concept may indeed be applicable to the 
current environmental factors (i.e. perinatal and psychosocial factors) believed to 
play a role in ADHD, but, considering the results of the RED studies, it may now 
be clear that the probabilistic concept is not applicable to food in children with 
FI-ADHD. 
9.4.8. Reconsidering the threshold model 
Whether or not genes are involved in FI-ADHD, the results of the RED studies 
have convincingly shown that food is a necessary cause of FI-ADHD, and it must 
be emphasized that FI-ADHD may be applicable to the majority of children with 
ADHD. Consequently, it is timely for an aetiologic paradigm shift and a revision of 
the threshold model to be taken into consideration. Above two causal possibilities 
concerning FI-ADHD have been discussed: one in which both genetic factors and 
food are necessary causes of FI-ADHD, and another (less likely, but still 
hypothetically relevant), in which genetic factors are not causally involved in 
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FI-ADHD. In both scenarios the threshold model does not hold. It genetic factors 
are involved in FI-ADHD (i.e. if in RED responders but not in RED nonresponders 
specific genetic factors may be established), then both genetic factors and food 
are necessary causes and are equally important, each being a component of a 
sufficient-component cause. The threshold model does not fit in this sufficient-
component model, because the threshold model is based on many causal risk 
factors, each having a small effect and none of them being necessary or sufficient. 
If genetic factors prove not to be involved in FI-ADHD (e.g. if these genetic factors 
are equally present in RED nonresponders), then food may be the one and only 
necessary cause, in which case the threshold model should also be dismissed. 
In this light the Bradford Hill considerations on causality are worth mentioning. 
Although Hill did not intend to write a checklist of criteria to assess causality, his 
points of view are often used to separate causal from non-causal associations.42 
Still, Bradford Hill seems to apply the counterfactual model, considering his 
words: ".. .the decisive question is whether the frequency of the undesirable event 
Β would be influenced by a change in the environmental factor A". Taking food 
and ADHD into account, the undesirable event ADHD may be influenced by a 
change in the environmental factor food. 
9.4.9. Classic ADHD (C-ADHD) 
It must be acknowledged, although many children respond to an RED and 
consequently may be diagnosed FI-ADHD, that the RED studies have also 
elucidated that 40% of children with ADHD do not respond favourably to an RED. 
Consequently in these children other causal factors must be involved, and in 
order to distinguish both groups of children, these children may be diagnosed 
with Classic ADHD (C-ADHD). The aetiology of the 40% of children with C-ADHD 
needs further attention and research, which will be discussed in section 9.6. 
Concluding, the RED studies have shed a new and promising light on the 
aetiology of ADHD. Food has been established as an important environmental 
factor and a necessary cause of ADHD in children with FI-ADHD, thus offering an 
important opportunity to improve the quality of care for ADHD patients in the 
future. Investigating whether a child suffers from FI-ADHD or from C-ADHD and 
subsequently determining and avoiding the incriminated foods in children with 
FI-ADHD will lead to prevention of ADHD in children with FI-ADHD. The number of 
children responding to an RED and the impressive scale of symptom reduction 
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are to such an extent that a paradigm shift concerning the aetiology and 
consequently concerning the therapy of ADHD is imperative. 
9.5. The mechanism underlying the effects of an RED 
As yet the occurrence of FI-ADHD is not widely recognised, consequently 
research into the mechanisms in which food exerts its effects are limited. Still, in 
order to improve and facilitate the RED procedures it is important to investigate 
and ascertain the underlying mechanism of food in children with FI-ADHD. Some 
mechanisms already have been explored, as discussed in Chapter 5. 6 and 7. 
First of all, in Chapter 5 it is hypothesised that, in children with FI-ADHD, 
ADHD may be considered a hypersensitivity disorder, commensurate with asthma 
and eczema.43 This hypothesis is based on the definition of hypersensitivity 
according to the revised nomenclature for allergy as discussed in the introduction44 
and has been tested in 8 RCTs and two pilot studies.18,213 The remission of ADHD 
following an RED1'8'2'3 and the recurrence of ADHD after exposure to normal 
amounts of foods'245 is evidential for a food hypersensitivity reaction according 
to the gold standard.45 No studies have been published negating these findings. 
In sum, there is convincing evidence that the hypothesis discussed in Chapter 5, 
i.e. ADHD being an hypersensitivity disorder, is accurate in the majority of the 
young children with ADHD and is in accordance with the results of the RED 
studies. Consequently, a logical and timely conclusion would be to accept this 
hypothesis. 
Subsequently, an important question to be answered is whether the 
mechanism of food in ADHD is allergic or non-allergic. Study results have shown 
that it is unlikely that an allergic mechanism is involved: 1) Two out of 3 RED 
studies investigating the relationship between an atopic constitution and hyper-
sensitivity to foods in ADHD2 '3 found no differences in atopic constitution between 
RED responders and nonresponders. One study found a significant higher 
percentage of atopic children in responders,5 but it is important to notice that the 
children participating in this study were selected via allergy clinics, which may 
have affected the results. 2) None of the RED studies including unselected groups 
of children and executing IgE blood tests1 Mound differences in IgE blood levels 
between responders and nonresponders. 3) As discussed in Chapter 6 an 
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IgG-mediated hypersensitivity mechanism has been investigated.' Although the 
provocation of foods following the RED resulted into a considerable and clinically 
relevant behavioural relapse in the RED responders (with a scale increase of 79% 
on the ADHD Rating Scale, thus confirming the hypersensitivity reaction in these 
children), equal behavioural responses were established after challenges with 
foods against which both high and low IgG levels were found in the blood samples 
at the start of the trial. In conclusion, considering that no relationship has been 
established between atopic constitution, IgE- or IgG-levels and FI-ADHD, it is 
unlikely that an allergic mechanism is involved, although we cannot rule out the 
involvement of a cell-mediated allergic response. Consequently, further research 
should focus on both a cell-mediated allergic response and on non-allergic 
mechanisms, such as mechanisms related to toxic, pharmacologic or epigenetic 
events, which will be discussed in chapter 9.6. 
An indirect non-allergic mechanism of the RED has already been investigated, 
i.e. the effect of an RED on family structure and family relationship, thus 
effectuating improvement of the child's behaviour (see figure 3). Chapter 7 
showed that the effects of an RED on ADHD and ODD were not mediated by 
improvement of family structure and family relationship."6 Indeed, at start of the 
trial parenting abilities in families with ADHD were equivalent or better than those 
of families without ADHD. Furthermore, parenting qualities did not change during 
the RED, which implies that the indirect route as shown in figure 3 did not take 
place, thus confirming the direct route of an RED on ADHD. Of course it should 
be emphasised that prior to entering the study as described in Chapter 7, all 
families received information on the challenges they were to expect when following
 σ 
the diet, so it is conceivable that only parents aware of their good parenting 
α 
qualities may have entered this study. Therefore the conclusion that behavioural 
improvements of children with ADHD and ODD are not mediated by improvements 
of family relationships and structure, cannot be extrapolated to families of all 
children with ADHD, but should be limited to those families motivated to follow an 
RED. 
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Figure 3 Mechanism of action of an RED on ADHD and ODD 
Indirectly 
Improvement 
Parenting 
Capability 
9.6. Follow-up research 
The RED studies have unequivocally established that an RED shows considerable 
and favourable effects on ADHD and ODD, in selected as well as in unselected 
groups of children. Consequently, an important question, i.e., to what extent may 
food be causal of ADHD, now has been answered satisfactorily. Still, the answers 
to questions may lead to even more questions; how true this is regarding this 
issue. In this part of the thesis the do's and don'ts regarding follow-up research 
will be discussed on the strength of the main points considered in this thesis, as 
listed below: 
• ADHD is not caused or cured by specific food components like additives or fish oil; 
• Both ADHD and comorbid ODD may be caused by food; 
• Comorbid physical complaints and sleep problems may be caused by food; 
• The mechanisms of food in ADHD involve neither an IgE- or an IgG-mediated 
allergic mechanism, nor are the behavioural improvements due to improved 
parenting capabilities; 
• In 40% of young children with ADHD the behavioural problems are not caused 
by food. 
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First of all this thesis may result in some "don'ts"^ Although it seems to be 
customary in scientific research to end a manuscript with the closing remark 
"more research is necessary", it is timely to acknowledge that in some cases the 
conclusion to reconsider the performance of further research may be warranted. 
This reconsideration might be applicable to the issues of additives and ADHD 
and fatty acids and ADHD. All in all, the results of additive and fatty acid studies 
in ADHD may be considered conclusive: in numerous studies (see Chapter 1) has 
convincingly been established that neither elimination of additives nor supple-
mentation of fatty acids are effective treatments of ADHD. Consequently, it is 
worth considering to no longer focus further studies involving additives or fatty 
acids on children with ADHD, but to pivot these studies on children of the general 
population (additive studies),4748 or on children with learning problems (fatty 
acids).49 Thus, recent developed research models concerning the effect of 
additives in children with ADHD,50 primed by the European Food Safety Authority 
advice to remove six colours from food and drink in the United Kingdom,'', might 
shift focus from ADHD to the effect of both colourings and preservatives in 
children of the general population.4748 In addition, it might be prudent for additive 
researchers to collectively stand up against policymakers who, impulsively and 
with apparent deficit of attention to the evidence available (i.e. colourings do not 
cause ADHD and either colourings or preservatives or both may cause a minimal 
increase of hyperactivity in all children), stubbornly focus on colourings only, and 
suggest far-reaching and definitely not evidence based measures. 
Similarly, fatty acid researchers might shift focus from increasing omega-3 to 
a neglected area that may be worthwhile to investigate when fatty acids are 
concerned, i.e. the at least ten to twentyfold increased ratio of omega-6 to 
omega-3 during the 20th century.525354 Data suggest that until 100 years ago the 
omega 6/3 ratio was 1:1,53 and it is not inconceivable that decreasing omega-6 in 
our foods may eventually proof to be more beneficial to our health than increasing 
omega-3, in particular because omega-6 fatty acids are known to increase 
inflammation,55-58 which is an important underlying problem of many lifestyle 
diseases.59"62 Consequently, fatty acid researchers might consider to shift focus 
from supplementing omega-3 to elimination of omega-6 fatty acids. 
Another "don't" concerns further research on whether or not an RED may 
have a beneficial effect on the behaviour of children with ADHD. It is now timely to 
acknowledge that sufficient evidence is available to underline the relationship 
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between an RED and ADHD. Consequently further research should not focus on 
the question if an RED may be effective in children with ADHD, but on the 
important question how food exerts its effects. Below the suggestions for follow-up 
research concentrating on this issue will be discussed. 
9.6.1. Suggestions for follow-up research regarding the RED mechanism 
The exact way in which food exerts its effects is not clear yet. In Chapter 6 and 
Chapter 7 it has been discussed that IgE, IgG and change in family structure are 
not the underlying mechanism of the RED effects. More research is necessary to 
investigate how an RED brings its impressive effect about and to define the role 
of gut, brain and genes in children with FI-ADHD. Furthermore the epigenetic 
effects of food might be investigated. Finally, a search for biomarkers might offer 
the opportunity to differentiate between FI-ADHD and C-ADHD. 
First of all, the gut may play an important role in the FI-ADHD mechanism. 
Many children with ADHD report gastrointestinal problems and further research is 
required to define whether this association is a matter of comorbidity, of 
co-occurrence, or whether there is a causal connection. In this light, an interesting 
object of study would be the effect of food on the gut flora and the consequential 
effect of the gut flora on ADHD. Metagenomics (studying the microbiome, i.e. the 
collective genome of all intestinal microbiota)61 and nutrigenomics (studying the 
effects of food on the microbiome)64 may lead to interesting new perspectives.65 
Second, research might focus on the brain of children with FI-ADHD. 
Functional magnetic resonance imaging (MRI) studies, in children before and 
after an RED, are necessary to answer this question. Even more important: how 
does food affect the brain and which food components actually pass the blood 
brain barrier? Or may other pathways be involved, e.g. the gut-brain axis, and 
may in children with FI-ADHD food result in a dysfunction of the pathway between 
the gastrointestinal tract and the central nervous system? 
Third, future research is necessary to find out into what extent genes are 
involved in FI-ADHD. Of course, considering that FI-ADHD may be present in 60% 
of children with ADHD and that ADHD is a disorder with many genes involved -
the genetic heterogeneity even broader than expected -,66 it is likely that an 
association will be found between food and genes In children with FI-ADHD. 
Therefore, it is first of all Important to focus on genetic differences between 
children with FI-ADHD and children with C-ADHD. In addition, research should 
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focus on the occurrence of FI-ADHD in siblings of children with FI-ADHD. If 
genetic factors are involved in FI-ADHD, it is expected to run in the family. 
Furthermore, several genes involved in the regulatation of the immune system 
are associated with the development of ADHD symptoms,6768 and the further 
unravelling of the relationship between genes, ADHD and the immune system is 
also an important area of research. Considering that dopamine, a neurotransmit-
ter involved in ADHD, and dopaminergic receptors are found on human T-cells, 
genes may be involved in a cell-mediated immune response which may be 
underlying FI-ADHD. 
When focussing on genetics, another intriguing subject of research may be 
the epigenetic effects of food. Considering that dietary factors may induce 
epigenetic alterations,69 it would be challenging to investigate whether ADHD may 
be mediated by epigenetic mechanisms influenced by specific foods. In light of 
epigenetic changes, parental nutrition may be an important area for research. 
Our food, that used to be a hunter-gatherer diet, has changed profoundly during 
the agricultural and industrial revolution in the past centuries. These changes 
may instigate epigenetic alterations70which may affect the offspring. It is tempting 
to hypothesise that, if epigenetic alterations proof to be part of the FI-ADHD 
mechanism and considering that epigenetic changes are reversible,71 a child who 
adheres to his or her diet for a longer period of time might "overgrow" the hyper-
sensitivity to food. Indeed, it would even be conceivable that the child's offspring 
might not inherit the specific genetic vulnerability anymore, thus breaking out of 
the heritability spiral. If this were the case, then the long-term effects of an RED 
would be immense. 
9.6.2. Suggestions for follow-up research regarding the challenge period 
In addition to further research focussing on the mechanism of food, additional 
research should also focus on the challenge period, following the RED in RED 
responders. It is important to emphasise that the RED never lasts longer than 5 
weeks, after which nonresponders (children with C-ADHD) may eat anything 
again and after which responders (children with FI-ADHD) start the challenge 
period. During this challenge period one food a week is added to the RED in order 
to investigate the behavioural consequences of the added food, i.e. to investigate 
to which specific foods each child reacts. Each child tends to respond differently 
to different foods, mostly to more than one food and in a for each child different 
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combination of foods.1 " It may take a year to define to which food a child responds 
unfavourably. Parents find this trial-and-error period very strenuous; the 
behavioural relapses during the challenge period are dreaded and are 
burdensome for the whole family. Unfortunately, at this moment no method is 
available to anticipate which foods may cause a relapse in behaviour or when (i.e. 
after which amount of food) this behavioural relapse will happen. Further research 
should focus on an easier method to define the incriminated foods and on a way 
to establish the individual sensibility of each child. 
Furthermore, research should focus on expert coaching of parents, child, 
siblings and teachers in order to increase the feasibility of the challenge period 
and to help parents and teachers to see this period through. Although the 
follow-up results of the INCA study have not been analysed yet, it is already clear 
that at least 50% of the responders actually finished the follow-up period which 
lasted 10 months. Families who left the trial prematurely indicated that they did 
not leave the study because the diet ceased to be effective, but they left because 
the recurrent behavioural relapses caused too much stress and disquietude in 
the family, or because their child's teacher found the relapses in behaviour difficult 
to handle and preferred medication. It is important to note that, until an easier 
method is available, the challenge period is crucial to determine the incriminated 
foods and thereby compose a feasible diet. At the end of the challenge period the 
child's diet will be practically normal and the child will have to avoid the 
incriminated foods only, thus, compared to the RED and the challenge period the 
final dietary restrictions will be "a piece of cake". Relapses will only occur if the 
child does not stick to the diet. Concluding, facilitating the challenge period is an 
important aim for further research. 
9.6.3. Suggestions for follow-up research regarding the long-term effect of 
food and the financial consequences of RED research implementation 
More research is necessary to establish the long-term effect of foods. Some RED 
studies have already shown that the RED effects continue unabated during a 
follow-up period of one year.24The preliminary results of the INCA 10-month 
follow-up study also show that the behavioural effects, in children who stick to 
their diet, persist. Still, it is imperative to investigate the effects of an RED after a 
longer period of time, and to investigate whether children may overgrow the 
sensitivity to specific foods when avoiding the incriminated foods for a longer 
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period of time. In addition, during long-term research a comparison might be 
made of the prospects of children treated with a diet with those of children treated 
with medication, and of the financial consequences of both treatments. 
It is calculated that the direct medical costs of children with ADHD are 11 
times higher than the costs of children without behavioural problems,72 as 
discussed in Chapter 1.4. The estimated costs of ADHD when most other societal 
costs like special education, behavioural interventions, placing in care, associated 
costs in adulthood, substance use and costs of crime are included, may vary 
from $12,005.- to $17,458- 2005 dollars per individual per year." The Dutch 
Foundation of Child and Behaviour already has calculated some financial benefits 
of RED research implementation in children with ADHD, which may amount to 
€ 280 million per year.74 In sum, it is obvious that the costs of ADHD are considerable 
and that prevention of ADHD may offer opportunities to decrease the costs of 
illness. A comprensive study including all costs of both treatment as usual and 
RED research, may shed more light on the cost effectiveness of implementation 
of RED research in children with ADHD. 
9.6.4. Suggestions for follow-up research regarding the effects of food 
on other psychiatric disorders and on somatic problems 
Another important objective of further research will be the effect of an RED on 
other psychiatric disorders as well as on somatic problems. In two RCTs (see 
Chapter 3 and Chapter 6) and in one pilot study (see Chapter 2) the effect of an 
RED on comorbid ODD has already been investigated, resulting in 74% 
responders1 who all showed impressive improvements of behaviour (89%). 
Considering the high percentage of responders, and considering that children 
with disorders like ODD give rise to substantial parenting stress and are more at 
risk for long-term maladjustment,75'77 it may be important to investigate the effects 
of an RED on ODD in children without ADHD. Interventions that may reduce ODD 
have great clinical potential, reducing long-term risks and improving the 
perspectives of these children. 
Furthermore, further research may focus on the effects of an RED on other 
child psychiatric problems (e.g. Conduct Disorder. Autism Spectrum Disorder, 
Obsessive-Compulsive behaviours and mood and anxiety disorders). Many 
associations have been found between various psychiatric conditions and 
comorbidity is a general phenomenon, rule rather than exception. It is important 
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to define whether the effects of food may exceed the borders of ADHD and ODD 
and may affect other disorders as well. 
In addition, the effects of an RED on physical complaints and sleep problems 
in children with and without ADHD need to be investigated. Physical complaints 
like gastrointestinal disorders occur frequently in children with78and without7982 
psychiatric disorders, and functional somatic symptoms are common health 
complaints in young children.83 It has already been shown that dietary intervention 
may result in a decrease of physical complaints in children and adults without 
ADHD,7982 consequently, further research into the effects of an RED on physical 
problems in children with and without ADHD is important. 
Finally, considering the high comorbidity between ADHD and physical 
complaints it is tempting to hypothesise that physical complaints in children with 
ADHD may be considered an exophenotype (on the analogy of endophenotype) 
of FI-ADHD, i.e. indicative of a hypersensitivity to food. If so, physical complaints 
or combinations of complaints might offer the opportunity to predict the results of 
an RED in children with ADHD. 
9.6.5. Suggestions for follow-up research regarding the phenotypic 
manifestation of a hypersensitivity reaction to food 
Another intriguing issue and subject of further research where the posited 
(epi)genetic contribution to FI-ADHD is concerned, is the assumption that the 
genetic constitution or the epigenetic alterations might define the phenotypic 
expression of food in individuals. Could it be that in child A food may trigger 
ADHD, while in child Β food may be the underlying cause of ODD, or compulsive 
behaviour, or depression? In other words, can a child's genetic predisposition 
determine which disorder actually will manifest itself as a consequence of the 
food hypersensitivity? Moreover, considering the fact that in girls the prevalence 
of ADHD is smaller but the prevalence of mood disorders is higher than in boys,84 
the effect of food might even be determined by a genetic predisposition associated 
with the sex of a child, i.e. in boys resulting in ADHD, in girls resulting in mood 
disorders. Thus, the relevant phenotype may be broader than just ADHD and 
ODD and include mood and anxiety disorders and maybe even autism spectrum 
disorders. Indeed, the phenotypic expression might also involve physical 
complaints, consequently, the phenotypic manifestation of a hypersensitivity 
reaction to food is a fascinating and challenging subject of research. 
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9.6.6. Suggestions for follow-up research regarding biological markers 
Finally, further research is recommended to answer the question whether any 
biological markers may be found. Extensive blood, urine, saliva and faeces tests 
in children with FI-ADHD, C-ADHD and their siblings is of the essence and will 
hopefully lead to tests that can predict whether RED research or treatment as 
usual should be first choice for each individual child. Hypothetically, biological 
markers may even provide information that could answer the questions which 
foods in which amount cause which trouble in which child. If further research 
would lead to such a marker, then in future a simple test might suffice to answer 
these questions. 
9.6.7. Suggestions for follow-up research regarding the characteristics of 
food that triggers FI-ADHD and for RED research in other continents 
More research is needed to define the characteristics of food that instigates ADHD 
in children with FI-ADHD. For example, does the reaction of a child, showing ADHD 
behaviour when eating potatoes, only depends on the amount of potatoes eaten 
(i.e. every day or once a week), or may the kind, or the quality (old or new), or the 
method of preparation of the potatoes be of importance as well? And will any 
similarities be found between the different foods a child reacts to, i.e. do these 
foods have a common component that may cause the change in behaviour? 
Another subject worth mentioning concerns RED research in other continents. 
Most RED studies (6/8) were executed in Western-Europe and the RED was based 
on the specific eating habits in this part of the world. In most follow-up studies 
children showed behavioural relapses after eating common everyday and 
frequently eaten foods. It is conceivable that in other continents, with different 
eating habits and other daily foods (i.e. rice or corn instead of wheat and potatoes), 
other (epi)genetic vulnerabilities may exist. If this would be the case, then these 
children might react to different foods, implicating that a different RED composition 
based on the specific eating habits in that part of the world may be needed in 
order to investigate the effect of food on the behaviour of these children. 
9.6.8. Suggestions for follow-up research regarding children diagnosed 
with C-ADHD 
According to the results of the RED studies 40% of children with ADHD do not 
respond favourably to an RED and may be diagnosed with C-ADHD. The aetiology 
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of ADHD in these children needs further attention and may focus on the following 
six questions. 1) Is the threshold model applicable to this group of children? 
2) Are other (necessary) causal factors yet to be discovered? Some environmental 
factors are associated with hypersensitivity reactions in children (e.g. propylene 
glycol and glycol ether in indoor air85) or may affect the central nervous system 
(e.g. thinner inhalation in painters86 or solvents in glue sniffers87). For this reason 
it is conceivable that other environmental factors yet to be discovered are involved 
in ADHD. Furthermore, in children using anti-asthma medication behavioural 
problems appear to be more common than in children who do not use this 
medication.88 In children not responding to an RED and using anti-asthma 
medication it is conceivable that the behavioural problems may be an adverse 
effect of the medication, and a temporary change of anti-asthma medication 
might be considered. 3) Does the disorder manifest itself independent of the 
child's genetic constitution? 4) Is it possible that mentally challenged children, 
highly talented children or children suffering from learning disabilities like dyslexia 
or dyscalculia may show symptoms of ADHD as a consequence of their learning 
problem? If the learning problems are not recognised and treated, the children 
may show ADHD behaviour (i.e. become restless, inattentive and so on) as a 
result of the learning problems and consequentially may be wrongfully diagnosed 
with C-ADHD. 5) Is an inadequate family environment or are parenting problems, 
which may be due to parental psychiatric problems, underlying the child's 
behavioural problems? 6) Would in some children the old and abandoned 
diagnosis minimal brain damage (MBD-ADHD) be appropriate? For instance, in 
children physically abused or in children with unfavourable prenatal or natal 
conditions like severe dysphyxia and hypoxia, the brain may have been damaged 
to such an extent that this may lead to abnormal behaviour and ADHD, 
9.6.9. In conclusion 
In conclusion, the RED studies have provided valuable information that contributes 
to our understanding of ADHD. In addition they have also provided worthwhile 
indications for further research into the mechanisms in which food may exert its 
effects. The results of further research will lead to better understanding of 
FI-ADHD as well as of C-ADHD. and will improve the diagnostic procedure and 
treatment of these children. 
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9.7. Practical implications and implementation of the 
RED in general practice: a proposal for a multi-
modal algorithm for diagnosis and treatment 
The results of the RED studies, convincingly showing that ADHD may be caused 
by food in the majority of young children with ADHD, may incite a child psychiatric 
paradigm shift when ADHD and ODD are concerned. Implementation of RED 
research in the ADHD diagnostic procedure, as suggested in Chapter 6. provides 
an opportunity to prevent ADHD and ODD in those children responding to the 
RED. A comparison of the pros and cons of both medication and an RED will 
elucidate why it is timely to implement an RED in ADHD, 
Medication has two advantages: First of all it is a "quick fix": soon after ingesting 
the tablet the child's behaviour will improve and the improvement will last until the 
moment the tablet has lost its effect. An RED is the opposite of a quick fix and asks 
for commitment of parents and child. It takes a year to establish to which foods a 
child reacts and during that year the child has to comply with a more or less strict diet. 
Second: medication is easy to apply and thus convenient for all families, while an 
RED needs a great deal of commitment and is not easy to apply. 
An RED also has some advantages. First of all, although medication used to 
be the most powerful treatment of ADHD with effect sizes varying from 0.6-0.9,9 
to date an RED may be considered the most effective ADHD treatment with a 
mean effect size of 1.2. Second, psychostimulants like methylphenidate, the most 
commonly used drug in ADHD, have a duration of action of 3-12 hours. This 
implicates that this medication does not solve the behavioural problems in the 
early morning and in the evening. Conversely, the effects of an RED last 24/7. 
Third, despite initial symptom improvement when treating ADHD with medication, 
the follow-up study in the Multimodal Treatment Study of children with ADHD 
(MTA),8'' showed that children who received medication exhibited significant 
impairment in adolescence, in fact comparable to children who had not received 
any medication at all. Follow-up research in RED studies, lasting 1 year, has 
shown beneficial effects throughout the year, but further follow-up studies are 
necessary. Fortunately, the prospects are promising: the initial RED will, slowely 
but surely, be expanded to a more or less normal dietary pattern, thus increasing 
the feasability of diet with a limited number of restrictions. Fourth, almost 60% of 
children do not continue medication despite initial favourable behavioural effects. 
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mostly because of adverse side effects like loss of appetite and perceived 
tolerability.90 Conversely, an RED has a beneficial effect on somatic and sleep 
problems. Still, the diet itself, with concurrent limitations when attending parties 
or celebrations, may especially during the first year be interpreted as an adverse 
side effect. Fifth, not all children with ADHD respond favourably to medication; 
children show individual variability in medication response and in duration of 
effect and for this reason determining the optimal dose and the choice of 
medication is a matter of trial and error.91 Of course neither do all children respond 
to an RED, but in 5 weeks it is clear whether the child suffers from FI-ADHD or 
C-ADHD. 
In sum, medication, the most applied treatment of ADHD, has some 
disadvantages while the RED has some advantages, accordingly, innovative 
treatment approaches like the RED would be welcome in ADHD. Therefore it is 
timely to present a proposal for new ADHD guidelines which include RED 
research. Once before, in 2001, an RED was included in a basic algorithm for 
treatment of ADHD, based on the 6 RED RCTs available at that time. Somehow 
this part of the algorithm has never been put into effect, probably as a result of the 
false claims that additives were the main cause of ADHD.?0 The negating of the 
RED trials and of the 2001 algorithm for treatment may ensue from these false 
claims or may be due to change blindness.92 Now, ten years later, additional RED 
RCTs haven been performed, confirming and strengthening the previous study 
results in unselected groups of children with ADHD, and thus warranting a revised 
algorithm for multimodal diagnosis and treatment of ADHD (see figure 4). 
9.7.1. The parenting part of the algorithm 
In this algorithm a multidisciplinary and multimodal approach is proposed, 
including educational therapists, RED experts, psychologists, psychiatrists and 
dieticians. It goes without saying that communication between these professionals 
is of the essence to optimise the diagnostic and therapeutic procedure. First, the 
OR or child health centre physician will make an inventory of the behavioural and 
physical problems. Subsequently, if applicable, the parenting capacities and 
family environment and structure may be considered by an educational specialist. 
If parents show at least average parenting qualities, the RED research may start. 
Conversely, if improvement of parenting capabilities (e.g. consistency, family 
interaction, affection and clear communication) seems important, this should first 
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Figure 4 Algorithm for Multimodal Diagnosis and Treatment of ADHD 
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be attended to. Still, it is conceivable that parenting incapabilities are consequential 
and not causal of the child s behavioural problems. Consequently, if the child's 
behaviour does not improve sufficiently despite parent training, the RED research 
should start. If a family proofs to be unable to comply with the 5-week diet, it is 
worthwhile to consider the parenting capacities once more and offer expert 
educational advice in order to help the family to comply with the RED. 
In addition to the inventory of parenting capabilities prior to the RED, it Is also 
important to investigate whether parents are willing and motivated to follow an 
RED. In families who do not want to start RED research or who repeatedly fail to 
adhere to the dietary restrictions, treatment as usual is indicated. Still, the results 
of the RED studies are striking and to such an extent, that no efforts should be 
spared to grant every child the opportunity to participate in RED research. For this 
reason it would be in the interest of children whose parents are not motivated to 
follow an RED to offer all assistance required to help these parents to see the RED 
through, and it is important to inform all parents in great detail of the pros en cons 
of participation in RED research and of treatment as usual. 
9.7.2. The RED research part of the algoritm 
When it has been established that parents are motivated to start an RED and that 
parenting capabilities are sufficient, the RED research may start. This research 
needs expert supervision by trained staff, i.e. a physician. There are several 
reasons why expert supervision is important to meet the conditions required for 
high quality diagnostic research in accordance with the model as applied in the 
INCA study (Chapter 6). First of all, most children with ADHD suffer from other 
disorders as well, and comorbidity is rule rather than exception, i.e., the problems 
involved are complex and in most children not limited to ADHD. This implicates 
that the RED research covers various areas of health problems and the RED 
expert must be capable to handle the variety of problems involved. Second, in 
children starting the RED and already taking medication the RED physician will 
monitor the reduction of medication which will take place in due course during the 
RED, consequently the RED expert must be clearly aware of all medical ins and 
outs of the child. Third, the RED expert will, depending on the child's behaviour 
during the 5-week RED, not only adapt the medication but also adapt the diet, in 
order to maximize the behavioural improvements. Unremitting consultation with 
parents and teacher on the effects of the RED is compulsory in order to maintain 
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the high quality and the impressive effect sizes achieved in the RED studies. 
Adapatations are made based on behavioural questionnaires, in accordance with 
the questionnaires used in the INCA study. It is important to emphasize the 
disadvantages of unsupervised elimination diets which may be prescribed 
undeservedly, which may lead to dietary insufficiencies or the results of which 
may be interpreted incorrectly because of missing reliable information. Finally, 
children diagnosed FI-ADHD who proceed with the challenge period and who 
subsequently show a severe behavioural relapse due to one of the challenged 
foods, may be advised to start or restart medication for a short period of time, i.e. 
until the effects of the challenged foods have faded away, in order to sooth the 
effect of the challenged food and to decrease the behavioural problems, 
especially at school. This is an important aspect of the challenge period which 
has to be monitored by an expert. At the end of the 5-week RED the diagosis 
FI-ADHD or C-ADHD will be made, based on the results of the questionnaires and 
the information of parents and teachers. 
9.7.3. Follow-up strategy in children with C-ADHD 
Parents need to be informed about the procedure that will take place when their 
child is diagnosed with C-ADHD. It will be obvious that these children, not 
responding to an RED, are allowed to eat anything again. They may proceed with 
psychological research to establish any other problems that may underly ADHD 
symptoms, e.g. learning disorders or learning problems, including an above 
average or high IQ. Unrecognised high talented children, similarly to children with 
unrecognised nonverbal learning disabilitiy (NLD) or dyslexia, may have problems 
at school, may show inattention problems or become restless and fidgety, may 
underperfom and may eventually be diagnosed with ADHD because they are 
showing the symptoms of ADHD. It must be acknowledged that ADHD is a 
symptomatic disorder, based on the number of symptoms and the concurrent 
problems in daily life. Consequently, unrecognised learning problems and 
disorders may lead to the diagnosis ADHD, and it is of the utmost importance to 
investigate and determine any psychological conditions which may be underlying 
of C-ADHD. If none of these psychological conditions are present or if an 
adequate approach of established psychological conditions does not improve 
the behavioural problems, then referral to a child psychiatrist is imperative, and 
medication as well as behavioural interventions should be considered. 
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9.7.4. Follow-up strategy in children with FI-ADHD 
Children diagnosed FI-ADHD will proceed with the RED challenge period, in 
order to define the incriminated foods which may differ per child and per amount 
of food. This period is considered aggravating for parents and teacher, due to the 
recurrent behavioural relapses. Consequently, expert coaching of parents and 
teacher is important to increase the feasibility of the challenge period. Families 
showing compliance problems may be offered complementary parenting training, 
including video home training. The results of the RED in children with FI-ADHD is 
to such an extent, that it is important to strain every nerve in order to help families 
to see this period through. At the end of the challenge period the child's diet has 
returned to almost normal, the incriminated foods have been pin-pointed and the 
individual sensitivity for each incriminated food has been established, resulting in 
an dietary advice to what extent these foods have to be avoided, i.e. partially or 
completely, thus preventing ADHD, 
If in the course of the RED challenge period a relapse in behaviour occurs or 
if the behavioural improvements manifest themselves predominantly at home and 
are less prominent at school, then also in children with FI-ADHD psychological 
research must be considered. Co-occurrence of ADHD with learning disabilities 
or learning problems is a conceivable option which might be the reason for less 
behavioural improvements at school. It is worth mentioning that in this algorithm 
psychological research consciously has been placed after the RED, to improve 
the reliability of the test results, because children with ADHD tend to underperfom 
which may affect the test results. Executing the psychological research following 
the RED will offer, at least in children with FI-ADHD and provided that the child 
has complied with the diet preceding the test, more reliable results because in 
these children the effects of ADHD are ruled out. Still, if in children with FI-ADHD 
the underlying cause of the relapse in behaviour cannot be established, and if the 
relapse is causal of malfunctioning at school or at home, then medication needs 
to be considered. 
It has to be acknowledged that the challenge period is the most poignant part 
of the RED research. Expert monitoring and coaching of family and teachers is of 
paramount importance, first of all in order to pull everyone through this period; 
secondly, in order to define to which foods a child reacts; and most of all to give the 
child a chance of a better future, without ADHD. There is no reason to expect, 
provided that the child sticks to the diet, the dietary effects to disappear or diminish. 
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Two RED studies and the INCA follow-up have shown that the effects of an RED 
may continue unabated for a one-year period. Consequently, although more 
long-term research needs to be done especially to verify whether children may 
outgrow their specific vulnerability, it is timely to implement RED research in ADHD. 
The concurrent economical effects of every child completing the RED research 
will be gigantic. According to a Dutch report, making a rough inventory of some 
of the costs of ADHD while comparing the costs including RED research with the 
current costs of ADHD, implementation of RED research may yield savings of 
7.000 euros per year per child starting the RED research.74 This sum is applicable 
to each child starting the RED research, independent of the fact whether the child 
proofs to be a responder or a nonresponder. The height of the sum may be 
explained by the fact that children diagnosed C-ADHD need expert supervision 
and medication for a great many years, while children diagnosed FI-ADHD need 
expert supervision for 1 year only. Consequently, if 100 children would start the 
RED research right now, the financial proceeds would, ina 10-year period, amount 
to 7 million euros (100 children χ 7.000 euros χ 10 years). Imagine the savings if 
all children with ADHD would start RED research! 
9.7.5. An overview of the RED research according to the algorithm 
1) RED research may be very effective, but certainly is not a quick fix method, 
2) parents need to be motivated and need to have sufficient parenting capacities, 
3) in the course of RED research a 5-week RED is necessary to establish whether 
the child is suffering from FI-ADHD (the RED diagnostic phase), 
4) the diagnostic phase ends with making either the diagnosis FI-ADHD or the 
diagnosis classic ADHD (C-ADHD), 
5) children diagnosed C-ADHD start assessment and treatment as usual, 
6) children diagnosed with FI-ADHD will proceed with a challenge period to 
establish which foods are causal of the behavioural problems (the RED 
therapeutic phase). 
7) the challenge period will take an average of 15 months, 
8) following the challenge period the child's diet will be almost back to normal, the 
child only having to avoid a small number of foods, 
9) the therapeutic phase ends with an individually dietary advice about which 
foods are incriminated and about the frequency in which the child is allowed to 
eat the incriminated foods. 
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10) it is not clear whether the child has to stick to the individual dietary restrictions 
perpetually, or whether children may overgrow the hypersensitivity, 
11) occasional non-compliance with the therapeutic dietary advice will not be a 
problem, because in most children the behavioural problems occur only if the 
incriminated food is eaten for several days in succession and if the amount of 
the food exceeds an individually established threshold. 
9.8. Suggestions for DSM-V 
The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders 
(DSM-V) will be published in May 2013. The DSM is a renowned and widely used 
standard handbook describing and classifying mental disorders. Most classifica-
tions are based on specific symptoms which have to occur for a determined 
period of time and which have to cause significant impairment, consequently, 
most DSM diagnoses are symptomatic, i.e. based on symptoms instead of on 
causes (causal diagnoses). Of course, in psychiatric disorders it is common 
practice and justifiable to make symptomatic diagnoses, considering that the 
aetiology of most disorders is complex and unclear. Nevertheless, in some 
psychiatric disorders the diagnoses do refer to the cause, e.g. in Substance-
Induced Delirium, Alcohol-Related Disorders, Amphetamine-Related Disorders 
and Cocaine-Induced Disorders. In accordance with these cause-related 
diagnoses the impact of an RED on ADHD has clearly been established, as a 
consequence of which part of the causal puzzle of this disorder is solved. Naming 
and blaming food as a cause of ADHD and integrating this knowledge (which was 
already incorporated in an algorithm for treatment of ADHD in 2001) in the DSM-V 
would be a considerable step forward towards understanding and treating ADHD, 
with concurrent beneficial effects for the children suffering from this disorder. 
In addition to the suggestion to include food-induced ADHD (FI-ADHD) in the 
DSM-V, it is worth considering to substitute the current dichotomic symptom 
inventory ("often" versus "not often") by an inventory that specifies the rather 
vague and ambiguous indication "often". It is important to define the exact 
meaning of "often" in order to make a correct inventory of the behaviour of the 
child. The absence of a specific definition of "often" may lead to misinterpretation 
of the child's behaviour in parents with a lack of resilience as well as in parents 
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who abound in resilience. Parents who lack resilience may answer too negatively 
and may interpret a frequency of twice a week as "often". Conversely, parents 
who abound in resilience may answer too positively, interpreting twice a day as 
"not often". To prevent these diagnostic problems, the ADHD Rating Scale (ARS) 
would be a convenient instrument to make an inventory of the behaviour, at home 
as well as at school. The ARS, based on the DSM-IV criteria for ADHD, consists 
of the well-known nine inattention and nine hyperactivity/impulsivity criteria, but 
uses a four-point scale in which the occurrence of the behaviour is specified: 0 = 
never (less than once a week); 1 = sometimes (several times a week); 2 = often 
(once a day); and 3 = very often (several times a day). Three measures may be 
taken from the ARS: total score (0-54), inattention score (0-27), and hyperactivity/ 
impulsivity score (0-27). A score of 2 (often= at least once a day) or 3 (very often 
= several times each day) points indicates that the child meets that specific 
ADHD symptom, while a score of 0 or 1 is considered normal behaviour. 
It must be noted that some questionnaires apply the following 5 point scale: 0 
= never; 1 = sometimes (occasionally); 2 = regularly (once a month); 3 = often 
(once a week); and 4 = very often (once a day).93 It is important to note that 
whenever this questionnaire is applied, children will meet the criteria for ADHD 
when the ADHD symptoms occur once a week only. According to the ARS the 
same child would exhibit normal behaviour, because any child is expected to 
fidget, to be inattentive, or to talk before its turn once a week. To prevent children 
from being diagnosed with ADHD too easily, the DSM-V might add guideline 
suggestions in order to realise consistency in questionnaires used in ADHD, and 
might replace "often" by "at least daily". 
Furthermore, the DSM-V Task Force might also reconsider the DSM-IV notion 
that ADHD is a discrete disorder. According to the current categorical approach 
of ADHD children who show evident clinical significant impairment but who do 
not meet the required number of symptoms (children with 5/9 inattention 
symptoms and 5/9 hyperactivity/impulsivity symptoms) will not be diagnosed with 
ADHD, while children with only 6/9 inattention symptoms and none of the 
hyperactivity/impulsivity symptoms will be (see figure in Chapter 1). Of course, 
children not meeting the symptom criteria may meet the criteria for ADHD-NOS, 
but somehow, unlike PDD-NOS, this diagnosis does not appeal to physicians and 
is scarcely used. The above described diagnostic problem, in which some 
children who show more problems do not meet the criteria of ADHD while children 
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showing less problems do, would be solved if the categorical DSM-IV notion of 
ADHD was replaced by a continuous notion in the DSM-V, 
To date the view that ADHD is a continuous rather than an discrete disorder 
seems to prevail.94'97 The notion of behaviour as a continuum with ADHD at the 
extreme end is commensurable to high blood pressure at the extreme end of 
blood pressure and obesity at the extreme end of weight. In all three conditions, 
behaviour as well as blood pressure and weight, it is important to establish the 
turning point: which weight, blood pressure, or number of ADHD symptoms are 
considered normal, and where does pathology start? One of the diagnostic 
DSM-IV criteria for ADHD might be considered the ADHD turning point, namely: 
"there must be clear evidence of clinically significant impairment in social, 
academic or occupational functioning". This may be a common-sense approach 
with a decisive role for the child's impairment reported by parents and teachers to 
make the diagnosis, indepently of the exact number of symptoms. 
In conclusion, the DSM-V will mark one the most anticipated events in the 
mental health field. Based on convincing evidence and the advices made in 
Chapter 6 concerning the effect of an RED on ADHD some changes are suggested 
to incorporate in the diagnostic category of Neurodevelopmental Disorders, 
specifically in ADHD. First of all it is timely to focus on food and to incorporate 
FI-ADHD in the DSM-V. Furthermore, the inventory of the behavioural problems 
might best be made using the ARS, in which "often" is defined as at least once 
a day. And finally, the DSM-V Task Force might take into consideration the 
replacement of the categorical ADHD notion by a continuous notion, in which the 
child's dysfunction or impairment may be considered as the pivotal and decisive 
important factor to define where normal behaviour ends en ADHD starts. These 
changes may contribute to the improvement of our child mental health care and 
the focus on food may offer opportunities for prevention of ADHD. 
9.9. To conclude 
Right now, the main therapy of children with ADHD is medication, eliminating 
symptoms during 3-12 hours depending on the drug, with an effect size of 0.6-0.9 
and with disappointing long-term effects. This dissertation has shown that in the 
majority of young children ADHD may be caused by food and that an RED is an 
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effective treatment of ADHD in children diagnosed FI-ADHD, preventing symptoms 
24/7 with an effect size of 1.2 and with promising long-term prospects. The pros 
of an RED are to such an extent that the current treatment might be expanded 
with RED research, especially in young children with ADHD. Although expert 
supervision is needed to diagnose a hypersensitivity to food in ADHD, a recent 
overview of 35 years of research into diet and ADHD resulted in an advice to 
encourage motivated parents, whether the child is on medication or not, to follow 
an RED.98 
The RED research consists of a diagnostic part to segregate between FI-ADHD 
(children responding favourably to the RED) and C-ADHD (nonresponders). 
Children diagnosed with FI-ADHD start a challenge period to establish the 
incriminated foods, and at the end of the challenge period the therapy consists of 
dietary advice to avoid certain foods. Offering children with ADHD the opportunity 
to follow an RED may result in prevention of ADHD and consequently in improvement 
of the children's prospects. Children diagnosed with C-ADHD start psychological 
research and treatment as usual, as has been shown in an algorithm for multimodal 
diagnosis and treatment of ADHD (see figure 4, chapter 9). Children of parents not 
motivated to start or to comply with an RED should start treatment as usual. 
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1. In general 
The study on the Impact of Nutrition on Children with ADHD (INCA) is a randomised 
controlled trial into the effects of a food elimination diet on the behaviour of a 
random group of school-going children who meet the DSM-IV criteria for ADHD. 
The study also includes immunological research on the effects of food. 
2. Introduction 
2.1. ADHD 
Attention Deficit Hyperactivity Disorder (ADHD) is a psychiatric disorder which 
affects 3 to 5% of all school-going children. The disorder generally manifests itself 
before the age of 7 and is characterised by symptoms of inattention, impulsive 
behaviour and hyperactivity.(l) ADHD is generally diagnosed in combination with 
other psychiatric disorders such as Oppositional Defiant Disorder (ODD) and 
Conduct Disorder (CD).(2) The demand for social and healthcare services is 
considerable among children with ADHD. Research has shown that in particular 
the attention deficit disorders are responsible for an early onset of criminal 
behaviour.(3) 
2.2. Causes 
Genetic factors play a dominant role in ADHD, but there are also a number of yet-
to-be-identified environmental factors that may contribute to the disorder's 
development.(4) Our knowledge of the mechanisms that trigger ADHD is still 
based largely on speculation, so that opportunities for prevention cannot as yet 
be fully explored.(5) 
One of the research areas meriting greater attention is the impact that food 
may have on behaviour and behavioural disorders. There is a growing awareness 
among healthcare providers that the composition and quality of our food may 
play a role in determining not only our physical well-being, but also our behaviour. 
In children who are (genetically) vulnerable to ADHD, for instance, external factors 
may well trigger symptoms of the disorder. A comparable triggering function has 
been observed in the development of asthma, which is also basically a genetic 
disease. Various external factors, including dust mites, pet animals, pollen or 
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foods, have been shown to contribute to the development of asthma, and avoiding 
these triggers may reduce the intake of drugs to a minimum. Similarly, therefore, 
as knowledge of the mechanisms triggering symptoms of ADHD increases, the 
need to prescribe drugs (see under 2.3.) may well decrease simply by avoiding 
certain triggers, such as specific foods.(6) 
2.3. Medication and behavioural therapy as methods of intervention 
At this point in time, medication and behaviour therapy are the main forms of 
treatment for children with ADHD.(7) There is no conclusive evidence, however, 
that any of these treatments improve the long-term prognosis.(7) Although 
methylphenidate, the drug most commonly used in the treatment of ADHD, has a 
statistically significant short-term clinical effect, there is a lack of long-term 
randomized trial evidence.(8) 
Most current scientific research projects centre on medication. In an effort to 
shift the focus from fighting symptoms into averting risk factors, this Study into 
the Impact of Nutrition on Children with ADHD (INCA Study) focuses on the 
question of whether nutrition can be regarded as a potential ADHD risk factor in 
some children. If so, a diet eliminating the foods involved could be considered as 
a treatment of ADHD, thus eliminating the incriminated risk factors and preventing 
the ADHD-symptoms. 
2.4. Diet as an intervention 
The occurrence of adverse physical reactions to foods (e.g. eczema, asthma, 
allergic rhinitis, gastrointestinal disturbances)(9), stimulated speculation that 
such foods could also have an impact on the brain and produce adverse 
behavioural effects.(10) Studies looking only at food dyes in the 1970s (the 
additive studies), showed no cause-and-effect relationship between these 
additives and behaviour.(11-14) Since 1985 dietary studies, excluding not only 
additives but many different foods, have been conducted (the diet studies). 
(10,15-19) The main difference to the additive studies, in which the children 
adhered to their normal diet, was that the dietary trials involved a total change of 
diet: the children were put on a 'few foods diet' for a number of weeks, a diet in 
which only a few different foods were allowed. The rationale for using a highly 
restrictive diet during a few weeks was the assumption that a child might show 
adverse behavioural reactions to any foods. That might explain why excluding just 
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one or two different foods, as the additive studies (11-14) and sugar studies 
(20-22) have shown, is not an effective method to investigate the existence of a 
diet-behaviour connection in a child.(10) 
Although different diet studies used different diets, the general idea of these 
randomised controlled trials was that only few different foods were allowed, 
including rice, turkey, lettuce, pears, and water.(10,15-19) These trials, exclusively 
involving children who met the criteria for ADHD, showed that 24% (in the most 
extensive diet and an unselected population (19)) to 82% (in the most restricted 
diet and a highly selected population (15)) of the subjects showed significant 
behavioural improvements. Unlike the additive studies, all trials based on the few 
foods diet showed improvements in behaviour, resulting in the conclusion that 
there is convincing double-blind controlled evidence for the efficacy of an 
elimination diet in a subgroup of children with ADHD.(22,23) Subsequently the 
National Institutes of Health recommends further research into the relationship 
between food and behaviour.(5) Hill and Taylor have meanwhile developed a 
protocol for treating ADHD patients based on both medication and dietary 
intervention (see Appendix 3).(24) 
2.4.1. Dutch elimination diet 
Following a few foods diet is difficult and puts a considerable strain on the whole 
family. Carter indicates that it may be possible to devise a less restricted diet, with 
similar levels of succes.(10) We have developed an elimination diet which is 
based on the few foods diet but is more extensive, allowing the children, on a 
limited scale, to use more foods than are permitted in the few foods diet. As a 
consequence, this elimination diet is easier to keep up and is much less 
burdensome for both parents and the children, which is an important issue for 
(grand)parents, children, and the Medical Ethical Board. The Dutch elimination 
diet consists of rice, turkey, lamb, a range of vegetables, pear, rice milk with 
added calcium and water. This basis is complemented with specific foods like 
potatoes, fruits, corn, some sweets and wheat, allowed in limited doses twice a 
week. Vegetables, fruits, rice and meat are allowed every day, in normal doses. 
Occasionally the diet will be varied to avoid foods for which the child has a 
particular craving or dislike.(10,15) 
We have already tested this diet, which will be used in the INCA Study, in the 
context of two earlier studies in which 100 children participated: more than 60% 
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responded significantly to the dietary intervention, improving their behaviour by 
50% or more-(25,26) The results of these Dutch studies are comparable to those 
shown in other diet studies.(10,15-19) Moreover, one of the Dutch studies showed 
that the dietary intervention had a positive effect not only on the ADHD symptoms 
but also on the comorbid ODD symptoms.(26) This is an issue because the 
prognosis of children also having comorbid problems like ODD, is relatively 
unfavourable.(2) 
In some studies it was noticed that a substantial number of subjects also had 
physical complaints, such as abdominal pain, diarrhoea, headaches, eczema, or 
asthma.(10,15,25,26) Of the participants in one of the Dutch dietary trials, 20 in 31 
participants even had three or more physical complaints. The diet caused a 
significant reduction in these complaints.(26) An elimination diet may not only 
have an beneficial effect on the behaviour of children with ADHD, but also on the 
comorbid physical complaints. Since children showing extensive physical 
symptoms tend to respond less favourably to drugs,(27) a dietary intervention 
may be optional for these children. 
2.4.2. Practical aspects of dietary research 
Dietary trials with ADHD children generally consist of two phases: an elimination 
phase and a reintroduction phase.(10,15,17) A phased approach is necessary 
because there is evidence that children who respond to food by showing 
ADHD-typical behaviour are generally sensitive to more than one food,(10) each 
child responding to different foods and in random combinations. This multiple 
sensitivity may explain the overall negative conclusions of the additive studies, 
eliminating or provoking just one element of the child's diet. 
The elimination phase, can be considered as a investigation phase, after 
which the diagnosis "ADHD being triggered by foods", can be accepted or 
rejected. During this phase will be investigated whether the child's behavioural 
problems decrease when following a restricted diet during some weeks. All 
children who show a significant response to the elimination diet will proceed to 
the second phase, the reintroduction phase. During this phase will be determined 
which foods are provoking the child's behaviour, by reintroducing one by one the 
foods which were eliminated during the first phase of the trial. This phase will last 
until the child has returned as much as possible to his or her normal eating 
pattern. The second phase is a diagnostic phase, establishing which specific 
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foods are incriminated. Eventually this phase will lead to a therapy, which consists 
of an advice about which foods should be avoided. 
Despite what parents expect, children seldom show ADHD behaviour after 
eating colorants or sugar alone,(11-14, 20-22) although a recent trial has shown 
that there is a general adverse effect of artificial food colouring and benzoate 
preservatives on the behaviour of all 3 year old children, not only in hyperactive or 
atopic subgroups.(28) 
Parents generally experience the reintroduction phase as extremely heavy, 
especially because their children revert to their former ADHD-typical behaviour 
when eating certain foods and there is no way to anticipate when this will happen, 
because each child responds differently to different foods.(10) This is one of the 
conclusions to be drawn from the follow up of a recent Dutch trial, 'A Randomised, 
Controlled Study into the Effects of Food on Young Children with ADHD".(29) This 
study has been registered in the trial register. International Standard Randomized 
Controlled Trial Number ISRCTN47247160. and is the forerunner to this INCA 
Study. Based on parents' ratings as well as teacher's ratings, the preliminary 
results of this study are that more than 70% of the children (N=27) show significant 
improvements in behaviour in response to the elimination diet, according to both 
the Abbreviated Conners Scale(17) and the ADHD Rating Scale.(30) The study 
also shows that the reintroduction phase is very strenuous, particularly when the 
behaviour of a child is triggered by several foods. This burden on child and family 
was confirmed by Carter.(IO) Added to this is the fact that the reintroduction 
phase is long, because the foods are reintroduced one at a time.(10) It is very 
important, therefore, to find a method to lighten the reintroduction phase and thus 
alleviate the burden of the second phase of dietary research. 
2.5. Immunological research 
As yet many research has been done on the relation between ADHD and 
allergy. Initially, a relation was assumed between ADHD and food allergies.(31) 
Another study found a surprisingly high proportion of children with ADHD having 
associated symptoms such as allergic disorders.(15) But randomised intervention 
studies showed no conclusive evidence for this association,(32,33) finding no 
discrepancy in the number of children showing ADHD-typical behaviour with and 
without an allergic disorder.(32) Recent research on ADHD and allergy is also not 
leading to any definitive answers.(34-36) 
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Despite the range of diverse studies that attempt to understand the 
comorbidity of allergies and psychiatric diagnoses, the controversy whether or 
not ADHD and allergies are causally linked still exists in the literature. According 
to Sellanti, in light of the increasing evidence that food may play a role in some 
children with ADHD,(10,15-19) more research is necessary into the immunological 
background and the impact of hypersensitivity reactions to foods.(37) To gain an 
insight in this matter, we will investigate in the INCA study whether in some 
children with ADHD an immunological mechanism might be involved. Hypersen-
sitivity is the coordinating term for all allergic and non-allergic reactions triggered 
by environmental factors (stimuli), according to the revised nomenclature for 
allergy. The definition in this nomenclature is as follows: Hypersensitivity 
describes objectively reproducible symptoms or signs, initiated by exposure to a 
defined stimulus at a dose tolerated by normal subjects."(38) The manifestation of 
asthmatic symptoms following exposure to dust mites by a child who has shown 
to be sensitive to dust mites, will meet the definition of hypersensitivity, the dust 
mite being the defined stimulus. If a child shows symptoms of ADHD after eating 
normal amounts of specific foods, the foods may, like the dustmite, be regarded 
as clearly identified stimuli tolerated by normal subjects. This means that in some 
children ADHD may be the result of a hypersensitive reaction as described in 
the definition above. Preliminary studies on the effects of pollen and food exposure 
on ADHD symptoms (10,15-19,39) support the existence of a hypersensitive 
mechanism. When in a specific case ADHD symptoms originate in response to 
food components, and when an immunological mechanism can be defined which 
underlies this process, then in this specific case ADHD may be considered as a 
consequence of an allergic response. This is in accordance with the revised 
allergy nomenclature.(38) 
Allergic hypersensitivity may be IgE- or non IgE- mediated. Immunoglobulin 
(Ig) molecules are the products of B-cells (unlike T-lymphocytes independent of 
the thymus) and are divided in several immunological classes (e.g. IgE and IgG), 
associated with a range of important biological properties.(40) Radioallergosorb-
ent test (RAST) tests are commonly used to demonstrate food-specific serum IgE 
antibodies. Although the clinical relevance of the detection of IgG-antibodies 
is not quite clear. Strobel indicates that in non-lgE-mediated immunological 
adverse reactions to food, determination of IgG, detected by an enzyme-linked 
immunosorbent assay (ELISA) test.(41) may be an helpful adjunct.(40) According 
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to Gaitens, a behavioural response to food is probably not IgE-mediated, but 
there might well be a connection between ADHD and allergies based on a non-
IgE-mediated mechanism.(42) Research by Atkinson on the Irritable Bowel 
Syndrome has shown that a diet, based on IgG antibodies in the blood, may have 
a positive effect on the complaints.(43) According to Sellanti, the results from 
Atkinson's research might also be useful in research on the potential hypersensi­
tivities in other disorders.(37) Maybe in children showing an ADHD-response to 
foods, a delayed type of allergy (mediated by a chronic immune stimulus to Τ 
cells) is involved.which is generally coupled with the presence of specific IgG 
antibodies.(44) 
Immunological tests on IgE and IgG-antibodies before and after a dietary 
intervention may provide additional information about the mechanisms of foods 
in children with ADHD, may enable us to segregate between non-allergic or 
allergic mechanisms in food-induced ADHD and may simplify the reintroduction 
phase. There have been no previous studies with a focus on the question into 
what extent the presence of IgG antibodies to specific foods in the blood might 
indicate a connection between those foods and behavioural disorders. As the 
connection between ADHD-like behaviour and allergy is still unclear and as it is 
important not only to know into what extent foods are playing a role in ADHD but 
also to unravel the possible mechanisms of action of foods, the INGA study not 
only investigates the influence of foods on ADHD, but also the possible 
mechanisms in which these foods exert their effects. 
2.6. What is already known about this topic 
2.6.1 A diet excluding just one food, like sugar or chocolate,(20-22) or an additive 
free diet is of little benefit to ADHD.(10) A recent trial has shown that some degree 
of hyperactivity, when exposed to artificial food colours and benzoate 
preservatives, may be applied to all 3 year old children, not exclusively to 
hyperactive or atopic subgroups.(28) These findings suggest that benefit would 
accrue for all preschool children, if these additives were removed from their diet. 
2.6.2. All diet studies, unlike the additive studies using a restrictive elimination 
diet, show convincing controlled evidence of efficacy for a selected subgroup. 
(10,15-19.22.23,29) 
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2.6.3. In 2001 a basic algorithm for treatment of ADHD has been published, a 
protocol derived from standard recommendations and evidence, intended for 
outpatient medical clinic practice in secondary care. In this protocol the use of 
a few foods diet is being advised in predetermined cases of children with 
ADHD.(24) 
2.6.4. To date hardly any research is done on ADHD in relation to foods In general 
the existence and the results of the diet studies are ignored, only seldom an 
elimination diet as a possible treatment for ADHD is mentioned.(45) Mostly only 
additive studies or sugar studies are quoted to underline that the idea of foods 
causing ADHD is wrong.(46) In a recent "balanced review of the literature, both in 
support and against the possibility of foods or additives causing behavior 
disorders" not any of the diet studies is mentioned.(47) 
2. 7. What this study adds 
2.7.1. Most previously performed diet studies have focussed on selected 
subgroups, e.g. the participants were recruited via diet clinics. The INGA study 
will investigate the effects of a few foods diet in an unselected group of children 
with ADHD, in order to determine how generally applicable this treatment might 
be within a general group of children with ADHD 
2.7.2. The INGA study will investigate the effects of an elimination diet on ADHD 
as well as on comorbid disorders. In at least 50% of the cases, children with 
ADHD also suffer from ODD.(2) As children with ADHD and comorbid ODD are 
more at risk for long-term maladjustment(48), we hope that the results of this 
study eventually may improve the prospects of these children. 
2.7.3. If the results of the INGA study will be in accordance with the results of all 
previous diet studies, then these findings are sufficiently strong to warrant 
attempts at replication in larger studies. We then also would advise to implement 
the basic algorithm for treatment of ADHD, as proposed by Hill and Taylor 
(appendix 3). 
2.7.4. The INGA study will be the first study investigating the influence of foods on 
ADHD, as well as the possibility of underlying immunological mechanisms by 
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which these foods may exert their effects. Immunological tests before and after a 
dietary intervention may provide additional information about the mechanisms of 
foods in children with ADHD, may enable us to segregate between non-allergic or 
allergic mechanisms and may simplify eventually the dietary treatment of children 
with food-induced ADHD, 
3. Trial objectives 
The trial is two-phased, an elimination phase, phase 1. and a reintroduction 
phase, phase 2. 
3.1 Objective of the elimination phase, phase 1 
The objective of phase 1 is to determine the impact of food on the behaviour of a 
heterogeneous, random group of children with ADHD m a randomised, controlled trial. 
The null hypothesis is that there is no effect of treatment (i.e. food elimination) on 
the behavioural scores of the subjects. 
3.2. Objective of the reintroduction phase, phase 2 
The objective of phase 2 is to examine whether the determination of IgE and IgG 
antibodies to specific foods in the blood can contribute to the application of 
dietary intervention in children with ADHD. All foods without elevated IgE or IgG 
antibodies are reintroduced concurrently to the diet of the responders. The effects 
of this provocation on the behaviour of the responders will be tested in a 
randomised, controlled trial. 
The null hypothesis is that there is no effect of treatment, i.e. there is no relationship 
between the level of IgE or IgG antibodies in the blood and the behavioural scores 
of the subjects. 
i 
3.3. Justification of phase 1 trial objective 
Contrary to most diet studies, this trial will investigate the effects of a few foods 
diet in a heterogeneous group of children who will not be selected based on 
background or affinity with diet interventions. In view of the highly positive 
outcomes of earlier diet studies in and outside the Netherlands, it is important to 
find out to what extent the outcomes of those trials are applicable to a random 
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group of children with ADHD. We may even gain insight into common character-
istics in responders or nonresponders. The significance of this INCA Study also 
lies, therefore, in the predictive value of the research: the question of predicting in 
which children, showing ADHD behaviour, this behaviour may be triggered by 
foods. The outcomes could be used to draw up guidelines with recommendations 
as to which children with ADHD might benefit from diagnostic dietary research. In 
these children a diet may contribute significantly to the provision of care, by 
professionals as well as at home, and may well reduce the intake of medication. 
3.4. Justification of phase 2 trial objective 
Once phase 1 ends, only the responders will be subjected to phase 2. This phase 
is used to identify the foods to which the child responds. In previous diet studies 
foods were reintroduced one by one and only one a week. In the unfortunate case 
of relapse in behaviour the reintroduced foods were eliminated again. This method 
takes long and demands much energy from the child, the parents and the child's 
social environment. But not knowing anything about the mechanisms in which 
foods exert its effects, no other method is available. 
Phase 2 of the INCA study, therefore, is based on blood tests, which will provide 
us with information about the possible existence of immunological mechanisms 
of foods and may simplify phase 2 by tracing the foods that trigger ADHD-typical 
behaviour. The reliability of the IgE- and IgG-values found will be tested by 
concurrently reintroducing to the elimination diet all foods for which no increased 
IgE and IgG levels were found in the first blood sample. If the behaviour of the 
responders has a relapse, we may conclude that blood tests on IgE and IgG do 
not play any significant role in the diagnostic process concerning ADHD and 
foods. But if the behaviour does not change, we may conlude that these blood 
tests can inform us about foods which do not trigger ADHD symptoms, which will 
make the appliance of dietary interventions in practice much easier. 
Immunological testing may simplify the reintroduction phase and yield a 
number of positive effects: (1) the reintroduction phase can be shortened 
considerably; (2) the reintroduction phase will become less strenuous, since 
foods identified as not producing a hypersensitive response can be reintroduced 
without further investigation after the elimination phase has been completed; (3) 
compliance will improve as a result of the shorter reintroduction phase and the 
quicker return to normal eating patterns. 
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Therefore, immunological research may form the basis for a more effective 
application of dietary research and may hence contribute to the prevention of 
ADHD symptoms in children who have been shown to respond to food by 
exhibiting ADHD-typical behaviour. 
If the response is IgG- rather than IgE-mediated, a determination of total IgG 
might help identify potential responders to the therapy and determination of 
food-specific IgG will be a useful tool in identifying the specific foods that trigger 
ADHD in a child. No research in this field has been published to date! 
4. Target group and selection 
4.1. Target group 
4.1.1. Inclusion criteria: 
(a) ADHD diagnosed according to DSM-IV(1); diagnoses based on structured 
psychiatric interviews and standard questionnaires (Abbreviated Conners 
Scale, ADHD Rating Scale, Strengths and Difficulties Questionnaire) to be 
completed by parents and teachers; 
(b) Children aged between 4 and 8; 
(c) Children not taking medication such as methylphenidate; 
(d) Parental permission for three blood tests; 
(e) Sufficient command of the Dutch language. 
4.12. Exclusion criteria: 
(a) Family circumstances hampering completion of the elimination diet; 
(b) Children already on a diet or having been on a diet in the past two months; 
(c) Children receiving behavioural therapy or medication at the time of registration. 
4.13. Justification of inclusion and exclusion criteria 
All children have to meet the DSM-IV criteria for ADHD, the presence of comorbid 
disorders is no reason for exclusion. As the questionnaires will not only be 
completed by parents but also by teachers, we exclude children younger than 4 
years, being the age for Dutch children to go to primary school. We have choosen 
a maximum age of eight years old in order to increase the compliance with the diet. 
The older a child becomes, the more freedom of movement it has, which inevitably 
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comprises more possibilities to eat foods that are not allowed during the elimination 
diet and more problems in monitoring the behaviour and the intake of foods. 
Children receiving medication or behavioural therapy at the time of registration 
are excluded, because we like to investigate the influence of foods on ADHD 
without the behaviour also being affected by other therapies. Children already on 
a diet are being excluded for the same reason. If the medication or the behavioural 
therapy was ended two months before entering the trial, than the child may be 
included, provided that it meets the other criteria. But we will not encourage 
parents to interrupt or stop these therapies, as we obviously do not want to 
undermine other medical advices. 
4.2. Registration and randomisation 
4.2.1 Registration 
Hundred participants will be recruited at medical and psychiatric centres, and 
through media announcements. Parents who are interested must contact the 
researcher for the study. If they wish to register their child, an intake interview will 
be conducted by telephone. This intake will include a structured psychiatric 
interview based on DSM-IV criteria (see under 5.4.4.) During the intake interview 
will be checked whether the child meets all inclusion and exclusion criteria listed 
above. Also the study will be thorougly described and the parents will be compre-
hensively and clearly informed about the possibility of their child being allocated 
to the control group. If it appears that the child meets all criteria, the parents who 
are still interested will receive a comprehensive Information Sheet, providing them 
with more detailed information on the study, including again the issue of the 
allocation to one of two groups. Before the randomisation process, the parents 
must consent in writing to an anonymous processing of all research data. The 
child will then be registered for participation. 
4.2.2. Randomisation 
Immediately after the first measurement (see under 5.2.1.) the children will be 
randomly allocated to (A) an intervention group and (B) a control group. This 
moment of randomisation, i.e. after the first measurement, has been choosen to 
prevent any feelings of disappointment of the parents, which might arise when 
the child will be allocated to the control group, to impede the first measurement. 
Randomization will be performed using randomised blocks, by means of ten 
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boxes each containing 10 sealed envelopes (5A+5B). The sealed envelopes will 
contain computer-generated cards with concealed assignment codes. This 
procedure will be organised and administered by an independent research 
associate. The parents will pick and open one of these envelopes in the presence 
of the researcher. Assignment will be dispensed in accordance with the allocation 
in the envelope. Whenever the first box will become empty, it will be replaced by 
the next box. Blocks are deemed necessary to prevent an unequal distribution of 
treatments over time and to adjust for possible trends in scoring over time due to 
a learning effect of the observers or seasonal trends in efficacy of the treatment. 
4.3. Paediatric examination and single blinded measurements 
All children will be examined by an independent and blinded paediatrician at 
Catharina Hospital in Eindhoven. This paediatrician is experienced in assessing 
ADHD in children and is member of the Dutch ADHD Paediatric Network. The 
blinded measurements will be conducted indepentently of the measurements of 
the researchers. The paediatrician will use the same questionnaires as the 
researchers, the ADHD Rating Scale (5.4.2.) and the structured psychiatric 
interview (5.4.4). The first examination consists of a general physical examination 
and a diagnostic assessment for ADHD and co-morbid disorders, to verify the 
diagnosis. This will be combined with the first taking of blood. The second and 
third examination consist of a diagnostic assessment for ADHD and co-morbid 
disorders, and will be combined with the second and third taking of blood, also at 
Catharina Hospital (see appendix 1). 
5. Study design 
5.1. General 
The diet used in this trial is very restrictive, it would be impossible to compose a 
reliable placebo diet without parents or teachers noticing this, thus impeding a 
placebo controlled trial. Therefore the INCA study is a a randomised controlled 
trial (RCT), as is also used by other studies where no placebo is available, such 
as studies into the effects of cognitive behaviour therapy,(49,50) eczema,(51), or 
other medical intervention trials.(52-54) 
It is not possible for the researchers to be blinded,(51) as they have to advise 
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the parents about the diet. Data entry will be done by administrative assistants, 
blinded to the assigned treatment.(54) In addition, an independent and experienced 
paediatrician who will be blind to treatment conditions, will execute three 
assessments to investigate whether the children meet the DSM-IV criteria for 
ADHD and co-morbid disorders.(55) The paediatrician will not be informed about 
the group the children have been assigned to. Children and parents will be 
instructed not to reveal this information to the paediatrician.(55) The paediatrician 
has to open a new file every time a child visits him, independently of the fact 
whether it is the first, second or third time the child is visiting the paediatrician. 
The dietary trial consists of two phases (see table I): the elimination phase 
(see under 5.2.) and the reintroduction phase (see under 5.3.). Three blood 
samples will be taken during the trial (see Chapter 6): in week 0 (start of the trial), 
week 9 (after the elimination phase) and week 13 (after the reintroduction phase). 
The trial will be conducted randomised and controlled (for an overview see 
Appendix 1). At week 13 the trial stops, not only out of ethical consideration (13 
weeks in a waiting list group is extremely long for families with an ADHD child) but 
also for practical reasons (parents who must wait too long will be sooner inclined 
to withdraw from the trial). All in all, 100 children will participate (see Chapter 7). 
Table I Overview of elimination and reintroduction phases 
Elimination phase: weeks 1-9 Reintroduction phase: weeks 9-13 
Baseline diet (see 5.2.2.) 
weeks 1-3 IgG-O provocation (see 5.3.) 
weeks 9-13 
Elimination diet (see 5.2.4.) 
weeks 3-9 
5.2. Phase 1, elimination phase, weeks 0-9 
The elimination phase lasts 9 weeks and comprises a baseline diet, an elimination 
diet, and three measurement points. Following the first measurement in week 0 
(see under 5.2.1.), the children will follow a 2-week baseline diet (see under 5.2.2.). 
After the second measurement in week 3 (see under 5.2.3.), the children will start 
with the elimination diet (see under 5.2.4.). At the end of this elimination diet, the 
third measurement will be conducted in week 9 (see under 5.2.5.). 
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The interviews in which the measurements are recorded will be held with the 
parents in the absence of the child. The child's behaviour is registered with the 
aid of questionnaires to be completed by the parents and the child's teacher, but 
not by the child itself. The interviews and questionnaires highlight the less 
agreeable aspects of the child's behaviour and could, therefore, be experienced 
as very negative by the child and, for that matter, by the parents as well. This is 
why we have chosen not to conduct the interviews in the child's presence. The 
child will be examined by a paediatrician (see 4.3.). 
5.2.7. Week 0, entrance measurements: first interview, first measurement 
(M1), first measurement by blinded paediatrician (MBP1) 
All 100 participants will start the trial with an interview, comprising a detailed 
anamnesis in which we discuss the child's medical and social history, the family 
situation, the mother's pregnancy and delivery of the baby, and the child's school 
career, personal development and behaviour. In addition, four questionnaires are to be 
completed (see under 5.4.). After the first measurement Ml, the participants are 
assigned at random to the intervention or waiting list group, as discussed under 4.2.2. 
The first measurement time is also the time that the first blood sample is taken 
(see Chapter 6) and that the first assessment by the blinded paediatrician (MBP1) 
will take place, both at Catharina Hospital in Eindhoven (appendix 1). 
5.2.2. Weeks 1-3, baseline period: between first and second measurements 
After the first measurement, all 100 children start with the baseline period, which 
is a 2-week period in which each child follows his or her own specific diet. No 
changes are made to the diet and no foods should be avoided. The parents will 
use this time to keep a detailed diary from which the child's normal eating habits 
may be inferred. In addition, the child's behaviour and any physical complaints 
and potential risks to compliance, such as before- and after-school care, staying 
at a friend's, or sports activities, are closely monitored and recorded. At the end 
of the baseline period the effects of this extra attention for the child are measured 
(M2). It is not entirely inconceivable that the child's behaviour already improves 
because of the special attention which parents give their child in order to fill in the 
diary correctly. 
Both the intervention group and the control group will keep a diary, which means 
that the two groups still run parallel to each other during the baseline diet. 
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5.2.3. Week 3: second interview, second measurement ( M2) 
The second measurement point for all 100 children, that is, both the intervention 
group and the control group, takes place after the baseline period. This 
measurement is particularly important to identify possible changes that may have 
occurred during the baseline period as a result, for instance, of the special 
attention given to the child. Parents and teacher fill in the questionnaires referred 
to under 5.4. This measurement point is also the time when the children from the 
control group are placed on a waiting list; their eating pattern will not change. The 
children from the intervention group proceed to the elimination phase (see 5.2.4.) 
5.2.4. Weeks 4-9: between second and third measurements: elimination 
period for intervention group, waiting period for control group 
Children assigned to the control group are placed on a waiting list whilst the 
intervention group follows the elimination diet. The waiting list group continues 
their normal eating pattern. No alternative form of treatment is offered to them, 
and parents are at liberty in this period to explore other research or treatment 
options. Like the intervention group procedure, the procedure for the control 
group also involves completion of all questionnaires, and the measurement points 
for this group coincide with those established for the intervention group, that is in 
weeks 0, 3, 9, 11, and 13 (see table II). To motivate families who have been placed 
on the waiting list to complete the trial, all families in the control group are offered 
an opportunity to start the elimination diet after the final measurement in week 13 
and to follow the same procedure as that followed by the intervention group. 
Children assigned to the intervention group will start a 5-week elimination 
diet. The diet will be preceded by a 'gradual transition week' in which the child's 
eating pattern will slowly be adjusted to the new diet and the parents are able to 
do the shopping and get accustomed to new foods. The elimination diet is based 
on the few foods diet, but it is more extensive, allowing the children, on a limited 
scale, to use more foods than are permitted in the few foods diet. We have tested 
the usability of the diet in three earlier studies, in which more than 60% of the 
subjects showed significant improvements in behaviour (>50%) in response to 
the diet.(25,26,29) (see 2.4.1.) All major allergen foods, ingredients and/or 
additives associated with behavioural disorders are eliminated from the diet. 
(15,16,19) The diet basically consists of bread, rice, corn, turkey, lamb, various 
vegetables and fruits, rice milk with extra calcium, margarine, and pear juice from 
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concentrate. This basis is complemented with specific foods like potatoes, fruits, 
corn, some sweets and wheat, allowed in limited doses twice a week. Vegetables, 
fruits, rice and meat are allowed every day, in normal doses. Occasionally the diet 
will be varied to avoid foods for which the child has a particular craving or dislike. 
(10,11) The diet clearly prescribes for each day which products and snacks the 
child may eat and drink. All ingredients are listed, and parents receive a grocery 
list, so that the risk of errors in the diet is reduced to a minimum. The diet is 
adjusted to the individual child in order to take into account the child's specific 
food preferences and to leave out all foods which the child does not like. 
Parents are given a diet programme which must be strictly observed at all 
times. They must also continue to keep a diary during this phase, registering not 
only the behaviour of the child but also any dietary infractions. If recurrent 
infractions are noticed, the child will be excluded from the trial. The intention to 
treat analysis of these children and of children who leave the trial prematurely, will 
be performed using two methods: last-observation-carried-forward (LOCF) and 
group mean imputation (GMI).(56) If the parents have any questions about the 
diet, they should contact the researcher for consultation. If the diet does not result 
in any behavioural changes after the first 2 weeks, the diet will be further restricted 
in consultation with the parents.(10) In the end, therefore, the diet may vary for 
each individual child, depending on the need to make interim adjustments. 
5.2.5. Week 9: third interview, third measurement (M3) .second measurement 
by blinded paediatrician (MBP2) 
The third measurement (M3) for both the intervention group and the control group 
is conducted at the end of the elimination diet (intervention group) or halfway 
through the waitinglist period (control group) at week 9. All questionnaires must 
be filled in once again and a second structured psychiatric interview is held. This 
third measurement point coincides with the second taking of blood samples from 
participants in the intervention group (see Chapter 6) and with the second 
measurement by the blinded paediatrician (MBP2). This MBP2 in week 9 is 
reserved for the children in the intervention group. The children from the control 
group will return to the hospital in week 13 (second blood test control group). We 
considered we would be demanding too much of the parents and children in the 
control group if they should have to travel four times instead of three times to 
Eindhoven, considering the fact that children are recruited from all the Netherlands. 
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So the MBP2 for the children in the control group will take place in week 13, 
combined with MBP3 and the third blood test for the children of the intervention 
group. 
After M3 the children in the intervention group are split up in responders and 
nonresponders, Responders are children who show significant improvements in 
behaviour in response to the elimination diet. Improvements are significant if the 
scores on the Abbreviated Conners Scale and/or the ADHD Rating Scale (see 
under 5.4.) show a minimum difference of 40% before and after the dietary 
intervention. Children with improvements of 40% or more on one or more 
questionnaires, i.e. the responders. proceed to the reintroduction phase. The 
nonresponders, who show no or insufficient behavioural improvements after the 
elimination phase, are referred back to their treating physician for further research 
and/or medication. They may return to their normal eating pattern: for these 
children, the trial has come to an end. The responders proceed to the reintroduction 
phase (see under 5.3). Children from the control group will remain on the waiting 
list for another 4 weeks after the third measurement. 
5.3. Phase 2, reintroduction phase, weeks 9-13 
The reintroduction phase is based on the IgE and IgG-levels, determined in the 
first blood test. The focus is on whether or not foods having yielded an IgG-O 
value during he first blood test and without increased IgE level, can be reintroduced 
to the child's diet without triggering any behavioural problems and, hence, 
whether IgG and IgE testing is useful in children with ADHD. This will be tested 
during weeks 9-13, all foods with IgG-O value and without increased IgE-level, will 
be reintroduced concurrently to the diet of the responders. 
After these 4 weeks, the controlled trial will be terminated in order to avoid 
families in the control group having to wait too long before they can start with the 
elimination diet. Too long a waiting list period poses the risk that parents may 
decide to withdraw during the course of the trial or not even start. Furthermore, 
the 4 week reintroduction of hypo-allergenic foods, i.e. according to the first blood 
test, will provide sufficient information to accept or reject the hypothesis that there 
is no relationship between low IgE / IgG levels and sensitivity to foods in children 
with ADHD. 
244 
INGA research protocol 
5.3.7. Participants and reintroduction 
5.3.1.3. Selection 
After the elimination phase, the responders. I.e. those children who have shown 
significant improvements in behaviour in response to the elimination diet, will 
proceed to the reintroduction phase. 
5.3.7.Ò. Number of participants 
Earlier Dutch trial has shown that approximately 10% of the parents are unable to 
comply with the diet consistently during the elimination phase,(25,29) We expect 
that, out of the 50 families starting the elimination diet, 45 families will successfully 
complete the first phase. We assume that 60% of the 45 children concerned will 
respond to the diet,(see chapter 7) and we expect that nearly all families with a 
child that has responded to the diet will be motivated to proceed to the 
reintroduction phase. So approximately 27 children will presumably start with the 
reintroduction phase. 
5.3.7.C. Reintroduction and measurements 
All foods without increased IgG value during the first blood test, i.e. foods with an 
IgG-O value, and without increased IgE-value, will be reintroduced concurrently. 
To start the reintroduction phase, the results of the IgG and IgE analysis of the 
first blood samples will have to be known to the researcher before the end of the 
elimination diet. All other laboratory results will be made known at the end of the 
trial. To prevent bias in interpreting the child's behaviour, all parents, of responders 
and nonresponders alike, will receive the results of the blood tests at the end of 
the trial. Measurements M4 and M5 will take place during the reintroduction 
phase, at week 11 and week 13, The questionnaires will be completed as 
described in chapter 5.4. 
5.3.2. Control group 
The children from the control group are still on the waiting list during this phase. 
The measurement points are equal to the measurement points of the intervention 
group and will take place in week 11 (M4) and week 13 (M5). (table II) The 5,h 
measurement, in week 13, will be combined with the measurements by the 
blinded paediatrician (MBP2) and the second blood test. After M5 the INGA study 
ends. All children from the control group will be offered an opportunity to start the 
elimination diet. 
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5.3.3. Responders of elimination group 
Immediately following the elimination phase, the responders will proceed to the 
réintroduction phase, during which all foods that did not yield any increased IgG 
value during the blood test, i.e. IgG-O value, are added concurrently to the 
elimination diet, provided that there are no increased IgE-levels for these foods. 
The number and combination of foods reintroduced may differ for each individual 
child, depending on the results of the IgG and IgE analyses of the first blood 
samples. All the foods that will be reintroduced may be eaten in normal quantities 
during the reintroduction phase (weeks 9-13). At the end of weeks 11 and 13, the 
4lh and 5lh measurements (M4, M5) will be conducted. M5 in week 13 will coincide 
with the 3,d blood sample (see chapter 6, table III) and with the 3rd measurement 
by the blinded paediatrician (MBP3). Using the questionnaires described under 
5.4. we will examine whether the child's behaviour in response to the IgG-O 
provocation (M5) is comparable to its behaviour at the end of the elimination 
phase {M3). In addition, the behaviour of these children is compared to that 
exhibited by children in the control group. Based on these comparisons, 
conclusions may be drawn as to the usefulness of IgG and IgE blood tests in 
children with ADHD who are sensitive to foods. 
If the child's behaviour does not change, the conclusion seems warranted 
that none of the foods with an IgG-O value an no increased IgE-value are affecting 
the child's behaviour. 
If the child's behaviour changes during the reintroduction phase, which can be 
assessed during the 4,h or 5,h measurement or earlier (i.e. when the parents report 
such a change in behaviour that they wish to terminate the IgG-O provocation 
immediately), the conclusion must be that foods with an IG-0 value may cause 
behavioural change and that there is probably no connection between IgG 
antibodies to specific foods and the impact of those foods on the child's 
behaviour. When parents want to stop prematurely with the reintroduction phase, 
the next measurement moment will not be awaited. Instead, the parents and the 
teacher will immediately complete the questionnaires and the provocation will be 
stopped. The third blood sample, scheduled for week 13, will be taken earlier, 
depending on when the decision is made to stop the provocation. 
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Table II Measurement points (M1-M5), blinded measurements (MBP1-MBP3) and blood tests (B1-B3) in intervention group 
and control group 
Measurement Points 
Weeks 0-9: Elimination Phase 
Weeks 9-13: Reintroduction Phase 
Intervention group 
^ 
WeekO 
V Measurement (M1) 
1« Blind Measurement {MBP1) Blood test (B1) 
Week 3 
2 c Measurement (M2) 
Week 9 
Start Trial 
M1,MBP1,B1 
Start baseline period 
End baseline period 
M2 
Start elimination diet 
End elimination diet 
3'° Measurement (M3) 
2,,d Blind Measurement (MBP2) Blood test interv. group 
(B2) 
Week 11 
4^ Measurement (M4) 
Week 13 
S1'1 Measurement (M5) 
2"" and 3^ Blind Measurements (MBP2, MBP3) 
Blood test control group (B2) 
Blood test interv. group (B3) 
M3. MBP2. B2 
Nonresponders: end Trial 
Responders: Start Reintroduction Phase 
Halfway IgG-O provocation 
M4 
End IgG-O provocation 
M5, MBP3, B3 
End RCT 
Control group 
Start trial 
Ml, MBP1. B1 
Start baseline period 
End baseline period 
M2 
Start waiting period 
Waiting period 
M3 
Waiting period 
M4 
End of waiting period 
M5, MBP2, B2 
End RCT 
Optional: start 
elimination diet 
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5.4. Dependent variables and measurement points 
In the INCA study five questionnaires will be used to assess any behavioural or 
physical changes during the trial. The four questionnaires assessing behavioural 
changes are the Abbreviated Conners Scale (5.4,1.), the ADHD Rating Scale 
(5.4.2.), the Strengths and Difficulties Questionnaire (5.4.3.) and a Structured 
Psychiatric Interview based on DSM-IV criteria (5.4.4.). The Other Complaints 
Questionnaire will be used to assess any physical complaints (5.4.5.). 
The Abbreviated Conners Scale (ACS) and the ADHD Rating Scale (ARS) are 
the two major rating scales for the outcomes of this study. They will be used 
during all measurement points, i.e. Ml (week 0), M2 (week 3). M3 (week 9). M4 
(week 11) and M5 (week 13). The other questionnaires will be used three times, in 
order not to overburden the parents: 
• The Strengths and Difficulties Questionnaire (SDQ) at M2, M3 and M5. 
• The Physical Complaints Questionnaire (PCQ) at M2, M3, M5. 
• The Structured Psychiatric Interview (SPI) at Ml, M3, M5. 
The measurement points of the researcher are in accordance with the 
measurement points of the blinded paediatrician. The measurement points by the 
blinded paediatrician are at Ml, M3 and M5, using the ARS and the SPI. 
5.4.7. Abbreviated Conners Scale 
The ACS, also called the hyperkinesis index, is a commonly used questionnaire 
in studies into the relationship between nutrition and behaviour.(19) The ACS was 
also used in the three Dutch studies conducted prior to this INCA Study,(25,26,29) 
and consists of 10 questions using a 4-point scale. A score of 15 represents two 
standard deviations (SDs) above the mean cut-off.(17) Scores can range from 0 
to 30. Three measurement points have been integrated into the elimination phase: 
Ml at the start of the trial (week 0). M2 after the baseline diet (week 3), and M3 in 
week 9, at the end of the elimination diet (intervention group) or halfway through 
the waiting period (control group). 
The responders to the elimination diet will proceed to the reintroduction 
phase after the 3rd measurement. The 4,h and 5lh measurements are conducted 
during the reintroduction phase: M4 halfway through the IgG-O provocation, i.e. 
the reintroduction of foods who did not produce any increased IgG and IgE-values 
in the first blood test (see under 5.3): M5 at the end of the IgG-O provocation, that 
is, in week 13 (see under 5.4.2). M4 (week 11) and M 5 (week 13) will also be 
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conducted in the children of the control group. The ACS is completed by the 
parents and the child's teacher at Ml, M2, M3, M4 and M5. 
5.4.2. ADHD Rating Scale 
The second questionnaire is the ADHD Rating Scale (ARS).(57) This questionnaire, 
based on the DSM-IV, is often used in ADHD diagnostics.(45) The questionnaire 
consists of 9 inattention items and 9 hyperactivity/impulsivity items, and uses a 4-point 
scale. The answers to each question vary from Never or Rarely (0 points). Sometimes 
(1 point), Often (2 points) to Very Often (3 points). For inattention, the mean cut-off 
score plus 1.5 SDs, based upon normative data, is 13.6 for boys younger than 7 (girls, 
11.2); for hyperactivity / impulsivity, that score is 14,9 (girls, 11.8); the total score for 
boys is 27.5 (girls, 21.8).(57) This questionnaire has also been used in two of the earlier 
Dutch studies.(26,29) The measurement points coincide with those of the ACS. 
The ARS is completed by both the parents and the teacher at Ml, M2, M3. M4 
and M5. This questionnaire will also be used at all measurement points by the 
blinded paediatrician: MBP1 in week 0, MBP2 in week 9 (intervention group) and 
week 13 (control group) and MBP3 in week 13 (intervention group). 
5.4.3. Strengths and Difficulties Questionnaire 
The Strengths and Difficulties Questionnaire (SDQ) is a standardised questionnaire 
on behaviour that is easy to complete by parents and teachers and is suitable to 
use for children aged 4 to 16.(58) The questionnaire is often used in research on 
behavioural problems In children.(45) Dutch research supports the use of the 
SDQ as an index for psycho-pathological problems among children.(59) Parents 
and the child's teacher must fill in the SDQ at M2, M3 and M5. 
5.4.4. Structured Psychiatric Interview 
Professor Jan Buitelaar, professor of child psychiatry at Radboud University in 
Nijmegen has prepared a Structured Psychiatric Interview (SPI) based on DSM-IV 
criteria. The SPI will be used to assess comorbid disorders like ODD and CD. This 
interview is taken on three occasions, at Ml, M3 and M5 and will be completed by 
both the parents and the teacher. 
This questionnaire will also be used at all measurement points by the blinded 
paediatrician: MBP1 in week 0, MBP2 in week 9 (intervention group) and week 13 
(control group) and MBP3 in week 13 (intervention group). 
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5.4.5. Other Complaints Questionnaire 
The purpose of the fourth questionnaire, the Physical Complaints Questionnaire 
(PCQ), is to identify other complaints the child may have. Questions concern the 
presence or absence of physical complaints such as gastrointestinal problems, 
headaches, eczema, unusual perspiration, sleep disturbances and asthma. 
Making a list of the child's physical complaints serves a purpose: Many of the 
subjects included in earlier studies appeared to have additional, physical 
complaints.(10,15) According to Barkley, medication may be less effective in 
children with ADHD who also suffer from physical ailments.(27) The PCQ was 
also used in the earlier Dutch studies.(25,26,29) The questionnaire is filled in as 
often and at the same time as the SDQ. Only the parents are required to fill in the 
PCQ.(60) 
5.5. Follow-up after the end of the trial 
After the end of the trial all children assigned to the control group will be offered 
an opportunity to start the elimination diet. The responders, like the responders of 
the intervention group, will also start with the reintroduction phase. All responders, 
from control group and diet group, will be offered after the end of the trial a 
monitoring period of 8 months, during which the food provocations will be 
continued, without any costs. 
5.6. Involvement of dietician 
The elimination diet contains all necessary nutrients, according to the Dutch 
Guidelines for Healthy Foods.(61) As no milk products are allowed, rice milk with 
extra calcium is added to the diet. If it occurs that a child does not want to eat 
some of the foods that are allowed, the diet will be adjusted. If the child refuses to 
eat any fruit or vegetables, a dietician will be called in to monitor the child's diet 
and check for any deficits and, where applicable, to provide the necessary 
supplements. 
5.7. Reporting 
All parties concerned will be informed about the results of the study. Parents will 
receive separate reports on the elimination phase and the reintroduction phase, 
in which they will also be advised about the relevance of a diet for their child. 
Parents will also receive a report on the group results. The results of the laboratory 
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tests will be made known to the parents after the trial has ended. Interim progress 
reports to the sponsors and the Medical Ethical Review Board will be issued 
every six months and at the end of the study. 
6. Laboratory tests 
From each child there will be taken at least two blood samples during the trial 
(see table III). Only responders to the elimination diet will be asked to provide 
blood samples thrice: in week 0 (start of the trial), week 9 (after the elimination 
phase) and week 13 (after the reintroduction phase). In week 0, blood samples 
will be taken from all 100 children, that is, from both the intervention group and 
the control group. In week 9, blood will be taken only from the children in the 
intervention group, that is, from 50 children. In week 13, finally, blood samples will 
be taken from the children in the control group (50 children) and from the 
responders to the elimination diet (x children). 
Table ill Blood sampling in intervention and control groups 
1" blood test, B1 2nd blood test, B2 
week 0 All children, of 
Intervention Group and 
Control Group 
week 9 All children of 
Intervention Group 
week 13 All children of 
Control Group 
The first analysis is a baseline analysis of the IgE and IgG values in the children's 
blood whilst they follow their normal eating pattern. The second analysis will be 
made at the end of the elimination phase (intervention group, week 9) or, as the 
case may be, the end of the waiting period (control group, week 13). The purpose 
of this analysis is to determine possible fluctuations in the IgE and IgG values. 
The results of the intervention group are compared to those of the control group. 
3rd blood test, B3 
Responders of 
Intervention Group 
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A comparison of measurements is also made for each individual child and. after 
the elimination diet in week 9, between the blood values of nonresponders and 
responders. 
After week 9, the responders proceed to the reintroduction phase and 
undergo 4 weeks of IgG-O provocation. A third blood test is then conducted in 
order to determine possible changes in the IgE and/or the IgG levels to specific 
foods caused by the change in diet. Since the mean half-life of IgG is 3 weeks, the 
third blood analysis in week 13 (after 9 weeks of diet, i.e. 5-week elimination 
phase plus 4-week reintroduction phase) should be sufficient to measure 
changes. The results of the blood tests in week 13 are compared to the results of 
the first measurements, and the blood values of the responders are compared to 
the participants in the control group. 
The amount of blood required to conduct the blood analysis is 12 ml per test 
(less than 1 % of the total blood volume). The blood tests are carried out by the 
Cell Biology and Immunology Group of Wageningen University and Research 
Centre (IgE and other measurements) and by the Pro Health laboratory in Weert 
(IgG). The results of each blood test, properly coded, are sent to the researcher. 
6.1. IgE blood tests 
Immunoglobulin E (IgE) is an antibody that can be found in case of an allergic 
reaction. Preliminary studies have suggested the possibility of an allergic mechanism 
concerning ADHD, finding a surprisingly high proportion of children with ADHD 
having associated symptoms such as allergic disorders.(15) When the serum IgE 
level is elevated, indicating that there might be IgE-mediated hypersensitivity 
reactions, the specific IgE antibody levels to food products and other allergens, such 
as mites, pets, and pollen will be measured in the blood of the child concerned. 
6.2. IgG blood tests 
The presence of IgG antibodies to 266 different foods will be tested using a 
traditional Enzyme-Linked Immunosorbent Assay (ELISA, see Appendix 2). 
(43.62) For each individual product, the level of IgG antibodies will be determined 
in the blood, following which a value of IgG-O, 1. 2, 3, or 4 will be assigned to the 
product based on the quantities of ;L/g IgG / ml serum measured. All foods with 
IgG-O-value will be reintroced during the reintroduction phase, provided that 
there are no elevated IgE levels measeured for these foods. 
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6.3. Other blood tests 
As there are associations reported between minerals, trace elements, carnitine, 
fatty acids and other dietary components and behavioural changes, these 
constituents are also included in the blood tests.(63-77) The children's blood will 
be kept during the trial period in order to be able to trace inflammatory mediators 
(cytokines) and/or other antibodies, such as anti-tissue transglutaminase IgA 
(anti-tTG IgA). In the Netherlands, physicians increasingly diagnose a genetic 
predisposition to hypersensitivity to gluten (a protein found in wheat, barley, and 
rye).(78) Zelnik has indicated that patients suffering from coeliac disease tend to 
develop neurological disorders, such as ADHD, more often (51.4%) than the 
subjects placed in a control group (19.9%) and recommends that further research 
be done into the impact of gluten-free diets on these neurological disorders.(79) 
Since wheat can be a trigger of ADHD,(10) it is important in the context of this 
study to find out whether the subjects show a response to gluten. A serological 
test on transglutaminase IgA would be a usable tool to screen children for gluten 
hypersensitivity.(80) 
6.4. Coding and storage of bodily materials during the trial 
Each time a blood test has to be done, the child will be assigned a code number 
by the researcher, in sequential order, which means that the codes will range from 
INCA-01 to INCA-227, i.e. 100 children having their first blood test plus 100 
children having their second blood test plus approximately 27 children having 
their third blood test. These codes are forwarded to the blinded paediatrician who 
will examine the children and who will state the code on the blood analysis request 
form. The only persons with access to the code key are the project leader, the 
researcher, and the independent supervisor (see under 8.7.). 
The Wageningen University will store the blood at minus 80 0C. After the trial is 
completed, all bodily materials will be collected in special hospital containers and 
destroyed according to standard medical waste removal procedures. 
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7. Statistical considerations and data analysis 
Dr. K. Frankena, senior researcher at the Wageningen University, will participate 
in the trial as epidemiologist/statistician. 
7.1. Statistical considerations 
The samples size for this study is estimated to be 100 children (50 children in 
each group) calculated using the package Stata version 9,(81) and based on the 
following assumptions: 
1. In a recent small-scaled Dutch randomised controlled study (29) 73% of the 
children in the diet group (n=15) showed behavioural improvements of 40% or 
more. The control group showed an overall behavioural improvement of 8%. 
none of the children of the control group (n=12) showed an improvement of 
40% or more. As we do not want to be overly optimistic about these figures, we 
assume that improvement (of at least 40%) in behaviour occurs in 60% of the 
children that follow the diet and in at maximally 20% of the children in the 
control group 
2. Power of 80%, 
3. Two-sided α of 5 %. 
The needed sample size is then 28 children per group. Due to a potential block effect 
(loss of 7 degrees of freedom) and potential drop outs (10%) the sample size needs 
to be increased further and we need approximately 40 children per group. To prevent 
loss of power due to a potential higher percentage of drop-outs, 10 children per 
group are included above the originally calculated sample size of 40 (+25%). 
The parents of the participating children fill in an informed consent. This 
consent is compulsory for participation. We assume that each participant is thus 
motivated and therefore a drop-out level of 10% is assumed, comparable to the 
drop-out level of 10% in the previous Dutch controlled study (29). Children will be 
randomly assigned to one of both groups, 50 to the intervention group and 50 to 
the control group (see 4.2.2.). 
7.2. Data analysis 
All statistical analyses will be carried out with SPSS Windows-version 9.0 and are 
based on 'intention to treat', using two methods: last-observation-carried-forward 
(LOCF) and group mean imputation (GMI).(56). The statistical unit of analysis is 
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the individual child, A p-value less than 0.05 will be deemed significant. All 
analyses concern the ratings of the parents as well as the ratings of the teachers. 
Ratings of the blinded paediatrician will be compared to those of the researchers 
using the kappa statistic which indicates an agreement beyond chance of 2 
raters.(81) Because a gold standard is not available it is only possible to assess 
the agreement between raters without assuming beforehand that one is the best. 
The logic of using kappa is that agreement beyond chance between raters is 
evidence of validity, whereas disagreement suggests that the ratings are 
untrustworthy. In general, \\ kappa = 0 (or smaller), then there is no agreement at 
all beyond chance. Kappa values greater than 0.75 may be taken to represent 
excellent agreement beyond chance. Values of kappa below 0.40 may be taken to 
represent poor agreement beyond chance and values between 0.40 and 0.75 
may be taken to represent a fair to good level of agreement.(81) The kappa for 
interrater agreement between the researchers and the paediatrician will be 
computed in every analysis. In cases where the ratings of the blinded paediatrician 
disagree with the ratings of the researchers (kappa < 0.40), the ratings of the 
blinded paediatrician will be used for further analyses. 
Prior to the start of this study the researchers and the paediatrician will 
independently assess 3 to 5 cases, to reduce the chance of serious rater disagreement. 
After the assessments of each case, the results will be discussed together. 
7.2.1. Analysis of ACS, ARS, SDQ and SPI scores (behaviour measurements) 
Scores indicating behaviour will be analysed using linear regression, a Normal 
distribution of scores will be Initially assumed; fit of the models will be evaluated 
using normal plots and the Wilk-Shapiro statistic.(see 82 and 83 as standard 
works) 
7.2.I.A. The first analysis of these scores will be restricted to the data collected 
during the elimination phase and will cover the first 8 months of the trial. 
Differences in behaviour measurements at M3 between intervention and control 
group will be analysed according to the regression model: 
M3l|k =/J + C, + Bj + M2l|k + el|k (1) 
Where: 
M3ljk = ACS, ARS, SDQ or SRI score of individual k (k = 1 to 50) of group i 
(i = 1,2) and block j (j = 1 tot 10) at week 9 
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μ = intercept 
G, = effect of treatment i (1 intervention, 2 = control) 
B, = effect of block j (j = 1 to 10) 
M2j|k = ACS, ARS or SDQ score of child k of group i and block j at week 3 
(M2) or SPI score at week 0 (M1) 
eijk = residual 
The null hypothesis is that there is no effect of treatment on the respective scores. 
Interaction between block and treatment will be evaluated as well. 
7,2.1.B. The second analysis of the behavioural scores is restricted to the 
responders of the intervention group only and includes data that cover the IgG-
0-provocation period. The total number of children included in this analysis is 
unknown as the number of responders is unknown but it is estimated to be 60%. 
With a potential drop-out percentage of 10, it is expected that this group consists 
of at least 27 individuals. 
Differences in behaviour measures between M5 and M2 (ACS scores, ARS scores 
and SDQ scores), between M5 and Ml (SRI scores), and between M5 and M3 
(ACS scores, ARS scores, SDQ scores and SRI scores) of the responders of the 
intervention group will be analysed using the model: 
M5jj = μ + BL + MX,, + e,, (2a) 
Where: 
M5ij = ACS, ARS, SDQ or SPI-score of individual j (j = 1 to n) of block ι at 
week 13 (M5) 
μ = intercept 
B, = effect of block i (i = 1 to 10) 
Mx,, = ACS, ARS. SDQ or SPI-score of child j of block ι at Ml, M2 or M3 
ejj = residual 
The null hypothesis is that there is no effect of treatment on the behaviour scores. 
Ideally, a group of responders of the intervention group that were not supplemented 
with IgG neutral food elements should be included in the analysis as reference 
group. However, we deemed this unethical as these children should take the strict 
diet for another 4 weeks. Instead, an additional analysis (model 2b, analogous to 
model (1)), including data of the control group will be carried out. 
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7.2.2. Analysis of IgG scores 
Initially logistic regression for polytomous outcomes (IgG score has 4 classes) 
will be used; fit of the model will be evaluated using Hosmer-Lemeshow statistic. 
(84) 
7.2.2.A, Model (3) will be used to analyse the effect of treatment on the IgG 
scores. 
IG2 l ]k=/7 + Cl + BJ +IG1 l ] k + e l ]k (3) 
Where: 
IG2l|k = IgG-score of individual k (k = 1 to 50) of group i (i = 1, 2) and block 
j (j = 1 to 10) at week 9 (intervention group) or week 13 (control group) 
μ = intercept 
G, = effect of treatment i (1 intervention, 2=control) 
Bj = effect of block j (j = 1 to 10) 
IG1||k = IgG-score of individual k of group i and block j at week 0 
ei]k = residual 
The null hypothesis is that there is no effect of treatment on the IgG score. 
Interaction between block and treatment will be evaluated as well. 
7.2.2.B. IgG-measurements of responders and nonresponders within the 
intervention group will be evaluated according to model (4): 
IG2ljk = ju + Rl + B| + IG1l|k + e l j k (4) 
Where: 
IG2ljk = IgG score of individual k (k = 1 to 50) of responder class i (i = 1,2) 
and block j (j = 1 to 10) at week 9 
μ = intercept 
Ρ, = effect of responder class i (1 = responder, 2 = nonresponder) 
B, = effect of block j (j = 1 to 10) 
IG1jji
<
 = IgG score of child k of responder class i and block j at week 0 
ei|k = residual 
The null hypothesis is that there is no effect of responder (yes/no) on the IgG 
score. 
Interaction between block and responder group will be evaluated as well. 
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7.2.2.C. Model (5) will be used to analyse the difference in IgG-scores between 
samples taken at week 13 and week 9 within the intervention group. 
IG3,, = μ + B, + IG2ij + e,, (5) 
Where: 
IG3i = IgG-score of individual k (k = 1 to 50) from block j (j=1 to 10) at week 13 
μ = intercept 
B, = effect of block ι (ι = 1 to 10) 
102, = IgG-score of individual j at week at week 9 
e,) = residual 
The null hypothesis is that μ equals zero, i.e there is no difference in IgG scores 
of samples taken at week 13 and 9. 
7.2.3. Additional analyses 
The association between responder (yes/no) and atopic background (yes/no) will 
be evaluated using Fisher's exact test. The null hypothesis is that there is no 
association between both characteristics. The association between responder 
(yes/no) and reduction of physical complaints (PCQ) (yes/no) will be evaluated 
using logistic regression and/or Fisher's exact test. The null hypothesis is that 
there is no association between both characteristics. 
Similar to IgG-scores, IgE-scores of responders and nonresponders, and other 
blood values will be analysed, 
8. Ethical considerations 
8.1. General 
The INCA Study will be conducted in full compliance with the ethical principles 
laid down by the WMA in the Declaration of Helsinki (as amended in October 
2000) as well as the rules of Dutch legislation. 
8.2. Ethical review 
The INCA Study will not be conducted until the Dutch Medical Ethical Review 
Board [(Medisch Ethische Toetsing Commissie (METC)] of Wageningen University 
has fully approved this protocol, which has already been submitted to the METC 
for review. 
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8.3. Informed consent 
It is the responsibility of the clinical researcher to obtain signed, legally valid 
consent forms from all participants. The information to be provided to obtain 
these consent forms must clearly specify the purpose and nature of the research 
and must also describe how the parents and the children are supposed to 
cooperate and what the pros and cons are of participating. The researcher will 
have to point out in very clear terms that the participants may withdraw from the 
study at any time without this having any consequences for them. If and when 
possible, the consent forms should be signed by both parents. The forms will be 
kept with the children's files. 
8.4. Participation fee 
Parents are not required to make any financial contribution in exchange for 
participating. We will not pay a financial fee for participation either, but the children 
will be given a little present every time their blood is taken. Parents and children 
will be motivated to complete the trial by offering them the following tokens of 
attention: 
• All children receive birthday cards; 
• All families receive season's greetings cards; 
• All children will be sent a certificate during the course of the trial. 
8.5. Involvement of family doctors and treating physicians 
If parents consent to their child participating in the trial, the family doctor and 
treating physician (if any) will be informed of the child's participation. They will 
also be sent an information sheet on the INCA Study. If the doctor involved with 
the child's medical care has concerns about the impact of participation on the 
child and his or her family, this will be discussed with both the parents and the 
doctor. If the parents still want to enter the study, they may feel free to do so. 
8.6. Burden on the child 
The main burden on the child is that it will have to follow a different eating pattern 
for a period of 5 weeks. The children who participated in the earlier studies had 
no real problems in practice with their diet. The social environment, grandparents, 
for instance, had more problems in dealing with the new situation than the children 
themselves. After the first 5 weeks, the nonresponders to the elimination diet may 
259 
Appendix 
resume their former eating habits, whilst the diet for the responders is extended 
significantly, which even further reduces the burden for the participants. Blood 
will be taken two or three times. This may be stressful for a number of children. 
However, all children will be allowed to pick a present after their blood has been 
taken. There are no additional risks involved in the trial. 
8.7. Independent medical supervisor 
Dr. Rodngues Pereira, a paediatrician at the Rijnmond-Zuid Medical Centre in 
Rotterdam and chairman of the ADHD Paediatric Network, will act as independent 
medical supervisor for this study. He will monitor compliance with all regulations. 
Parents may contact him at any time if they have any questions. See also the 
information sheet that has been prepared for the parents. 
9. Administrative affairs 
9.1. Contacts 
• The contact person for all questions regarding this Research Protocol is the 
researcher, Lidy Pelsser of the ADHD Research Centre (telephone number 
+31 (0) 40 2488393). 
• The contact person for all questions regarding the IgG-laboratory test is 
Theodoor Scheepers of the Pro Health Laboratory in Weert (telephone 
number +31 (0) 495545000). 
• Prof. Dr. Huub Savelkoul, professor of Immunology at Wageningen University 
(telephone number +31 (0) 317 483925), is the project leader and can be 
contacted for all other matters. 
9.2.Insurance 
The Wageningen University and Research Centre has a valid insurance contract 
providing cover against all loss and damage, injury or death caused by 
participation in the INCA Study. This insurance is in full compliance with the Dutch 
Act regarding Medical and Scientific Research on Human Beings. 
9.3. Use of information, publication 
All new data acquired and all outcomes of the study will be published in scientific 
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journals. The INCA Study also forms part of PhD research into the Impact of 
nutrition on behaviour. 
9.4 Documentation 
Before starting the trial, the researcher will have obtained the following documents: 
• Letter of approval from the METC 
• Sufficient sponsoring commitments to finance the trial 
• ISRCTN Registration 
9.5. Reporting 
During the course of the trial, the (anonymised) data collected will be analysed at 
the end of each phase, and analysis reports will be sent to the supervisory 
committee, the sponsors, and the METC. No personal data of the participants will 
be used, neither in the scientific publications nor in the reports or the thesis. All 
personal data is treated as strictly confidential. 
9.6. Duration of the trial 
9.6.7. Period of recruitment and selection 
Participants will be recruited through doctors, hospitals, child psychiatrists and 
the media. It will take approximately 3 months for the first children to start with the 
trial. In the mean time the recruitment efforts will be continued until there are 100 
eligible participants. 
9.6.2. The first phase, the elimination phase 
It is logistically not feasible to have all children start at the same time. Approximately 
ten children will start with the trial each month. Children will not be able to enter 
the trial during the summer holiday, as this would impede the teachers' 
measurements. All in all this phase will take about 14 months. 
9.6.3. The second phase, the reintroduction phase 
All responders to the elimination diet will proceed to the reintroduction phase 
after having completed the first phase of the trial. Expectations are that at least 27 
children from the intervention group will proceed to this phase. The reintroduction 
phase will take 4 weeks and will be executed directly following the first phase of 
the trial. 
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9.6.4. Daia processing 
The processing of data, preparation of reports, and writing of publications for 
journals will take approximately 3 months. 
9.6.5. Total duration 
The anticipated overall duration of the study is approximately 13A years. 
10. Supervision 
The supervisory committee is made up of the following persons, all from the 
Netherlands: 
Prof. Dr. Jan Buitelaar, professor of child psychiatry 
Radboud University, Nijmegen 
Reinier Postlaan 10. P.O. Box 9101 
6500 HB Nijmegen 
Telephone: +31 (0) 24 3613490 
E-mail: j.buitelaar@psy.umcn.nl 
Prof. Dr. Huub Savelkoul, professor of cell biology and immunology 
Wageningen University & Research Centre, Wageningen 
Marjan de Boer, representing Dutch Food Allergy Foundation 
Ton Haagen, paediatrician, neurologist 
Medical Centre VieCuri, Venlo 
Prof Dr Ewoud Dubois 
University Medical Centre Groningen, 
Beatrix Child Clinic, Child Allergology, Groningen, 
Rob Rodrigues Pereira, paediatrician 
Maasstad Hospital, Rotterdam 
Jan Toorman. paediatrician 
Cathanna Hospital. Eindhoven 
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11. Current Controlled Trial register 
This INCA Study, which is conducted independently, will be registered and 
recorded in the International Standard Randomized Controlled Trial register, 
12. Field contacts, implementation 
The outcomes of this study may lead to new insights into the use of dietary 
intervention and of blood tests in children with ADHD. Moreover, the study can 
verify results from earlier Dutch studies which showed that food could be a cause 
of ADHD in 60% of the participating children,(25,26,29) If behavioural disorders 
are triggered by food, they can be prevented or be countered with an adequate 
diet, so that the children concerned need not be subjected to medical and social 
care procedures, and further costs can be saved. Given the fact that blood tests, 
whether or not combined with an elimination diet, can be conducted quickly and 
efficiently, a blood analysis might become a standard differential diagnostic tool 
in any examination of children with behavioural problems if the results of the 
immunological research as part of this study are promising. The results of the 
INCA study may provide additional leads for the diagnostic and therapeutic 
procedures concerning ADHD, 
Post-study action (4 steps): 
1. Protocol: Based on the results and the methodology of this study, a protocol 
will be developed enabling blood tests and dietary interventions to be applied 
in general practice, subject, of course, depending on the outcomes of the 
study, to specific conditions and only where specific patients are concerned. 
2. Guidelines: Based on the results, guidelines will be formulated, describing 
which children with ADHD may benefit in particular from dietary intervention 
and blood tests, e.g. children who may suffer from a combination of physical 
complaints and behavioural responses to food. 
3. Education: Universities and institutions for higher education will be contacted 
in order to have new insights integrated into the teaching materials of doctors, 
psychologists, educators, teachers, and dieticians. 
4. Publications: an article describing the outcomes of the study will be submitted 
for publication. 
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Time Schedule: Weeks O to 13 
ro 
o 
Intervention group 
Control group 
Week 0 Week 1 Week 2 Week 3 Week 4 
Elimination phase Elimination phase Elimination phase Elimination phase Elimination phase 
starts 
M1 
B1 
MBP1 
M l 
B1 
MBP1 
baseline diet 
baseline diet 
baseline diet 
baseline diet 
M 2 
\Ί2 
transitional week 
waiting list 
Intervention group 
Control group 
W e e k s Week 6 Week 7 Week 8 Week 9 
Elimination phase Elimination phase Elimination phase Elimination phase Elimination phase ends, 
Reintroduction phase for 
elimination diet elimination diet elimination diet elimination diet 
waiting list waiting list waiting list waiting list 
responders starts 
elimination diet, 
M3 
B2 
MBP2 
waiting list, 
M3 
ro 
Responders of 
intervention group 
Control group 
Week 10 
Reintroduction phase 
starts 
IgG-O provocation 
waiting list 
Week 11 
Reintroduction phase 
IgG-O provocation 
M4 
waiting list 
M4 
Week 12 
Reintroduction phase 
IgG-O provocation 
waiting list 
Week 13 
Réintroduction phase 
IgG-O provocation 
M5 
83 
MBP3 
waiting list 
M5 
B2 
MBP2 
start of elimination diet 
(optional) 
Ml = first measurement 
B1 =first blood test 
MBP1 =first measurement by a blinded paediatrician 
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Details of IgG Measurements 
The presence of IgG antibodies to 266 different foods will be tested using ELISA, 
a traditional Enzyme-Linked Immunosorbent Assay (ImuPro test). This testing 
system was CE certified in 2004._ 
ELISA operates as follows: Extracts from foods are fixed to a microtiter plate. 
Antibodies in the serum bind to available antigens. This binding is made visible in 
colour by adding an antibody-enzyme complex and a suitable reagent. The 
intensity of the colouring is straight-line proportionate to the concentration of 
antibodies and can be read using an ELISA reader. The exact concentrations of 
IgG antibodies can be determined with the aid of a standard curve, that is a curve 
of standards calibrated against a WHO standard. 
Standard 1 contains 2.5 ^ g IgG / ml of standard fluid. 
Standard 2 contains 10.0 ^ g IgG / ml of standard fluid. 
Standard 3 contains 40.0 μg IgG / ml of standard fluid. 
Standard 4 contains 200.0 μ§ IgG / ml of standard fluid. 
To eliminate irregular antibodies, each microtiter plate is fitted with an internal 
control system. In addition, internal positive and negative checks are performed 
on each microtiter plate. 
Based on the measured quantities of/jg IgG / ml serum, each analysed food can 
be assigned an IgG value ranging from 0 to 4. The hypothesis is that IgG-O 
represents no response to the food, lgG-1 corresponds to a minor response, etc. 
The higher the value the greater the response to the food in question. Level 4 
should, therefore, correspond to a significant response to the product. 
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Appendix 3 
Basic algorithm for treatment of ADHD 
Inform and advise 
Information for parents and child on nature of condition 
Information about sources of information, local support group etc 
Advice on parental handling 
• Realistic expectations, expressed in well communicated rules 
• Minimal confrontations 
• Positive parental attending to child plus praise for settled 
activities 
• Time out after (firstly) instruction and (secondly) warning for 
excitable and aggressive behaviour 
• (can add) response cost programme 
Inform GP, school doctor, and (with parents' permission) school and 
educational psychologist of diagnosis. Liaise as appropriate 
Insufficient 
improvement 
If 
1. Clue In history that dietary factors significant 
and 
2. Paediatric dietician available to monitor 
and 
3. Child and family can undertake diet regime 
Elimination diet under using few foods (oligoantigenic') 
approach under supervision of paediatric 
dietician for at least three weeks 
Add in separate foods sequentially to construct full diet 
Medication 
1. Methylphenidate titration 
2. Dexamphetamine titration 
3. Imipramine titration 
Insufficient 
Improvement 
Insufficient improvement or excessive side effects 
Consult specialist centre 
Source Ρ Hill'1, E Taylor" (2001). An auditable protocol for treating attention 
deficit/hyperactivity disorder In Archives of Disease in Childhood, 84, 404-409 (May) 
• Great Ormond Street Hospital tor Children, London WC1N 3JH. UK 
" Institute of Psychiatry, London SE5 8AF. UK 
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Amendments Protocol INCA study, 10 July 2008 
Reference: THELANCET 06PRT7719 
1. In the protocol the children assigned to the control group are placed on a 
waiting list during week 4-13 (see INCA protocol page 15), whilst the intervention 
group will follow the elimination diet. The intervention group has to keep an 
extended diary during this period, and has to follow an elimination diet, i.e. they 
will be focussed on food. The waiting list group will just be waiting. 
The first change in the protocol is that we would like to increase the resemblance 
between the control group and the intervention group. Therefore we suggest that 
the control group, like the intervention group, has to keep an extended diary as 
well. We also suggest to provide the control group with broad recommendations 
for a healthy diet, conform the guidelines of the Netherlands Nutrition Centre, so 
that the control group will be occupied by their food as well. 
2. During weeks 9-13 the responders of the intervention group will start with the 
reintroduction phase (see INCA protocol page 17). All foods with IgG-O value 
and without increased IgE will be reintroduced concurrently to their diet. This is 
an open introduction, of only IgG-O-foods. 
We would like to change this open introduction phase in a double-blind cross-over 
design of not only IgG-O- foods, but of lgG-4-foods as well. Children will be 
independently and randomly allocated to the IgG-O-group or the lgG-4-group. 
Raters and parents will be blinded to this design. For the record, both reintroductions 
will only concern foods without increased IgE. 
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Parents' and children's accounts: 
RED research in real life 
How a boisterous, bothersome boy calmed down and got friends 
Teun had always been a lively boy. He couldn't sit still for a moment, was constantly 
chattering and seemed to be unlucky all the time: he often had bruises and 
scrapes. His teacher at nursery school once sighed: "I would not mind if Teun 
became a little less enthusiastic." When he grew older he became increasingly 
boisterous and impulsive, he talked a lot and very loudly, and he constantly 
touched and bothered other people. In the end children didn't want to play with 
him anymore and Teun was no longer invited to birthday parties. It was very sad. 
On top of that, his school results suffered from his behaviour. When Teun was six 
years old, his teacher suggested to have him tested for ADHD. Considering the 
nine month waiting list for an ADHD examination we decided to apply for the INCA 
study. 
During the first weeks of the RED we already noticed a change at home. Teun 
behaved more calmly, was less impulsive, talked less and stopped touching or 
bothering others all the time. Results at school were positive as well: Teun 
managed to finish his work, wasn't constantly talking out of turn and was able to 
sit next to other children without bothering them. Given the positive results, Teun 
was eligible to enter the RED challenge period, during which foods were added to 
the diet. This period, lasting at least one year, was very tough but we couldn't 
have made a better decision for Teun, Halfway, my husband and I almost wanted 
to give up, exhausted from Teun's mood swings during the challenge period. But 
our son insisted on continuing the research, he did not want to loose his friends 
again. The RED research ended some time ago. We now know which foods are 
causal of ADHD, and we make sure he doesn't eat them. Right now he is almost 
nine years old and he is a great child - he still is a lively boy, but without ADHD 
Peace and quiet through medication: a blessing for school 
In primary school we were already told that Monica showed worrisome behaviour. 
She constantly claimed the teacher's attention, couldn't sit still during group 
discussions and exhibited bossy behaviour towards other children; she even hit 
or threatened them sometimes. Those were the moments she had 'tickles in her 
body', as Monica explained her behaviour. She also complained about headaches 
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several times a week. In second grade rewards for good behaviour were 
introduced, and we all wondered whether Monica might need more challenging 
school tasks. In third grade at first her behaviour improved, but than got worse 
again by autumn holiday. A psychologist diagnosed Monica with ADHD, combined 
with an above average intelligence. Medication was advised and after consulting 
a paediatrician Monica started to take ritalin. Results were good, she was able to 
focus on her school tasks, and she behaved more calmly towards other children. 
It was a blessing for school! 
We also had an appointment at ADHD Research Centre as well, as we weren't 
too eager to have Monica taking medication. We started the RED and took her off 
medication. Five weeks later, at the end of the RED, the headaches had diminished 
but her behaviour had not improved: she was not able to focus on her schoolwork, 
she had a lot of angry moods and she behaved badly towards other children. 
Considering that Monica's behaviour did not react to food, we were advised 
to start medication again. Fortunately, she reacts well to that. We would like to 
have her participate in a special training course to improve her social skills and to 
support the effect of medication. Although the diet did not change her behaviour, 
we're happy she participated in RED research, as we wanted to know whether our 
child might be able to do without medication. We also know now that Monica has 
great perseverance; she stuck to the diet even on her own birthday and on two 
other children's parties! And she likes to eat mango now (but no rice crackers 
anymore...). 
How a troublesome toddler turned into a cooperative adolescent 
Bram's start of life wasn't easy. He was a whiny baby and seemed to have 
bellyaches all the time. His defecation was always too thin and definitely too often, 
the diapers could not be bought fast enough. Doctors called it toddler diarrhoea 
and tried to treat it. but whatever they did, the problems did not disappear. When 
he grew older he often complained of stomach-aches, he also drank a lot - he 
was always thirsty - and every night he was dripping with sweat. Apart from these 
physical complaints he couldn't sit still, not even a minute, and not only was he 
very active, he also developed tics, like squeezing his eyes, coughing, and pulling 
strange faces. He just couldn't stop doing it. He was compulsive as well: if it 
happened that he was not the first to go downstairs, he started screaming and 
shouting until everyone was upstairs again, letting him go first. At school he could 
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be aggressive, beating other kids for no reason, pinching them or pushing them 
off their chairs. In fact, he had been a 'troublesome child' ever since playgroup. 
Several examinations of Intestines and blood did not reveal a cause of the physical 
problems, although he had been suffering from diarrhoea for more than four 
years. And his defiant behaviour, well, that might be resolved by parent training 
and maybe some medication, according to the physician. 
I did not Intend to settle for the doctors answer. Our other children were doing 
just fine, so I considered it unlikely that our parenting capacities were causal of 
Bram's behaviour. But something had to be done, because not only our son. but 
also the siblings and everyone around suffered from his behaviour. Considering 
that he never had had normal defecation, I thought that food might be the cause 
of that problem. I contacted the food allergy foundation and happened to find 
Information about the RED research on their site. We decided to give it a try. We 
started the RED when Bram was four years old and within three weeks we knew 
he strongly responded to food. His unmanageable, oppositional and aggressive 
behaviour disappeared, at home as well as at school. The teacher thought it was 
a miracle. Moreover, for the first time in his life he had normal defecation and his 
tics diminished, Incredibly! His compulsory behaviour disappeared as well, he 
didn't feel the need to go downstairs first anymore. After four years of struggling 
and all kinds of examinations this fantastic result was achieved In no more than 
three weeks! 
The following months were difficult. It's not easy for a child to continue a diet 
but with help of teachers, other parents and friends. Bram completed the RED 
challenge period with positive results. We found the foods he reacted to; products 
we were used to eat dally before we started the RED. Of course we stopped to eat 
these foods. Bram Is 15 years old now, a son I'm proud of. He's a very social, 
cooperative and humorous adolescent with a lot of friends. He Is doing quiet well 
at school and he wants to go to college. He is allowed to eat almost anything, but 
he still had better not eat some foods. Sometimes he eats them anyway, for 
example when he's with friends and can't resist the temptation. Than we all notice 
the effects. He becomes restless, the tics and compulsive behaviour return, he 
starts wiggling and coughing, and the intestinal problems return as well. 
Fortunately, we now know the cause of these problems, and they will disappear 
again, at least, if he sticks to his diet. 
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Mends and fun 
Jeroen, a 7 year old boy suffering from ADHD started RED-research in 2007. He sent 
this letter at the end of the challenge period, resulting in the diet prescription to better 
not eat strawberries, liquorice or tomatoes. 
"Hi Mrs Peliier1 
I aM glad that you Help us with my diet, and that you adviie my Mother about 
what I May and may not eat, and that you are working io Hard for all this. I am 
very Happy that I feel better now, and that I am calM. I really Have MUCH more fun 
atichool, becauie now I Have more friendi. ί found it Hard if iomeone was eating 
treacle waf f lei at a party, but other than that the diet was not so bad. And I 
really think I am nicer now. 
Thank you that you invented tHii diet for me. 
iAJith many regardi Jeroen" 
In 2011 Jeroen is 11 years old and he wrote another letter. 
*/ am itili very Happy and I am very calm now. I don't Mind to stick, to the diet. I 
Have got many friendi, at ichool and in the neighbourhood. I alio do ice hockey 
and I Have to listen very carefully to the instructions of the coach. I am very good 
at it, and it is no problem to listen and to keep quiet. 
I am very Happy that we did the REV. Everything is much more fun. ί never want to 
Have AVHV again. 
Jeroen" 
Rebellious behaviour disappeared like snow in summer 
Sigrid was a cheerful although very lively toddler, but she got more rebellious as she 
aged; she became angry a lot, opposed rules, wouldn't listen and had a hard time 
dealing with changes or disappointments. She also had sleep problems and did not 
fall asleep until late in the evening, lying awake for hours. At home we were able to 
deal with her behaviour, although it was very demanding and aggravating. But at 
school Sigrid did not come up to the mark, she could not concentrate at all. Finally, a 
child psychiatrist diagnosed her with ADHD and medication was prescribed. 
As Sigrid started to take medication, she changed. She looked washed-out 
and displayed robotic behaviour, unnatural to her real character. She seemed 
depressed and even said she wanted to die, even though she was only seven 
years old. In a newspaper we read about the RED research. It seemed like a good 
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idea to participate. Wouldn't it be great to prevent all the trouble by just not eating 
some foods? Maybe our daughter would no longer need medication. 
After the first four weeks of diet we didn't know what was happening to us. 
Sigrid became balanced and was able to deal with everyday events, without 
getting upset or defiant. All the above-mentioned complaints disappeared like 
snow in summer, she wasn't angry and rebellious anymore but became reasonable 
instead. She listened when she was told to do something without protesting right 
away. The sleep problems disappeared simultaneously with the behavioural 
problems. The teacher at school noticed a big difference: Sigrid's concentration 
was fine, she was able to do her work independently and she got better grades. 
Sigrid has followed her diet for three years now. She will start secondary school 
and tests have revealed that she will be able to go to a higher level than expected. 
We are convinced that this wouldn't have happened without the RED. 
Constantly vigilant to prevent trouble 
The most striking memories I have from Joris as a toddler are the everyday 
struggles. If he got his coat put on, he immediately would take it off again. The 
very same happened when he had to put on his shoes, or his socks, or when he 
had to get in the car; he made an issue of anything and life turned into a constant 
struggle. He easily got angry if something didn't work out the way he wanted, for 
example when a tower he had built would collapse. Joris often lost his temper, he 
was uncontrollable and he never listened. When we warned him not to do 
something, he interpreted it as an encouragement to do it right away. I was 
prepared for anything, since everything seemed to challenge him. He misbehaved 
in shops, running away, climbing on things and throwing with everything, so I had 
to keep him in the pram. 
When Joris was two years old, we started homeopathy. We found that his 
concentration improved, but the therapy did not result in structural improvements. 
He grew older and his behaviour got worse. He never played with toys for a good 
while, but he constantly turned from one toy to another, in the mean time calling 
for a lot of attention. He also was selfish, the last piece of apple-pie was always 
c 
supposed to be his, he didn't show any consideration for his brothers. It really 
Isn't easy to be constantly vigilant, anticipating what might happen in order to 
prevent troubles and quarrels. Somehow things seemed to occur in his head and 
he was not able to suppress them. 
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When Joris was six years old, we learned about the INCA study. Joris was 
diagnosed with ADHD and ODD, and we decided to participate. After a 3-months 
waiting-period we could start the RED. It made a world of difference: our son, who 
never took 'no' for an answer, now accepted it and he listened to us, without 
arguing all the time. He calmed down and he became less angry and less 
rebellious. He could play with his brothers without fighting and we could drink our 
coffee without having to be alert and to intervene all the time. We really had to get 
used to this new situation, it was both bizarre and wonderful. Right now we're still 
sorting out to what products Joris reacts. He is doing very well, unless he eats 
something he should not eat. Then the 'old behaviour' returns. Those moments, 
when he behaves as he used to behave, we really wonder how we ever managed 
to cope with that behaviour. 
hood Marks at school 
Simon followed the RED in 2008, when he was 10 years old. He suffered from 
ADHD and ODD. Right now he is aged 13 and he still adheres to his diet 
prescription, consisting of the advice to avoid potatoes, vanilla, peanut and 
cocoa. He wrote a letter. 
""iïallo, I am SiMOn and I have been on a diet f or several years now. Right now I feel 
fine, and I am doing well at school, but before I followed the diet I often felt 
terrible, especially when my Medication had worn off, in the evening. Then I 
became restless, and I felt terrible and stupid, because ί could not do my 
homework properly. Everything went wrong and I was full of grumbles. Then we 
started the diet, and at first I did not like it at all, and I did not want to stick to 
it, but then I felt better, and now I am used to it. Many different foods were 
tested, like sugar, and nuts and peanut and cheese and colourings and everything. 
Sometimes I felt worse, but most of the time I really was happy and I got good 
marks at school. Uow I am allowed to eat almost anything because we now know 
which foods are causing my AVftl), and I am doing fine at school." 
Medication definitely needed 
Our son Michael is diagnosed with ADHD and he followed the RED. Unfortunately, 
it did not affect his behaviour, he remained hyperactive, unfocused and impulsive. 
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During the RED we took him off medication, but his teacher immediately raised 
the alarm: Michael did not finish his schoolwerk anymore. We quickly started 
medication again, the diet was adjusted and once more we took him off 
medication, but again the problems returned. The diet just did not change our 
son's behaviour. We would have been happy if Michael were not to take his 
medication anymore, but now we know for sure that he really needs it, and the 
effects are quite well. 
Although Michael's behaviour was not affected by the diet, we do not regret 
that we participated in this RED research. Michael stuck well to the diet, so he has 
shown that he really is able to go for something. We have supported him all the 
time, and that felt good; this experience has positively influenced our sense of 
family. We have also learned a lot about healthy food. Most of all, it is a good thing 
to know that for Michael there is nothing for it but to take medication. 
From psychiatric day-care to public primary school 
Our daughter Femke had serious behavioural problems, she suffered from 
extreme mood swings, compulsive behaviour and severe temper tantrums. She 
also often complained about headaches and bellyaches, but her behaviour was 
our most important concern. When she was six years old, our daughter was 
referred to psychiatric day-care. After an extensive period of examination, in the 
course of which, among others, MCDD was suggested, she finally was diagnosed 
with ADHD. We were told that she most likely would not be able to focus at school 
or even to learn at all without medication. Femke was advised to start medication 
and she was referred to a special education primary school. 
We did not mind to send her to a special education school, but we did not like 
to start medication, so we asked for other options that might be helpful. The 
psychiatric institute's doctor told us about a diet that seemed to achieve 
spectacular results. We read all about it on the website, and we learned that RED 
research was a method to investigate the cause of ADHD and that this diet had 
high success rates. We considered this diet to be a more healthy approach than 
fighting symptoms through medication, therefore we decided to participate in the 
INCA study before starting medication. 
When we started the RED we knew it wasn't going to be easy, so we decided 
that the whole family would follow the diet, not Femke only. First we were shocked 
when we received the RED instruction, however, within 2 weeks we were used to 
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it, we baked cookies ourselves and - to our surprise - the children did not protest. 
We didn't notice much of a result in the first weeks, whereupon my husband 
concluded that "we could not expect miracles from a diet, could we". But the 
INCA-team was of a different opinion and they prescribed a more stringent diet. 
2 Weeks later a miracle did happen: the temper tantrums, compulsive behaviour 
and mood swings disappeared, she became calm, happy and flexible and she 
could handle setbacks easily. For the first time in years we enjoyed ourselves 
during dinner, even though our dinner options were limited! Headaches and 
bellyaches disappeared as well, and her teacher was lyrical: Femke now finished 
schoolwork that used to take her one week in one day! She obviously felt good. 
She changed so drastically that even people who didn't know that we had started 
a therapy noticed the change. 
One year later Femke had improved to such an extent that she switched to a 
public primary school, and she is doing really fine. Although she has some difficult 
moments, such as parties and birthdays, she is pleased with the diet that now is 
close to normal. During holidays, when it is difficult to stick to the diet, she may 
fall back in her old behaviour and she may become sad, angry and easily upset, 
fighting a lot. Fortunately that behaviour disappears quickly when we exclude the 
triggering foods, and Femke will be the first to stop eating them, stating: "I don't 
want to be angry and fighting anymore". We're all really happy that the RED has 
solved a really difficult problem and has given us a happy child. We hope this 
method will become widely accessible. 
How a diet made a beehive in an adolescent's head disappear 
We already noticed that Dennis was hyperactive and unable to focus when he was 
attending nursery school, and this behaviour continued when Dennis started 
primary school in 1998. Although he found himself lying under his chair more often 
than sitting in it, and although he could hardly be described as an attentive pupil, 
he kept up remarkably well. Through the years his behavioural problems increased, 
his social behaviour did not develop as it should, and he even tended to walk away 
from school if he did not like the way things went. Other children did not really like 
him, because they constantly needed to say things like: "Dennis, stop it; Dennis, 
don't do that: no Dennis, we're not changing the rules; Dennis, don't touch that; 
Dennis, be quiet," etcetera. Especially during school trips and other activities he did 
not know how to behave and seemed completely on the wrong track. 
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When he was nine years old it was not quit clear whether he should be 
diagnosed with ADHD or PDD-NOS. Eventually, PDD-NOS was chosen and it was 
advised to put Dennis on medication. In secondary school, a special education 
school for children with serious behavioural problems, we actually decided to 
start medication, risperdal. We definitely noticed distinct beneficial effects, but 
Dennis still needed a lot of structure and we always had to keep an eye on him, 
one never knew what would happen or what he would do when he was in company. 
His fantasy was boundless (what if..., imagine..., suppose we...), and he still 
talked all the time, mostly very quickly and unintelligibly. We were worried about 
his future, whether his maladjusted behaviour might lead him astray. Nevertheless, 
we also enjoyed Dennis and although there were some problems and conflicts in 
school (Dennis had been suspended for a couple of days), he graduated for his 
lower secondary education and started higher education. 
Dennis remained an extremely restless adolescent, and our paediatrician 
advised to switch medication to Concerta. This change turned out well, Dennis 
indicated that his concentration improved substantially and he was able to play 
the piano for a longer period of time. Unfortunately, he still felt "a pressure in his 
head like a beehive hidden behind a wall", being his very words. When he 
happened to see a television program about the RED he knew for sure that he 
wanted to try that diet. He wanted the beehive to disappear. Although he was 
aged fifteen already, he was so highly motivated that he was allowed to participate 
and one and a half years ago we started the RED. 
Now, in 2011, Dennis is still on the diet and he is off Concerta. He talks more 
calmly and clearly and most of all he does not sail close to the wind anymore. He is 
happy with the diet and indicates that the beehive has disappeared, except for the 
moments he eats foods he should not eat. We really had to unlearn to vigilantly 
watch him every moment in order to correct him if things went wrong, as we were 
used to. When he is among others we don't need to interfere anymore to keep 
things pleasant. There has been taken a weight off our shoulders. Meanwhile we 
have finished the RED challenge period and we know to what foods he reacts. 
Dennis is very aware of the effects of food and he is determined to stick to his diet. 
We're really proud of our son! He does not feel sorry for himself about not being 
able to eat certain things, on the contrary, he would rather feel sorry if he didn't stick 
to his diet, because then all his behavioural problems would return. We completely 
agree with him: the diet isn't a restriction, but an enrichment of his life. 
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ftOMcwork 
ivo, an 8 year old boy diagnosed ADHD started RED-research in 2011. He made 
these drawings at the end of the 5-week RED. During the challenge period, which 
has only just started off, he reacted adversely to cheese. 
Before the RED 
At school·, the teacher s.ayi: *ivo, you've got homework anai you'll have to write 
Imes." 
After the RED: 
At school·. Almost every child has qot homework, but I haven't. 
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Before the RED 
At Home·. I atvt always, fighting with my brother 
After the RED: 
At home: ivty brother and I hardly ever fight 
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More support needed during RED challenge period 
Thom especially had behavioural problems at school and at football. He just 
couldn't focus, whether it was on his schoolwork or on the ball. Eventually, he 
even was forbidden to participate in football matches, because he was rather a 
nuisance in the field than anything else. Of course, that is a woeful experience for 
a boy who loves to play football. We had him tested and he was diagnosed ADHD. 
We also were informed about the RED research, so we put forward our son for this 
investigation. To put it briefly, the improvements in Thom's behaviour were 
gigantic, at school and at football. He was allowed to play games again, which 
really was wonderful. He even scored a goal! We were very happy, and so was his 
teacher, he did well at school. 
We started the RED challenge period, but this really was a disappointment. 
Every time we introduced a new food I spent the next ten days anguishing about 
how it would turn out, because I desperately wished him, and us, a less strict diet. 
I also found it aggravating that we always had to take his diet into account, we just 
couldn't have a day out or go out for dinner, because we always had to bring 
something along for him to eat and drink. Furthermore, the longer we participated, 
the more difficulties I experienced in judging his behaviour. I knew this challenge 
period would take about 15 months and would eventually come to an end, but I 
did not know when it would end or to what foods Thom would react, and this 
uncertainty unbalanced and unsettled me. In truth, more guidance, a coach, 
someone to lean on, someone who might visit us and might offer practical 
assistance would have been very welcome. The monthly consultations at ADHD 
Research Centre unquestionably were encouraging, but it was not enough to help 
us see this period through. One month ago we have stopped, and we're not sure 
how we will proceed. It really is great not to have to think about his food anymore 
and to be able to eat whatever and wherever we want, but Thom's behaviour 
definitely has worsened. Right now it is our summer holiday, so we will manage. 
In September, when he has to go to school again, we must decide whether we will 
start medication or give the RED challenge period another try. If we opt for the 
RED, then I honestly wish we would get some more help. 
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Medication if a diet doesn't work 
Jeffrey, our 10 years old son, started the RED four months ago, with remarkable 
effects. We're definitely not opposed to medication: after he was diagnosed with 
ADHD in 2007 Jeffrey got medication, for three years, with varying success. He 
first was on Concerta, which worked quite well in the beginning, but eventually the 
effects diminished. We switched to Sfratterà but Jeffrey did not react favourably 
to this medication, so we continued with Medikinet. This worked out fine, although 
in the evening when the effect of medication had worn off, the restlessness in his 
head returned. That's why we started the RED research. During the RED we took 
him off medication and we honestly couldn't believe what happened: our son 
became calm and concentrated, sat still at dinner table but most of all, he was 
cheerful, laughing and enjoying life. This was our Jeffrey. 
In the RED challenge period we figured out what products were causing 
Jeffrey's behaviour. We started with beef, slowly increasing the amount. Within a 
few days he started bouncing through the room and the ADHD behaviour 
completely returned. We couldn't really believe this, we were doubting ourselves. 
We stopped the beef challenge and one week later his peaceful behaviour 
returned. It was unbelievable, but true! 
We think it is remarkable how well Jeffrey continues the diet. It's not easy, so 
he says, but it's worth it. He pointed out that the motor in his body has been 
switched off now and he is feeling much better. The every evening's restlessness 
in his head has disappeared, and he is keen on keeping it that way. Not only 
Jeffrey, but also his environment (his family, his teacher and the children at 
school) profits from the behavioural changes, it seems a win-win situation. We 
would like to advise other parents to try this diet first. In case it does not help, 
medication will always be an option. 
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Temper tantrum 
Floor, 8 years old, was diagnosed ADHD and ODD. She entered the INCA study 
in 2009. She responded favourably to the RED, and the ADHD and ODD behaviour 
returned when eating too much wheat, corn or fish. She sent a postcard and a 
drawing at the end of the challenge period. Now she is 10 years old, she still 
adheres to the diet prescription based on the results of the challenge period and 
she is doing fine. 
w*r GRmLuk 
D.-.oATje NU zo SRUWCtUK 
O U D / J O N S BOOT.' 
D... tsAT J E Me zo GRJHBL'SK 
^GOEb scKOi-pew H e B f i 
D ... DAT Jff IM zo w S^UWEL'Jk 
NIEUW HUIS G A A T
 ω 0 Μ € Λ , ^ 
• ...bAT IK zo ^RÜWELOIC VAAK 
AAM J E t>EWKi 
Q - DAT ut zo <5RÜWEi,ai< vEec 
VAW JE HOU l 
® 
• ^ O O G & B L I K | D E B E Z j G ^ B I J ^ 
Nu m de bock handel? 
' ^ heb een 
rriëë*. haf, rlsfih—" 
Text postcard: 
Dear Mrs Pelsscr, I wtadc a drawinq for you. THanks to your diet I hardly ever have 
a temper anyMore. That Makes Me very happy. 
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Text drawing: 
Before the REV-, qrrrr, I am angry and I've got a headache 
After the REV-. I am not angry anymore, I don't have a headache anymore 
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ADHD 
Attention-Deficit/Hyperactivity Disorder (ADHD), een aandachtstekort-hyper-
activiteits-stoornis, is een psychiatrische stoornis die wereldwijd bij ongeveer 5% 
van alle kinderen voorkomt en die een sterke erfelijke lading heeft. Hoewel de 
naam ADHD nog maar enkele decennia bestaat, is de stoornis zelf al bijna 
honderd jaar bekend in de geneeskunde. In de eerste helft van de twintigste 
eeuw sprak men nog niet van ADHD, maar van Minimal Brain Damage (MBD). 
Toen men ontdekte dat er eigenlijk geen sprake was van beschadiging van de 
hersenen, werd de naam gewijzigd in Minimal Brain Dysfunction. Rond 1980 werd 
de stoornis onder de naam ADHD opgenomen in de derde versie van de 
"Diagnostic and Statistical Manual of Mental Disorders" (DSM-III). Dit classificatie-
systeem, waarin de symptomen en kenmerken van psychiatrische stoornissen 
worden omschreven, wordt ook in Nederland gehanteerd. 
De diagnose ADHD wordt gesteld aan de hand van de huidige versie van de 
DSM, de DSM-IV, en is niet alleen gebaseerd op het aantal en de ernst van de 
symptomen, maar ook op de impact van de symptomen op het leven van het 
kind. Het gebruik van de term "diagnose" is verwarrend, omdat een diagnose 
idealiter zou moeten verwijzen naar een oorzaak. Dit is echter bij ADHD, evenals 
bij bijna alle andere psychiatrische stoornissen, niet het geval, vandaar dat de 
benaming "symptomencomplex" of "syndroom" een betere omschrijving zou zijn. 
Aan de hand van de klachten wordt ADHD in 3 subtypes onderverdeeld: 
1) ADHD met voornamelijk concentratieproblemen (voorheen ADD genoemd); 
2) ADHD met vooral hyperactiviteitproblemen; en 3) ADHD met zowel hyper-
activiteitproblemen als concentratieproblemen. Deze laatste subgroep komt het 
meeste voor. Kinderen met ADHD kunnen dus zeer uiteenlopende problemen 
hebben. ADHD komt in de meeste gevallen samen met andere stoornissen voor, 
zoals bijvoorbeeld Oppositional Defiant Disorder (ODD), een oppositioneel 
opstandige gedragsstoornis. Kinderen met ODD zijn snel driftig, opstandig en 
houden zich vaak niet aan de regels. Kinderen met ADHD en ODD lopen een 
groter risico om ook Conduct Disorder (CD), een antisociale gedragsstoornis, te 
ontwikkelen en om te ontsporen. Ze behoren vaker tot de vroegtijdige school-
verlaters en zijn oververtegenwoordigd in het jeugdchminele circuit. Driekwart 
van de kinderen met ADHD heeft nog steeds problemen als ze volwassen zijn, 
ADHD verdwijnt dus bij de meeste kinderen niet als ze ouder worden. 
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Oorzaak van ADHD 
Erfelijke en omgevingsfactoren spelen beide een rol bij het ontstaan van ADHD, 
echter de precieze oorzaak van ADHD is niet duidelijk. Het is heel goed mogelijk 
dat er meerdere factoren zijn die ADHD kunnen veroorzaken, en dat per kind met 
ADHD de precieze samenstelling van deze factoren anders is. De behandeling 
van ADHD bestaat op dit moment vooral uit medicatie, gericht op het verminderen 
van de symptomen, en gedragstherapie, eveneens gericht op het verminderen 
van symptomen en het leren omgaan met ADHD. De lange-termijn effecten van 
de huidige therapie zijn helaas teleurstellend te noemen, daarom is verder 
onderzoek naar de oorzaak van ADHD en naar nieuwe therapieën belangrijk. 
Vooral de interactie tussen genetische en omgevingsfactoren verdient meer 
onderzoek. 
Een belangrijke omgevingsfactor die een rol zou kunnen spelen bij ADHD is 
de voeding, net zoals voeding van invloed kan zijn op andere erfelijke ziektes, 
zoals astma en eczeem. De relatie tussen voeding en ADHD is sinds de jaren 
zeventig van de vorige eeuw uitgebreid onderzocht, waarbij de onderzoeken in te 
delen zijn in twee categorieën: de kleurstofonderzoeken en de dieetonderzoeken. 
Onderzoeken naar de invloed van kleurstof, conserveermiddelen en suiker op 
ADHD hebben overtuigend aangetoond dat ADHD niet veroorzaakt wordt door 
kleurstoffen of door suiker. Wel is gebleken dat a//e kinderen, met of zonder 
ADHD, van additieven iets drukker kunnen worden. Maar of dit effect nu 
veroorzaakt wordt door kleurstoffen, door conserveermiddelen of door beide is 
nog niet onderzocht. Ook blijkt uit onderzoek dat er weinig bewijs bestaat voor de 
effectiviteit van supplementen zoals visolie. 
Onderzoeken naar de invloed van voeding op ADHD hebben overtuigend 
aangetoond dat er een sterk verband is tussen voeding en ADHD. Tijdens deze 
onderzoeken volgden de kinderen een restricted elimination diet (RED), een 
streng eliminatiedieet. Tijdens het RED wordt gedurende 5 weken het volledige 
dieet van het kind aangepast. Het kind mag dan uitsluitend voedingsmiddelen 
eten waarvan bekend is dat ze geen allergieën of ADHD veroorzaken. Op basis 
van de resultaten van eerdere RED-onderzoeken werd in 1999 geconcludeerd dat 
er voldoende en overtuigend wetenschappelijk bewijs is voor de effectiviteit van 
een RED bij kinderen met ADHD. In 2001 werd door Engelse wetenschappers de 
toepassing van een RED bij kinderen met ADHD aanbevolen. Al deze gegevens 
leidden er echter niet toe dat RED-onderzoek standaard werd toegepast. Daarom 
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werd in Nederland nieuw onderzoek opgestart om meer duidelijkheid te krijgen 
over de invloed van een RED op ADHD. 
Resultaten van het onderzoek in dit proefschrift 
In dit proefschrift worden meerdere onderzoeken naar de effecten van een RED 
(in Nederland het Pelsser Voeding en Gedrag (PVG)-dieet geheten) op ADHD 
beschreven. Deze Nederlandse onderzoeken bevestigen de resultaten van eerder 
buitenlands onderzoek: bij 60% van de jonge kinderen met ADHD kan een RED 
grote gedragsverbeteringen tot gevolg hebben, zowel volgens oudermetingen als 
leerkrachtmetingen. Het effect van het RED op ADHD (gemiddelde effect size 
1.2) is groter dan het effect van medicatie (gemiddelde effect size 0.8). Bovendien 
werkt het RED de hele dag, terwijl medicatie 's ochtends nog niet is ingewerkt en 
's avonds weer is uitgewerkt, waardoor het kind en zijn/haar omgeving op die 
momenten nog steeds geconfronteerd worden met de gedragsproblemen. Een 
RED kan dus belangrijke voordelen hebben. 
Het RED heeft niet alleen een gunstig effect op ADHD, maar ook op ODD. Dit 
is een belangrijke bevinding, want niet alleen komt ODD bij driekwart van alle 
kinderen met ADHD voor, ook lopen deze kinderen een groter risico om later te 
ontsporen. Uit de RED-onderzoeken blijkt dat het RED eveneens een gunstige 
invloed heeft op lichamelijke klachten, die net als ODD vaak voorkomen bij 
kinderen met ADHD. Vooral hoofdpijn, buikpijn, slaapproblemen en overmatige 
dorst en overmatig zweten zijn klachten die nagenoeg verdwijnen bij kinderen die 
het RED volgen. Tenslotte is onderzocht of het RED mogelijk kan zorgen voor 
structuurverbetering in een gezin: wellicht zou deze structuurverbetering de 
veranderingen in het gedrag van het kind tijdens het RED kunnen verklaren. Dit 
bleek echter niet het geval te zijn: de gezinnen die deelnamen aan het onderzoek 
vertoonden voorafgaand aan het onderzoek een goede gezinsstructuur, en het 
RED had vervolgens geen positieve of negatieve invloed hierop. 
Concluderend kan gesteld worden dat uit de dieetonderzoeken blijkt dat bij 
60% van de kinderen met ADHD een overgevoeligheid voor voeding een 
belangrijke oorzaak is van ADHD. De term 'overgevoeligheid', in dit geval dus het 
krijgen van ADHD na het eten van normale hoeveelheden van een voedingsmiddel 
dat normaliter prima verdragen wordt, wordt gehanteerd voor allergische en voor 
niet-allergische reacties die veroorzaakt worden door bepaalde omgevings-
factoren. Bij een allergische overgevoeligheid is er sprake van een immunologisch 
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mechanisme (hetgeen vastgesteld kan worden door middel van bloedonderzoek); 
bij een niet-allergische overgevoeligheid wordt geen immunologisch mechanisme 
gevonden. Tijdens een van de onderzoeken, de INCA-studie (zie hoofdstuk 6), is 
onderzocht of er een immunologisch mechanisme aanwezig is bij kinderen die na 
een RED geen ADHD meer hebben. Dit bleek niet het geval te zijn: bloedonderzoek 
naar immunoglobulines (IgE en IgG) is bij kinderen met ADHD dus niet zinvol. 
Bij kinderen met ADHD die na het volgen van een maximaal 5 weken durend 
RED geen gedragsproblemen meer hebben, kan gesproken worden van 
food-induced ADHD (FI-ADHD), om duidelijk te maken dat bij deze kinderen 
voeding een belangrijke oorzaak is van ADHD. Deze kinderen gaan na het RED 
verder met een provocatieperiode, waarin uitgezocht wordt op welke voedings-
middelen elk kind reageert; in deze periode wordt het RED dus steeds verder 
uitgebreid. Uiteindelijk hoeft het kind slechts enkele voedingsmiddelen te 
vermijden en heeft het weer een zo normaal mogelijk voedingspatroon. 
Bij kinderen die geen gedragsverbeteringen vertonen na het volgen van een 
RED, kan gesproken worden van Classic-ADHD (C-ADHD). Deze kinderen mogen 
weer alles eten en starten met de gangbare therapie. 
Toepassing in de praktijk en aanbevelingen voor verder onderzoek 
Gezien de resultaten van RED-onderzoek bij kinderen met ADHD verdient het 
aanbeveling om dit onderzoek in de praktijk standaard toe te passen bij jonge 
kinderen met ADHD. Hoewel uit onderzoek is gebleken dat het RED ook effectief 
is bij oudere kinderen, wordt algemene toepassing vooral aanbevolen bij jonge 
kinderen, omdat deze kinderen minder buitenschoolse activiteiten hebben en 
zich meer "onder moeders vleugels" bevinden. Hierdoor is het gemakkelijker om 
het RED toe te passen en vol te houden. 
Een voorstel voor een diagnostisch protocol, uit te voeren door artsen die 
hiervoor een speciale training hebben gevolgd, wordt weergeven in hoofdstuk 
9.7, figuur 4. Toepassing van het RED-onderzoek bij kinderen met ADHD kan; 
1) er voor zorgen dat de gedragsproblemen voorkómen worden waardoor de 
kwaliteit van zorg sterk kan verbeteren, 
2) het aantal kinderen dat medicatie nodigt heeft verminderen, 
3) de prognose van veel kinderen verbeteren, en 
4) veel kosten besparen, zoals is berekend door de Stichting Kind en Gedrag. 
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Naast implementatie is verder onderzoek van belang. Dit onderzoek zou zich 
allereerst moeten richten op de provocatieperiode waarin onderzocht wordt op 
welke voedingsmiddelen een kind reageert. Dit is een zware periode die veel 
vraagt van ouders en kind. Het inzetten van gezinscoaches zou dit traject wellicht 
sterk kunnen vergemakkelijken, waardoor hopelijk meer gezinnen de provocatie-
periode tot een goed einde brengen. Ouders die het RED-onderzoek niet vol 
kunnen houden, zouden daarnaast ook extra opvoedondersteuning kunnen 
krijgen. De provocatieperiode zou wellicht eenvoudiger kunnen worden wanneer 
door verder onderzoek meer inzicht verkregen wordt in het werkingsmechanisme 
van voeding. Tenslotte is ook meer onderzoek nodig naar de effecten van een 
RED op andere psychiatrische stoornissen, naar de effecten op lichamelijke 
klachten (ook bij kinderen zonder ADHD), naar de lange-termijn werking (kunnen 
kinderen eroverheen groeien) en naar de effecten van voeding op hersenen en 
genen. 
Samenvattend kan gesteld worden dat de RED-onderzoeken hebben 
aangetoond dat ADHD bij veel kinderen veroorzaakt wordt door een over-
gevoeligheid voor voeding. Het gaat hierbij niet om kleurstoffen of suiker, maar 
om gewone voedingsmiddelen zoals bijvoorbeeld vis, soja, aardappel, 
sinaasappel of broccoli. Elk kind met ADHD dat gunstig op het RED reageert, 
blijkt uiteindelijk overgevoelig te zijn voor meerdere voedingsmiddelen en bij elk 
kind kunnen dat andere voedingsmiddelen zijn. Verder is gebleken dat niet alleen 
ADHD, maar ook ODD en lichamelijke klachten veroorzaakt kunnen worden door 
voeding. Gezien de grote effecten van het RED op kinderpsychiatrische 
stoornissen en de daarbijbehorende gunstige gevolgen voor het kind en de 
samenleving is, naast verder onderzoek naar het werkingsmechanisme van 
voeding, vooral implementatie van groot belang, zodat kinderen met ADHD de 
kans krijgen op een betere toekomst. 
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The story of Perky Peter 
(restrict your diet and be quiet) 
A poem by Lidy Pelsser, a Dutch researcher, published in 2011 
This story is a tale of woe, 
Of Peter, always on the go. 
His feet, they run, he never walks. 
He doesn't listen, but he talks. 
And the meals, we don't know how. 
They always end up in a row, 
A game with Pete turns into fight. 
We just can't leave him out of sight! 
How we love our perky Peter, 
And how we wish he would be sweeter. 
We know he tries with all his might. 
Still, it never turns out right. 
What to do with his behaviour. 
Could a diet be his saviour? 
His life right now it is a curse, 
A 5-week diet cannot be worse! 
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That very evening mum and dad 
Talked about their little lad, 
Gravely they deliberated, 
Pros and cons considerated. 
Might they prevent their Pete run riot, 
By following this 5-week diet? 
"All right, let's try, let's start and see. 
What happens with an RED!" 
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Within 5 weeks of stringent food, 
A change was seen in Peter's mood, 
The stormy boy became so quiet, 
A miracle cure for Pete, this diet. 
Our thoughtless, hasty, turmoil boy 
Changed into our greatest joy. 
This RED sure did delete 
The bad behaviour of our Pete! 
This tale's end is full of joy. 
And if you had a similar boy 
Then let this story be a plea 
For diagnostic RED, 
To apply in every child 
Impulsive, turbulent and wild! 
If RED does not succeed. 
Then medication is a need. 
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Postface: how it all turned out 
I wrote my first research protocol on ADHD and food, the "Validation of early 
Intervention and Prevention (VIP)" study, fifteen years ago. The VIP study was 
meant to be the continuation of the Restricted Elimination Diet (RED) studies 
conducted between 1985 and 1994, all showing convincing evidence for the 
effects of an RED on ADHD. The study consisted of a 5-year research including 2 
groups of young children with behavioural problems, a VIP group and a control 
group. The VIP group was not only to follow the RED but also to receive Very 
Important Person (VIP) treatment (i.e. psychological research, improvement of 
parenting capacities, and coaching of parents, siblings and teachers), whilst the 
control group would neither follow the RED nor the VIP treatment, but would 
receive treatment as usual only. 
Unfortunately, in spite of all efforts to find a university to support and a sponsor 
to fund this study, I did not succeed. Daring to think outside the box makes one 
vulnerable and my research proposal was ridiculed and dismissed, many times. 
There was nothing else for it but to try a different approach. I decided to start all 
over again and write a new proposal as though no RED research ever had been 
conducted. Now I found a professor (thank you, Jan), we found a sponsor (thank 
you. Stichting Kinderpostzegels Nederland) and the results of this study are 
described in chapter 2. 
The reader may have noticed the time span between the first (2002) and the 
second study (2009), which is attributable to several factors; 1) fund raising of the 
second study took some time; 2) recruitment of subjects proved difficult: parents 
willing to participate were often discouraged to do so by GP, psychologist or 
psychiatrist; and 3) editors' and reviewers' unfamiliarity with the subject. Most 
editors dismissed the manuscript by return of post, and even when it survived the 
editor's scrutiny, the reviewers dealt summarily with it. One reviewer motivated his 
rejection as follows: "..., this means that 83.3% of the children responded to 
dietary intervention!" Apparently this reviewer was shocked by the results, which 
may be understandable considering the subject, but rejecting a paper based on 
the surprising results is not quite a scientific attitude. 
While the above mentioned manuscript was sent from one journal to the other, 
I wrote a hypothesis paper (see chapter 5), I wrote the protocol for the INCA study, 
I tried to raise the funds necessary to start the INCA study, and I stubbornly went 
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on studying. I was especially interested in fish oil. Could it be true that a simple 
capsule a day would keep ADHD away? I was very keen to find out, because if it 
were true it would be a much more convenient and easier therapy than an RED. I 
contacted companies manufacturing fish oil and presented a research proposal 
to compare the effects of an RED with the effects of fish oil. Surprisingly, none of 
them were interested, and one of the companies politely explained the rejection 
as follows; "We will not cooperate in this study because the risks for negative 
results with respect to the effectiveness of the supplements are substantial". My 
further study into this subject showed that the anxiety reflected by the polite 
company was appropriate, indeed. In chapter 1.7 and chapter 9.6 the negative 
results of recent studies investigating the effect of fish oil on ADHD are discussed. 
Studying fish oil (omega-3 fatty acid) also means studying sunflower oil 
(omega-6 fatty acid), and I read a lot about the differences between omega-3 and 
omega-6 fatty acids. Not only do they differ in biochemical structure, they also 
differ in function (omega-3 inhibiting inflammation, omega-6 promoting 
inflammation). The most striking distinction, though, is the at least tenfold 
increased omega-6/omega-3 ratio in our food during the last 50 years. Given that 
omega-6 and omega-3 compete for the same enzymes it seems rather useless 
to supply omega-3 without a concurrent drastic decrease of omega-6. There is 
evidence that the huge increase of omega-6 fats in our food may be causal of the 
Western world's lifestyle diseases characterised by an increase of inflammation, 
like type 2 diabetes and obesity (see chapter 9.6). I am convinced that it would be 
worthwhile to investigate whether a major decrease of omega-6 in our food might 
result in an equally major decrease of our chronic Western diseases, and I 
earnestly stand wondering why scientists continue to focus on less saturated fats 
and more unsaturated fats (omega-6 and omega-3), while simultaneously lifestyle 
diseases unabatedly increase. 
I would have loved to study this subject more comprehensively, but my fatty 
acid adventures were interrupted by a sudden rapid development of the ADHD 
research. The protocol of the INCA study was accepted by The Lancet (see 
appendix), the manuscript that had travelled from one editor to another for more 
than 3 years was finally accepted for publication (see chapter 3), and the 
long-lasting fund-raising campaign to raise money for the INCA study ended with 
a passionate plea broadcasted by EenVandaag, a Dutch television station, after 
which a maecenas generously donated the money needed to start. 
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And here we are now. The INCA study has been published in The Lancet (see 
chapter 6), which of course may be considered the crowning glory of this thesis. 
Still, there it is, in my drawer, the protocol of the VIP study. Unabated a highly 
topical subject, and I would love to conduct this implementation study as well as 
the other RED-ADHD studies I have in mind (see chapter 9.6). It is evident that 
many children may benefit from our findings, as you may read in chapter 9.7, 
describing the pros and cons of both treatment-as-usual and RED treatment. It 
would be truly sad if it took another fifteen years before follow-up research like the 
VIP study might be realised. I sincerely hope that this thesis may lead to an RED-
ADHD Research Centre and may instigate a paradigm shift necessary to improve 
child psychiatric health care (whether that be an RED or, if necessary, medication 
and psychological interventions or any combination of these), thus offering our 
children suffering from ADHD the ultimate chance of a more favourable future. 
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Net zoals een topscorende spits zijn doelpunten niet kan maken zonder de 
andere spelers van zijn team, zo kan een wetenschapper geen onderzoek doen 
en zeker geen proefschrift schrijven zonder de hulp van haar omgeving. Daarbij 
zijn niet alleen de medespelers belangrijk, maar ook de coaches, scheidsrechters, 
sponsoren, verzorgers en supporters. Elk zijn zij op hun eigen wijze onmisbaar 
om uiteindelijk te komen tot die ene goal, in dit geval tot dit ene proefschrift. 
Belangrijke spelers waren allereerst de ouders en kinderen die deelnamen 
aan de onderzoeken. Aan een half woord hadden zij genoeg om hun onbaat-
zuchtige medewerking te verlenen aan vele activiteiten, zoals rondetafelgesprekken 
in de tweede kamer, interviews in kranten en tijdschriften, of optredens voor radio 
en tv. Zonder hen was er hoogst waarschijnlijk geen subsidie geweest voor de 
INCA-studie en was ook dit proefschrift er niet geweest. Daarom wil ik al deze 
ouders, hun kinderen en ook de leerkrachten heel hartelijk bedanken. 
Twee andere spelers die een zeer grote rol hebben gespeeld, vanaf de eerste 
kiem van dit proefschrift in 1993 tot nu toe, wil ik in het bijzonder noemen: Jan C. 
Karman en Marjan de Boer. Jan, ik weet niet of ik zonder jouw niet aflatende steun 
dit onderzoek ooit van de grond had gekregen, en zonder de altijd weer 
bemoedigende woorden van Marjan had ik het denk ik niet volgehouden. De 
tegenslagen waren talrijk en meerdere malen hebben jullie mij ervan moeten 
overtuigen dat ik toch echt door moest zetten en dat ik al die kinderen niet in de 
steek kon laten. Dank jullie wel! 
Geen proefschrift zonder coaches: mijn promotoren prof.dr. J.K. Buitelaar en 
prof.dr. H.F. Savelkoul, mijn copromotor dr. N.N. Lambregts-Rommelse, en mijn 
statisticus dr. K. Frankena. Beste Jan, als je destijds niet akkoord was gegaan 
met mijn voorstel om samen subsidie aan te vragen voor onderzoek naar ADHD 
en voeding, dan had ik nu nog in je kamer in Utrecht gezeten, vrees ik, zo 
vastbesloten was ik om me niet weer te laten afschepen. Ik ben je heel dankbaar 
dat je het hebt aangedurfd om je nek uit te steken voor dit onderwerp, dat destijds 
zeer controversieel was. Zonder jouw steun en medewerking had het onderzoek 
naar de invloed van voeding op ADHD niet zo'n vlucht kunnen nemen. Dank je 
wel voor je vertrouwen! Huub, je speelde een belangrijke rol bij het tot stand 
komen van de INCA-studie en ik heb veel geleerd van al je kennis op het gebied 
van de allergologie. Er is op dit gebied nog een wereld te ontdekken. Nanda, ik 
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had me geen betere copromotor kunnen wensen. Ik ben zeer onder de indruk van 
al je kennis en inzicht en ik heb zeer veel van je geleerd, niet alleen qua tact, 
hetgeen niet mijn sterkste punt is, maar ook wat betreft het schrijven van artikelen. 
Het was een voorrecht om met jou te mogen samenwerken. Ik hoop dan ook dat 
we hierna, op wat voor manier dan ook, ons samen verder kunnen verdiepen in 
dit uitdagende en boeiende onderwerp. Klaas, je nuchtere kijk op het leven en de 
wetenschap, je statistische kennis, je humor, het was werkelijk geweldig om met 
jou te mogen samenwerken. Al mijn vragen werden per kerende mail beantwoord, 
en grafieken en tabellen werden met eindeloos geduld steeds opnieuw ontworpen 
als ik het weer eens anders wilde hebben. Dank je wel! 
Zonder scheidsrechters geen voetbalwedstrijd, maar ook geen promotie: ik 
wil dan ook de leden van de promotiecommissie, prof.dr. R. de Groot, prof.dr. E. 
Taylor, prof.dr. J.J. van Binsbergen, prof.dr. R.J. van der Gaag, prof.dr. M. 
Danckaerts, dr. H de Groot, prof. dr. G.J. van der Wilt en dr. A.P.J. Scheres heel 
hartelijk bedanken voor hun bereidwilligheid om het proefschrift kritisch te lezen 
en om te opponeren. Dear professor Taylor; thank you so much for participating 
in this PhD committee, I feel truly honoured that you came to the Netherlands for 
this occasion. 
Zoals voetbalclubs niet alleen sponsoren maar vaak ook een maecenas 
hebben, zo prijst dit onderzoek zich eveneens gelukkig met een maecenas 
zonder wie de INCA-studie niet gerealiseerd had kunnen worden, simpelweg 
omdat na jaren van lobbyen de benodigde gelden nog steeds niet bijeen waren. 
Na een tv-uitzending van EenVandaag op 1 april 2008, waarin ik een wanhopige 
en laatste poging deed om de INCA-studie gefinancierd te krijgen, kreeg ik een 
telefoontje waar ik nu nog stil van ben. Ik wil vanuit de grond van mijn hart, mede 
namens alle gezinnen die hierdoor de kans kregen om deel te nemen aan dit 
onderzoek, de maecenas die zo genereus de ontbrekende gelden doneerde heel 
hartelijk danken. De Stichting Kind en Gedrag, met Camilla Waelen als drijvende 
kracht en enthousiast voorzitter, verdient eveneens een apart woord van dank. De 
betrokkenheid van de Stichting, die zich niet alleen zorgen maakte over financie-
ringsproblemen maar ook over mijn gezondheid, was van onschatbare waarde. 
Ook alle andere subsidiegevers ben ik heel dankbaar voor hun belangeloze 
betrokkenheid en inzet. 
De verzorgers, dat zijn natuurlijk de paranimfen dr. N. de Jonge en drs. C.J. 
Brink. Nicolaas en Carla, ik ben er trots op dat jullie mijn paranimfen zijn. Nicolaas, 
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we hebben de afgelopen 35 jaar heel wat lief en leed gedeeld, met als dieptepunt 
het door mij gebouwde konijnenhok in jouw tuin en als hoogtepunt de gezamenlijke 
kampeervakanties met de kinderen. Ook kan ik me nog goed alle door jou gezette 
rode strepen herinneren in de eerste versie van mijn eerste onderzoeksvoorstel; 
er bleef geen spaan van heel. Diep beledigd was ik, maar wat had je gelijk en wat 
heb ik ervan geleerd. Carla, dierenarts in hart en nieren, vriendin sinds onze 
studietijd en door de jaren heen, kritisch volger van het zijpad dat ik ben 
ingeslagen, denker en doener, altijd druk, maar ook altijd aanwezig op de 
momenten dat het nodig was. Er is absoluut een wetenschapper aan je verloren 
gegaan. 
Supporters, mijn vrienden en familie, ik wil jullie allemaal heel erg bedanken 
voor alle steun en begrip voor zowel mijn vaak letterlijke, als helaas soms ook 
figuurlijke afwezigheid. Iedereen leefde mee, soms hoofdschuddend, maar altijd 
met engelengeduld als ik weer eens in een "denkdip" zat. Mijn grootste supporter, 
mijn moeder, "'t Leej", wil ik speciaal bedanken. Niemand die zo trouw al mijn 
avonturen volgde, meeleefde, krantenknipsels opstuurde en familie inseinde als 
er weer eens wat stond te gebeuren. 
Tot slot, een speciaal woord van dank voor drie jonge vrouwen die elk op hun 
eigen wijze een verpletterende indruk op mij hebben gemaakt en nog steeds 
maken, en die een zeer speciale plaats innemen in mijn leven. 
Susan, mijn geweldige pleegdochter, die nu zelf een fantastische dochter 
heeft. Ik kan me nog goed herinneren hoe je als dertienjarige ineens deel 
uitmaakte van ons gezin, en ik heb heel veel geleerd van jouw doorzettingsver-
mogen en je moed. Zonder jou was er een proefschrift geweest met verkeerde 
paginanummers en een warboel aan kopteksten, want sommige geheimen van 
de computer heb ik nooit kunnen doorgronden. Dank je wel voor al je hulp! 
Anne, Merle, mijn dochters, mijn trots! Meer kan een moeder zich niet wensen. 
Het moge duidelijk zijn; zonder jullie was dit onderzoek er met geweest. Met recht 
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de oorsprong van en de drijvende kracht achter mijn werk, en zijn daarin gegroeid 
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jullie enthousiasme is voor mij een grote steun en inspiratiebron. Mijn dank en 
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Abbreviations 
Abbreviations 
ACS 
ADHD 
ADHD-NOS 
ARS 
C-ADHD 
CD 
DBPC 
DBPCFC 
DSM-IV 
ES 
FC 
FES 
FI-ADHD 
FRI 
FSI 
igE 
IgG 
INCA 
ISRCTN 
MCDD 
NICE 
ODD 
OR 
PCO 
PDD 
PDD-NOS 
RCT 
RED 
SD 
SDQ 
SPI 
Abbreviated Conners scale 
Attention-Deficit/Hyperactivity Disorder 
ADHD not otherwise specified 
ADHD rating scale 
Classic ADHD 
Conduct Disorder 
Double-blind placebo controlled 
Double-blind placebo controlled food challenge 
Diagnostic and Statistical Manual of Mental Disorders, fourth edition 
Effect size 
Food challenge 
Family environment scale 
Food-Induced ADHD 
Family relationships index 
Family structure index 
Immunoglobulin type E 
Immunoglobulin type G 
Impact of Nutrition on Children with ADHD 
International standard randomised controlled trial number 
Multiple Complex Developmental Disorder 
National Institute for Health and Clinical Excellence 
Oppositional Defiant Disorder 
Odds ratio 
Physical complaints questionnaire 
Pervasive Developmental Disorder 
PDD not otherwise specified 
Randomised controlled trial 
Restricted elimination diet 
Standard deviation 
Strengths and difficulties questionnaire 
Structured child psychiatric interview 
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Propositions / Stellingen 
Accompanying the thesis 
ADHD, a Food-Induced Hypersensitivity Syndrome: 
in Quest of a Cause 
The effects of a restricted elimination diet (RED) on ADHD, ODD and comorbid 
somatic complaints, and a preliminary survey of the mechanisms of an RED 
1. ADHD is not caused by colourings or sugar (this thesis). 
2. An important cause of ADHD and ODD in children is a hypersensitivity to everyday 
foods (this thesis). 
3. 60% of young children with ADHD show normal behaviour following a restricted 
elimination diet (RED), consequently it is advised to implement RED research in 
children with ADHD (this thesis). 
4. The positive results of an RED are not due to family structure improvements during 
the RED (this thesis). 
5. A change of food may metamorphose the larva of a honey bee into a queen bee, 
just like a change of food may turn a child with ADHD into a child with normal 
behaviour. 
6. Scientists may be considered contemporary explorers, who fortunately do not 
have to leave their chair to make important discoveries. 
7. Parents are always right until evidence to the contrary has been provided. 
8. Scientific manuscripts submitted to a journal might be judged completely different 
if not reviewers but authors were anonymous. 
9. A politician who does not want others to cross the border literally, should himself 
not cross the border of others figuratively. 
10. Scientific truth is not defined by facts and figures, but by the coherence of new 
findings with current views. 
11. Anyone who is refractory to innovative ideas or unexpected scientific results is not 
suited for science. 
12. The drastic replacement of saturated by unsaturated fats in our food has, despite 
promising advertisements and consensus of scientists, not led to a decrease of 
coronary heart disease, consequently the hypothesis "the more saturated fat the 
less Western health diseases" is worth investigating. 
13. Obesity may not predominantly be caused by eating too much or exercising too 
little, but by the.drastic increase of unsaturated omega-6 fatty acids in our foods. 
Lidy M.J. Pelsser, Nijmegen, 10 October 2011 
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Stellingen 
1. ADHD wordt niet veroorzaakt door suiker of kleurstoffen (dit proefschrift). 
2. Een belangrijke oorzaak van ADHD en ODD bij kinderen Is een overgevoeligheid 
voor gewone voeding (dit proefschrift). 
3. Gezien het feit dat 60% van de jonge kinderen met ADHD na het volgen van een 
restricted elimination diet (RED) normaal gedrag vertoont, verdient het aanbeveling 
om RED-onderzoek standaard toe te passen bij kinderen met ADHD (dit 
proefschrift). 
4. De positieve gevolgen van een RED zijn niet te wijten aan verbetering van de 
gezinsstructuur tijdens het RED (dit proefschrift). 
5. Zoals door aanpassing van de voeding een bijenlarve tot koningin kan worden, zo 
kan door aanpassing van de voeding een kind met ADHD veranderen in een 
doorsnee kind. 
6. Wetenschappers kunnen beschouwd worden als hedendaagse ontdekkings-
reizigers, met als grote voordeel dat ze hun stoel niet hoeven te verlaten om 
belangrijke ontdekkingen te doen, 
7. Ouders hebben altijd gelijk tot het tegendeel bewezen Is. 
8. De aanduiding onderzoekster/wetenschapster voor een onderzoeker/wetenschapper 
van het vrouwelijk geslacht mag uitsluitend gehanteerd worden wanneer de nadruk 
ligt op de laatste lettergreep. 
9. Als niet de reviewers maar de auteurs anoniem zouden zijn, zou dit lelden tot een 
totaal andere beoordeling van wetenschappelijke artikelen. 
10. Een politicus die niet wil dat anderen letterlijk zijn grens over gaan, moet zelf niet 
figuurlijk over andermans grenzen gaan. 
11. De waarheid In de wetenschap wordt niet bepaald door de feiten, maar door de 
mate van coherentie van nieuwe bevindingen met bestaande opvattingen. 
12. Als spreken zilver Is en zwijgen goud, dan Is bespreekbaar maken wat verzwegen 
wordt briljant. 
13. Wie niet van standpunt kan veranderen en niet open staat voor Innovatieve ideeën 
of onverwachte onderzoeksresultaten. Is ongeschikt voor de wetenschap. 
14. Drastische vervanging van verzadigd vet door onverzadigd vet in onze voeding 
heeft niet geleld tot een afname van hart- en vaatziektes, daarom Is de hypothese 
"hoe meer verzadigd vet, hoe minder welvaartsziektes" zeker het onderzoeken 
waard en kan wellicht lelden tot een nieuwe slogan: "verzadigd vet, goed voor 
hart en bloedvaten". 
15. De voornaamste oorzaak van obesltas Is niet te weinig bewegen of te veel eten, 
maar de drastische toename van onverzadigde omega-6-vetzuren In onze voeding. 
Lldy M.J. Pelsser, Nijmegen, 10 October 2011 


